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Abstract
Background
Antenatal care can contribute towards promoting the public health aims of the European Union 
(EU) and provides a catalyst that enables the process of growing together as a community of 
nations. Moreover, patient mobility and its implications for patient safety become increasingly 
important throughout the EU. Differences in the approaches to antenatal care need to be 
known in order to avoid duplications or gaps in care for women seeking care in a country other 
than their home country.
Aims
The overall aim of this study was to make cross-border antenatal care safer and to contribute 
to the evidence base to enable the best possible starting conditions for the Community’s future 
citizens. To meet this aim, the best available sources on antenatal care within all member 
states were critically analysed, examining evidence-based and expert recommendations. The 
theoretical background for making decisions on antenatal care was developed.
Moreover, a comprehensive review of the content of national guidelines on antenatal care was 
required to find out whether a common minimum guideline would be beneficial, and what this 
guideline might contain. A model was needed to be developed for integrating existing 
guidelines to a common minimum guideline to complement national health policies.
Study design
The study used a mixed methods approach, which consisted of a survey conducted across the 
EU and an extensive critical review of the state of the art regarding guidelines and antenatal 
care. In addition, a critical in-depth appraisal of the national guidelines from England and 
Wales and Germany was conducted, using the instrument of the AGREE collaboration for the 
appraisal of guidelines for research & evaluation as well as a critical comparison of the 
individual recommendations of the two national guidelines.
In the survey, the Ministries of Health and equivalent bodies, as well as the societies of 
obstetricians and midwives were asked to complete a structured questionnaire on the content 
of national guidelines for antenatal care. Descriptive analyses identified which and how many 
states recommend a test and to how many people this applied. The tests which were 
recommended by more than 50% of the states and applied to more than 50% of the 
inhabitants of the EU were compared to the measures supported by scientific evidence. Finally 
the correlation between the Gross National Product (GNP) of a state and the number of tests 
recommended was investigated.
Results
After sending 155 questionnaires and 61 reminders via surface and e-mail, as well as 
distributing another three questionnaires at a conference, answers were obtained from all 25 
member states. 20 of them have a national guideline. A total of 47 tests were reported.
From the review of the literature and other sources, a model for decision-making based on 
double majorities, i.e. recommended by more than 50% of member states and applying to 
more than 50% of the Union’s inhabitants, was derived. The in-depth appraisal of the two 
national guidelines and the subsequent comparison of their recommendations gave evidence 
that the recommendations made by national guidelines can have high quality, irrespective of 
what an assessment with a tool to assess guideline quality suggests. Despite their similarly 
good recommendations, areas to improve the credibility of the guidelines from England and 
Wales and Germany were identified. Moreover, also weaknesses of the AGREE-instrument 
were identified, followed by suggestions for alleviating them.
Using the model of double majorities on the findings from the survey, it was found that 23 of 
the reported tests were recommended for routine care by more than 50% of the countries and 
apply to more than 50% of inhabitants. All but four of these tests were also supported by 
scientific evidence, which supported the validity of this model for integrating national guidelines
to a common minimum guideline on antenatal care. States with a GNP below EU-average 
recommend more tests than the others.
Conclusion
This study presents in detail what the national guidelines of the member states of the EU 
recommend for antenatal care and how they relate to current scientific evidence. As the 
findings from the survey were seen as important for enhancing safety in cross-border antenatal 
care, they were published during the course of the study (Bernloehr et al 2005; 2007).
In addition, the findings from the study demonstrate for the first time that extracting the 
measures from national guidelines that are recommended by the majority of states and apply 
to the majority of inhabitants of the EU leads to the development of a guideline compatible with 
scientific evidence. On the basis of all parts of the study, a common minimum guideline for 
antenatal care in the EU was established and recommended as it was found that such a 
guideline is useful and possible under the legislation of the EU.
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XGlossary of terms
Alpha-fetoproteine
Cardio-tocography
Chlamydia trachomatis 
Cytomegalovirus 
Foetal fibronectin
Fundal height
Gestational diabetes
Gestational week
Glucose tolerance test
Gonorrhoea
Group B streptococci 
Haemoglobinopathy 
Hepatitis B
HIV
Listeria monocytogenes 
Lues
Multigravida 
Papanicolaou smear 
Pelvimetry 
Pre-eclampsia
Primigravida 
Puerperium 
Rubella 
Toxoplasmosis 
Triple test
a protein produced in the foetus, which can be used as a 
marker for Down’s Syndrome
a record of the foetal heartbeat and the uterine 
contractions
coccoid rickettsia causing venereal infections 
a Herpes virus
a glycoprotein, which can indicate an increased risk for 
preterm birth
the distance between the highest part of the uterus and 
the symphysis pubis, the umbilicus, or the rib
maternal carbohydrate intolerance diagnosed during 
pregnancy, which results in hyperglycaemia
week of pregnancy after the first day of the last menstrual 
period
blood tests of glucose levels after controlled oral intake of 
glucose
a venereal disease, caused by the bacterium Neisseria 
gonorrhoeae
Streptococcus agalactiae
a blood disease characterized by abnormal haemoglobins
a viral hepatitis, transmitted by ingestion of contaminated 
bodily fluids
Human Immunodeficiency Virus, the virus causing the 
acquired immune deficiency syndrome (AIDS)
a Gram positive bacterium, causing Listeriosis
a venereal infection caused by Treponema pallidum 
spirochete, which can be transmitted through the placenta
a woman who is pregnant for at least the second time
cervical cytology to test for malignant cells
measurement of the bony pelvis
a multisystem disorder, with the leading symptoms of new 
hypertension and proteinuria manifesting after 20 weeks 
of gestation
a woman who is pregnant for the first time
the period from childbirth to about six weeks post partum
a viral disease, potentially damaging to the foetus
an infection with the parasite Toxoplasma gondii
the assessment of three serological markers to estimate 
the risk for Down’s Syndrome
Chapter 1 - Introduction to the study
1.1 Background
First and foremost, practical experience as the midwife in charge of the labour ward in a major 
hospital in Western Germany triggered the study. Each year about 1700 deliveries take place 
there. About 140 children are born to British women, most of them accompanying their 
husbands who are based in Germany with the British Army. Some of the women start 
antenatal care in the UK, some of them in Germany. Those starting in Germany are cared for 
according to a scheme, which was agreed between the hospital and the medical centre of the 
British Forces Germany. Although care is now well established and shared between the 
hospital, the British midwives and the medical centre, it took several years before this system 
was operating to the satisfaction of all parties. In the early years of co-operation, several tests 
were performed on admission to the labour ward instead of being performed at specific times 
during pregnancy. This was because these measures were part of the German guidelines on 
antenatal care (Bundesausschuss der Arzte und Krankenkassen 2003), but were not within the 
protocol used by British health professionals, or were scheduled at different times during 
pregnancy (National Collaborating Centre for Women’s and Children’s Health 2003).
Although many of these differences were resolved after several years of co-operation, other 
specific traits remained. As an example, at the British medical centre, blood for hepatitis B 
screening is taken at the first antenatal appointment, as it is recommended in the guideline for 
England and Wales (National Collaborating Centre for Women’s and Children’s Health 2003: 
35). On admission to the German hospital, this test is repeated, as it is specified in the German 
guidelines that the screening should take place after the 32nd gestational week 
(Bundesausschuss der Arzte und Krankenkassen 2003). Due to a lack of communication 
between the two parties, such issues initially led to dissatisfaction amongst the British and the 
German health professionals, as each of the parties felt mistrusted by their colleagues. 
Moreover, both parties perceived the different courses of action as non-adherence to the
guideline, rather than realising that ‘the guideline’ was in fact two similar guidelines, but with 
sufficient differences as to cause misunderstandings. These misunderstandings amongst the 
health professionals also led to mistrust and dissatisfaction in the pregnant women, although 
clinical outcomes did not differ with regard to maternal and infant morbidity or mortality.
Although the degree of feeling ‘not well cared for’ and the feeling of insecurity were never 
assessed formally, the problem was evident from complaints to the management of the 
German hospital, as well as to the medical centre of the British Forces. In the first years of co­
operation, frequent meetings of the professionals had to be held. Within these, the 
dissatisfaction of carers from both sides as well as the perceived dissatisfaction of the women 
was the most important issues on the agenda. Another sign for feeling insecure was that the 
British women asked the midwives of the British Forces to accompany them to the labour 
ward, although the British midwives were not allowed to practice in the setting. They were 
brought into the situation as advocates. Only after assessing the differences of the two 
guidelines in depth and after setting up instructions of how to manage the differences, the 
British women stopped bringing their midwives to the German labour ward. Also the complaints 
arising from discrepancies between the two systems diminished. As there is a constant 
turnover of British soldiers and their wives, as well as a regular turnover of British staff, this 
effect can not be ascribed to a mechanism of simply getting used to the German system. 
However, the situation was and is still worse when the women started antenatal care within the 
UK and changed countries during pregnancy. Due to the differences in the national guidelines, 
which are not known to the average practitioner, such patients still cause distress amongst the 
health professionals and leave the pregnant women feeling insecure. The fact that cross- 
border health care has implications, which need to be assessed, is also evident from activities 
of the European Commission. This is demonstrated in the following section.
1.1.1 Free movement of persons, services, capital and goods
One of the major challenges of the European integration process is the right of free movement 
of persons, services, capital and goods (Paton et al. 2002: 4). On April 28th 2001, the 
European Court of Justice has ruled that patients are allowed to seek ambulatory medical 
treatment in other EU countries. Since then, national institutions as well as health insurance 
companies are obliged to pay for this extra-territorial ambulatory treatment (Busse 2002: 240, 
Wismar et al. 2002: 23). In May 2003, the European Court of Justice again simplified the 
mechanisms for this off-territorial treatment. From then on, patients do not even need to inform 
their health insurances before seeking routine treatment in a country other than their home 
country (Deutsches Arzteblatt 2003). Latest case-law of the European Court indicates that this 
right has been extended to hospital care (Commission of the European Communities 2004, 
The European Commission’s Health and Consumer Protection Directorate General 2006).
However, the resulting situation was well described by the former Commissioner for Health 
and Consumer Protection, David Byrne. He stated that according to EU law, patients have the 
right to go for treatment in other member sates, but that this is not easy in practice. His speech 
at a conference on free movement and cross-border co-operation in Europe, held on 20 June 
2003 in Luxembourg, highlights the need for transparency (Byrne 2003). In this, Byrne claimed 
that in order to being able to access health care in another member state information is 
required about the quality, availability and appropriateness of the treatments available there.
At present, there are not yet numbers available, as to how many people seek medical 
treatment in a country other than the one from which they originate (Commission of the 
European Communities 2004). In addition, it is difficult to estimate, how many women change 
country completely during pregnancy, or immediately before becoming pregnant. Moreover, an 
increasing number of people are just seeking medical treatment in another member state, but 
not changing countries totally. The European Commission acknowledged this problem by 
starting a series of meetings and publications for a “high level reflection process on patient 
mobility”, which was launched by two Commissioners in December 2003 (Commission of the
European Communities 2004, European Commission (n.d.) a, b + f, South East Partners
2003). At present, the minutes of an important meeting are available, which has taken place on 
November 21 2003 in Luxembourg (Fahy 2003). More detailed data were announced for 2004, 
but were not included in the follow-up document of this high level reflection process 
(Commission of the European Communities 2004). Instead, the European Commission 
recently adopted a policy to not only tolerate cross-border health care, but to actively support it 
(Commission of the European Communities 2005, Kyprianou 2005a). Cross-border care and 
an increased co-operation at European level are now regarded as a means to improve the 
quality and accessibility of health care by sharing information and spare capacity.
Although classified as urgent, no clarification as to how to apply the rulings of the Court of 
Justice to health services is available to date (European Communities 2006). For this, the 
European Commission launched in September 2006 a public consultation regarding EU action 
on health services, with which comments on how to ensure legal certainty regarding cross- 
border health care under Community law is sought, and on how to support co-operation 
between the health systems of the member states (The European Commission 2006).
Flowever, the need for transparency and information is not only evident for patients, but also 
for health professionals wanting to practise in another member state. The practical experience 
at the German hospital only reinforced the insights gained as a postgraduate student in the 
UK. In this course, midwives from across the EU studied together. Especially the non-UK 
midwives reported difficulties in familiarising with a system, in which they were not trained. This 
is of special interest, as the European Court of Justice argued that cross-border care does not 
pose a threat to human health, as a similar standard of health care can be expected in all 
member states of the European Union (Wismar et al. 2002: 25). This opinion was based on the 
assumption that the mutual recognition of diplomas and established minimum training 
requirements for health care personnel go some way to guarantee this similar standard. 
However, the practical experience from the German hospital as well as the discussions 
amongst the midwives from across the EU gave rise to major concerns with regard to this 
statement. On the one hand, there are sufficient differences in the national guidelines to
produce gaps or an unnecessary, expensive and possibly harmful multiplication of tests for 
pregnant women. On the other hand, it was found that health care workers practising in a 
country other than that in which they were trained need clear guidelines to integrate 
themselves fully and safely. A major problem in this respect was a perception that it was nearly 
impossible to gain an overview of what was the current state of the art in the other EU states. 
This was reinforced by a policy update on public health, in which the Health Ministers of the 
member states, representatives of Europe’s health care sector, the European Parliament and 
the European Commission recommend activities to meet the information requirements of 
patients, professionals and policy-makers (South East Partners 2003).
From the above situation in the German hospital, which triggered the study, it was decided to 
use antenatal care as an example to explore the issues arising from cross-border health care 
in greater depth. This idea was reinforced by the statement of the Council of Europe, that 
antenatal care is a classic example for health problems, which are treated similarly across the 
EU regarding its organisation and content (Europarat 2001: 25). However, whilst on the one 
hand it needs to be demonstrated in detail, whether the organisation of care is similar, on the 
other, it needs to be specified, what the similar content of antenatal care is. It was therefore 
expected that antenatal care offers an excellent field for analysis on the European level. 
Moreover, it was also found that antenatal care is one of the most commonly used preventive 
measures and has therefore public health implications on a broad basis (Europarat 2001: 24ff). 
As a consequence, antenatal care has also the potential to be a rewarding field to study. After 
some initial reading on the subject, it was found that with two or three exceptions at least the 
member states of before May 2004 have some kind of guideline for antenatal care (Blondel et 
al. 1985). However, a study including 13 European countries also found that there are 13 
different organisational systems for providing antenatal care (Hemminki & Blondel 2001). Both 
findings demonstrate that it was justified to expect to find sufficient material for study.
However, already the broad reading on antenatal care in the context of the EU stimulated the 
thought that it is worth exploring the potential for a common minimum guideline. This 
essentially means to address the basic conflict between independence and unification in the
member states of the EU. However, providing information about the existing guidelines for 
antenatal care in normal pregnancies is only a first step to ensuring safety in cross-border 
health care. A common guideline on antenatal care in the EU might help to highlight areas of 
good practice, as well as to identify areas for potential improvement. As EU health policy 
provides the basis and framework for a potential common minimum guideline, the 
cornerstones of the current health policy in the EU needed clarification. This is explored in a 
separate section of the thesis. At this stage, the implications of crossing borders are addressed 
as they provide a clearer picture of the background situation in the European Union.
1.1.2 Implications of crossing borders
From the obligation to pay for medical services outside the home country of the patient, 
several problems arise. Even within themselves, the member states’ health care systems are 
subject to conflicting pressures. From practitioners, managers, politicians as well as from the 
public, there is a rising demand for optimum, effective, efficient, evidence-based and affordable 
care, with different weighting of these factors, according to the perspective taken (Byrne 2004, 
Commission of the European Communities 2004, Harrison et al. 2002c). On the one hand, the 
proportion of the gross domestic product devoted to health care spending has doubled over 
the last three decades and is rising steadily. This development was found to be mainly due to 
demographic factors, the cost of new medical technologies and citizens' increased 
expectations from health care (Commission of the European Communities 1998). On the other 
hand, although the member states of the EU all have a high standard of living and have 
invested a lot into their more or less well developed health systems, they are still confronted 
with high expectations from the public, and finally, they have limited resources to meet these 
needs and expectations (European Health Management Association 2000).
Even within the member states themselves, the health systems face an explosion of costs. By 
setting up practice guidelines that consider the quality of care as well as the cost-effectiveness 
of measures, the national key stakeholders try to limit expenses. The stakeholders try to
achieve a rationalisation of care in order to avoid the rationing of care to special patient groups 
(Guntert 1998 + 1999). However, the rational allocation of resources becomes a nearly 
insurmountable task when the former restrictions to patient mobility are abolished, as the 
former limits to mobility helped the effective planning as well as the control of costs (The 
European Commission (n.d.) c). As this barrier falls, a new strategy needs to be developed.
However, before the financial implications of cross-border health care are assessed, another 
fundamental prior condition must be fulfilled. A similar standard of health care must be 
achieved within the member states in order to avoid gaps or an unnecessary, expensive and 
possibly harmful duplication of care. With regard to this quality aspect, the European Court of 
Justice argued that cross-border care does not pose a threat to human health, as a similar 
standard of health care can be expected in all member states of the EU (Wismar et al. 2002: 
25). However, as discussed before, this was based on the assumption that the mutual 
recognition of diplomas and established minimum training requirements for health care 
personnel go some way to guarantee this similar standard. This means that health care 
workers are allowed to practice in all member states, given that certain training criteria are 
fulfilled. However, health professionals practising in a country other than that in which they 
were trained need guidelines to integrate themselves safely into the respective national 
practice. Another problem of this general assumption is that it was made before ten new 
member states joined the Union in May 2004. It is possible that the former members have 
achieved similar standards over the years, but that this assimilation process starts just now in 
the new member states. However, it might also be that the picture is less homogenous even 
for the member states which joined the EU earlier.
In order to support or refute this rather general assumption of the European Court of Justice, it 
seems to be important to explore the actual basis and content of care in the member states. It 
might not be the case that a similar standard of health care can be expected on the basis of 
mutually recognised professional training. Philippe Busquin, the European Commissioner for 
Research stated that there is a need for a coherent, policy-oriented research effort at the EU 
level in the field of public health (Busquin 2002: v). The European Commission recommends
bringing together information about how certain issues are addressed in the member states. 
Moreover, common elements across the EU should be identified (The European Commission
2004). It demands a European strategy to ensure that citizens can seek care in other member 
states, and a European co-operation that helps to meet the challenges, the health systems 
face. The improvement of information and knowledge about health systems in order to enable 
the identification of best practice is highlighted.
Bringing the issues of costs and quality of care together, another problem of allowing or even 
stimulating cross-border health care becomes evident. Cross-border care and an increased co­
operation at European level are now regarded as a means for improving on quality, as well as 
accessibility of health care by sharing information and spare capacity. However, as a by­
product, this consumer-driven introduction of market forces changes the health systems. 
Although the member states still have the right to determine what health benefits their citizens 
are entitled to, and how this should be financed (Kyprianou 2005b), consumers now have the 
right and the chance to select the care they consider to be best. By consumers selecting what 
care they want to receive, member states might be forced to introduce measures which they 
do not think are beneficial, but which are offered by a neighbouring country.
When this mechanism works for a while, antenatal care will become very similar throughout 
the European Union, but will consist of measures which should not be offered to the whole 
population on a routine basis. In addition to that, care will not only become problematic with 
regard to its quality, but also more expensive. As these are serious issues, a counter-acting 
mechanism needs to be developed.
91.2 Aims and objectives
In this study, the best available sources with regard to antenatal care within all member states 
of the European Union will be critically analysed.
Aims of the study
The overall aim of the study is to make cross-border antenatal care safer by establishing the 
current state of the art within the EU, and to contribute to the evidence base for the best 
possible starting conditions for the Union’s future citizens.
Subsidiary aims
The subsidiary aim is to develop the theoretical understanding on antenatal care further, which 
may improve the acceptance of widely recommended methods throughout the EU, and to 
contribute to making policy-makers as well as practitioners aware of outdated and possibly 
harmful interventions. The distribution of limited resources will be optimised by highlighting 
interventions, which are proven to be effective.
The objectives are to
establish what guidelines on antenatal care exist in the different member states
examine the implications of different sorts of evidence on guideline development and clinical 
practice
develop the theoretical background for making health policy on antenatal care in the European 
Union
develop a model, which can be useful for making policy decisions in other disciplines in the 
health sector
recommend a common minimum guideline on antenatal care for the member states of the 
European Union, if this is appropriate.
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1.3 Study design
Phase 1
The objective of critically appraising the relation between evidence-based guidelines and 
guidelines based on expert opinion for the defined public health problem ‘antenatal care’ was 
tackled by analysing the paradigms underlying and the methods for setting up evidence-based 
guidelines and guidelines based on expert opinion. The critical discussion of the nature of 
evidence was part of this, highlighting differences and similarities between scientifically 
generated evidence and evidence referred to by experts.
A critical appraisal of the implications that different methods for setting up guidelines have on 
guideline quality was achieved by a critical in-depth assessment of the methodological quality 
of the guidelines from England and Wales (National Collaborating Centre for Women’s and 
Children’s Health 2003) and Germany (Bundesausschuss der Arzte und Krankenkassen 
2003), using the instrument developed by a group of experts funded by the European 
Commission (The AGREE Collaboration 2001).
Phase 2
In this phase of the study it was planned to find out, whether the basic principle for decision 
making on the basis of ‘double majorities’ (majority of states and majority of citizens) is suitable 
for making decisions in the health sector, when regulations based on different paradigms 
already exist. In order to test the hypothesis that a guideline based on ‘double majorities’ of all 
national guidelines on antenatal care in the EU contains the same recommendations as a 
guideline based on the principles of evidence-based medicine, the following steps were taken:
Developing a questionnaire and conducting a survey on the content of national guidelines on 
antenatal care in all member states of the EU.
Extracting all tests which are recommended by at least 50% of the member states and which 
apply to at least 50% of the inhabitants of the EU (double majorities).
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All measures recommended by double majorities were compared to the measures 
recommended by the most comprehensive evidence-based guideline on antenatal care to date 
(National Collaborating Centre for Women’s and Children’s Health 2003).
Phase 3
In order to develop a framework according to which the existing national guidelines on 
antenatal care could be used to efficiently set up a common minimum guideline, without 
compromising its quality, the horizon had to be broadened by exploring whether a common 
minimum guideline based on the findings of Phase 2 would mean insurmountable hardships 
for the less wealthy member states of the EU. For this, the number of measures currently 
recommended by the member states with a gross national product below average was 
compared to the number of measures recommended by the potential minimum standard based 
on the findings of Phase 2 of the study.
Phase 4
After critically reviewing and drawing together the findings of Phases 1 to 3 of the study, a 
common minimum guideline on antenatal care for the EU was provided. To achieve this, the 
potential strengths and weaknesses of such a guideline were critically analysed, and the 
guideline was located in the current health policy of the EU. On the basis of this, a new method 
for integrating national guidelines into a true European approach was suggested.
1.4 Summary of the chapters of the thesis
To delineate the research problem and to demonstrate how the problem is tackled, Chapter 1 
of the thesis provides the reasons for and the background information to the study. In addition, 
the aims and objectives are set out together with the study design. The chapter ends with this 
brief summary of what to expect from the following chapters of the thesis.
Chapter 2 is occupied with the initial review of the literature. The first review explores the 
current knowledge about guidelines on antenatal care in the EU. This includes a search for 
national guidelines, as well as for trials comparing different schedules of care.
In Chapter 3 on material and methodology it is argued that the concepts underlying guidelines 
need to be critically analysed before the research plan can be devised. Hence, in this chapter 
the critical analysis of the theoretical aspects of the thesis can be found. In order to 
demonstrate the rigour of the reviews, the selection and the use of the literature is described in 
detail along the development of the theoretical discourse. To ease the delineation of the 
underlying concepts, Chapter 3 is divided into three parts. Part 1 is focused on the theoretical 
basis of guidelines, while part 2 addresses health care and decision-making in the EU. Part 2 
ends with an analysis of the implications of the reviews for the study, before the detailed 
research plan is devised in the third part of this chapter.
Chapter 4 details the results of the survey, reporting the response rates and the sources of 
national guidelines as well as their actual content. Following this, the findings from the survey 
are compared to the current evidence-base. In the second part of Chapter 4, the results from 
the in-depth appraisal of the two national guidelines are presented.
After the detailed description of the results in the previous chapter, the findings of all phases of 
the study are discussed and synthesised in Chapter 5. Special care was taken to relate the 
findings to what was previously known and to demonstrate the implications of the study, while 
acknowledging its potential limitations. At the end of the chapter, it is demonstrated what new 
knowledge is gained from the study, and what might be researched in the future.
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Chapter 2 - Review of the literature
2.1 Introduction
To achieve the aims and objectives of the study, a broad review of the literature was 
necessary. The following chapter provides a systematic review of the literature on antenatal 
care in the EU, which lays the basis for the study. In particular, it was necessary to establish, 
what guidelines existed in the member states on antenatal care. Special care was taken to 
describe the databases and the methods used for the identification of relevant publications.
2.2 Selection and use of the literature
2.2.1 Antenatal care in the member states of the EU
It is the aim of this review to identify and synthesise the relevant evidence from the published 
literature in order to provide a detailed picture of the current recommendations for antenatal 
care in the countries of the EU. In order to describe the situation exactly, a systematic review 
of the literature was conducted. The operational definition of systematic review is the 
systematic and exhaustive search for published material according to predefined criteria, which 
are presented in detail within this chapter. It relates not to the systematic synthesis of the 
results of the identified material, resulting in a meta-analysis of the findings. The analysis and 
presentation of the review’s findings is critical and comparative, though descriptive, as it aims 
at providing a detailed picture of the situation. The search for relevant literature started with a 
search for national guidelines on antenatal care from the member states of the EU. 
Unfortunately, national guidelines seem to be published in a manner inaccessible to an 
international community. As a consequence, the search was extended to publications on the 
following:
- studies comparing antenatal care between the member states of the EU
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- national guidelines on antenatal care from the member states of the EU
- timing, number and scheduling of antenatal visits in the member states
- randomised controlled trials testing new models for antenatal care 
Databases
In order to demonstrate the detailed track record of how the literature was identified, all 
accessed databases are listed in Appendix 1 to the thesis. In that register, the databases can 
be found together with the abbreviations used in the text, as well as the source, which provided 
the gateway to the databases. To ease reading, in the following text only the names or the 
reference numbers of the databases are mentioned.
As basis for the literature review on antenatal care, the database Medical Literature On-Line 
[MEDLINE] was used (Appendix 1, Reference 11). MEDLINE was chosen as primary source, 
as it is the most commonly used source when searching for medical publications, including 
reproductive biology. With about 4,800 journals, it covers the widest range of national as well 
as international medical journals (National Library of Medicine 2005, Polit & Hungler 1999: 88). 
However, antenatal care is not only provided by obstetricians and other physicians, but also by 
midwives. Therefore, the specific databases “Midwives Information & Resource Service” 
[MIDIRS], and the “Cumulative Index to Nursing and Allied Health Literature” [CINAHL] were 
used to complement the searches (Appendix 1, References 12 + 6). The latter contains 
excerpts from more than 950 nursing journals, in which articles by and for midwives might also 
be published (Polit & Hungler 1999: 85).
Initially, the search was performed from 1993 to date, which marked the past decade at the 
time of searching, but it was subsequently enlarged to go as far back as to when the electronic 
databases were available. In particular very few studies were found, in which antenatal care 
between member states of the EU was compared. It was hoped to identify some additional 
studies on this specific topic by going further back in time in the literature. This was done in 
order to gain more information about the differences and similarities of antenatal care in the
member states, but also to get more information about the methods, which other authors used 
to compare care schemes. To detect any relevant material, MEDLINE was searched from 
1966 to date, the MIDIRS database was used in the most recent version, and CINAHL was 
searched from 1982 to present. As it was possible with that approach to pick up early and 
possibly outdated publications, it was decided that on the basis of those, comments could be 
made about the development of antenatal care in Europe. To prevent false conclusions, it is 
indicated that the current state of the art might be different, when old references are used.
A problem when searching for national guidelines is that they are not necessarily published in 
journals, which are included in international databases. However, if a national journal is of high 
profile, there is a high probability of it being referenced in MEDLINE, and that at least an 
English abstract is available. Nevertheless, even major guidelines published in the journals of 
the national professional bodies might not be covered by the aforementioned search strategy. 
Even worse is the situation, when national guidelines are issued by the government of a 
country, and are published in legal or administrative journals, rather than in medical ones. Due 
to this, the search for national guidelines on antenatal care from the member states of the EU 
was extended to other sources. First of all, the website of the International Confederation of 
Midwives was searched in order not to miss potential guidelines issued by professional 
organisations of midwives (Appendix 1, Reference 10). This international non-governmental 
organisation unites 85 national midwives’ associations from over 75 countries. In addition to 
that, the database of the World Health Organization on maternal and infant health was 
searched (Appendix 1, Reference 20). Unfortunately, this search did not bring up information 
about antenatal care in the individual member states of the EU. In order to gain at least access 
to the national guidelines from the two member states, which will be analysed in depth, the 
registers for evidence-based clinical guidelines of the German and the British medical societies 
and the societies of obstetricians were searched. Why these two guidelines were selected for 
the in-depth appraisal is explained in the chapter on material and methodology.
To cover guidelines from the UK, the guidelines section of the Royal College of Obstetricians 
and Gynaecologists’ homepage was searched (Appendix 1, Reference 16). Moreover, the
clinical guidelines section of the National Institute for Health and Clinical Excellence [NICE] 
was searched (Appendix 1, Reference 14). This was perceived as an important source, as 
NICE is the independent organisation responsible for providing national guidance on the 
promotion of good health and the prevention and treatment of ill health within the National 
Health Service for England and Wales. However, the NICE guidelines are usually developed 
under the auspices and with funding of the National Institute for Health and Clinical Excellence, 
but in one of seven National Collaborating Centres. These centres set up the guidelines 
commissioned by the Department of Health for England and the Welsh Assembly Government. 
The most relevant centre for this study is the National Collaborating Centre for Women’s and 
Children’s Health. However, the guidelines of this centre can also be accessed via the 
homepage of NICE (Appendix 1, Reference 14). In addition to the databases targeted at 
guidelines for England and Wales, for Scotland the guidelines section of the Scottish 
Intercollegiate Guidelines Network [SIGN] was used (Appendix 1, Reference 17). SIGN was 
established by the medical Royal Colleges to develop evidence-based national guidelines for 
National Health Service Scotland. It provides excellent information on guideline development 
and guideline quality, but does not issue a guideline on antenatal care.
For Germany, the guidelines database of the “Arztliches Zentrum fur Qualitat in der Medizin” 
[AZQ] was used, the central German institution for quality assurance in medicine (Appendix 1, 
Reference 1). The members of this institution are recruited from the German Medical 
Association and the National Association of Statutory Health Insurance Physicians. From this 
starting point on, the links to the German as well as the international databases on guidelines 
were followed. This was an efficient way, as under these internet addresses a search engine is 
operated, by which international guidelines can be located according to medical specialties 
and specific topics. No additional sources were accessed, as the investigator knew from her 
professional background that there is only one official guideline available from Germany.
For searching publications about the timing, number and scheduling of antenatal visits in the 
member states, as well as for randomised controlled trials testing new models for care, an 
additional source for locating literature was used. The databases for the additional searches
were the Cochrane Database of Systematic Reviews and the Database of Abstracts of 
Reviews of Effectiveness of the Cochrane Collaboration (Appendix 1, Reference 4). The 
Cochrane Collaboration is a well known source for rigorous up-to-date systematic reviews 
about the effects of health care interventions (The Cochrane Collaboration 2004). However, it 
is important to note that the systematic reviews of the Cochrane Collaboration select studies 
with a randomised controlled trial design only. The argument for this was that there is “general 
acceptance that this study design will lead to the most reliable estimates of effects” (The 
Cochrane Collaboration 2004). Although this can be accepted when investigating into the 
effects of interventions, using such data only would not have sufficed for the aims of this 
thesis. For locating studies comparing antenatal care between countries, or to find national 
guidelines on antenatal care from the member states of the EU, the Cochrane databases 
would not have led to suitable results, as it references no such studies.
Search strategies: languages, search terms and additional strategies
Although the official language of the searched databases is English, it is possible to identify 
publications in other languages when using MEDLINE. In such cases, only the abstracts are in 
English. As English is the main publication language within the scientific community, it is likely 
to identify comparisons between member states of the EU, or publications on new models of 
care in English. However, it is very likely that national guidelines on antenatal care are not 
published in English, but in the national languages. Although this problem could not be 
overcome completely, it was decided to include at least articles in German and French into the 
review. German was chosen as it is the native language of the reviewer, and her French is 
sufficiently good to enable an understanding of publications related to the subject of the study.
Before entering the databases, the keywords for the searches were defined. For this, the 
Medical Subjects Heading thesaurus / MeSH tree of the US National Library of Medicine was 
used, which is the hierarchically organised system used for indexing articles (Appendix 1, 
Reference 19). Two approaches were used for identifying the best keywords. To start with, the 
MeSH tree was searched from top down, starting from ‘Health Care’ down to ‘guidelines’. In a
second step, the terms ‘antenatal’ and ‘prenatal’ were used as a starting point, from which on 
the search was broadened to identify more keywords by the respective cross-references.
In order to identify studies, which provided a direct comparison of antenatal care between 
member states of the EU, the following search terms were used: ‘antenatal’ and ‘antenatal 
care’, ‘prenatal’ and ‘prenatal care’, ‘antenatal visits’, ‘prenatal visits’, ‘antenatal screening’, 
‘antenatal tests’, ‘prenatal testing’, ‘pregnancy’, ‘national’, ‘guidelines’, ‘regulations’, ‘clinical 
guidelines’ and ‘pregnancy care’. Also a combination of search terms was used. In addition to 
that, all terms were also truncated, e.g as antenatal test*, in order to bring up studies 
referenced under antenatal tests, as well as antenatal testing. After this, the names of the pre- 
May 2004 member states of the EU were cross-matched with the results of the searches 
mentioned before, e.g. ‘German*’ and ‘antenatal’ as well as ‘German*’ and ‘antenatal care’. 
Also ‘Europe’ was used to cross-match the searches. To identify studies about the timing, 
number and scheduling of antenatal visits, as well as to locate national guidelines on antenatal 
care from the member states of the EU, the same search terms were used. Also trials testing 
new models for antenatal care should be covered by this search.
As search terms for the Cochrane databases, the following keywords were used in their full, as 
well as in truncated form: ‘antenatal’, ‘prenatal’, ‘pregnancy’ and ‘care schemes’. Moreover, all 
tests recommended for antenatal care in the member states of the EU as identified in the 
previously mentioned literature search were used as search terms, e.g. ‘hepatitis’, ‘rubella’, 
and ‘ultrasound’, etc. However, the titles of the systematic reviews were additionally hand- 
searched for relevant studies. As Cochrane reviews represent a very high standard in 
systematic reviews, this effort was judged as being justified. Using this strategy, it was to be 
avoided to miss any relevant review for reasons of using the wrong key words.
After the keyword searches in the electronic databases, additional searches were conducted 
with different strategies. The databases MEDLINE, MIDIRS and CINAHL were searched again, 
using the names of the authors of the most significant papers for a search on authors’ name.
As examples, Elina Hemminki and Mika Gissler were identified as key publishers for Finland,
Marion Hall for the UK, and Beatrice Blondel for France. These authors were for example 
involved in several relevant publications from their respective countries, and they were cited 
also in international publications.
In addition to the above mentioned searches, several journals were hand searched from 1999 
to date. This was done to identify possible additional material not covered by the database 
searches. The hand-searched Journals were MIDIRS Midwifery Digest, Der Frauenarzt, 
HebammenForum, and Deutsches Arzteblatt, where most medical guidelines were expected. 
As a last step, the references of all publications identified by the methods mentioned above 
were searched. By this, any seminal papers that had been missed by the other search 
strategies where then included in the evaluation of the current state of the art.
Methods of the review: selection criteria and data analysis
All trials identified by the methods described in the search strategy were scrutinized by the 
review author for their properties with regard to the studied topics. Before the selection of the 
literature commenced, the concept of antenatal care was operationally defined on the basis of 
the literature (National Collaborating Centre for Women’s and Children’s Health 2003):
Only literature that focused on the baseline clinical care of healthy women with uncomplicated 
singleton pregnancies was considered.
Moreover, only routine antenatal care up to the estimated date of delivery was included in the 
review. Every piece of literature reporting on a relevant aspect of care was reviewed, 
regardless of its methodological quality. However, as it is a critical review of the literature, 
problems regarding the quality of publications are clearly addressed.
As it was aimed at providing a detailed picture of the current recommendations for antenatal 
care in the member states of the European Union, it was necessary to synthesise the relevant 
evidence. In order to describe the situation exactly, narrative analysis was the overall method 
of choice for analysing and demonstrating the results of the comprehensive descriptive 
literature review. The findings of the review are presented under a series of subheadings, with
a commentary relating to the respective literature (Forbes & Griffiths 2002), including the 
critical appraisal of the literature as well as their relevance to the subject.
The search for studies comparing antenatal care between the member states of the EU 
brought up five publications (Blondel et al. 1985, Hemminki & Blondel 2001, Heringa & Huisjes 
1988, Langer et al. 1999, World Health Organization 1987). Unfortunately, none of them 
included the member states of the EU either completely, or exclusively. Moreover, all of them 
are either focused on the general organisation, or on the provision of care, rather than on its 
content. Acknowledging these limitations, the studies are critically analysed and presented in 
the review. However, as no publication could be identified, which compared all national 
guidelines of the member states of the EU, the search strategy was broadened by searching 
for individual national guidelines.
Despite an extensive search for national guidelines on antenatal care from the member states, 
only limited information can be presented. When searching for literature in English, German or 
French, the national guidelines of most member states are very likely to be missed. They are 
usually not published in the journals accessible to foreign researchers, and they are likely to 
use titles and keywords in the national languages only. Therefore, the search strategy was 
again broadened.
As only the complete national guidelines for Germany and England and Wales were accessible 
to the reviewer, indications were sought of what might be contained in the other national 
guidelines through the analysis of general papers on antenatal care in the member states. 
Additional information was sought from publications on certain aspects of care, which 
originated from the EU-15 States. An example for such a search is the combination of 
‘hepatitis’ and ‘Italy’ as search terms. The search on this topic was complemented by the 
findings from the Cochrane databases, especially with the results from the publication on 
patterns of routine antenatal care for low-risk pregnancy (Villar & Khan-Neelofur 2001).
However, picking information from studies only marginally related to the original search topic is 
an extensive task. In addition to that, it has to be kept in mind that the extracted information is
only a by-product of these publications, which makes it less reliable. As a consequence, it was 
decided to limit the review to the EU-15 states. In addition to limiting the review to the EU-15 
member states, no attempt was made to access grey literature, or to consult national experts 
on the subject. It was decided that the gap in knowledge was sufficiently large to justify the 
structured collection of reliable and comparable data.
In order to prepare the extracted information from the literature on national guidelines for 
comparison, a structured way of presenting the data was required. However, no tool for doing 
so was found in either of the publications identified during the literature review. As a 
consequence, a tool needed to be developed to disentangle what is recommended with regard 
to the number and distribution of visits. Moreover, the tool also needed the ability to 
demonstrate, which tests are recommended and at what time during pregnancy. For this, a 
comprehensive table was developed, in which all required information could be recorded. As 
this tool was also used for the survey, it needed to be developed and piloted carefully. How 
this was done, and what the properties of the tool are, is described in detail in the methodology 
section of the survey. The entire survey tool is included as Appendix 2 to the thesis.
After it was found that the search on studies comparing antenatal care between the member 
states of the EU did not bring up a single satisfying study or report, it was decided that 
additional evidence was needed about the effectiveness of different models for antenatal care. 
In the introduction to the chapter on antenatal care in the European Union, the uncertainties 
around the clinical effectiveness of antenatal care are debated (World Health Organization 
(2003). Also the methodological problems in attributing outcomes identified in research to any 
one particular aspect of care are addressed there (Department of Health 2005). On the basis 
of this, it was decided to conduct an additional search on randomised controlled trials 
comparing different schedules of care. By this search, also a systematic review and meta­
analysis of randomised controlled trials of routine antenatal care was identified, which was 
performed on behalf of the World Health Organization (Carroli et al. 2001). With regard to the 
quality of the literature review here, it was reassuring to find that the underlying studies of the 
WHO review were also detected by the primary search strategy used to retrieve the literature
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for the thesis. This small triangulation of methods indicates the validity of the search strategy.
One important aspect when using the study of the World Health Organization [WHO] as core 
reference is that the literature search of the WHO was completed by December 2000. As the 
final thesis assesses the usefulness of a common minimum guideline on antenatal care for the 
member states of the EU, it was considered crucial not to stop this search for literature before 
handing in the thesis. Hence, care was taken not to miss any relevant study published after the 
completion of the systematic review. Although special care was taken to locate studies that 
provided contradictory evidence to what was found by the WHO, no such study was found.
The question of whether this is due to the fact that studies with positive results are more likely 
to be published, or whether the evidence is unequivocal can not be answered finally. However, 
the most interesting and important finding of this search was that the WHO developed what 
was called “The WHO new model of antenatal care” (World Health Organization 2003). As this 
WHO model for antenatal care is of utmost importance for the thesis, it merits its own section 
in which it is subject to an in-depth analysis.
Limitations
The classical definition of a systematic review as being used for locating, appraising and 
synthesising evidence from scientific studies in order to provide informative empirical answers 
to scientific research questions is not fulfilled completely by the literature review demonstrated 
above (NHS Centre for Reviews and Dissemination 2001). Although it used open, rather than 
empirical questions, it was nevertheless conducted systematically, aimed at being 
comprehensive, and tried to cover pre-defined fields around the research problem. This 
approach was considered useful for providing a detailed picture of the situation, setting the 
scene for the study by identifying gaps in and problems with the published literature to date.
Despite these problems with locating and accessing the content of the relevant literature as 
previously discussed, a strategy was developed to overcome these problems at least partially. 
An attempt was made to minimise selection bias by the comprehensive search strategy, and 
the literature that has been identified is generally judged as representative for the current state
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of the art in the field. However, the track record of this literature review suggests a significantly 
large gap in the published literature, which justifies a separate study. To support this, the main 
results and the conclusions to the literature review are described in the section on antenatal 
care in the European Union. Although it could be criticised that the adopted search strategy 
leads to an incomplete picture of the situation, the huge differences with regard to the amount 
of detected information suggests that the search strategy was efficient for detecting the 
relevant literature, if this was available.
2.2.2 Implications, advantages and disadvantages of guidelines
On completion of this thesis, it should be possible to answer the question as to whether a 
common minimum guideline on antenatal in the EU is useful, and what its possible advantages 
and disadvantages would be. To achieve this, a search for already existing national guidelines 
does not suffice. Hence, the review was extended to the literature on guidelines and especially 
guideline development. In this part of the review, it was aimed at providing a comprehensive 
thematic analysis of the implications, advantages and disadvantages of guidelines, which are 
important in the context of antenatal care. It was planned to identify all relevant arguments in 
favour and against guidelines, but not to identify all publications concerned with them. 
Searching and reading therefore proceeded until no new aspects relevant to the study were 
found, which is equivalent to a saturation of the data.
According to the above criteria, the search commenced with a broad reading on evidence- 
based medicine, starting from a widely used textbook from Germany called “Lehrbuch 
Evidenzbasierte Medizin in Klinik und Praxis” (Kunz et al. 2000). In this, the background of 
evidence-based medicine is addressed, as are the techniques and the practical application of 
it. Moreover, the book provides a comprehensive collection of internet resources on the 
subject. However, an important finding when searching for relevant publications was that the 
literature on guidelines is developing fast. Although there are excellent textbooks to lay the 
basis for an understanding of the subject, it was found that there is a lively discussion in
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scientific as well as professional journals. In addition to the classical print media, a lot of the 
argument takes place on the internet. Due to this, several internet sources were used as a 
basis for this review. At the beginning, the thesaurus system of the US National Library of 
Medicine was searched for the relevant medical subject headings (Appendix 1, Reference 19). 
The identified MeSH tree was the following:
Health Care
Health care quality, access, and evaluation 
Quality assurance, health care 
Guidelines
Practice guidelines 
Quality of health care
Health care evaluation mechanisms 
Guideline adherence
In addition to the search with search terms, a wealth of national as well as international 
websites was identified on the development and appraisal of guidelines for clinical practice 
(Appendix 1, References 1, 3, 8, 13,14,16,17 + 20). They provide search engines and links 
to each other, leading step by step into the depth of concepts, as well as to the original papers. 
As the references for the original literature are cited alongside the evidence used in the 
findings of the review, only the organisations and their entrance sites are listed in Appendix 1 
to the thesis, which were used as gateways to the topic.
2.3 Antenatal care in the member states of the European Union
2.3.1 Basic documents
It is the aim of this literature review to identify and synthesise relevant evidence from the 
published literature to provide a detailed picture of the official guidelines regulating antenatal 
care in the countries of the European Union. The findings are critically analysed and
synthesised. In the following, the focus is put on the screening tests recommended as well as 
the timing and scheduling of them. In addition to that, the results of randomised controlled trials 
testing new models for antenatal care are critically evaluated. Before investigating the details 
of its organisation and components, antenatal care is defined and explored for its properties.
The WHO defines antenatal care as the complex of interventions that a pregnant woman 
receives from organized health care services (World Health Organization 2003). Again 
according to the same authority, the purpose of antenatal care is to prevent or identify and 
treat conditions that may threaten the health of the foetus/newborn and/or the mother, and to 
help a woman approach pregnancy and birth as positive experiences. To a large extent 
antenatal care can contribute greatly to this purpose and can in particular help provide a good 
start for the newborn child. The operational definition for antenatal care used within this thesis 
is not as comprehensive as that of the World Health Organization. Although all the 
components named by the WHO are important and well established aspects of complete and 
good antenatal care, they all have their own body of literature, and their own methodologies 
used to research them. Preparation for childbirth, antenatal classes, and maternal expectations 
from care are only some of them, which will not be explored within this thesis.
The operational definition of antenatal care
In this study, antenatal care is used synonymously to the routine diagnostic care for normal 
pregnancies. The exact operational definition used is that antenatal care is the baseline clinical 
care of all pregnancies of a healthy woman with an uncomplicated singleton pregnancy 
(National Collaborating Centre for Women’s and Children’s Health 2003).
Moreover, only routine antenatal care up to the estimated date of delivery is considered. Care 
beyond this point can be defined as the treatment of an alteration from the normal course of 
events, and the line between normal and abnormal can be drawn at different points after the 
estimated date.
For this study, it was decided that antenatal care is studied on the population / public health
level, rather than at the level of the individual pregnant woman. Public health is operationally 
defined as measures and strategies that are occupied with ensuring and improving the health 
of populations. Treating individual patients is not at the centre of interest (Department of 
Health, Chief Medical Officer 2003). As a consequence, the focus is put on national guidelines.
Clinical properties of antenatal care
Another important aspect to discuss with regard to antenatal care is its effectiveness and cost- 
effectiveness. Although antenatal care is supposedly always provided with the best intentions 
in mind, the dimension of its positive properties can be and are debated. There are measures 
in antenatal care, which are very likely to improve outcomes, such as identifying and treating 
severe anaemia. For other measures, the proof of effectiveness and cost-effectiveness is not 
that easy. This is especially the case, as measures in antenatal care are normally not taken in 
isolation, but are provided as part of a package consisting of several tests and interventions. 
Also the WHO (World Health Organization 2003) acknowledges the uncertainties around the 
clinical effectiveness of antenatal care, especially in relation to its costs. The WHO stated 
clearly that given the limited resources of health care and the wide range of services provided 
as part of antenatal care, such questions must be dealt with and highlights that care should be 
“appropriate, cost-effective and based on the needs of the specific pregnant woman”.
As the National Service Framework for Children, Young People and Maternity Services 
(Department of Health 2005) states under section 11:
“..., designing research to take account of the many factors (such as multi-disciplinary working, 
women’s views and clinical outcomes) that contribute to the delivery of high quality care for 
women is challenging and it can be difficult to attribute outcomes identified in research to any 
one particular aspect of care.”
According to this, later in this chapter, also studies will be analysed in which complete models 
of care are compared. The issue of effectiveness is critically followed throughout the entire 
thesis, but it is specifically discussed in the sections on evidence-based care, evidence-based
policy and the section on guidelines. Although it is not at the centre of interest in this thesis, 
another important aspect around antenatal care is its relative expensiveness. Costs must be 
viewed especially critical with regard to the clinical effectiveness of antenatal care. 
Unfortunately, this is beyond the borders of what this study can achieve.
The coverage of antenatal care
To get an impression about the coverage of antenatal care in the EU, data from the former 15 
member states are presented. From these data it becomes obvious that at least the EU-15 
States share the idea that antenatal care should be provided to all pregnant women. As can be 
seen from Table 2.1, all of the EU-15 states provide a system for antenatal care, and the 
uptake is generally high. Table 2.1 shows that in 12 of 15 countries at least 90% of pregnant 
women have contact with the health care system. Unfortunately, no national data for Greece, 
Ireland and the UK were available to the WHO (World Health Organization 1997).
Table 2.1: Coverage of antenatal care in the EU-15 
states (World Health Organization 1997)
Country Uptake of antenatal care in%
Austria 100
Belgium 90
Denmark 100
Finland 100
France 99
Germany East 100 .
Germany West 98
Greece no data
Ireland no data
Italy 100
Luxembourg 98
Portugal 96
Spain 96
Sweden 100
The Netherlands 95
United Kingdom no data
Although according to the WHO (World Health Organization 1997) a coverage of antenatal
care is achieved in over 97% of all pregnancies, it has to be noted that all pregnant women 
having contact to a health professional at least once during pregnancy were counted. This is 
definitely not the quality of antenatal care, this study aims at. Unfortunately the number of 
contacts needed to be counted as having had antenatal care is not known for the EU-funded 
PERISTAT project. In this study, data were extracted from official statistics of the years 1997 
to 2001 (Wildman et al. 2003). However, as the uptake of antenatal care was not at the focus 
of the publication, only a few facts are mentioned. In this publication it was stated that 2.5% of 
women in Greece did not receive antenatal care. Moreover, it was found that less than 1% of 
women of all other EU-15 States were without any contact with the health care system during 
pregnancy. This would mean that in Ireland and the UK less than 1% of women did not receive 
antenatal care, or that incomplete data were provided. However, from personal contact with 
British midwives and women, the first option is more likely to be the case. Hence, the nearly 
full coverage of antenatal care again reinforces the idea that antenatal care is a major public 
health issue for the EU. Although not yet complete, it is likely that over the coming years such 
data are made available for the states that joined on 1 May 2004 with the efforts for compatible 
or common statistical systems within the EU. Up to now, such data are not available. Only the 
World Health Organization (2003) acknowledges possible problems with access to antenatal 
care services in some countries. The authors from the WHO state that in Western Europe, full 
coverage for antenatal care appears to exist. However, in Eastern Europe, the countries which 
have made a transition from the Soviet model of health care to social insurance were found to 
provide full coverage. For the ‘other countries’, the authors report anecdotal evidence which 
indicates problems of access due to incomplete coverage, geographic problems etc. In 
contrast to that, there might be particular other reasons why there were no data available for 
Greece, Ireland and the UK. It could be possible that these are the member states which do 
not have national guidelines on antenatal care, and as a consequence of this no national 
recording system for local services. Later in this literature review, an answer should be 
possible whether no data means no service provision, or whether there might be other reasons 
for the non availability of data to the WHO in 1997.
Drawing all the above mentioned facts together, it can be concluded in line with the WHO that
- every pregnant woman should have full access to antenatal care.
- excessive, unneeded and unproven interventions are often provided to women with normal 
pregnancies (World Health Organization 2003).
All these factors make antenatal care to an important issue in public health. As the WHO 
(World Health Organization 2003) stated clearly:
“Any health care programme that sincerely wishes to improve the health of its population must 
pay serious attention to the health of the pregnant woman and her fetus.”
Public health aspects
Antenatal care is directed at the health of women, but also aims at ensuring the best possible 
starting conditions for the future citizens of the EU. It contains aspects of health protection, as 
it screens for harmful maternal conditions caused by pregnancy, and tries to treat them 
immediately. Antenatal care has also major aspects of health promotion, as it aims at 
improving intrauterine conditions for the foetus. Possible examples for this are ensuring a good 
maternal diet, and ensuring good oxygenation by controlling or improving maternal 
haemoglobin levels. However, it has to be noted that antenatal care can be studied on the 
basis of the individual pregnant woman, or at the population and public health levels.
Health policy is influenced by several internal factors, such as political systems, culture, 
religion, and ethnicity. Moreover, there are exogenous factors that might influence health 
policy, such as threats from war or terrorism, and the prevalence and marketing strategies of 
international or multinational companies. These factors have the potential to influence health 
policy (Walt 1994: 3ff). However, one of the common traits of the European Union is that the 
member states share most of these factors and values. As is exhaustively discussed in the 
chapter on general trends, reproductive health and patient mobility, the EU takes an active 
stance in public health in the years to come. The 6th framework programme for research and
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development for the years 2002 to 2006 has set three major public health themes on the 
agenda (Commission of the European Communities 2000, CORDIS 2002, European 
Commission Research Directorate General 2001). Exactly the same aims were set out in an 
extended version in the Union’s public health programme for the years 2003 to 2008 
(Commission of the European Communities 1998, European Parliament and the Council of 
Europe 2002, Watson 2001). These aims are to
- improve health information and knowledge,
- respond rapidly to health threats, and to
- address health determinants.
With its abilities to address health determinants, which means preventing ill health before it 
develops, antenatal care fits perfectly into the public health context of the EU (Byrne 2004). 
However, as is demonstrated and criticized in the sections on EU health policy, it is observable 
that the specifications from sides of the EU relate mainly to major illnesses of older people, 
rather than taking a more general stance (Commission of the European Communities 2005: 7, 
CORDIS 2002, Kyprianou 2005b). According to the above mentioned EU documents and 
programmes, premature deaths due to major illnesses of adulthood should be reduced by 
addressing some of the underlying causes of major illnesses, such as lifestyle behaviours, 
socio-economic circumstances and the environment. However, the important contribution 
antenatal care has to make in this respect is neglected. By considering a healthy lifestyle and a 
healthy diet throughout pregnancy, as well as by treating unfavourable conditions immediately, 
best starting conditions are ensured for the future citizens. As research suggests, conditions 
during the intra-uterine period can programme an organism for the rest of its life (Barker 1995, 
Barker et al. 1993, Paneth et al. 1995, Eriksson 2005). As this is especially evident for cardio­
vascular diseases -  one of the major health problems in Europe -  antenatal care fits perfectly 
into the public health strategy of the EU (Commission of the European Communities 2005: 44).
Up to now, Children’s health is not mentioned in the documents on public health in the EU at 
all, although it would be of utmost importance to investigate into this aspect of public health as
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well. Children are citizens in their own right, but not yet able to act as self-advocates, 
particularly at the population level (Rigby et al. 2003). Here, the EU could make a unique 
contribution towards the health of its citizens, as children’s health determines the health of the 
future population (Rigby et al. 2003). As children suffer particularly from unfavourable 
conditions in their (social) environment, ensuring best starting conditions for all future citizens 
would be also an important act with regard to the equality of citizens of the Union.
An initial critical analysis of the literature has revealed six major themes, namely, antenatal 
care in the EU, timing and number of ante-natal visits, tests recommended for antenatal care, 
guidelines on antenatal care in the member states, comparisons of different schedules of care 
and the WHO model of care. These will be discussed in turn.
2.3.2 Antenatal care in the EU
Studies comparing antenatal care in the EU
All in all, five papers were found that provide a comparison of antenatal care in the countries of 
the European Union (Blondel et al. 1985, Hemminki & Blondel 2001, Heringa & Huisjes 1988, 
Langer et al. 1999, World Health Organization 1987). However, they are either focused on the 
general organisation, or on the provision of care, but not on the guidelines according to which 
care should be provided. Although these aspects form the context of antenatal care, guidelines 
that specify what care should be provided represent the core decisions about what is seen as 
optimum care in the member states. They therefore justify a separate investigation.
Langer and colleagues reported on antenatal care practice in nine settings within eight 
countries of the EU (Langer et al. 1999). Included were Belgium, the United Kingdom, 
Luxembourg, The Netherlands, Spain, France, Germany and Italy. In this study, the policy of 
individual departments was assessed, rather than the policy of the countries themselves. 
Moreover, it does not become clear, why not all member states of the EU were included, or 
how the departments were chosen. In addition, with the chosen questionnaire survey there
might be more information about what care was intended to be provided in the settings, rather 
than what care does in fact take place there. There were neither additional observations, nor 
did the authors perform any counter-checks with data from antenatal records. In spite of the 
mentioned methodological limitations, the study demonstrates that there are significant 
differences in the routine use of clinical examinations and investigations performed during the 
first visit in pregnancy between as well as within countries.
Already in 1985, Blondel and colleagues highlighted the scarcity of details about medical 
practice in European countries, and concluded that there are not sufficient and no reliable data 
on recommendations on antenatal care in EC countries (Blondel et al. 1985). Also the 
differences and similarities of care between the countries were demonstrated. Unfortunately, 
the situation has not changed much since then. The rest of the study with the Perinatal Study 
Group of the WHO Regional Office for Europe was mainly occupied with organisational 
characteristics of antenatal care in 13 European countries. Again, not all member states of the 
EU were included. Reference is made to the situation in Belgium, Denmark, Finland, France, 
Luxembourg, The Netherlands and Sweden. As the data stem from 1981, Germany was still 
divided in the Federal Republic of Germany and the German Democratic Republic. Moreover, 
England and Wales were analysed separately from Scotland. Northern Ireland was not 
included at all. This makes the use of findings more difficult. In general, their findings were that 
most countries demand a minimum number of visits necessary for the women to be eligible for 
prenatal allowances. It was also found that the required number of visits varies in the EU 
countries from five in Luxembourg to 14 in Finland. In addition, some organisational features of 
antenatal care were mentioned. It was found that the Scandinavian countries and The 
Netherlands give an important role to midwives and to a lesser degree to general practitioners. 
In other countries, mainly obstetricians were found to be responsible for providing antenatal 
care. As examples, Belgium, Germany and Luxembourg are mentioned. For France and the 
UK it was found that obstetricians frequently carry out visits, but rarely provide the entire care.
In a later study of Hemminki and Blondel, 13 European countries were included (Hemminki & 
Blondel 2001). Unfortunately, not exclusively and not all member states of the European Union
were included, and there is no reason provided for this. Data are available for Finland,
Sweden, Germany, Portugal and Denmark. For these and the other countries studied, the 
authors identified 13 different organisational systems for providing antenatal care. The only 
common features were that in all countries care is provided either free, or at low cost for the 
women. However, the two most important findings of the study were that only six of the studied 
countries have a dominant system according to which antenatal care is provided. All other 
countries have parallel systems in operation. However, although different professionals might 
provide antenatal care in different organisational systems, they also found that most health 
authorities or other national bodies provide guidelines and other recommendations for care 
provision. The existence of guidelines was also reported by other authors, e.g. with Blondel 
and co-workers citing recommendations or regulations from Finland, Luxembourg, The 
Netherlands and Sweden (Blondel et al. 1985). Backe & Buhaug reported that guidelines exist 
for all Nordic countries (Backe & Buhaug 1994). However, as guidelines are often published in 
the national languages only, they do not lend themselves to international comparisons.
Definitely the most comprehensive study is that of the World Health Organization’s study group 
on perinatal care in the WHO European region (World Health Organization 1987). Between 
1981 and 1982, the group conducted a postal survey on routine antenatal care in 31 of the 33 
countries of the European region. Unfortunately, the WHO does not provide the names of the 
countries, to which any findings apply. It is for example just stated that 21 of the 33 countries 
recommend a specific examination or a certain pattern of care, but there is no hint, which 
countries might be meant. As this applies to the entire publication, only general information can 
be extracted. Moreover, much information is provided about who is doing the examinations, 
how many visits are planned, and where the visit is taking place. Less information was 
collected about the actual content of care.
The most significant findings were that in 21 of the 33 countries examined the number of 
antenatal visits is legally specified. 18 countries reported that they have official guidelines on 
routine examinations that have to be conducted during pregnancy. 12 of them have guidelines 
issued by the state, 6 countries have recommendations issued by major universities (World
Health Organization 1987:19ff). However, even after their major survey, the authors 
concluded that very little information is available about the actual content of antenatal care. 
This still needs to be brought together, as to how this will be done as part of this thesis.
As background information it is therefore important to know that about 50 years ago, the 
countries of the European region started to formalise and regulate the provision of antenatal 
care. Most of them defined the time span between the individual visits, the examinations that 
have to be carried out routinely, which have to be carried out by a medical doctor or midwife 
who was accredited by the government. Today, each country was found to have a legally 
required or recommended scheme for all pregnant women (World Health Organization 1987: 
83). However, all different schemes cannot be based on sound scientific evidence. It is evident 
that those antenatal care schemes including many visits require immense sums of monetary 
and personnel resources. Although the positive effect of these intensive care schemes is not 
sufficiently proven, they tend to persist. As this is difficult to change, the WHO recommends 
putting the focus on the content of care, rather than on the number of visits.
As expected, also in the WHO study (World Health Organization 1987), major differences are 
reported with regard to the recommended examinations. Blood group testing is recommended 
for all pregnant women by all but one country. This country recommends blood group testing 
only on a selective basis. In contrast to that, screening tests for lues are common in 5 
countries for all pregnant women, in 19 countries only on a selective basis. Differences in 
recommendations are even larger for ultrasound examinations. Three countries provide it 
routinely, 19 on a selective basis. Unfortunately, also here the names of the countries are not 
given so that no conclusions can be drawn about the effectiveness of the care schemes.
Similar to the other studies mentioned, the publication by Heringa and Huisjes provides 
information about the provision of antenatal care in the individual countries of the European 
Union, but not on possibly existing official guidelines (Heringa & Huisjes 1988). These authors 
did a very detailed study on what care was provided in 1985 in the university hospitals of the 
countries of the EU. A maximum of ten university hospitals were approached per country for
this EU-funded project. Finally 67 obstetricians from nine member states answered the 
questions on 30 different screening procedures in their hospitals. Unfortunately, in 1985 the 
EU did not have the current number of member states, so that sixteen of today’s members are 
not included. These countries are Luxembourg, Sweden, Portugal, Spain, Finland, Austria, and 
all states which joined the Union on 1 May 2004.
Variations in antenatal care practice
Some of the most interesting findings are described in the following discussion, as they provide 
a very good overview about what can be and is tested routinely during pregnancy. For 
example, vaginal examinations were carried out by all studied units at the first visit. However, 
in Belgium, France, Germany and Italy, the majority of clinics performed this examination at 
each visit. This is supported by the findings of other studies (Breart 1995, Kristensen et al. 
1995). In the other countries, this is not the case. In 1985, all clinicians checked the mother’s 
blood pressure at each visit. Since then, other patterns of blood pressure measurement have 
been tested (Hall et al. 1985). Whether they found their way into official recommendations, or 
into practice, is not clear. The same applies to routine weighing of the mothers. Nearly all 
clinicians reported that the women are weighed at each visit. Also this practice was debated 
over the past years. According to the study of Heringa and Huisjes, 63% of the responding 
clinicians routinely perform a cervical smear during pregnancy (Heringa & Huisjes 1988). 
Another 33% recommend this practice. In this case it would be interesting to know whether this 
practice grounds on any perceived benefit, or whether this follows official guidelines.
In all university hospitals included, the maternal blood group was typed routinely. In 64 out of 
67 departments, typing of the Rhesus factor (D) is also included. The three departments 
missing did not respond to the question, which could have happened by mistake. The 
haemoglobin level is tested by 90% of the respondents at least once during pregnancy. Most 
of them screen more frequently. An additional 19% screen for haemoglobinopathies. In the 
countries with the highest prevalence of such conditions, i.e. Italy and Greece, all clinicians 
recommended screening.
Serological screening for rubella is either routinely performed or recommended by 91% of the 
clinicians. This finding is not surprising. However, a rather unexpected finding was that 97% of 
the clinics routinely screen for lues. In one country the test is repeated several times during 
pregnancy. In contrast to that, toxoplasmosis screening is not widespread. Only 34% of the 
clinicians test for this condition, mainly in Italy, Belgium and France.
In addition to the routinely, or at least frequently performed tests, there are several tests not 
performed on a routine basis. Screening for cytomegalovirus is disregarded by 63%, and for 
listeria monocytogenes by 75% of the clinics. Also for group B p-haemolytic streptococci no 
routine screening is performed in 61% of the clinics. For hepatitis B virus, in 1985 only 36% of 
the clinicians screened routinely. Another 19% recommended it at least. It would be interesting 
to know how these numbers changed during the past two decades. Today, numbers might be 
much higher, as the subject gained importance. One example is e.g. that during that time 
routine vaccination against hepatitis B was introduced in Germany.
Relatively simple is the test for bacteriuria, which is routinely performed by 54% of the 
clinicians. Another 21% recommend it. 66% of the clinicians reported that they performed 
some kind of glucose tolerance test to screen for gestational diabetes, i.e. impaired glucose 
tolerance during pregnancy. It might be interesting to know how things changed until today.
The importance of information about ultrasound screening is difficult to assess. In this field, 
much has happened over time since the investigation took place. It can be estimated that 
numbers are much higher today than they were in 1985. However, already then 82% of the 
clinicians carried out a routine ultrasound examination for several purposes, and most of them 
did so more than once during pregnancy. In addition to these ultrasound examinations, 25% of 
the clinicians in the studied countries carried out a cardio-tocography during pregnancy. In 
Belgium, Germany and Italy the majority of clinicians did this. It is not clear whether this 
practice has increased or decreased over the past decade.
Foetal movement counts on a routine basis were conducted by 64%, the assessment of 
placental functions by hormones was reported by 22%, and screening tests for coagulation
disorders by 9%. 28% of the clinicians routinely screened for maternal serum alpha- 
fetoproteine.
All in all there was no study identified which compared or demonstrated official guidelines on 
antenatal care in the countries of the European Union. For this, a broad search of the 
published literature on antenatal care in the countries of the EU was conducted. From these 
studies, as a by-product some information could be extracted about the guidelines on 
antenatal care of individual countries. The results of this search are presented in the following.
2.3.3 Timing and number of antenatal visits
In Table 2.2, all available information about the timing and scheduling of antenatal visits in the 
EU-15 states has been compiled. When different schedules for first and subsequent 
pregnancies were available, the scheme for primigravidae was used. Unfortunately, only for 6 
of the EU-15 states there were data available. From the data shown, a certain pattern of 
scheduled visits becomes evident. In most countries, women meet a health professional every 
four weeks until the 28th gestational week. From week 32 on the latest, the women attend 
every two weeks. Weekly visits are scheduled from weeks 36 or 37 on in Denmark, Finland, 
The Netherlands, and Sweden. However, over the past years efforts have been made to 
reduce the number of routine visits, especially for multigravidae. This is already evident in the 
schedule for Denmark and that of the United Kingdom (National Collaborating Centre for 
Women’s and Children’s Health 2003). In section 2.3.6 on randomised controlled trials 
comparing different schedules of care this will be discussed in detail. In general, the comment 
that the intervals between antenatal visits as introduced in 1929 by the United Kingdom 
Ministry of Health had been chosen arbitrarily and have little scientific basis might be true, if a 
reduction of visits can be achieved without limiting the benefits of care itself (Liu et al. 1992). 
Nevertheless, several countries have adopted and kept this scheme until today.
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2.3.4 Tests recommended for antenatal care
In order to demonstrate what tests are recommended for routine antenatal care throughout the 
European Union, all tests recommended in one or the other country of the Union have been 
compiled in Tables 2.3a to 2.3c. From the information given in these tables it becomes clear 
that no pattern could be identified of tests that are recommended throughout all countries of 
the European Union. However, from the detailed descriptions of the countries in the following 
section it will become clear that there is only rudimentary information about official 
recommendations. Only for the countries for which a guideline was available, sufficient 
information is presented, e.g. for Denmark, Germany, Sweden and the UK. Due to the scarcity 
and unreliability of information, a comparison of the tests used in the different countries is not 
valid and should be postponed until more information is available, i.e. from the survey.
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2.3.5 Guidelines on antenatal care in the member states of the EU
The description of the current guidelines on antenatal care in the individual countries follows a 
certain scheme. The questions are whether there is a national guideline on antenatal care in 
the respective country and who has issued this guideline and is therefore responsible for its 
content and update. In addition to that, any information about the intervals at which the 
guideline is revised and on how legally binding the guideline is was collected.
After this, it is attempted to disentangle what care scheme is recommended for uncomplicated 
pregnancies with regard to the number and distribution of visits. In this context, it is also 
demonstrated which tests or interventions are scheduled, and at what time during pregnancy. 
For this, a comprehensive table is used, in which the individual tests are recorded. This table 
has been developed during the review process.
Austria
For Austria, no document was found on the regulations or practice of antenatal care. However, 
a common recording system for results of antenatal screening procedures exists, which is 
called “Mutter-Kind-Pass”.
Belgium
Belgium is one of the countries for which nearly no data are available in the published 
literature. However, it was stated by one author that in 1986 no official regulations by the 
Belgian health system existed, which prescribed or recommended a special scheme or content 
of antenatal care (Wollast et al. 1986). Another author stated that there was no specific 
legislation dealing with prenatal care in Belgium (Humblet et al. 1989).
Although a study was identified with the title “Organization of prenatal care in Belgium”, no 
comments can be made about the content of care. In this paper, a compilation of literature is 
cited, which is mainly occupied with the question of who is providing antenatal care, rather 
than what this care consists of. Moreover, it does not become clear for which reasons the cited 
studies have been included or what aim is followed with this paper (Humblet et al. 1989).
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Although these methodological problems leave many questions unanswered, some 
conclusions can be drawn about prenatal care in Belgium.
General practitioners and obstetricians/gynaecologists mainly provide antenatal care in 
Belgium. Interesting is that there are major differences in care between the Flemish and the 
French speaking communities. Humblet and colleagues (1989) state that in the French 
speaking communities nearly all pregnancies are supervised by obstetricians, whereas in 
Flemish-speaking communities, only 60% of the pregnancies are supervised by obstetricians.
With regard to special screening procedures, only two policies were mentioned. In Belgium, no 
standard prevention programme for the vertical transmission of hepatitis B exists (De Groote et 
al. 1997). However, most gynaecologists were reported to screen for hepatitis B virus during 
pregnancy, but the type of serology tested and the timing of the screening varied widely. 
Moreover, the data stem from a preliminary survey amongst 32 Antwerp gynaecologists only.
The second test on which data are available is HIV screening. In 1990, no official guideline 
regulating HIV screening in pregnancy existed for Belgium. By a postal questionnaire, Belgian 
gynaecologists have been asked for their screening policy [815 contacted, responses: 54.7%]. 
91% of the respondents offer HIV screening to pregnant women. 49.1% of them to all pregnant 
women, 41.9% to those with risky behaviour. Unfortunately, there is no mention of what ‘risk 
behaviour’ is and how it is identified (Denayer et al. 1990).
Denmark
In Denmark, the Danish National Board of Health issues guidelines on antenatal care, and the 
16 Danish counties are responsible for the local application of these guidelines. Within them, 
reference is made to content and scheduling of visits (Kristensen et al. 1995, The Ministry of 
Health 1997). Timing and scheduling of the visits has been demonstrated in Table 2.2. The 
guidelines are called “Directives on Pregnancy Hygiene and Maternity Care”, but are published 
in Danish. The part that could be extracted is compiled in Table 2.4.
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The tables on technical tests and laboratory tests were omitted, as nearly no information was 
provided about such tests. With regard to these, it was only found that urinalyis should take 
place about seven times during pregnancy. However, this does not provide a complete picture. 
The Danish association of midwives reported in a personal letter to the author that the National 
Board of Health has issued new guidelines on maternity care in summer 1998. Also these are 
not available in English, but they build the basis of the facts cited under the agenda on the 
basis of the personal communication with the Danish association of midwives (Den 
Almindelige Danske Jordemoderforening 1998). One publication might provide valuable 
insights, as it is directed on “Preventive health examinations of pregnant women in Denmark. 
Structure and organisation”. However, this is also published in Danish, and the MEDLINE 
abstract was truncated at 250 words (Andersen et al. 1989).
Antenatal care in Denmark is shared between general practitioners, midwifery centres and 
hospital departments, and is generally free of costs for the pregnant woman (Den Almindelige 
Danske Jordemoderforening 1998, Kristensen et al. 1995). Seven antenatal examinations are 
to be carried out by a midwife. Three visits are scheduled with a general practitioner, and one 
visit takes place at 16 to 18 gestational weeks at a specialist hospital department (Kristensen 
et al. 1995). In contrast to that, Backe and Nakling (1993 citing Kamper-Jorgensen et al. 1986 
who published in Nordic languages only) as well as Blondel and colleagues (1985) state that a 
second examination by a specialist in obstetrics is mandatory in the last trimester.
Some hints towards what care is recommended by the Danish National Board of Health can be 
gained from a study comparing practice to the official recommendations (Kristensen et al. 
1995). For this cross-sectional, nationwide study, a randomly selected group of general 
practitioners, midwives and hospital doctors received questionnaires on the content of their 
antenatal care. With 75 to 89% response rates in the different professional groups and large 
samples of 958 GPs and 678 midwives, some valid conclusions could be drawn about actual 
practice. The authors concluded that nearly all GPs carried out procedures with unproven 
value, which were additionally not recommended in the national guidelines.
It is interesting that the authors judged screening for rubella antibodies as insufficient, although 
this procedure was reported as not recommended in the guidelines. Also cervical smears were 
frequently carried out although not recommended. Problematically, there are no data available 
for any of the tests as to whether they were performed at the recommended time during 
pregnancy, nor whether there were any comments on the optimal timing. Some additionally 
recommended measures were mentioned, but there was no hint as to when they should be 
performed. These tests were a check for oedema, clinical pelvimetry, fundal height 
measurement, urine culture and a test for lues. The only tests recommended to be carried out 
regularly at each visit are urine analysis and the measurement of blood pressure and maternal 
weight. In addition, at two visits after the booking visit, a vaginal examination is recommended. 
These examinations are scheduled during visits to the general practitioner.
With regard to ultrasound scanning, the Danish Board of Health has its own policy. The board 
did not recommend any routine screening since 1986 (Kristensen et al. 1995, Stoll et al. 2001). 
In 1995, the issue of routine ultrasound scanning was under consideration as a part of a 
general revision of the Danish antenatal care programme. However, despite this obvious 
recommendation, ultrasound scanning found also in Denmark its way into routine practice. 
Already in 1995, the 49 departments responsible for hospital antenatal care in Denmark 
offered routinely to 51.4% of pregnant women an ultrasound scan in weeks 10 to 20. 34 of the 
49 departments wanted to continue or start offering ultrasound screening (Jorgensen 1998).
Finland
In Finland, antenatal care is based on individual free of charge outpatient centres, which are 
part of primary municipal health care since the 1940s. Private health services, subsidised by 
the national sickness insurance since 1964, are responsible for outpatient care. In addition to 
these, public health services are available. The distribution of public services is under the 
responsibility of the local authorities, but planning and allocation of resources are directed from 
the central government by directives and state subsidies (Hemminki 1983).
By the end of the 1950s, the use of maternity centres became common practice and covered 
99.9% of all antenatal care in 1978 (Hemminki 1983, Ministry of Health and Social Affairs 1984 
[Finnish] cited by Hemminki & Gissler 1993). In these maternity centres, primary physicians 
supervise care. In practice, mainly public health nurses or midwives provide it. On average, 
women had 3.5 visits to a medical doctor, and 12.9 visits to a midwife. Traditionally, midwives 
are responsible for antenatal care and normally there was continuity of carers throughout 
pregnancy. If the physician is involved in the care, it is in most of the cases a general 
practitioner who is employed by the state. Only major towns might have a specialist 
obstetrician available for antenatal care. If specialist care is required, women are sent to 
hospital outpatient departments. However, it has to be noted that these data refer to the time 
span between 1950 and 1980. Major changes will most likely have occurred since then 
(Hemminki 1983, Hemminki & Gissler 1993). The organisation of the Finnish prenatal care 
system is described as very uniform. According to the nationwide Medical Birth Registry, over 
80% of antenatal visits took place in these special outpatient maternity centres between 1987 
and 1990 (Hemminki & Gissler 1993). However, in ‘recent’ years, care is reported to shift from 
the traditional maternity centres outside the hospitals that are run by municipalities to hospital 
outpatient clinics (Hemminki et al. 1990).
In 1993, an expert group gave out new recommendations for antenatal care in Finland. 
Unfortunately it is not clear, what experts were represented in this group and how binding and 
accepted these recommendations are. Problematically, these recommendations are published 
in Finnish only. From the scarce data available in English it becomes evident that it is 
recommended that primigravidae attend early in pregnancy, but that healthy women expecting 
a subsequent child could postpone their first visit up to the 16th gestational week. However, it 
is not clear how these women should be sure about the gestational week in which they are in 
(Lumme et al. 1993 cited by Gissler & Hemminki 1994). In contrast to these later 
recommendations, in 1987, early attendance at maternity centres was encouraged “for full 
utilization of the potential benefits” (Hemminki & Gissler 1993).
According to the previously cited recommendations, in 1987, Finnish women started antenatal 
care early in pregnancy. 22% of the women attended before the 8th gestational week, 79% 
had their first appointment before the 12th gestational week, and only 4% came in the 16th 
gestational week or later. As a consequence of this early attendance, but also due to a 
schedule with relatively frequent visits, Finnish women clearly had the most antenatal visits in 
western European countries between 1987 and 1990 with a mean of 15.2 visits.
Two laws are concerned with the organisation of prenatal care in Finland. The law of municipal 
midwives originating from 1944 and the law on maternity benefits from 1949. The latter 
specifies that maternity benefits are paid to women, if early contact with health care providers 
was established (Hemminki et al. 1990, citing a ministerial paper [Finnish]).
In general, the following schedule of visits was officially recommended in 1984, but was still 
identical at time of publication of the cited study in 1993: in gestational weeks 6 to 32, one visit 
in every four weeks. From weeks 33 to 36, one visit every two weeks and in weeks 37 to 40, 
one visit a week was recommended. After the 40th week, two visits a week were scheduled 
(Ministry of Health and Social Affairs 1984 [Finnish], cited by Hemminki & Gissler 1993). This 
recommended schedule, which is also represented in Table 2.2, led to good compliance from 
sides of the women. In 1987, only 6% of primigravidae and 9% of multigravidae had fewer 
antenatal visits than the recommendations suggest (Gissler & Hemminki 1994).
Unfortunately, no data on the content of antenatal care are available for Finland. The only fact 
mentioned in the published literature was that in 1987 there was no national recommendation 
on any ultrasound scans during pregnancy (Hemminki et al. 1990).
France
Although no official guideline for antenatal care in France was found, a law is reported that 
prescribes four antenatal examinations during pregnancy. These examinations should take 
place before the end of third month, during the sixth month, during first fortnight of the eighth 
month and in the fist fortnight of ninth month (Garcia & Saurel-Cubizolles 1983). The first three
visits were also required to be eligible for antenatal allowances in 1983. In 1993 this number 
was changed to seven required visits (Blondel et al. 1993). In 1983 it was found that less than 
5% of the women fail to attend the required visits. For these four visits, some antenatal 
screening procedures are required and others are recommended. Unfortunately, no evidence 
could be found about which procedures these are.
From 1983 on, there was a trend towards more frequent visits in France in contrast to the trend 
towards a reduction of visits in Britain with an average of about seven visits in France and still 
12-13 visits in Britain (Garcia & Saurel-Cubizolles 1983). It was common practice in the 1980s 
to commence with a very early initial visit and to return for one visit per month to an 
obstetrician or midwife (Rumeau-Rouquette et al. 1984 [French] cited by Blondel et al. 1993).
Germany
In Germany, the Federal Joint Committee has issued guidelines on antenatal and intrapartum 
care which are based on social law and insurance laws and regulations (Bundesausschuss der 
Arzte und Krankenkassen 2003). These guidelines, which are called ‘Mutterschaftsrichtlinien’, 
are published in the official organ of the German government.
In the preface of the regulations, their purpose is described. It is to ensure that care by 
physicians is based on the commonly accepted state of the art in medicine and is sufficient, 
suitable and cost-effective throughout pregnancy, delivery and the puerperium. It is highlighted 
that physicians should decide on care within this framework and that physicians, insurances 
and midwives should work together in order to communicate the importance of medical care 
during this time. At the end of the guidelines it is highlighted that a midwife can also carry out 
some examinations, such as blood pressure measurement, urine examinations, control of 
haemoglobin levels and fundal height measurement. However, in 1998, less than 50% of the 
German midwives provided antenatal care (Mead & Ashton 1996 + 1998: 42).
The German guideline recommends the early commencement of antenatal care, that is, as 
soon as pregnancy is diagnosed. Similar to other guidelines, the German guideline specifies
what examinations are recommended and at what time during pregnancy. At the first visit, the 
detailed history should be taken, including the pregnant woman’s own, family- and 
reproductive history. In addition to that, her work- and social circumstances should be 
addressed. The history is followed by a general physical examination and a gynaecological 
examination. If during history taking a genetic risk becomes evident, the pregnant woman has 
to be informed about the opportunity of genetic counselling or screening. In addition to the 
regulations for normal pregnancies, an exact definition of risk pregnancies is included, 
combined with a schedule for further measures to be taken when a risk has been detected. 
However, as the German guideline will be appraised in depth in Chapter 4 of the thesis, its 
content is not further discussed here.
Greece
Hemminki and Blondel (2001) report from their survey, that Greece was one of the three 
countries that had no national or regional guideline. From the article of Lekea-Karanika and 
colleagues (1991), some conclusions about antenatal care in Greece can be drawn, although 
the article itself concentrates on risk factors for preterm delivery. Their study takes into account 
a retrospective analysis of 10.859 singleton births, which took place during 30 consecutive 
days in 1983 in entire Greece. In the study group it was found that an obstetrician with or 
without a midwife cared for 99% of the pregnant women. 95% of the pregnancies were cared 
for by an obstetrician alone and 1% by a midwife only.
It was also reported that the blood pressure is taken at some point during pregnancy, although 
there is no hint as to how often or when this is done. The same applies to tests for proteinuria. 
In 67% of the cases in their studied group, the haematocrit levels were reported. Tests for 
blood group were made, and the Rhesus factor was known in 94.8% of cases. More 
information could not be obtained about antenatal care in Greece by this extensive review.
Ireland
Data on antenatal care in Ireland is more than scarce. The only information that could be
detected by the literature review was a study concerned with hepatitis B testing. Routine 
antenatal screening for hepatitis B carriage was found to be cost-effective in a sample of 
16.222 pregnant women in Ireland. The measure was well accepted by the women, with 
99.98% of women agreeing on being tested. The authors of the study recommend routine 
antenatal screening as a standard of care in Ireland (Healey et al. 2001).
Italy
Italy is one of the three EU-15 countries for which no hints about official recommendations or 
guidelines on antenatal care were found (Hemminki & Blondel 2001). In nine of the EU-15 
states, midwives are generally permitted to provide antenatal care for women experiencing a 
normal pregnancy. Again, Italy is one of the exceptions that do not allow midwives to provide 
antenatal care (Mead & Ashton 1998: 41).
Only two measures of antenatal care are mentioned in the literature with respect to Italy. 
Routine cervical examination for the identification of risk for preterm delivery is reported to be 
conducted routinely (Breart 1995). Although this is reported to be common practice, it might 
also be that it is not an official policy. The second measure discussed is universal HIV-testing. 
An expert group of the reference centre for HIV and pregnancy in Milan recommend universal 
testing for their population (D’Ubaldo et al. 1999), but they acknowledge that the uptake and 
the practice of offering the test are not always appropriate. The authors conclude that specific 
guidelines should be issued in order to implement and uniform universal HIV testing during 
pregnancy. Who should be the issuing body of the guidelines is not specified.
Luxembourg
No official guidelines were found for Luxembourg. However, some facts could be extracted 
from other published literature. Langer and colleagues report that in Luxembourg mainly 
obstetricians are responsible for the provision of antenatal care (Langer et al. 1999). 
Surprisingly, in a major study on the competences of midwives in European countries it was 
found that more than 50% of midwives in France and Luxembourg undertook ultrasound as
part of normal antenatal care procedures. Whether they do this under the responsibility of an 
obstetrician was not mentioned. In addition to that it was stated that in Luxembourg 7% of 
pregnancies were first diagnosed by midwives (Mead & Ashton 1996 + 1998: 42). In general 
terms, midwives are permitted to provide antenatal care for women experiencing a normal 
pregnancy (Mead & Ashton 1996 + 1998: 41).
The Netherlands
For The Netherlands, no official guideline was found. However, there is a major study 
available, which examined antenatal care practice between 1995 and 1996 (Wildschut et al. 
1999). The authors collected data on frequency and content of standard care in a nationwide 
structured survey by mailed questionnaires among a sample of specialist obstetricians and 
midwives who were asked to report the standard tests routinely used for antenatal care in their 
own setting. With return rates of 80% and 71% for 132 and 394 accessed obstetricians and 
midwives, the study provides valuable insights into the actual situation.
The most common procedures reported were the assessment of maternal blood pressure, 
which was recorded at nearly all visits, and the maternal weight. This was assessed by 81% of 
the obstetricians and 94% of the midwives at each visit. Urinary tests for protein were also 
reported frequently. Screening for hepatitis B antigen was reported by 96% of the obstetricians 
and 100% of the midwives, and screening for lues in 95% and 99% respectively. Screening for 
the rubella titre was reported less frequently (66% of obstetricians, 59% of midwives). Vaginal 
examinations were performed infrequently.
In The Netherlands, neither obstetricians, nor midwives routinely administer an oral glucose 
tolerance test to screen for gestational diabetes. Midwives assess haemoglobin levels three 
times during pregnancy, obstetricians only twice. Interesting is that despite the large proportion 
of antenatal care provided by midwives, the duration of the gestation is frequently estimated by 
ultrasound. Surprisingly, also 33% of the midwives reported the use of ultrasound, as well as 
69% of the obstetricians. An additional ultrasound scan to screen for anomalies at 18 to 20 
weeks is offered by 30% of the obstetricians and 44% of the midwives. To a much lesser
extent, ultrasound is used for detecting foetal growth restriction. However, another study found 
that from 1996 to 1998 no routine ultrasound screening was performed (Stoll et al. 2001).
In The Netherlands, usually community midwives provide care for low risk women. Shared 
care is not common, as for women at risk obstetricians provide care. For both professions, a 
routine pattern for the distribution of visits is evident. In the first trimester, monthly visits are 
common practice. From 24 to 28 weeks on, every two to three weeks a visit is scheduled.
From 36 weeks on, weekly assessments are planned. There were no different schedules for 
first or subsequent pregnancies. Interesting is that 75% of obstetricians and 94% of midwives 
did not consider it necessary to change the traditional frequency of antenatal visits.
In another study, the policy of antenatal screening for hepatitis B was assessed (Grosheide et 
al. 1995b). The authors reported a nationwide increase in test rates from 1989 to 1992 from 
46% to 84%. In detail, they found test rates of more than 95% in rural areas as well as in large 
city hospitals. Most tests were performed at about 14 gestational weeks, but 10% of the 
screenings took place at delivery (Grosheide et al. 1995a).
Portugal
About antenatal care in Portugal no information but the following was found. In Portugal, 
midwives are not generally allowed to provide antenatal care (Mead & Ashton 1996 + 1998: 
41). In addition, the WHO published that in 1995 91% of women who gave birth had four or 
more antenatal visits (World Health Organization 1997). Obviously, Portuguese societies or 
scientists tend not to publish in English, French or German journals.
Spain
In Spain, there are recommendations of SEGO, the Spanish Gynaecology and Obstetrics 
Society, on different quality criteria of the procedures used in antenatal care. Unfortunately, 
they are published in Spanish only, so that only the English abstract of the study mentioning 
these guidelines is cited (Goberna I Tricas et al. 1996 [Spanish]).
Antenatal care in Spain is provided to 99% by gynaecologists and to 32% by midwives. 22% of
pregnancies were cared for by GPs and 1% by “other specialists”. These were the results of an 
observational study in two counties of central Catalonia for which 171 women were interviewed 
after they had given birth in 1994. Other authors found that less than 50% of the midwives in 
Spain provided antenatal care (Mead & Ashton 1996 + 1998: 42).
Sweden
Although no official guidelines could be found for Sweden, there are hints that regulations exist 
(Aberg & Lindmark 1992, Blondel et al. 1985, Lindmark & Cnattingius 1991). However, these 
guidelines are not necessarily legally binding, as Aberg & Lindmark stated in 1992: “There is 
no m andatory  national recommendation about the number of visits or the content of the care.” 
Their comment is that regional variations do exist with regard to the number of visits as well as 
to the use of tests. In each county, an obstetrician is appointed who is responsible for good 
and equal quality of antenatal care. This obstetrician is also required to set up guidelines on 
how to handle prenatal complications in the county. However, in 1992 the accepted routine 
programme of antenatal care followed the recommendations of a professional working group of 
the Swedish Association of Obstetricians and Gynaecologists from 1989 (Aberg & Lindmark 
1992). These recommendations are shown in Tables 2.5a to c.
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Prenatal care in Sweden is mainly provided by midwives who organise extra visits to a 
physician, if this is required (Lindmark & Cnattingius 1991). In contrast to that, another author 
claimed that one examination by a specialist obstetrician is mandatory in the last trimester 
(Kamper-Jorgensen et al. 1986 cited by Backe & Nakling 1993). Again differently described is 
the situation by another author (Westin 1980). He found that a healthy woman has more than 
15 antenatal visits. Two visits to an obstetrician, and the rest to a qualified midwife who refers 
to an obstetrician or hospital, if necessary. However, although the author claims to describe 
the Swedish system of antenatal care, it does not become clear, whether he refers to entire 
Sweden, or to the hospital he works at. In 1992, other authors claimed that Swedish antenatal 
care is provided by midwives in close collaboration with hospitals. They report that the doctor 
is consulted on one occasion during normal pregnancy. Most of them are said to be 
obstetricians, but in remote areas also general practitioners participate in care (Aberg & 
Lindmark 1992). Finally it was reported that there is a traditional model of care which was 
recommended in 1981, consisting of 14 visits to a midwife and two visits to an obstetrician, and 
a revised model of antenatal care, recommended by an expert committee in 1989, consisting 
of 11 to 12 visits to a midwife and one to two visits to an obstetrician (Lindmark 1992).
As expected, also in Sweden theory is different from practice. With 13 visits, Swedish women 
do have the highest number of visits per pregnancy on average compared to the United 
Kingdom and all Nordic countries. Moreover, compliance to the routine program is extremely 
high according to a national survey in 1990 (Lindmark & Cnattingius 1991, Lindmark 1992).
The authors found in a national survey that all women have had antenatal care. 90% have had 
9 visits; the mean number of visits was 13.2.
In general, the history of Swedish antenatal care is better documented than that of most other 
European countries. Organised antenatal care was introduced in the late 1920s due to the idea 
that pregnant women living under deprived conditions would especially benefit from attention 
during pregnancy. At this time, the focus was put on counselling in hygiene and nutrition. In 
1937, Parliament accepted a proposition by the National Medical Board, which recommended
a certain scheme for prenatal care. Initially, three visits were planned with the doctor: the 
booking visit, and at 24 and 36 gestational weeks. In addition, monthly visits were scheduled 
with the midwife until 24 weeks. From then on, biweekly visits were recommended until 36 
weeks, thereafter, weekly visits were recommended (Lindmark 1992, citing an official source 
[Swedish] called SOU). According to this scheme, at every visit the maternal weight was 
measured, blood pressure and haemoglobin taken and a urine test for glucose and protein 
were performed. In the second half of the pregnancy also the foetal heart rate was assessed.
In 1955, a statute on maternity health care was issued that prescribed blood group testing and 
lues screening for all women. In 1969, a revised version was issued. From then on, cervical 
cytology and pulmonary x-ray (!) were recommended additionally. Moreover, urine tests for 
bacteria were recommended. The timing and frequency are not mentioned. In 1981, a new 
programme was approved by the Commission for Maternal and Child Health Care that clearly 
states additional aims of antenatal care, e.g. preparation for parenthood. Unfortunately, both 
statutes from 1955 and 1969 and the new programme from 1981 were published in Swedish 
only (cited by Lindmark 1992). In contrast to the previous recommendations, in 1981 no 
recommendations on the exact content and procedures of the visits were made. In contrast to 
that, other authors cite the recommendations of a professional working group of the Swedish 
Association of Obstetricians and Gynaecologists from 1989 (Aberg & Lindmark 1992), which 
were shown in Tables 2.5a to c.
United Kingdom
From the UK, it was found that antenatal care was first systematically introduced by the 
Ministry of Health in 1929 (Liu et al. 1992). The traditional schedule parallels the current one of 
several other countries, such as Finland, Germany, The Netherlands and parts of Sweden. 
Within this schedule, antenatal visits were planned monthly until 28 weeks, every two weeks 
until 36 weeks and every week until delivery (Audit Commission of the National Perinatal 
Epidemiology Unit 1998: 25, Jewell et al. 2000). Despite the existence of the traditional 
schedule, there is evidence that up to at least 1992 there seemed to be no singular official
guideline on antenatal care in operation (Liu et al. 1992). Instead, a system was prevalent, in 
which individual health care trusts decided on a care scheme (Audit Commission of the 
National Perinatal Epidemiology Unit 1998: 23). However, in 1998, the National Perinatal 
Epidemiology Unit reported that the government had recommended reviewing the provision of 
antenatal care (Audit Commission of the National Perinatal Epidemiology Unit 1998).
In October 2003, the envisaged guideline on routine antenatal care for the healthy pregnant 
woman was issued (National Collaborating Centre for Women’s and Children’s Health 2003). 
However, it is important to note that the guideline was commissioned by the National Health 
Service National Institute for Clinical Excellence on behalf of the Department of Health and the 
Welsh Assembly Government (NHS National Institute for Clinical Excellence 2002a + b). This 
means that although the guideline is a milestone in the re-organisation of antenatal care in the 
UK, it was set up for the NHS in England and Wales. For Scotland no guideline was found.
After the critical assessment of the new guideline it was concluded that it is based on the most 
extensive critical literature review on the subject to date. All in all, 631 pieces of original 
publications and meta-analyses were analysed by a multi-professional group of nine 
specialists and two consumer representatives. The reviewers analysed in a structured manner 
the literature published to date and clearly specified the methods used for identifying, 
selecting, analysing and integrating the evidence. Also economic data about cost-effectiveness 
were introduced, where available and appropriate. However, as not for all measures there is 
sufficient evidence to come to a unambiguous conclusion, recommendations were classified 
from grades A to D, depending on the robustness of the underlying evidence. In addition to 
these grades, also the label “good practice point” was introduced for recommendations based 
on the view of the guideline development group. It was therefore found that this report provides 
excellent transparency so that a skilled critical reader is able to follow the argument, access 
the underlying literature and draw his or her own conclusions.
However, the guideline is more comprehensive than needed for the thesis. In addition to the 
recommendations about which screening tests should be performed at what time during
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pregnancy, also reference is made to the provision of information, antenatal education and 
lifestyle considerations. Also the issues of where and by whom care should be provided are 
addressed. Although these are necessary components of a comprehensive guideline, these 
aspects will not be covered by the thesis. As the guideline on routine antenatal care for the 
healthy pregnant woman will be discussed in greater detail in all following chapters of the 
thesis, a compilation of recommended tests is not provided here.
2.3.6 Randomised controlled trials comparing different schedules of care
In recent years, attempts have been made to evaluate new, mainly reduced, schedules of care 
by randomised controlled trials. Although ethical aspects have formerly made it nearly 
impossible to alter established and trusted care schemes, such trials recently came to be 
approved for several reasons. The new care schemes are developed by multidisciplinary 
expert panels, which also include consumer representatives. This makes changes acceptable 
to professionals as well as to the recipients of care. Secondly, the care packages do not alter 
the number of visits much, and most of the usual examinations are carried out also within the 
reduced care schemes. Moreover, all women of the study groups are offered the opportunity to 
arrange additional visits, if they feel a necessity for this, or if complications arise. Finally, the 
new care schemes are more and more backed up by scientific analyses of individual measures 
and their clinical effectiveness. Hence, it has become easier to conduct scientific trials with the 
exclusion of ineffective measures than some years ago, when these measures were still 
regarded as effective. The special traits of the trials will be presented in detail in the following, 
but their results are discussed and compared together at the end of this section.
To start with, one systematic review of randomised controlled trials/RCTs of routine antenatal 
care could be identified, which was performed on behalf of the World Health Organization 
(Carroli et al. 2001). The reason for conducting the systematic review was a perceived lack of 
strong evidence on the effectiveness of the content, frequency, and timing of visits in standard 
antenatal care programmes. The main hypothesis was that a model with a lower number of
antenatal visits would be as effective as the standard local antenatal care model in terms of 
clinical outcomes, perceived satisfaction, and costs. All RCTs were considered, which 
compared a model of a lower number of visits with the standard model in the respective 
setting. Finally seven randomised controlled trials were included, involving 57 418 women.
The conclusions to the systematic review were that there were no differences between the new 
and the standard models of care with regard to clinical outcomes (Carroli et al. 2001). This was 
statistically proven by a meta-analysis for all chosen outcome indicators, which were pre­
eclampsia, urinary tract infection, postpartum anaemia, maternal mortality, low birthweight, and 
perinatal mortality. However, the authors state also that the sample sizes were not large 
enough to measure differences in maternal mortality accurately, as the event is rare.
Flaws in the systematic review
Although the statistical analysis is well founded, the systematic review itself has some flaws. 
First of all, the reason for conducting it was a perceived lack of strong evidence on the 
effectiveness of the content, frequency, and timing of visits in standard antenatal care 
programmes. Unfortunately, the study does not contribute information on most of these 
aspects. Despite the acknowledgement of whether care was “goal-oriented” or not, the details 
of the individual models, which were assessed, are not explained in greater detail. This applies 
at least to the published material. Individual measures, such as laboratory tests to screen for 
different conditions are not mentioned. Also no comment was made about the timing of visits. 
All in all, only the frequency, i.e. the absolute number of antenatal appointments, is mentioned. 
Therefore, the review is not able to answer the questions placed by the trigger of the study.
Another problem is that the compared interventions were the provision of a lower number of 
antenatal visits, and a standard programme for antenatal care. All RCTs were considered, 
which compared a model of a lower number of visits with the/a standard model. Despite this 
common trait, a comparison or combination of results is questionable, as the final number of 
visits in the reduced schedules varies between 4 and 12 in studies 2+7 and study 4. This
means that the number of visits in the reduced schedule of one RCT equals the standard 
model of care in another study. In one case, the number of visits in the reduced scheme even 
exceeds the number of scheduled visits for routine care in Europe. It is therefore not surprising 
that clinical outcomes are similarly good, as has been described in study 4.
It has to be noted also that the variation in absolute numbers of visits in the reduced care 
schemes themselves is sufficiently large, as to make a combination of results again difficult. In 
addition to that, the respective reduction in visits varies between approximately 18% and 37% 
in studies 1 and 5. This demonstrates that the true reduction rate in visits varies much greater 
than the commonly achieved reduction of 3 visits suggests. Despite these methodological 
problems, the authors combine the results of all studies without weighting the differences in 
settings, sample sizes, reduction in the number of visits, or the original models of care.
Other questions apply to the outcome indicators pre-eclampsia, urinary tract infection, 
postpartum anaemia, maternal mortality, low birthweight, and perinatal mortality. The authors 
claim that they had selected a priori outcome indicators, “for which antenatal care should have 
an effect”. No further comments were made on how the authors came to this judgement. It 
would have been beneficial if they justified their indicators against scientific evidence, or had 
other explanations for choosing them. Unfortunately, neither is the case. Moreover, it can be 
also asked whether these indicators make sense in every setting. Postpartum anaemia might 
not be a relevant indicator in wealthy settings with only two children per woman, but a very 
relevant indicator in poorer settings, or those with a higher birth rate.
When drawing all above mentioned facts together, it is concluded that a reduction in the 
number of antenatal visits seems to be possible without compromising clinical outcomes. It 
should be nevertheless kept in mind that the measures included in the care packages were not 
made explicit for either one of the models in the systematic review of the WHO. In addition to 
that, three of the underlying studies took place in countries not comparable to the EU. 
Therefore it was decided to analyse those underlying studies of the WHO systematic review in 
detail, which are likely to be relevant for antenatal care in the EU.
The underlying studies of the WHO systematic review
After analysing the studies included in the WHO systematic review in depth, three were chosen 
for closer analysis (McDuffie et al. 1996, Sikorski et al. 1996, Villar et al. 2001). With study 
number 7 one study was dropped, as no reduction of visits was achieved at all, but a goal- 
oriented approach was introduced in antenatal care. In addition to that, the study was 
conducted in a rural area of Zimbabwe, and one of the outcome indicators was the use of rural 
health centres for delivery. It is unlikely, that this study with a total number of antenatal 
appointments of four in the study- as well as in the control population contributes to solve the 
problems currently encountered in the European Union. The same reason led to the decision 
not to analyse study 2, which was also conducted in Zimbabwe. Another study was not used 
for closer analysis due to the high risk of bias. Randomisation problems made the results 
questionable (Binstock & Wolde-Tsadik 1995). A fourth study was not analysed in greater 
detail, as it took place in what the authors called a “free-standing birthing center in southern 
California” (Walker & Koniak-Griffin 1997). The findings of this study are included in the WHO 
systematic review, and do have their due place there. However, it was found that the study 
population within an alternative birth setting in the generally conservative medical system of 
the United States was highly selective. Therefore it was decided not to use this study in greater 
detail. The three remaining studies from the WHO systematic review (Carroli et al. 2001) are 
critically analysed and described in the following.
McDuffie and co-workers conducted from 1992 to 1994 a study in Colorado, including 2.764 
women with diagnosed low-risk singleton pregnancies (McDuffie et al. 1996). They used a 
multi-disciplinary expert panel to develop a schedule with a reduced total number of antenatal 
visits. The schedule defined the exact content and the duration of the visits. After an initial risk 
assessment, the women were randomly allocated to the study group with 9 scheduled visits, 
and the control group, following the traditional care scheme with 14 visits. However, the tests 
performed seemed more or less identical in both groups.
In the new scheme, at the fist visit, a “routine laboratory blood analysis” was carried out,
presumably consisting of at least blood group, Rhesus factor and haemoglobin testing. In 
addition to that, a Papanicolaou smear, a culture for gonorrhoea and testing for chlamydia 
were performed. At 15 through 18 weeks of gestation, a test for maternal serum alpha- 
fetoprotein was offered. Routinely, screening for gestational diabetes was performed by a 1- 
hour glucose tolerance test. The haematocrit was assessed between 24 and 28 gestational 
weeks, and antibody screening was performed at 28 weeks, if the mother was Rhesus 
negative. At each return visit, blood pressure and weight were established, as well as the 
foetal heart rate and the fundal height. Usually, a urine test for glucose and protein was also 
performed (McDuffie et al. 1996). In this context it is interesting to remark that this nearly 
parallels antenatal care for normal pregnancies in Germany.
In contrast to that, the group of Sikorski used care schemes with a more significant change in 
the number of visits (Sikorski et al. 1996). Their control group followed the traditional British 
schedule with 13 visits. The women of the study group with a first pregnancy attended 7 times, 
women with subsequent pregnancies 6 times. The new distribution of visits for primigravidae 
was as follows: booking, then visits at 24, 28, 32, 36, 38 and 40 gestational weeks. For 
subsequent pregnancies, care commenced at 26 gestational weeks after the booking visit, and 
the visit at 28 weeks was left out. Unfortunately, the content of care was not mentioned at all.
When analysing the findings of Sikorski and co-workers, it is definitely noteworthy that a 
reduction in the number of visits does not compromise the clinical outcomes of pregnancy 
(Sikorski et al. 1996). This finding was found to be reinforced by other studies. However, the 
main conclusion of the authors themselves was that a reduced schedule of antenatal visits 
may lead to reduced psychosocial effectiveness and dissatisfaction with the frequency of visits. 
Unfortunately, this study provides insights into the effects of a new care scheme in a local area 
in southeast London, rather than in an entire country or region. Nevertheless, with 2 794 
women taking part in the study, at first sight the sample size appears to be large enough to 
draw some valid conclusions. However, in a letter to the editor of the British Medical Journal, in 
which the study was published, severe critique is uttered (O’Connell 1996). The writer of the
letter found that the study population was recruited from 3 inner city locations in London. 30% 
of the participants of each group were drawn from 8 or more ethnic minorities. Non-participant 
rate was 26.3%, and amongst those who agreed to take part the non-response rate to 
questionnaires on satisfaction ranged from 30% to 37%. The sample is therefore not 
representative for a wider population. In addition to that, the real differences in the findings 
were small, although statistically significant. As the authors of the study described themselves, 
a major problem in reducing the number of antenatal visits is the lack of acceptability to the 
pregnant women themselves. Irrespective of the clinical effectiveness, there seems to be a 
strong emotional binding to the traditional care scheme.
The third study, a large multi-centre randomised controlled trial, was conducted under the 
agenda of the World Health Organization (WHO) in Argentina, Cuba, Saudi Arabia and 
Thailand and included 24.678 women in 53 clinics (Villar et al. 2001). Most important is that 
this study put the focus on a new model of care which highlighted actions known to be effective 
in improving maternal or perinatal outcomes, and not only on a reduction in the number of 
visits. The new schedule of care was compared to the respective care schemes recommended 
by the governments, which were based mainly on the traditional western model of care with 
about 12 visits. In contrast to the studies mentioned before, this WHO-trial used outcome 
measures, which are not that common to be used to evaluate care in more industrialised 
countries. As typical and universal indicators, low birthweight and pre-eclampsia/eclampsia 
were introduced. In addition to those, severe postpartum anaemia and treated urinary tract 
infections were used, indicators that might be more suitable for countries with partially poorer 
living conditions, less access to antibiotics and food supplements, or different nutritional habits. 
This idea is reinforced when the authors mention that multiple dipsticks were given to the 
clinics where urine culture was not possible, and that free folic acid and iron supplements for 
all women at clinics were provided where these have previously not been available.
Most interesting in this study, however, is that an assessment for quality of care and an 
economic evaluation were carried out. In contrast to other authors, Villar and colleagues
(2001) did not randomly allocate women in one site to study or control, but randomised entire 
clinics. This must lead to several specific consequences with regard to the interpretation of 
findings, as confounding factors, such as living conditions, regionally different education and 
training levels, or the motivation of personnel might have had an impact on outcomes.
The results of the studies mentioned were as follows. McDuffie and colleagues found no 
significant differences between the study group with a reduced number of visits and the control 
group (McDuffie et al. 1996). However, the content and schedule of the new model of care was 
described exactly, but the deviations from the old model were not mentioned. The average 
total number of visits did not deviate much from the usual care scheme, with 10.3 +/- 2.8 visits 
compared to 12.9 +/- 2.8 visits. Again it has to be remarked that 10.3 visits on average are 
rather similar to the traditional schedule of care in most European countries. For example, 10 
visits are recommended for normal pregnancies in Denmark and Germany, 12 visits are 
recommended in The Netherlands, Sweden, England, Scotland and Wales (Blondel et al.
1985). A WHO study group found also, that ten countries of the European region have legally 
binding recommendations of 10 to 12 antenatal visits for normal pregnancies (World Health 
Organization 1987:19). However, these are officially recommended numbers, which do not 
necessarily reflect practice; hence they have to be interpreted with caution. Moreover, little is 
known about the actual content of care -  information that might be more interesting than solely 
the number and distribution of visits.
As McDuffie and colleagues, Sikorski and co-workers found also no differences in the clinical 
effectiveness of their new model and the traditional model of care, although their study group 
had only 8.6 visits on average +/- 2.77 (McDuffie et al. 1996, Sikorski et al. 1996. No significant 
differences were found regarding the incidence and potential complications related to 
pregnancy induced hypertensive disorders. Also no significant differences were reported for 
maternal or perinatal morbidity. However, these authors reported poorer psychosocial 
outcomes.
Irrespective of the difficulties with the interpretation of findings as mentioned above, both
authors concluded that they maintained equivalent perinatal outcomes with significantly fewer 
visits (McDuffie et al. 1996, Sikorski et al. 1996). However, it can be debated whether a 
statistical power to detect a 2.5% increase in preterm delivery rates is sensitive enough, as the 
retrospective analysis revealed that the sample size had 80% power to detect a 2% absolute 
increase in the rates of preterm birth and low birthweight (McDuffie et al. 1996). Already in 
monetary terms, it might well be true that an increase in preterm delivery rates by 2% is much 
more expensive than 2.7 visits more for all pregnant women in a certain population, not to 
speak of other ‘costs’ involved, such as grief and other personal and societal ‘prices’ to pay. 
Unfortunately, with such sample sizes and settings, only rises in negative outcomes can be 
measured. A decrease in unwanted side-effects of antenatal care, or positive effects of the 
new care schemes, can not be detected. For measuring a decrease here, much larger 
samples would be required. As a consequence, studies on reducing numbers of antenatal 
visits are not planned to improve care in the sense of improving clinical outcomes, but to 
reduce numbers of visits and thus limit costs without compromising clinical outcomes.
In contrast to the trials conducted in the USA and Britain (McDuffie et al. 1996, Sikorski et al. 
1996), the women in Cuba, Thailand, Saudi Arabia and Argentina had a median of five visits 
only (Villar et al. 2001). However, their control groups had only a median of eight visits, which 
is even less than the study groups in the trials conducted in the USA and Britain. In the WHO 
trial, the authors found in both care schemes similar rates of low birthweight, post partum 
anaemia and urinary tract infections. However, rates for pre-eclampsia and eclampsia were 
slightly higher in the study group with fewer visits. This trend persisted also after correction for 
confounding factors. The results for other clinical outcomes were again similar in both groups.
With regard to the costs involved, it has to be mentioned that calculations were available for 
Thailand and Cuba only. For these countries, the costs involved were calculated per 
pregnancy, including costs for neonatal specialist care, if required. In general terms, costs for 
the standard model of antenatal care were higher than for the new model of care. However, 
the detailed analysis of costs and their distribution goes beyond the scope of this thesis. As a
final thought it might be worth to consider that in the trials in the western countries, only the 
number of visits was reduced, but not the tests. Therefore, the reduction of costs might apply 
to the costs of health personnel, rather than to those for test material, laboratory equipment, 
etc. Relating this back to the member states of the EU, this makes huge differences in the 
potential to save money, as the costs for personnel vary greatly. The financial benefits will be 
much greater in countries where labour is expensive. The poorer countries, where labour is 
cheap, might not benefit as much as hoped for.
Consequences from the literature comparing different schedules of care
Taking all mentioned facts into consideration, it can be concluded that however promising 
results might be, the antenatal care scheme recommended by Villar and colleagues is not 
transferable to Europe (Villar et al. 2001). Pregnant women as well as health professionals 
would hardly be prepared not to have any ultrasound examination for example. By the similar 
good clinical results that could be achieved by each of the tested new models of care in their 
local context, but the somehow limited satisfaction of women with care, it becomes clear that 
antenatal care has to be tailored to the cultural and traditional needs of the populations it is 
planned to serve. These findings demonstrate that current regulations for antenatal care have 
to be carefully analysed, before a common European approach could be developed, which 
leads to similarly good, or even improved clinical and psycho-social results.
From the studies mentioned above, it becomes also evident that there is a worrying lack of 
documentation and communication between countries. An example of this is the fact, that 
researchers of one country assess a ‘new’ model of care, although this kind of care seems to 
be already standard practice in another country. One example for this is the care scheme used 
by McDuffie and colleagues, which is similar to standard practice in Germany (McDuffie et al. 
1996). What makes things complicated is the fact that there is not enough description of the 
details of care for normal pregnancies, their general use and the timing of the respective 
interventions. This need for a detailed description and the need to avoid a multiplication of 
research efforts again highlight the need for an assessment of current guidelines used in the
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countries of the European Union. Despite these needs for further investigation, the WHO 
developed a care model for the European region on the basis of its randomised controlled trial, 
which has been described above (Villar et al. 2001). This new model of antenatal care will be 
analysed in the following section.
2.3.7 The WHO new basic model of antenatal care
The world health organization issues a manual on essential antenatal, perinatal and 
postpartum care, which was especially designed to be used in the European region (World 
Health Organization (n.d.)). Although it was regarded as highly important to compare the 
findings of the study here to the recommendations of the WHO, this will not be possible.
Despite major efforts and multiple enquiries through the secretaries of the European Institute 
of Health and Medical Sciences, it was impossible to obtain a copy of this manual. The 
minimum facts about the manual, which are published on the internet, are that it is available in 
English and Russian for governments, governmental agencies or other organisations. In 
addition, it is stated that there are still wide differences in care and outcomes between the 
countries in the European region, and that the tool of the WHO can help national governments 
to alleviate this. However, although it would have been most important to have the WHO 
manual in hands, the fact that it is targeted at health care providers at peripheral levels, which 
were specified as health centres, health posts and dispensaries, suggests that the focus of the 
WHO is different from this study. This study here uses national guidelines, approaching the 
problem from top down, rather than from the bottom-up perspective. Despite this limitation for 
future comparison, the search for the WHO manual was continued. Although it was finally not 
possible to obtain the manual directly, the Department of Reproductive Health and Research of 
the WHO published a handbook for the implementation of the new model on the internet 
(Department of Reproductive Health and Research (n.d.)). From this, the basic model for 
antenatal care in the European region could be extracted.
When assessing the basic model on essential antenatal, perinatal and postpartum care closer,
which was according to the WHO designed for the European region, it was a surprise to 
discover that it is the same model as the one that had been tested in the randomised 
controlled trial by Villar and colleagues on behalf of the WHO (Villar et al. 2001). As discussed 
in the previous section, the working group of the WHO concluded after the trial that the new 
basic model for antenatal care “provides the benefits of more complicated models while 
tending to save money” (Villar et al. 2001, World Health Organization 2003). However, after 
this randomised controlled trial, the WHO obviously went on to publish the tested model as a 
new basic model for antenatal care that should be introduced in common practice, also in the 
European region. As this thesis aims to explore the options for a common minimum guideline 
for antenatal care in the EU, it became necessary to assess the WHO model for its properties 
for the member states of the European Union, rather than for the entire European region.
Properties of the WHO new model of antenatal care
To start with, it is important to note that the working group of the WHO stated itself that many 
of the underlying studies assessing models for antenatal care have been carried out in 
different settings and countries, and that therefore generalising from the results may be difficult 
(World Health Organization 2003). This is also true for the study of the WHO working group 
itself, especially as the new model was tested in no single European state, but included Cuba, 
Thailand, Saudi Arabia and Argentina (Villar et al. 2001).
The new WHO basic model for antenatal care claims to be based only on measures which 
have been scientifically proven to be effective (World Health Organization 2003). As the model 
is strictly limited to these measures, the authors recommend that it should only be applied to 
women who have no evidence of pregnancy-related complications, medical conditions, or 
major health-related risk factors. When trying to use the WHO guideline for this study, it has to 
be noted that as a major difference the WHO model applies to screening, therapeutic 
interventions and the education of women. This study includes screening tests only. However, 
both guidelines are targeted at healthy pregnant women (World Health Organization 2002: 8).
As the model of the WHO strictly stays within the borders of what has been scientifically 
proven to be effective, only four antenatal visits are recommended. However, the authors also 
warn from the possible side-effects of a radical reduction in contact with the health care system 
during pregnancy. Perceived social support by means of antenatal appointments might be an 
important component of antenatal care in its own right. A reduction of contact might therefore 
have unwanted side-effects. In addition, also the huge gap between the initial visit at probably 
six or eight gestational weeks without any further contact up to the 26th gestational week, might 
lead to dissatisfaction and fears. Although this does not put the idea forward that the WHO 
basic model for antenatal care should be transferred without major adjustments to the EU, it 
demonstrates how far care can be reduced without compromising clinical outcomes.
A problematic aspect of the WHO basic model is that before a woman is eligible for the basic 
model of care, an assessment is made as to exclude all factors which would justify a more 
sophisticated care scheme (Department of Reproductive Health and Research (n.d.), World 
Health Organization 2003). For this initial grouping, a checklist is available. This list consists of 
18 questions about the obstetric history, the current pregnancy and the medical history of the 
pregnant woman. The questions are kept simple and should be answered by yes or no only. 
According to the authors, the questionnaire aims at identifying those approximately 25% of 
women, who require more than basic care. Unfortunately, there is no hint in which sample 
these 25% of women are to be detected. It would be more than helpful to know whether this 
applies to populations in poor countries with their specific risks, or especially to women living 
under relatively affluent circumstances in the western world. It would be crucial to answer this 
question before transferring the WHO basic model to the member states of the EU. It would be 
necessary to test the checklist for initial grouping in western populations, as these are likely to 
carry different risks from the populations of Cuba, Thailand, Saudi Arabia and Argentina.
Although appealing in its nature, it is difficult to think of replacing the established models of 
antenatal care in an EU member state, by that of the WHO. In order to illustrate the scarcity of 
tests and appointments, the full model of basic care is demonstrated in Tables 2.6a to c.
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One of the first problems is the severe reduction in contacts with the health care system and 
the tests performed. It seems unlikely that a woman who had routine antenatal care in 
Germany in a first pregnancy (Bundesausschuss der Arzte und Krankenkassen 2003) could 
accept the WHO model for subsequent ones. As an example, it might be difficult to explain 
why no ultrasound examination is performed at all, when she was told in her first pregnancy 
that at least three such examinations are necessary. The same applies to several other 
examinations. This problem is reinforced by the findings of the WHO systematic review of 
randomised controlled trials of routine antenatal care (Carroli et al. 2001). This study found that 
although clinical outcomes are not compromised by reduced numbers of visits and tests, some 
dissatisfaction with care occurred, particularly among women in more developed countries.
Another important aspect when thinking about the introduction of the WHO basic model is that 
clinicians from the European countries might feel disturbed when they have to change their 
practice back to more manual medicine. Many of them might not be used to perform and rely 
on clinical examinations to test for anaemia, rather than taking blood to check the haemoglobin 
level. The same is likely to occur when clinicians are requested to screen for symptomatic 
sexually transmitted diseases, instead of performing laboratory tests for lues, for example. Also 
the idea of immunising women in the developed countries during pregnancy against tetanus 
has a strange appeal. Moreover, the routine supplementation with iron and folic acid as 
recommended by the basic model of the WHO is often regarded critically by pregnant women 
themselves, and by a significant proportion of health professionals. At this point the latest it 
must be severely doubted that the basic model for antenatal care of the WHO was either 
developed for, or is transferable to the member states of the EU.
This doubt is further aggravated by the weighting of issues within the WHO basic model. Three 
components are postulated as essential. The first one is the screening for health and socio­
economic conditions likely to increase the possibility of adverse outcomes. The second is the 
provision of therapeutic interventions known to be beneficial, and the third component is to 
educate the pregnant woman about planning for safe birth and how to deal with emergencies
during pregnancy. Although all these components are covered by routine antenatal care, e.g. 
in Germany (Bundesausschuss der Arzte und Krankenkassen 2003), they do not have the 
same weighting as in the WHO model. In the traditional western models, screening for socio­
economic conditions plays a minor role. Planning for safe birth and educating for emergencies 
plays also a minor role, as the broad and cheap availability of hospital care is self explaining 
and well established in most of the member states.
Drawing together all the facts discussed above, it can be concluded in line with the WHO itself 
that the recommendations for a basic care scheme are a goal for a minimum level of care for 
all women worldwide (Department of Reproductive Health and Research (n.d.)), rather than as 
a common guideline for antenatal care in the European Union. Although due to the exclusive 
testing in non-European countries doubts are still prevalent, the WHO model might be suitable 
for some of the less developed countries of the European region, with probably less firmly 
established schedules for antenatal care. However, it is concluded that the WHO model is not 
appropriate to be transferred to the member states of the EU. It seems to be more promising to 
build a minimum consensus out of the existing national guidelines, rather than defining a new 
basic model, which does not acknowledge the current situation in the member states of the 
EU. This notion is finally supported by the WHO, which despite the recommendation of the 
very basic model also for the European region, a reduction of the number of antenatal visits in 
existing care schemes is not recommend.
In contrast to recommend leaving the number of antenatal visits unaltered, the Antenatal Care 
Trial Research Group of the WHO (World Health Organization 2002) concluded also that in 
developed countries, each activity included in standard antenatal care should be scrutinized or 
tested for evidence of its effectiveness before being retained in the standard model. However, 
if this was systematically applied, this would lead directly to the basic WHO model. According 
to the authors, only measures with scientifically proven effectiveness are retained in the basic 
model for antenatal care. As a consequence, a common minimum guideline seems to be a 
suitable step forward, when it is based on a practicable compromise of scientifically proven
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evidence of effectiveness, but also on current care schemes in the member states of the EU. 
The necessity of such a step is, despite all critique, documented well by the most important 
statements of the WHO on antenatal care (World Health Organization 2002). Firstly, the main 
issue is the need to evaluate the content of antenatal care and to determine it in a balanced 
manner so that the individual receives appropriate care. Secondly, it has to be considered that 
in some countries medico-legal pressures, or other influences, make it difficult to cut unneeded 
services. Finding a common basis for antenatal care in the EU requires action of policy­
makers, rather than that of the individual providers, or individual member states. Only this 
could be a true step forward.
2.3.8 Conclusions to the review on antenatal care in the member states
One of the main objectives set out at the beginning of the thesis was to conduct a systematic 
review of the literature of the best available sources with regard to antenatal care within all 
member states of the European Union. Through the subsequent critical analysis of the current 
knowledge in the field, gaps and weaknesses in the literature were identified. This applies to 
knowledge about the content of official guidelines as well as to actual care practice.
Although some studies were identified that compared at least antenatal care practice from 
several countries, in the best case, eight of the former 15 member states were included.
Hence, information about seventeen other members of today’s union is missing. On the one 
hand, this is due to the time when the studies were conducted, on the other hand, either not all 
countries responded, or it was not reported why some countries were included and others not.
Moreover, it was found that nearly all of the 15 member states of before May 2004 have some 
kind of official guideline, but only for two states these guidelines were accessible. For all other 
countries, information was extracted as a by-product of studies occupied with antenatal care in 
the widest sense. This made the literature review extensive, but left the results unsatisfactory. 
What became clearly evident was that the obvious lack of knowledge and documentation has
detrimental effects on subsequent studies and care. Much effort could be saved, if the current 
situation was analysed properly and if the results were made easily accessible. Based on the 
findings of the systematic review it was concluded that there is a sufficiently large gap in the 
literature as to justify an investigation into the subject.
Analysing the currently available literature on randomised controlled trials comparing different 
schedules of care, and a systematic review of such trials, it was found that a reduction in the 
number of antenatal visits is clinically safe. There are no more detrimental clinical outcomes 
with regard to pre-eclampsia, urinary tract infection, postpartum anaemia, maternal mortality, 
and low birthweight. Unfortunately, some dissatisfaction among pregnant women was found 
with a reduced schedule of care. However, lower costs were achievable with such a schedule.
During the review on antenatal care it was also found that the World Health Organization 
established a new basic model for antenatal care, claiming that it would also be useful for the 
countries of the European region. As this model is suggested by one of the most influential 
organisations in the international health sector, this new basic model was analysed with regard 
to its properties for EU member states. Despite the credibility of the recommending 
organisation it was found that although the model is also recommended for the countries of the 
European region, it should not be transferred to the member states of the EU without major 
adoptions. However, by this analysis, the idea that a common minimum guideline would be 
beneficial also for the member states of the EU was reinforced.
2.4 Implications, advantages and disadvantages of guidelines
An operational definition of guidelines and their aims
A wealth of national as well as international publications from electronic as well as print media 
was identified, which are concerned with guidelines for clinical practice. In one of these 
publications (Harrison et al. 2002b), guidelines were defined as being
“essentially algorithmic formulations that guide their users to courses of (diagnostic or 
therapeutic) action, dependent upon stated prior conditions, though they do not necessarily 
claim to determine clinical action completely.”
However, an easier definition (Field & Lohr cited by European Commission Directorate 
General for Employment, Industrial Relations and Social Affairs 1999: 41) is that they are
“systematically developed statements to assist practitioner and patient decisions about 
appropriate health care for specific clinical circumstances.”
Both definitions try to capture the nature of guidelines by highlighting the fact that guidelines 
have the aim to guide or recommend a certain course of action, rather than to prescribe it. 
However, for the study here, ‘guidelines’ needed to be operationally defined and set into the 
context of antenatal care in the EU. First of all, a precisely defined prior condition is required, 
to which the guideline relates. For this study, this is uncomplicated singleton pregnancies in 
healthy women. The required action is the baseline clinical care for them (National 
Collaborating Centre for Women’s and Children’s Health 2003). Baseline clinical care is 
additionally limited to diagnostic tests only. Preventive interventions, such as the administration 
of anti-D immunoglobulin for Rhesus negative women, are excluded. In addition, guidelines are 
limited to national guidelines. Clinical guidelines from individual trusts, hospitals, or other 
settings are not considered. For the thesis, the focus is put onto the entire population of 
pregnant women, thus conceptualising antenatal care as public health issue. Budgetary 
constraints and the need to allocate limited resources require decisions on the population level 
when setting up guidelines. However, the fact that care needs to be adapted to the individual 
pregnant woman is not neglected. The entire population refers to the sum of all pregnant 
women of the EU, or to the pregnant women of the individual member states, where indicated. 
On the basis of this operational definition, the review on the implications, advantages and 
disadvantages of guidelines commenced.
In addition to the definition of guidelines, a concise description of their aims was found. This
stated that it is the aim of guidelines to assure and to improve continually a high level of health 
care for the public, to avoid outdated and possibly harmful interventions, also leading to 
unnecessary costs. In addition, guidelines intend to stimulate evidence-based and cost- 
effective care, respecting individual patient’s needs and wishes. Another aim is to keep the 
public informed about the latest state of the art in the health field (Bundesarztekammer & 
Kassenarztliche Bundesvereinigung 1997). Although this is an excellent description of what 
guidelines can achieve, it has nevertheless to be doubted, that all guidelines can fulfil this 
ambitious aims. The continuous inclusion of newly acquired evidence can improve care. 
However, it is a major task to constantly review and include upcoming evidence.
Moreover, there might be also conflicts of interest, which need to be outweighed against each 
other. As an example, it might be that a new diagnostic test is effective for detecting a 
condition. However, if the condition is rare, cost-effectiveness will not be achieved. Yet another 
problem of the above mentioned aims might be that there are tests, which are statistically 
found not to be effective according to the protocol of a randomised controlled trial. 
Nevertheless, the same tests might be well known and perceived as reassuring by pregnant 
women, e.g. from previous pregnancies. Excluding such measures from a guideline might 
have negative effects outside the realm of clinical effectiveness. From this argument it 
becomes clear that the process of setting up guidelines is not a linear one. It always needs a 
person to weigh the evidence, and to finally decide. This will be explored in the section on 
evidence-based health care. Up to this discussion, a preliminary and less ambitious synthesis 
of the definitions and aims will be used. Until then, guidelines are defined as a straightforward 
way to integrate scientific evidence into practice.
Potential advantages and disadvantages of guidelines
When exploring the disadvantages of guidelines, a common critique is that the individual 
situation of a patient might not be considered, i.e. that the attempt to standardise care ignores 
the heterogeneity of patients and the complexity of medical decisions (Woolf cited by 
European Commission Directorate General for Employment, Industrial Relations and Social
Affairs 1999: 45). This argument might lead to the idea that guidelines should be regarded as a 
suitable instrument to decide about the care for entire populations, but not for the care of 
individuals. However, the same critics could argue that a guideline for a population, e.g. 
pregnant women in the United Kingdom, does not consider the special circumstances of a 
group of vegans living in a small town in Yorkshire. Guidelines have clear advantages on local, 
as well as on population level. Avoiding the use of guidelines would be a rushed measure, 
eradicating the advantages of guidelines together with their limiting factors. It might be better to 
acknowledge the requesting character of guidelines with regard to adopting the content to the 
individual situation of a pregnant woman, a state, or even a confederation of states, such as 
the EU. Guidelines enable individuals to tailor care to specific needs. In the sense of the word, 
they guide decisions, rather than prescribing a certain way of action. Guidelines should only be 
used in combination with the clinical expertise of the health care practitioner and the individual 
preferences of the recipient of care. Hence, using guidelines does not mean to follow a strict 
schedule for all patients with the same diagnosis, but to provide clear high-quality guidelines 
that can and should be adapted to the individual situation of patients as well as to the specific 
situation of countries, when a national guideline is concerned (Europarat 2001:18, Sackett et 
al. 1997). Evidence-based guidelines therefore lay only the basis for individual care decisions.
However, another facet of the same point of critique is that the practitioner will be limited in his 
or her clinical judgement (Harrison et al. 2002b). In contrast to that, it could be also argued that 
a guideline of high quality, which is regularly updated, helps the practitioner to stay up to date 
in a challenging environment. The enthusiasm of health professionals to permanently update 
their knowledge should probably not be overestimated.
A clear advantage of guidelines could be that they are a way to demonstrate the scientific 
basis of the work of health professionals. By issuing well founded guidelines, a profession 
gains trustworthiness and enhances its status. However, this is likely to apply more to 
professions with a lower status (Berg 1997 cited by Harrison et al. 2002b). Groups with a 
higher professional status, e.g. medical doctors, were found to have a tendency to being bored
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by clinical guidelines. They tend to have less positive attitudes on guidelines than e.g. nurses 
(Harrison et al. 2002b). However, the professionals with a higher status might have other 
reasons for interest in guidelines. For them, guidelines can be an instrument to delegate less 
popular or routine work to other professions, mainly some way down the hierarchical ladder. 
This was demonstrated for general practitioners and practice nurses in England (Harrison et al. 
2002b). Transferred to antenatal care, the same mechanisms might apply. In countries with 
obstetricians as the lead professionals for antenatal care, midwives might be occupied with 
routine tasks, while the obstetrician has the competence to explain the results to the woman. 
This can end up with a midwife taking bloods and blood pressure as an auxiliary to the 
obstetrician, with the latter being the one in charge of care.
However, also professionals from groups with a higher status have negative attitudes towards 
guidelines. This group was found to fear that professional elites use guidelines as an 
instrument to diminish the professional independence and status of other members of their 
own profession (Harrison et al. 2002b). Yet another common suspicion is that the intent of 
guidelines is a managerial one which diminishes the independence and role of the health 
profession as such through bureaucratic rules (Harrison et al. 2002b).
In contrast to the negative argument from diverse standpoints, a positive view is that guidelines 
can be a tool to protect practitioners from medico-legal claims (Harrison et al. 2002b).
Adhering to a guideline places a practitioner on the safe side, especially if the guideline was 
issued by a person or organisation of high profile. However, others again fear the opposite, 
with practitioners being assailable, if they do not follow the “arbitrary standards proclaimed by 
guidelines” (Hyams et al. 1996 cited by European Commission Directorate General for 
Employment, Industrial Relations and Social Affairs 1999: 46).
This debate offers valuable insights into the possible ‘dark sides’ of guidelines. They have the 
potential to being used as an instrument to exert power, forcing individual practitioners or other 
professions into directions, which they would have perceived as unfavourable otherwise. It 
might be that there are conflicts of interest between stakeholders. An individual pregnant
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woman is likely to have other priorities as have the professions occupied with antenatal care. 
Also the interests of policy makers, the users of guidelines and the recipients of care are 
unlikely to be congruent in every aspect. This highlights the need to critically assess the quality 
of a guideline, together with a clear identification of the issuing body and its aims. A critical 
mind can not be overestimated. Even guidelines of superb quality, issued by well respected 
authorities should not be obeyed without critical thinking.
Besides the aspects already discussed, there are other factors limiting the positive potential of 
guidelines. One of these is the fact that they are only one instrument to enhance the quality of 
health care. Considering this, their relative expensiveness is clearly counterproductive for the 
broad use of guidelines. The estimated costs to set up a clinical guideline are 200.000 US 
Dollars in Germany (114.000 GBP), and about 900.000 US Dollars (513.000 GBP) in “other 
countries” (Merten 2006). Unfortunately, these countries were not specified, and the sources of 
the information are not quoted. Despite this, the reliability of the information is enhanced by the 
fact that the information about German guidelines stems from one of the members of the 
German office of the institution for quality assurance in medicine. These sums become 
plausible when considering that the development of a good guideline takes several months 
(Europarat 2001: 25). However, although important and interesting, this thesis will neither 
cover the monetary aspects of guidelines, nor will it investigate into the dissemination, 
implementation, or the uptake of them (Ollenschlager et al. (n.d.)). All these aspects are 
relevant after a guideline of high quality has been set up, but represent a field for research on 
their own. Trying to include them would have led too far from the focus of the study. Moreover, 
e.g. the monetary consequences of a guideline are assessed better by health economists. 
Other disciplines are suited better to assess whether the potential savings on the basis of a 
guideline outweighs its costs, in case the guideline is adhered to.
In addition to the monetary and political implications guidelines have, there are also ethical 
aspects to consider in the context of setting up and issuing guidelines on antenatal care.
These are addressed in the following section, together with the ethical implications of a
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potential common minimum guideline for the European Union.
2.4.1 Ethical implications of guidelines
Much of the advantages and disadvantages of guidelines has been already discussed in the 
previous section. Despite this, the main conclusions will be summarised and assessed for their 
ethical implications in the following. First and foremost it was stated that it is the aim of 
guidelines to assure and to improve continually a high level of health care for the public, to 
avoid outdated and possibly harmful interventions, also leading to unnecessary costs. In 
addition, guidelines intend to stimulate evidence-based and cost-effective care, respecting 
individual patient’s needs and wishes (Bundesarztekammer & Kassenarztliche 
Bundesvereinigung 1997). However, it was also concluded that this is what guidelines can 
achieve in the best case, but that it can be doubted that all guidelines fulfil this. It is therefore of 
utmost importance to ensure the highest possible quality to ensure that a guideline is ethical.
A common point of critique was the idea that the individual situation of a patient might not be 
considered, i.e. that the attempt to standardise care potentially ignores the heterogeneity of 
patients and the complexity of medical decisions (Woolf cited by European Commission 
Directorate General for Employment, Industrial Relations and Social Affairs 1999:45).
Although this fear of guidelines making care formal and not responsive to the individual’s 
needs, this is not necessarily the case. In the sense of the word, they guide decisions, rather 
than prescribing a certain way of action. Another facet of the same critique is that the 
practitioner will be limited in clinical judgement (Harrison et al. 2002b). However, the opposite 
can apply, if a guideline of high quality helps the practitioner to stay up to date in a challenging 
environment, as they readily present the evidences of the medical part of decisions. It can be 
concluded that guidelines recommend a pathway, on the basis of which choices should still 
made by clinicians and pregnant women themselves.
Despite their ability to put the focus on effective measures of antenatal care, guidelines might
also have the negative effect of focusing care on medical aspects. Moreover, when following a 
pre-defined scheme of care, routine and a false feeling of security can become evident. When 
this occurs, important personal and psycho-social issues can easily be overlooked, which 
means that valuable components of antenatal care are lost. In contrast to that, it can be argued 
that guidelines save resources by freeing up time of practitioners for other tasks, such as 
exploring the pregnant woman’s preferences and her non-medical needs.
Another important issue is the fear that professional elites could use guidelines as an 
instrument to diminish the professional independence and status of other members of their 
own profession (Harrison et al. 2002b). If guidelines are issued by institutions other than the 
professional organisations themselves, such as by the Ministry of Health, or a group that has 
several members from funding bodies, there might be fears that the intent of guidelines is a 
managerial one which diminishes the independence and role of the health profession as such 
through bureaucratic rules (Harrison et al. 2002b). Guidelines therefore need not necessarily 
be ethical, as they have the potential to being used as an instrument to exert power, forcing 
individual practitioners, other professions, or members of the own profession into directions, 
which they would not have pursued otherwise.
Despite the above argument of ethical implications of guidelines of high or questionable quality 
and the possible unethical use of guidelines to reach other aims than ensuring the best 
possible care, the most important positive ethical effect of guidelines should not be overlooked. 
This is the fact that guidelines have the potential to limit or prevent unequal treatment due to 
gender, native origin or social status. When health care professionals are obliged by guidelines 
to provide a certain extent of care, deviations from routine practice have to be justified. This 
means that exceptions can be made when certain circumstances from sides of a pregnant 
woman suggest this, but not for reasons of withholding effective care from individuals or 
groups due to the idea that they are not worth a measure. Guidelines therefore help to ensure 
that a useful amount of care is provided on a broad basis.
From the above argument it can be concluded that guidelines should not be declared as
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ethically questionable for principal reasons, nor does it say that whatever is recommended by 
guidelines is ethically justified. Guidelines can be instruments for implementing ethical 
standards in antenatal care, but this is not necessarily the case. Much depends on the content 
of guidelines, which will be critically discussed in the following.
2.4.2 Ethical challenges when setting up guidelines on antenatal care
When dealing with antenatal care on the population level, the crucial question is how limited 
resources can be used best. The WHO (World Health Organization 2003) summarised this 
problem stating that the central ethical problem in antenatal care relates to access, questioning 
whether it would be ethical to refuse the routine provision of interventions with proven benefit. 
However, the WHO also questions whether it would be ethical to provide intensive antenatal 
care to low-risk women, thus wasting scarce resources that could be used elsewhere.
As this statement poses more than one question, it is necessary to disentangle the underlying 
aspects. To highlight the ethical questions arising when setting up guidelines on population or 
national level, the key ethical principles of deontology and utilitarianism will provide a 
framework for the discussion. To start with, the question will be addressed of whether it is 
ethical not to provide an intervention routinely, when benefits for maternal and child health are 
clear. Directly related to this is the question of whether it is ethical to provide intensive 
antenatal care to low-risk women, wasting scarce resources that could be used elsewhere.
One factor limiting the positive potential of guidelines is that they are only one instrument to 
enhance the quality of care, but that they are relatively expensive. The costs to set up a clinical 
guideline were estimated as 200 000 US Dollars in Germany (114 000 GBP), and about 900 
000 US Dollars (513 000 GBP) in “other countries” (Merten 2006). These sums become 
plausible when considering that the development of a good guideline takes several months 
(Europarat 2001: 25), and involves a multidisciplinary team of experts and lay representatives 
(National Collaborating Centre for Women’s and Children’s Health 2003). As this means that
money is used for setting up guidelines, rather than for the care itself, it can be argued that this 
wastes valuable money for managerial activities.
However, it can also be argued that a guideline based on the assessment of the monetary 
consequences of different courses of action can help to save resources, and to allocate them 
most effectively. According to utilitarian ethics, this course of action is justified as it helps to 
bring the highest benefit for the greatest number of people (Montgomerie 2000, Wikipedia 
2006b). However, this applies only as long as the costs for setting up a guideline do not 
outweigh its benefits. Health economists are able to assess whether the costs from introducing 
a screening test on a routine basis are outweighed by the reduction of treatment costs if the 
condition goes undetected. It is also possible to calculate the costs for setting up a guideline 
and to subsequently compare them to the savings from using it.
Conflicting interests
However, the monetary implications of guidelines are relatively easy to calculate. Much more 
problematic are conflicts of interest, or when non-monetary factors need to be weighed up 
against each other. Although theoretically possible, the scenario of a routine screening test 
and the subsequent treatment of the detected condition being cheaper than the treatment of a 
higher number of the same undiagnosed condition pictures an ideal situation. A less 
favourable option would be that a new diagnostic test is effective for detecting a condition, but 
that the condition is rare, and cost-effectiveness will not be achieved. In such cases the 
question arises of whether the test should be performed although the money could be used for 
effective tests that screen for more common conditions. But how to decide if the test has a 
slightly lower predictive value as the one, which screens for the rare condition? How to decide, 
if for one condition no treatment exists? And how to decide, if no treatment exists, but the 
termination of an affected pregnancy saves such amounts of money as to enable better 
screening for many others?
Yet anther problem is that there are tests, which statistically are found not to be effective for
detecting a clinical condition. Nevertheless, the same tests might be well known and perceived 
as reassuring by pregnant women, such as the auscultation of the foetal heart rate (National 
Collaborating Centre for Women’s and Children’s Health 2003). Excluding such measures from 
routine action might have negative effects other than clinical effectiveness. This would mean 
that the test is not effective in the sense of detecting a condition, but in providing reassurance 
to the women. Should such a test be performed? What, if the test is cheap? What, if the test 
has the potential to frighten some women by false positive results? The International 
Confederation of Midwives international code of ethics for midwives (International 
Confederation of Midwives 1999) suggests that midwives and women should work with policy 
and funding agencies to define women's needs for health services. This will ensure that 
resources are allocated considering priorities, therefore ensuring justice and fairness.
The last question arising from the above statement from the WHO is whether it is ethical to 
provide intensive antenatal care to low-risk pregnant women, which perhaps causes harm to 
them (World Health Organization 2003). This means that in addition to the process of 
optimising effectiveness and efficiency of actions, also risks arising from procedures need to 
be reduced as far as possible (Seedhouse 1998:209). However, this situation is further 
complicated by the fact that positive as well as negative effects are likely to be weighted 
differently by different persons, populations and institutions. Such questions are usually 
addressed by philosophers, rather than by health professionals.
The position of deontologists
The proponents of deontologist ethics state that praiseworthy goals can never justify immoral 
actions. In brief, one of the most important statements of deontology is that ends do not justify 
the means. According to deontologists, decisions should be made solely or primarily by 
considering one's duties and the rights of others. It claims that a priori moral obligations exist 
that do not change merely as a result of a change in circumstances (Wikipedia 2006a). In 
further explorations of deontological ethics, the distinction between the right and the good was 
explained. It was stated that whereas utilitarianism argues or assumes that an act is right and
should be carried out, if it maximizes the good, deontological theories assert that an act can 
maximize the good, but still be wrong. An act should therefore not be carried out if it violates 
some deontological principle, such as a right or a duty (Rawls cited by Wikipedia 2006a). 
Deontologists therefore believe that actions can be inherently right or wrong, irrespective of 
their consequences (Montgomerie 2000).
Applying the principles of deontology to antenatal care would lead to a major reduction in the 
number of tests performed. Tests with the potential to lead to false positive results are likely to 
be questionable according to deontological ethics. They have the potential to be beneficial for 
some pregnant women, but to hurt others. The same applies to tests, which carry a risk of 
following complications, such as miscarriage after amniocentesis. However, questions remain 
as long as the relation between the mother and the foetus is not defined. If the foetus is 
defined as a person in his or her own right, it would be immoral to terminate a pregnancy, 
when i.e. a genetic disorder was diagnosed. If the foetus is not defined as a person with own 
human rights, it might be possible that deontologists accept the termination of pregnancy. The 
law would then be that the mother’s rights prevail as long as the foetus is in utero.
Utilitarian philosophers’ views
In contrast to deontologists’ views, utilitarian philosophers claim that a measure is justified, if 
more people benefit from an action than are harmed by it. Utilitarianism is a theory of ethics 
that prescribes the quantitative maximization of good consequences for a population. Although 
happiness is usually named as the classical wanted outcome of utilitarian ethics, other 
consequentialists argued that consequences such as justice or equality should also be valued, 
regardless if they increase happiness or not. According to utilitarianism, ends can justify the 
means because decisions are judged primarily in terms of their consequences (Wikipedia 
2006a + 2006b). In its final consequence, this theory provosts that harm to one individual may 
be sanctioned if it is for the benefit of a larger group (Coldicott et al. 2003). A concise definition 
is that utilitarianism is the doctrine that the morally right thing to do is whatever produces the 
greatest good for the greatest number...” (Montgomerie 2000).
When using utilitarian ethics to re-think antenatal care, negative utilitarianism might also be 
applicable. In contrast to utilitarian theories that deal with producing the greatest amount of 
good for the greatest number, negative utilitarianism requires to prevent the greatest amount of 
harm for the greatest number of people. This was proposed according to the idea that the 
greatest harms are more consequential than the greatest goods (Wikipedia 2006b).
However, there are several issues that need discussion, before using utilitarianism to make 
decisions on antenatal care. First of all, this is the statement that utilitarianists judge all actions 
by their ability to maximise good consequences, and that this always justifies harm to a single 
individual, if there is a greater gain to other individuals. However, it is clearly stated that this is 
only true if either the number of those who benefit is sufficiently large to outweigh the loss for 
the individual, or the gain for a few is larger than the loss for the individual (Wikipedia 2006b). 
When applying this to antenatal care, the problem becomes evident. How to compare the 
grievance from the termination of a pregnancy on the basis of a false positive test result 
against the relief of the termination of a pregnancy with a truly affected foetus? Is the 
grievance outweighing one relieved mother, or two, or are loss and gain balanced, when one 
hundred were diagnosed correctly? This example demonstrates well the difficulty of calculating 
happiness or harm. Even more difficult is the situation, when happiness, or grievance, need to 
be compared to monetary factors, which then can be subsequently used to do good things. 
Would it be justified to force a woman to terminate an unhealthy pregnancy, to enable better 
care for several women with lower risk? Although it is of vital importance that each society 
finds its own standpoint within such discussions, it has to be kept in mind that other laws and 
principles should not violated, such as human rights, which are not negotiable.
Summary of the implications, advantages and disadvantages of guidelines
In the above discussion, extreme examples were used, which lay mostly in the realm of 
prenatal diagnosis. This was done to illustrate the ethical and moral implications of any tests 
performed during the antenatal period more clearly. However, also the ethical theories 
presented can have extreme implications, if used consequently. The most radical version of
utilitarianism could, for example, mean the complete cessation of antenatal care, if money 
would do more good if used for other things, such as free housing for everyone. If 
deontological ethics were applied consequently, antenatal care would be also reduced to an 
absolute minimum of measures, which are 100% safe. However, antenatal care for healthy 
pregnant women is different from such extremes.
In current practice, guidelines on antenatal care seem to represent something that might be 
called a system immanent utilitarian approach with a moral component. Within the system, as 
money is set aside specifically for antenatal care. Within this budget, the money is used for 
those measures that produce the most good. The moral component, however, ensures that 
ends do not justify means in any case. Care is taken not to harm individuals for the benefit of 
others. However, what also became clear from the above examples is that values are difficult 
to assess, but are most influential in antenatal screening.
In addition to the above mentioned ‘extrinsic’ problems of guidelines, which have to do with 
questions of whether guidelines as such are a good thing, they might have also problems and 
limitations in themselves. However, as the evaluation of guidelines is not yet familiar to the 
average practitioner, it is of utmost importance that guidelines fulfil certain standards, and are 
labelled according to their properties. Those standards, as well as the currently available 
instruments for the appraisal of guidelines are explored in the corresponding section on 
material and methodology. This theoretical discourse on the quality of guidelines will contribute 
to shed light onto the ‘intrinsic’ problems of guidelines that need consideration.
Chapter 3 - Material and methodology
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3.1 Introduction
After the initial review of the literature it became clear that the objective of Phase 1 of the 
study, i.e. the critical appraisal of the relation between evidence-based guidelines and 
guidelines based on expert opinion, can not be reached by a simple review of the literature. In 
order to achieve the objective, the paradigms underlying and the methods for setting up 
guidelines needed to be theoretically discerned and analysed.
From the literature it was also found that the quality of guidelines is of overriding importance, 
but that the concept of guideline quality is difficult to grasp. It was therefore decided that a 
theoretical discourse on the quality of guidelines will contribute to shed light onto the ‘intrinsic’ 
problems of guidelines, and also the nature of evidence will be addressed. To achieve this, a 
critical analysis of the literature will be conducted with the intent of a concept analysis on the 
theoretical basis and the quality of guidelines, treating the literature as secondary data. This 
analysis is demonstrated in Part 1 of the following chapter.
Part 2 of the chapter is focused on the current health policy of the European Union and the 
strategies of decision-making on European level, as these two themes lay the basis for the 
research. Based on the concept analyses from Parts 1 and 2 of this chapter, the research plan 
will be further specified and presented in Part 3 of this chapter.
Finally, the study uses a mixed methods approach, consisting of a survey, an extensive critical 
review of the literature and of the state of the art, theoretically discerning and analysing the 
paradigms underlying and the methods for setting up evidence-based guidelines and 
guidelines based on expert opinion, and a critical in-depth appraisal of two national guidelines. 
Although an established instrument is used for the appraisal of the guidelines, the method for 
this part of the study was amended. Despite using simply the recommended number of four 
appraisers with unspecified qualifications, a panel of experts was selected purposefully in
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order to elicit informed judgements about the quality of the two national guidelines on antenatal 
care from England and Wales and Germany. Special care was taken to relate the 
interpretations of the experts back to the original guidelines, bringing up their individual 
professional views. This approach was chosen as the theoretical analysis of the state of the art 
demonstrated the relative nature of evidence and the need for expert judgement to make good 
policy decisions.
3.2 Selection and use of material for the concept analysis
It is the aim of this part of the review to describe and analyse the conceptual underpinnings of 
the research problem. This section is therefore less practice, but more theory-oriented. 
Concepts are operationally defined as abstractions of observable phenomena (Polit & Hungler 
1999:125). Only by defining and operationalising the underlying concepts, the findings of the 
study will become meaningful and generalisable, and enable an evaluation of what can be 
learned from the collective application of the findings. Conceptual clarity will be achieved by a 
comprehensive quantitative overview of the concepts, their theoretical discussion and the 
synthesis of the theoretical framework at the end. The relationship between and the trends 
within the concepts are to be analysed and made explicit. However, it has to be kept in mind 
that although the findings should be generalisable to some degree, the concepts are analysed 
in the direct context of the study, which is antenatal care in the EU.
In contrast to problems with a clearly formulated research question, a concept analysis is not 
approachable by means of a systematic review of the literature in the classical sense. For 
clinical questions, there are preferred corresponding research designs, such as randomised 
controlled trials or cohort studies with accepted criteria for assessing their respective validity. 
With them, informative empirical answers should be given to scientific research questions 
(NHS Centre for Reviews and Dissemination 2001). However, when addressing complex 
phenomena, there are less direct links to study designs and their validity (Greenhalgh 2003). In
addition to that, a review of theories and concepts means to explore intellectual ideas of 
different validity. This was thought to be best assessed by a broad exploration of the concepts 
related to the study. Therefore, it was decided to conduct a comprehensive critical descriptive 
review of the state of the art with open questions. Evidence from scientific studies is critically 
appraised and subsequently synthesised with evidence from other sources, such as 
publications on methodology, theoretical discourses, conceptual literature, textbooks, 
newspapers and consultations with experts. Citation tracks are followed up, and a 
comprehensive picture will evolve of how the concepts and ideas from different authors relate 
to each other. This methodology was recommended as being acceptable to approach the 
conceptual literature by a consulted expert for health policy (Harrison 2005).
In order to get an impression of the wider context of the research problem, the review of the 
state of the art commenced with a broad reading on the subjects identified during the 
systematic review on antenatal care in the EU. The evolving ideas were followed up and 
constantly refined through a more and more focused search on the key concepts and theories. 
This means that again narrative analysis was the method of choice, with the presentation of 
findings under a series of subheadings and a commentary relating to them (Forbes & Griffiths 
2002). Care was taken to consider not only material which reinforced an idea, but to search for 
contradictions and gaps in the literature, as well as for publications challenging an idea. It was 
considered to be of utmost importance to keep this critical stance throughout.
With regard to the depth of the review, it was aimed at providing a comprehensive thematic 
analysis of the key concepts and theories that are important to the study. All relevant concepts 
should be identified, together with the arguments in favour and against them. The aim was 
therefore to be comprehensive with regard to the concepts and the issues around them, but 
not with regard to identifying all publications concerned with them. All aspects that develop a 
concept further should be included in the final review. However, the focus was put on the 
saturation with regard to having explored the entire properties of a concept, rather than having 
read all publications on it. Searching and reading commenced until no new aspects relevant to
the study were found, or when the point was reached at which authors seemed to cite each 
other. These searches were conducted throughout the entire process of the thesis.
The overall thematic analysis of the key concepts and theories should acknowledge their core 
facets, the specific strengths and weaknesses in general, as well as in relation to the focus of 
the study. The outcome of this section takes the form of a theoretical discussion, trying to 
depict the relationship between, the trends within and the discussions around the identified 
concepts. Consistencies as well as contradictions should become clear. Possible explanations 
for the contradictions, such as different conceptualisations are made explicit. At the end of this, 
the theoretical stance of the study within the current debates should become evident.
An important factor in the review of concepts is the rigour of the method, which is applied. This 
is demonstrated by providing a detailed track record of the searches. Special care is taken to 
describe the data sources and the methods used for the identification of publications alongside 
the concept analysis. From this it should become evident, how the themes for the theoretical 
discussion emerged during the review process, and how they are used.
However, the application of uniform and rigorous standards of appraisal is also essential to 
synthesise the available evidence critically and concisely. For this, a pre-defined set of 
questions was used to guide the review. The questions guiding the critical exploration of the 
concepts were derived from deductive reasoning, publications of previous research and the 
conceptual literature. The questions applied to each idea were the following:
- Is the described aspect of relevance to the study?
- Is the (methodological) quality of the material such as to justify its inclusion?
- Is the argument plausible (face validity)?
- Are there other explanations?
- Is it an opinion or a theory?
- Is there more than one author / group of authors reporting the phenomenon?
- Is there literature from other disciplines reinforcing the ideas?
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- What is the relation to other literature (does it fit into the picture, or is it a different view)?
- What are the strengths and weaknesses of this concept?
- How do the ideas relate to antenatal care?
- How do the ideas relate to the European Union?
- What are the implications of these ideas on EU-level?
- Is there a need to continue reading?
Themes evolving from the reviews on antenatal care and the implications of guidelines
A variety of themes and issues arose from the review process on antenatal care, which was 
described in the literature review. During this review, the initial concepts of interest to the study 
were identified. The first and foremost aspect that needed thorough consideration was 
guidelines as such, which was partially presented in the literature review. However, during 
these initial reviews, themes emerged, which needed to be followed up. These were:
- the need to discriminate between the concepts ‘guideline’ and ‘recommendations’,
- the appraisal of guideline quality,
- the question of what ‘evidence’ really is and
- how evidence of different sources and qualities should be handled.
Especially during the reading process on the last two aspects, it was found that the concepts
- evidence-based medicine / health care / policy and
- the diverse aspects of making and assessing health policy
play an important role for the thesis and need further exploration. These will be presented in 
the following section.
Part 1 -  The theoretical basis of guidelines
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3.3 Guidelines
3.3.1 The quality of guidelines
On the basis of the literature review on the implications, advantages and disadvantages of 
guidelines it was concluded that a search for existing national guidelines on antenatal care 
does not suffice for the purposes of the study. For the clarification of concepts, the search 
commenced with a broad reading on the subject, as has been described in the section of 
selection and use of the literature. Starting from the aforementioned textbooks, the search to 
determine the current state of the art developed into the national as well as international 
websites on the development and appraisal of guidelines for clinical practice. They provide 
search engines and links to each other, leading step by step into the depth of concepts, as well 
as to the original papers. As the references for the original literature are cited alongside the 
evidence used in the review, only the organisations and their entrance sites are listed, which 
were used as gateways to the topic (Appendix 1, References 1, 3, 8, 13, 14, 16, 17 + 20).
By critically assessing the publications from the above internet sources, as well as the original 
publications cited by the organisations active in the field of quality assurance in health care, 
the concepts of relevance for the theoretical framework were identified. A theme that was 
discussed fiercely is the quality of guidelines, and how this can be assessed and assured. It 
was found that over the past decade, much has been published about the quality and the 
appraisal of clinical guidelines. In most of the member states of the European Union, 
institutions were constituted that developed a national approach to assure the quality of 
guidelines. One example for this is the German “Arztliches Zentrum fur Qualitat in der 
Medizin”, in brief AZQ, which was planned to be a competence centre for guidelines and 
patient information in medicine (Rabbata 2003). This centre aims at supporting science-based 
practical guideline programmes (AZQ (n.d.) a). As one of its central achievements, the AZQ 
has set up a formalised process for the critical assessment of guidelines in order to enhance
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their transparency, practicality, scientific quality and cost-effectiveness (Ollenschlager 2003, 
Ollenschlager et al. 1998).
Despite major advantages of formalising the process of assessing the quality of guidelines, 
also fears have to be acknowledged that governmental control or the interference of health 
insurances might have too much influence on the treatment of individual patients. There are 
also sceptical voices, which fear that financial aspects might supersede the interests of 
patients in general (Richter-Reichhelm & Encke cited by Rabbata 2003). When bias is to be 
minimised, the assessment of guideline quality can not be solely left to organisations, such as 
the AZQ. At the very least, each practitioner should be able to assess the quality of guidelines 
using one of the currently available instruments for this task. However, from the initial reading it 
was found that the instruments to assess the quality of guidelines are addressing the structural 
quality of guidelines, but not the quality of the recommendations they make. For this, the 
clarification of the concepts ‘guideline’, ‘recommendation’ and the underlying evidence is 
necessary before the instruments to assess the quality of guidelines are analysed.
3.3.2 Evaluation of recommendations
When appraising the quality of guidelines, it is of utmost importance to distinguish clearly 
between the quality of a guideline, and the quality of its individual recommendations.
‘Guideline’ refers in this study to the entity of diagnostic tests recommended for baseline 
antenatal care of healthy women with uncomplicated singleton pregnancies.
‘Recommendation’ is used for a final statement about whether a single diagnostic test should 
be included in the guideline or not.
In the following, schemes for the evaluation and grading of recommendations are analysed. A 
popular example for a system to classify the quality of recommendations is provided by the 
Oxford Centre for Evidence-based Medicine (Phillips et al. 2001). Basically, this scheme
consists of two steps. In the first, the studies leading to a recommendation are assessed for 
their level of evidence as defined in the ‘Oxford-Scheme’. This means that the studies are 
grouped according to their scientific impact following from design and quality of the study in 
relation to the study type. The ranking gives marks from 1 for high-quality systematic reviews 
of randomised controlled trials to a mark of 5 for publications of expert opinion without explicit 
critical appraisal. In a next step, the recommendation itself receives a label from A to D 
according to the levels of evidence of the studies on which it is based. In this scheme, Class A 
recommendations are based on Level 1 studies only. Class D is reserved for 
recommendations based on weak, or no scientific evidence.
As this is a common way of grading recommendations, other examples with similar schemes 
can be named. For example, the Royal College of Obstetricians and Gynaecologists [RCOG] 
has set up its own grading system for recommendations, which uses a simpler form than that 
of the Oxford Centre for Evidence-based Medicine (Phillips et al. 2001, Royal College of 
Obstetricians and Gynaecologists (n.d.)). Within this grading system, recommendations are 
labelled only from A to C. According to this system, Grade A recommendations are based on 
randomised controlled trials only. Grade B indicates that a recommendation is based on robust 
experimental or observational studies. Finally, recommendations which are “based on more 
limited evidence but the advice relies on expert opinion and has the endorsement of respected 
authorities” are graded as C (Royal College of Obstetricians and Gynaecologists (n.d.)). As 
another example, also a task force of the German Society of Gynaecology and Obstetrics 
[DGGG] uses a similar scheme, which for example was used to draw up a guideline on the 
treatment of breast cancer, for example (von Minckwitz et al. 2002).
In contrast to the other instruments demonstrated above, the German task force was more 
explicit with regard to what consequences should be drawn from the grade of a 
recommendation. Although it might not be appropriate in every setting to give such explicit 
advice, this seems to be perceived as helpful in Germany. According to the task force, Grade 
A recommendations are based on strong evidence, and the intervention or treatment should
therefore be used in a specific situation on a routine basis. Grade B means that there is 
moderate evidence for the routine use of an intervention or treatment. Grade C labels 
insufficient evidence, which means that it is not clear whether practitioners should recommend 
or dismiss the intervention/treatment. Grades D and E are used for measures that should be 
considered as harmful or useless according to either moderate or strong scientific evidence.
Unfortunately, such easily applicable and straightforward grading systems bear the danger of 
doing more harm than good. A common way of drawing the wrong conclusions is to 
overestimate recommendations that are based on randomised controlled trials only. Important 
information is likely to be left out when no additional evidence than that of randomised 
controlled trials is considered. In addition to that, such Grade A recommendations bear the 
danger of being judged as untouchable gold standard, which can lead to forget about 
integrating new evidence as it is coming up. Such recommendations might then be adhered to 
for too long without any reassessment. Another major limitation is that findings from qualitative 
studies are generally never labelled as Level 1, although many aspects of antenatal care can 
be assessed by such designs only. As an example, the attitudes of women with regard to 
certain diagnostic tests are likely to be captured best by studies with a qualitative design.
As another disadvantage, such grading systems are not directly applicable to diagnostic tests 
and screening procedures (Royal College of Obstetricians and Gynaecologists (n.d.)). For 
these, experimental designs are not appropriate for proving their effectiveness. Instead, 
sensitivity, reliability, positive- as well as negative predictive values and false positive and false 
negative rates are appropriate criteria for screening tests. When setting up screening 
programmes, other important factors have to be considered, such as ethical implications of the 
test and of the consequences drawn from the test result. Moreover, also the costs, the risks for 
adverse outcomes and the acceptance in the public play a role.
Taking all of the above mentioned into consideration, it is concluded that it is necessary to 
determine the scientific basis of the recommendations of a guideline. Due to the central role of 
the NICE guideline on routine antenatal care for this study (National Collaborating Centre for
Women’s and Children’s Health 2003), its levels of evidence, as well as the grading system 
used for their recommendations is used, whenever reference is made to the quality of 
recommendations within guidelines. Both systems are presented in Tables 2.7 and 2.8:
Table 2.7: Levels of evidence according to NICE
(National Collaborating Centre for Women's and Children's Health 2003)
Level Criteria
1a Systematic review and meta-analysis of randomised controlled trials
1b At least one randomised controlled trial
2a At least one well-designed controlled study without randomisation
2b At least one other type of well-designed quasi-experimental study
3 Well-designed non-experimental descriptive studies, such as comparative studies, correlation studies or case studies
4 Expert committee reports or opinions and/or clinical experience of respected authorities
Table 2.8: Grading system for recommendations according to NICE 
(National Collaborating Centre for Women's and Children's Health 2003)
Grade Criteria
A Directly based on Level 1 evidence
B Directly based on Level 2 evidence or extrapolated recommendation from Level 1 evidence
C Directly based on Level 3 evidence or extrapolated recommendation from either Level 1 or 2 evidence
D Directly based on Level 4 evidence or extrapolated recommendation from either Level 1, 2 or 3 evidence
However, it is also acknowledged that although such hierarchies and grading systems for 
evidence and recommendations appear straightforward and easy to use, there are important 
issues behind them. When addressing the quality of guidelines and the quality of their
recommendations, it is vital to examine the underlying evidence more critical than by just 
assigning a certain level according to the method, with which the evidence was generated. As 
this aspect plays a key role in the thesis, this will be critically explored in depth in the following.
Another finding from the analysis of grading systems to classify the robustness of 
recommendations was that evidence does not translate itself into guidelines. Each system 
defines the grade of a recommendation according to the level of evidence. The crucial factor 
for setting up guidelines is therefore a good strategy to deal with and weight the evidence. To 
clarify the underlying concepts, an in-depth analysis of the following was necessary:
Defining and critically discussing the nature and the hierarchy of evidence, exploring the 
different kinds of evidence, such as expertise and scientific evidence. This includes the 
definition of the advantages and limitations of the role of experts, the nature and role of 
scientifically generated evidence, as well as of what might be categorised as context-free and 
context-sensitive research evidence (Canadian Health Services Research Foundation 2005, 
2006a + 2006b). However, before analysing the above concepts, the second quality aspect of 
guidelines needs consideration: the methodological quality and the instruments to assess it.
3.3.3 Instruments for the systematic appraisal of guidelines
When exploring the current state of the art for appraising the quality of clinical guidelines, it 
was found that efforts are made to develop instruments for the formal appraisal of guideline' 
quality. These instruments address e.g. the methodological, the structural and the process 
quality of a guideline. For this part of the review, it was aimed at identifying different 
instruments to assess guideline quality, using them to explore potential strengths and 
weaknesses. To explore the concept completely, the early national stages of guideline 
appraisal are also demonstrated, using Germany as example. However, the main aim was to 
find an instrument, which can be used on guidelines from different countries. In addition to the 
entrance links mentioned above, links available under the heading ‘evidence based medicine’
were searched (Appendix 1, Reference 9). In a next step, the specific strengths and 
weaknesses of the instruments are critically analysed.
In 1997, the German Medical Association and the National Association of Statutory Health 
Insurance Physicians published criteria for the evaluation of guidelines (Bundesarztekammer & 
Kassenarztliche Bundesvereinigung 1997). The criteria of this catalogue specify what 
information should be contained in guidelines. For example, which methods and materials 
were used to set up the guideline, how the material was analysed and which professions or 
groups were represented in the team that has developed the guideline. Unfortunately, within 
this catalogue there is no hint as to what standards have to be fulfilled to make up a good 
guideline. In order to standardise the conclusions drawn from the evaluation of a guideline, it 
seems to be necessary to specify not only which information should be contained, but also 
how this information has to be evaluated. For this, it is concluded that an important step is 
missing for a final conclusion about the quality of a guideline.
Another problem of the instrument is its format. In contrast to later instruments, this one has no 
inviting and structured format to extract and record the relevant information. The criteria are 
listed under subheadings, but there is no form on which the answers can be collated. As a 
consequence, this early catalogue of criteria might make more sense for those intending to set 
up a new guideline, rather than for those trying to evaluate an existing one.
Acknowledging the problems of the aforementioned instrument, another working group 
developed it further (Ollenschlager et al. 1998). The new instrument for a standardised 
evaluation of guideline quality came in the form of a checklist. It was not only based on the 
criteria of the previous instrument, but also included the ideas of seminal papers available at 
that time, e.g. from the Scottish Intercollegiate Guidelines Network. When using the new 
instrument, there is a more detailed analysis of the rigour of the development of a guideline, as 
well as a clear focus on the comments made by the issuing body concerning its applicability. 
However, although this instrument is structured more clearly, it still is not user friendly with 41 
questions to be answered. In addition, it still does not invite the user to make a final decision
about the overall quality of a guideline. However, the major problem of this instrument is that it 
seems to have never been piloted in this version. All in all it might have been a good idea that 
the authors labelled their instrument with an expiry date, which was January 1999.
In contrast to these earlier attempts, the next instrument came in the form of a checklist with 
boxes to tick (AZQ 1999). This instrument was again a further development of the 
aforementioned one (Ollenschlager et al. 1998). However, also the work of other experts in the 
field, e.g. from the USA, Scotland and England was considered. As its predecessor, the 
instrument consists of 41 questions in three categories: ‘Process quality’, ‘content and format’ 
and ‘applicability of the guideline’. However, also this instrument contains no summary of the 
quality of the assessed guideline. In this case, the user ends up with ticked boxes, rather than 
with an unambiguous comment or mark. Despite these limitations, the developers of the 
instrument named an expiry date for it, which is 11 December 2003. As with the dates for the 
previous instrument (Ollenschlager et al. 1998) it does not become clear whether these dates 
were chosen arbitrarily, or whether there is a certain system behind it. Moreover, there is also 
no comment to what should be done with the guideline after that date. It is just a speculation 
that the developers intended to do the same thing to their instrument, as they perceive as 
necessary for guidelines: to fix a date, at which it must be revisited. However, in this case it 
must be questioned whether Christmas time is suitable for such a process.
From 1999 onwards, the development of instruments for the systematic evaluation of 
guidelines started to gain an international dimension. The collaboration of Cluzeau and 
colleagues developed an instrument, which they claimed to be the basis of a common 
approach to assessing guideline quality in Europe (Cluzeau et al. 1999, Europarat 2001:17ff). 
As a major step forward, this instrument was extensively tested by 120 raters on 60 guidelines 
for its face validity, reliability, internal consistency and its inter-rater agreement. It was found 
that the instrument led to acceptable results in all categories. With its 37 items in three 
dimensions, the instrument was well accepted by the raters. On the basis of this, the authors 
concluded that their instrument was useful for judging the extent to which the assessed
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guidelines were developed systematically, and to what extent knowledge about the successful 
implementation of guidelines is considered. However, a major flaw of the system is that after 
assessing a guideline with this instrument, the scientific quality of the guideline’s 
recommendations still needs to be assessed. Only comments can be made about the rigour of 
the guideline development process, the clarity of presentation and about issues on guideline 
implementation. Not least, again there is no graphical work up of the instrument as to facilitate 
the assessment procedure, and a scoring system is missing.
A major step away from the more or less national approaches to the appraisal of guideline 
quality is marked by the engagement of the Council of Europe. One of the key 
recommendations of the Council was that the governments of the member states should 
create a coherent and comprehensive framework which ensures that the national methods for 
drawing up and evaluating guidelines for optimum medical practice fulfil criteria that are 
internationally accepted and most up to date. In addition to that, the Council recommended 
that an internationally co-ordinated network of researchers should critically assess the 
methodology for evaluating guidelines, including the effects on cognitive processes and 
medical knowledge of health professionals (Europarat 2001:10-14). Probably as a 
consequence out of the engagement of EU institutions, between 1999 and 2000, a group of 
experts from most member states and the accession states of the EU has developed a 
recommendation for a framework on drawing up, evaluating, renewing and the active 
dissemination of evidence-based guidelines on a national basis (Europarat 2001: 6).
These efforts on EU-level brought together experts from national institutions that publish 
information about the development and evaluation of guidelines, such as from Scotland, 
Germany, the Netherlands and France. In order to boost these efforts, the EU funded an 
international group of experts, which developed an instrument for the evaluation of guidelines 
in Europe. This instrument is called AGREE, which stands for Appraisal of Guidelines for 
Research and Evaluation in Europe (The AGREE Collaboration 2001, Europarat 2001:17ff).
3.3.4 Appraisal of Guidelines for Research and Evaluation in Europe
AGREE, which stands for Appraisal of Guidelines for Research and Evaluation in Europe, is an 
international collaboration of experts from 13 European countries, which was funded under the 
BIOMED-2 Programme of the European Commission (The AGREE Collaboration (n.d.), The 
AGREE Collaboration 2003). This collaboration developed a framework and an instrument for 
assessing the quality of clinical practice guidelines, by which a global assessment of a 
guideline can be achieved. In the end, marks should give evidence about the level of quality for 
each of the more formal criteria according to which a guideline can be judged. With the 
instrument and an additional collection of recommendations for people setting up guidelines, 
AGREE aimed at improving the quality and effectiveness of clinical practice guidelines.
The AGREE-instrument for assessing the overall quality of guidelines (The AGREE 
Collaboration 2001) is a further development of the instrument of the collaboration around 
Cluzeau, which has been described above (Cluzeau et al. 1999). Its predecessor was already 
designed for the use on guidelines from different countries, therefore laying the basis for 
assessing guideline quality in Europe. The previous instrument had been tested by 120 raters 
on 60 guidelines for its face validity, reliability, internal consistency and inter-rater agreement, 
and was found to provide appropriate results in all categories. As the further development of 
this, the AGREE-instrument was also intended to appraise not only guidelines in the country of 
its development (Europarat 2001:17ff). Its abilities for this were proven in a test run on more 
than one hundred guidelines in twelve different countries, and also the development and 
refinement of the instrument are well documented (The AGREE Collaboration 2001 + 2003).
As another major advantage, the AGREE-instrument was designed and found to be 
appropriate for guidelines set up by multidisciplinary teams. This is of critical importance when 
appraising guidelines on antenatal care. Moreover, the AGREE-instrument can be used for 
guidelines on any disease area, including also such on diagnosis, health promotion, treatment 
or interventions. Also this is of critical importance for the appraisal of guidelines on antenatal 
care. Finally, it was reassuring to find that the AGREE-instrument was also judged by the
Council of Europe as the most promising instrument for the evaluation of guidelines in different 
countries that were set up by different groups of experts (Europarat 2001:17ff). In order to 
demonstrate the instrument’s abilities with regard to assessing national guidelines on antenatal 
care in the EU, it is discussed in greater detail. For this, the authors of the instrument were 
asked for additional material about the instrument itself, its development and testing (Burgers 
2004, Cluzeau 2004, The AGREE Collaboration 2003).
Properties of the AGREE-instrument
The developers of the AGREE-instrument identified six domains, which define the overall 
quality of a guideline. Each of these domains was designed to shed light onto a separate 
dimension of guideline quality. The domains are:
Scope and purpose
Contain a specific statement about the overall objective(s), clinical questions, and describes 
the target population
Stakeholder involvement
Provide information about the composition, discipline, and relevant expertise of the guideline 
development group and involve patients in their development. They also clearly define the 
target users and have been piloted prior to publication.
Rigour of development
Provide detailed information on the search strategy, the inclusion and exclusion criteria for 
selecting the evidence, and the methods used to formulate the recommendations. The 
recommendations are explicitly linked to the supporting evidence and there is a discussion of 
the health benefits, side effects, and risks. They have been externally reviewed before 
publication and provide detailed information about the procedure for updating the guideline.
Clarity and presentation
Contain specific recommendations on appropriate patient care and consider different possible 
options. The key recommendations are easily found. A summary document and patients’ 
leaflets are provided.
Applicability
Discuss the organisational changes and cost implications of applying the recommendations 
and present review criteria for monitoring the use of the guidelines.
Editorial independence
Include an explicit statement that the views or interests of the funding body have not influenced 
the final recommendations. Members of the guideline group have declared possible conflicts of 
interest.
In order to demonstrate the validity of the domains, the developers of the instrument assessed 
their face validity, construct validity and criterion validity individually. It could be demonstrated 
by a field test that 95% of the appraisers found the instrument useful and manageable to 
assess guidelines. Moreover, p-values below 0.05 and 0.01 confirmed the construct validity of 
the individual domains. The constructs used within the instrument are therefore sufficiently 
useful for discriminating high-quality guidelines from those with a lower overall quality. To 
assess criterion validity, it was necessary to use a rater’s overall assessment of guideline 
quality as proxy measure. This revealed with correlation coefficients of p < 0.001 that a rater’s 
overall assessment of guideline quality correlated with the scores of the individual domains.
All in all it can be concluded that the AGREE-instrument is useful for appraising the overall 
quality of a guideline, able to capture the properties of a guideline, relevant for its quality. 
However, this is only the case, when a guideline and its development process are well 
documented (The AGREE Collaboration 2003). It can not be excluded that a guideline fulfils all 
relevant criteria, but that a lack of documentation of these issues leads to a categorisation as a
guideline of minor quality.
In addition to the domains’ properties for appraising the quality of a guideline, this 
categorisation helps the user of the AGREE-instrument to approach the appraisal of a 
guideline in a structured way. To critically assess a guidelines quality, 23 questions are used 
altogether. As an additional advantage, these questions are set up in the easy format of a 4 
item Likert scale. Ratings from strongly agree to strongly disagree add a specific weight to the 
assessed criteria. In order to avoid wrong judgements and misunderstandings, additional 
information and explanation is available for most of the items. With this approach, for the first 
time the level can be assessed, to which a criterion is fulfilled. This is a definite improvement 
and goes far beyond the simple recognition of the presence or absence of a criterion, which 
was common in the earlier instruments. However, the question must be asked of whether the 
rating is subjective, or sufficiently reliable.
To demonstrate the internal consistency, the Cronbach a coefficient was calculated for each 
domain. The intra-class correlations were calculated to assess the reliability within each 
domain. This was done for single raters’ ratings, and for the mean ratings of two, three and 
four appraisers. It was found that the internal consistency ranged between 0.64 and 0.88. This 
was judged as acceptable for most domains, and explained for the domain ‘editorial 
independence’, where this was not the case. However, also the domain ‘clarity and 
presentation’ scored low with a Cronbach a of 0.69 and an intra-class correlation of 0.57. 
Unfortunately, this was not explained. It is assumed that the findings from the appraisal of two 
national guidelines on antenatal care presented later in the thesis will shed light on this.
Another finding from the testing of the instrument’s reliability demonstrated that the number of 
raters appraising a guideline affects the reliability of the intra-class correlations. Intra-class 
correlations substantially improved with the number of raters. As an example, the intra-class 
correlation for the domain ‘scope and purpose’ increased from 0.44 for one rater to 0.76 for 
four raters. The same effect was observable for all domains. With four raters, intra-class 
correlations from 0.57 to 0.91 are achievable. It was therefore concluded that at least four
raters should be used for appraising a guideline with the AGREE-instrument.
In its final section, one of the real advantages or the AGREE-instrument becomes clear. In 
contrast to the previously discussed instruments, AGREE leads to a conclusive decision about 
the level, to which the quality criteria are fulfilled for each of the domains. However, it is not 
wanted to make an overall numerical judgement of an appraised guideline by summing up the 
final judgements to a single mark (The AGREE Collaboration 2001). Instead, the appraisers of 
a guideline are requested to make a clear final judgement as to whether a guideline is of such 
quality that it should be implemented. Options for the final judgement range from “strongly 
recommend” to “would not recommend”. “Unsure” is also on offer, as it is “recommend (with 
provisos or alterations)”. This final step is the key to ensuring that only guidelines of sufficient 
quality are implemented, and to a real improvement of guideline quality. However, the AGREE- 
instrument does not provide a measure for estimating the impact of a guideline on patients’ 
outcomes (The AGREE Collaboration 2001).
However, also the best available instrument to assess guideline quality to date has its flaws. 
One of the difficulties involved with the application of the AGREE-instrument is that it should be 
used by more than one appraiser on the same guideline to achieve satisfactory reliability. For 
optimum results, four raters are recommended. This can be difficult to achieve, e.g. when it is 
used for a thesis. However, as this issue of reliability is made transparent by the authors of the 
instrument, measures can be taken to overcome this problem.
In addition to that problem, the idea of splitting up the quality of a guideline into several 
separate domains provides an in depth view into the quality of each domain, rather than of the 
entire guideline. In the user manual it is clearly stated that the scores of the individual domains 
should not be used to calculate a single quality score. Therefore, this in-depth procedure might 
hinder a comparison of guideline quality, when other guidelines have been assessed with 
instruments that judge quality by a less detailed procedure, ending up with a single score. The 
situation becomes even more complicated, when another instrument is used that uses other 
domains, or defined the same domains differently from those in the AGREE-instrument. As a
consequence, it is obvious that when it is the aim to compare different guidelines on the same 
topic, they have to be appraised with the same instrument.
Conclusions from the review on the appraisal of guideline quality
Drawing the findings of the review on the quality of recommendations and on Instruments for 
the systematic appraisal of guidelines together, the following conclusions were drawn:
- An important step in the evaluation of a guideline is the appraisal of the scientific quality of its 
recommendations.
- The scientific basis of a guideline is only one indicator for its overall quality, although of 
crucial importance.
- Other indicators, such as the scope and purpose of a guideline, stakeholder involvement, 
rigour of development, clarity and presentation, its applicability and editorial independence are 
important factors to indicate the quality of a guideline in Europe.
- An instrument is available, which was specifically designed to assess the overall quality of 
guidelines set up by multidisciplinary teams, and is applicable to guidelines from any disease 
area, including also such on diagnosis, health promotion, treatment or interventions. Moreover, 
this is the first instrument with proven validity and reliability for the appraisal of guidelines from 
different countries.
- The AGREE instrument has a lack of discriminating properties between guidelines of minor 
quality, which do not fulfil the set criteria, and guidelines with a lack of documentation (The 
AGREE Collaboration 2003). It could be therefore that a guideline fulfils all relevant criteria, but 
that a lack of documentation of these issues leads to a categorisation as a guideline of minor 
quality. This lack of discrimination might be overcome by using a high-quality guideline on a 
certain topic as a reference value, against which the recommendations of a guideline with a 
lack of documentation can be compared.
However, the most important conclusion to this analysis is that there is still the link missing
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between the overall quality of a guideline, and the quality of its recommendations. In the best 
case, the overall quality of a guideline is excellent, and its recommendations are based on the 
best available evidence. However, it is unlikely that this is always the case. It seems to be 
possible that the recommendations of a guideline are based on scientific evidence, but that the 
overall quality of the guideline is poor. It might also be that the overall quality of a guideline is 
excellent, while the recommendations are lacking scientific backup. However, the relation 
between the methodological quality of a guideline and the quality of its recommendations 
needs to be explored. This will be addressed by the thesis.
3.4 Theoretical framework: Evidence-based policy
One of the conclusions from the previous analysis was that the quality of the evidence 
underlying a guideline’s recommendations plays an important role for the quality of the entire 
guideline. Initial reading on the subject brought up a number of publications from professional 
and scientific journals, from textbooks and also from the public press, which inform the debate. 
From this it was found that the crucial theoretical problem when setting up guidelines is how to 
make decisions on recommendations in the light of limited or contradictory evidence, or on the 
basis of evidence from different sources and disciplines. After critically exploring this 
phenomenon it was found that evidence-based policy-making exactly deals with this problem. 
Which concepts exist under the paradigm of evidence-based policy will be critically analysed in 
the following description of the theoretical framework of the study.
At the beginning of the following section, it is demonstrated how debates about the evidence- 
base for any decision in health care have arisen from legislative changes, improvements in 
technology and changing professional practices. It becomes also evident that such debates 
and conflicts can be very complex and protracted, involving numerous agencies in their 
attempts to provide the best evidence to prove their case. Hence, the conflicts about what 
suitable evidence to inform professional practice and decisions on health care needed to be 
analysed. From this it was found that a thorough description of the nature of evidence is
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needed to lay the basis for a profound discussion.
Despite the aim to ensure the generalisability of the discussion, it was decided to appraise all 
concepts and themes in direct relation to antenatal care as the subject of study. The study 
therefore started with an extensive review and analysis of the literature on the evidence for 
antenatal care in the EU and resulted in the development of a conceptual framework for 
analysing evidence that informs policy and practice. The framework uses evidence as a central 
theme. Assumptions about evidence-based health care and health policy, the nature and 
hierarchy of evidence, the use of evidence to set up guidelines, and factors with the potential 
to modify decisions will be discussed and used as the main frame of reference for this study.
3.4.1 Evidence-based health care and evidence-based policy
As will be discussed in greater depth in a separate chapter of this thesis, the member states of 
the European Union are striving to limit their health care expenses through the rational 
allocation of resources in order to avoid the rationing of health care. This is due to the fact that 
the demand for unlimited access to and use of health care can not be satisfied with the limited 
resources. Throughout Europe, this lead to an increase in management activities in the health 
sector (European Commission Directorate General for Employment, Industrial Relations and 
Social Affairs 1999, Mossialos 1998: 2). Despite this increase in managerial activities, no 
country has as yet gone so far as to exclude services which go beyond a core package of vital 
care, which would be unwise as the commitment of the Union’s citizens to a universal health 
system was found to be high (European Commission Directorate General for Employment, 
Industrial Relations and Social Affairs 1998:15+18). However, there is a clear trend towards 
evidence-based medicine and the setting up of clinical guidelines in order to meet the 
challenges of some of the most prominent factors affecting the health care systems in the 
member states of the EU at present. These factors are (European Health Management 
Association 2000 citing multiple sources):
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• The drive for cost-containment in the public sector against the background of economic 
pressures.
• The increasing pressures of ‘consumerism’ and of higher expectations from patients 
and citizens.
• The declining power of the medical profession, in particular its reduced role (or 
demands for a reduced role) in decision-making within health care systems and in 
resource allocation.
• The role of the health care industry in the national economy.
From the exposure to these forces, changes in medical care practice were suggested to have 
arisen (Harrison 2002a, Harrison et al. 2002c). The most prominent reaction is the movement 
for evidence-based medicine and evidence-based health policy. When searching the literature 
on evidence as such, and especially evidence-based health care and health policy, an 
excellent definition was found, which grasps the entire problem (Canadian Health Services 
Research Foundation 2006b):
“Evidence is information that comes closest to the facts of a matter. The form it takes depends 
on context. The findings of high-quality, methodologically appropriate research are the most 
accurate evidence. Because research is often incomplete and sometimes contradictory or 
unavailable, other kinds of information are necessary supplements to or stand-ins for research. 
The evidence base for a decision is the multiple forms of evidence combined to balance rigour 
with expedience - while privileging the former over the latter.”
Conceptualising the problem according to this definition and considering the previous analyses 
of the related concepts, the idea that evidence-based health care is an easy and 
straightforward task is clearly a misconception and underestimates the gaps and contradictions 
in knowledge. Nevertheless, in 1999, the European Commission Directorate General for 
Employment, Industrial Relations and Social Affairs still claimed that evidence-based health 
care is currently offering the most sophisticated approach for integrating these pieces of 
evidence in decision-making, as it is based on the systematic synthesis of existing information
provided by primary studies. However, only three years later, other authors started to become 
more critical, acknowledging that it can be extremely difficult to produce sound evidence for 
complex health care situations (Forbes & Griffiths 2002). One suggestion to deal with these 
problems was to develop methods complementary to the principles of evidence-based health 
care, which deal with complexity and different forms of empirical expression (Forbes & Griffiths 
2002). Guidance for dealing with what can be called ‘imperfect evidence’ is needed. Before 
this problem is addressed, evidence-based health care / practice / medicine and evidence- 
based policy need to be operationally defined. First of all it can be said that (Harrison 1998a),
“Evidence-based medicine is the doctrine that professional clinical practice ought to be based 
upon sound biomedical research evidence about the effectiveness of each diagnostic or 
therapeutic procedure.”
This definition acknowledges that evidence-based medicine is the statement of a rule of how to 
deal with ‘evidence’. Moreover, it makes clear that biomedical research evidence should form 
the basis of clinical practice. However, the following definition relates this general comment to 
specific situations (Sackett et al. 1996 cited by European Commission Directorate General for 
Employment, Industrial Relations and Social Affairs 1999: 46):
“Evidence-based medicine is the conscientious, explicit and judicious use of current best 
evidence in making decisions about the care of individual patients.”
This means that evidence-based medicine is the combination of clinical expertise with the best 
available scientific evidence (Sackett et al. 1997). In this context, scientific evidence is used to 
re-assess and improve the effectiveness and safety of commonly accepted therapeutic 
procedures and tests, or to replace them by more effective ones. In its pure meaning, 
evidence-based care is mainly about using best evidence for decisions on individual patients. 
However, evidence-based care can also be used to guide care for defined groups, e.g. women 
with normal pregnancies. In contrast to the years of euphoria at the beginning of the 
movement, today also critical texts on evidence-based care are published (Beller 2002,
Canadian Health Services Research Foundation 2005). When analysing the critique in greater 
detail, it becomes evident that it relates to the approaches to the synthesis of and the 
conclusions drawn from scientific evidence, rather than to EBM in general. From this it can be 
concluded that evidence-based medicine is only as good as the reviewer, the scientific quality 
of appraising the underlying evidence, and the consequences drawn from this.
However, the fact that there is a trend towards the introduction of evidence-based guidelines 
for nearly all questions in health care demonstrates that there seem to be major doubts with 
regard to the abilities or the willingness of individual practitioners to constantly appraise the 
evidence-base. The introduction of evidence-based guidelines is one of the options to fulfil this 
obligation without putting the burden of permanent scientific reviews onto the individual. 
Therefore it has become more and more standard practice to set up clinical guidelines. 
However, the quality of such guidelines is clearly a factor that needs to be addressed.
Another finding was that the advantages of evidence-based care are obviously judged to be 
important enough to make it the basic principle for health care in Germany, as well as in the 
UK. In Germany, the government decided that health care professionals holding contracts with 
health insurances, health insurances and public hospitals are obliged to provide evidence- 
based care. This was even put down in the German compendium of social laws (AZQ (n.d.) b, 
Kunz et al. 2002). In the UK, evidence-based practice is official policy for the National Health 
Service and has become institutionalised with the establishment of the National Institute for 
Clinical Excellence (European Commission Directorate General for Employment, Industrial 
Relations and Social Affairs 1999: 23, Harrison 1998a, Harrison et al. 2002b).
Drawing the above definitions and aspects of EBM together, the crucial point is that evidence- 
based care is the combination of the best available scientific evidence with the judgement of 
the clinical expert. Although there might be strong or weak scientific evidence for a certain way 
of action, a decision needs to be made about how to deal with this. The principles of evidence- 
based health care/ practice/ medicine provide the basis for decisions, but do not make them 
(Mossialos 1998). In general it can be said that the same principles that apply to evidence-
based health care/ practice/ medicine apply to evidence-based policy, which can be defined as
“the integration of experience, judgement and expertise with the best available external 
evidence from systematic research.” (Davies 1991 cited by Policy Hub 2005).
Essentially, this definition again exemplifies the need and role of expert judgement in addition 
to research evidence for the making good policy. Good policy is not the mere dictate of 
research evidence, but needs the expert to weight the evidence and to define the wanted 
outcome with regard to effectiveness and efficiency, but also with regard to ethics, 
interrelations with other policies, and the available resources. By highlighting the need to 
include such factors in the decision-making process, the possible critique that the concept of 
evidence-based health care illegitimately reduces the complexity of clinical decisions and 
policy decision-making (Canadian Health Services Research Foundation 2005, European 
Commission Directorate General for Employment, Industrial Relations and Social Affairs 1999: 
33 citing Carr-Hill 1998) can be avoided. Evidence-based policy essentially aims at improving 
the competence of decision makers and to strengthen the decision maker’s motivation to use 
scientific methods when making decisions. It clearly addresses the question of how to make 
health policy and management decisions, including the fact that these must be based on 
scientific evidence (Muir Gray 1997: 7).
In yet another definition of evidence-based health care, the weighting of evidence is clearly 
addressed (European Commission Directorate General for Employment, Industrial Relations 
and Social Affairs 1999: 33 citing Hicks 1998):
“Evidence-based health care takes place when (any) decisions that affect the care of patients 
and populations are taken with due weight accorded to all valid, relevant information”.
This definition relates to evidence-based health care, and not to evidence-based policy, but it 
highlights a crucial factor within all evidence-based activities. Although none of the above 
definitions gives a hint as to how ‘all valid and relevant’ information is defined, this can be 
answered relatively easy and according to the standard rules of science. The person gathering
and assessing the evidence for a problem needs to define the scope and the strategy before 
searching for valid and relevant information, and has to perform the search accordingly. In 
contrast to that, the question of what is ‘due weight’ is much more difficult to answer. In the 
following, it is attempted to shed light onto this. To start with, the factors which might play a 
role in setting up evidence-based policies are assessed in greater depth.
3.4.2 The nature and the hierarchy of evidence
When searching the literature on evidence, the most important finding was that this concept is 
not as straightforward and one-dimensional as it was hoped for. In the previous section, the 
grading system of the National Collaborating Centre for Women’s and Children’s Health was 
already presented, as it is used for the study (National Collaborating Centre for Women’s and 
Children’s Health 2003). However, there are other popular examples for the grading of 
evidence, such as the ‘Oxford-Scheme’, provided by the Oxford Centre for Evidence-based 
Medicine (Phillips et al. 2001), or the RCOG (Royal College of Obstetricians and 
Gynaecologists (n.d.)). Also a task force of the German association of gynaecologists and 
obstetricians issues a similar scheme (von Minckwitz et al. 2002). As the thesis is studying the 
baseline clinical care for healthy pregnant women, the evidence-levels of the categories 
‘Therapy/Prevention, Aetiology/Harm’, ‘Diagnosis’ and ‘Economic and decision analysis’ might 
play a role. Therefore the evidence levels of these three are used as examples from the 
Oxford-scheme. Other schemes for grading evidence, such as that of Royal College of 
Obstetricians and Gynaecologists (n.d.), or that of the task force of the German association of 
gynaecologists and obstetricians (von Minckwitz et al. 2002) are not presented. Both 
associations provide much simpler schemes than the Oxford one, providing no additional 
information than the above mentioned one of the National Collaborating Centre for Women’s 
and Children’s Health. This makes them less useful with regard to discussing the concept 
‘evidence’. Although the Oxford-scheme might be too differentiated and too difficult to use for 
the average practitioner, it has excellent properties to frame the nature of evidence.
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Table 2.9: Levels of evidence according to the Oxford Centre for Evidence-based 
Medicine (Phillips et al. 2001): Therapy/Prevention, Aetiology/Harm
Level Criteria
1a Systematic review (with homogeneity) of randomised controlled trials (RCT)
1b Individual RCT (with narrow confidence interval)
1c All or none case-series
2a Systematic review (with homogeneity) of cohort studies
2b Individual cohort study, including low-quality RCT
2c Outcomes research; ecological studies
3a Systematic review (with homogeneity) of case-control studies
3b Individual case-control study
4 Case-series (and poor quality cohort and case-control studies)
5 Expert opinion without explicit critical appraisal, or based on physiology, bench research or ‘first principles’
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Table 2.10: Levels of evidence according to the Oxford Centre for Evidence-based 
Medicine (Phillips et al. 2001): Diagnosis
Level Criteria
1a
Systematic review (with homogeneity) level 1 diagnostic studies; clinical decision 
rule (algorithm or scoring system which lead to a prognostic estimation or a 
diagnostic category)
1b Validating cohort study with good reference standards; or clinical decision rule tested within one clinical centre
1c
Absolute diagnostic findings whose specificity is so high that a positive result'rules- 
in the diagnosis; or a diagnostic finding whose sensitivity is so high that a negative 
result rules-out the diagnosis
2a Systematic review (with homogeneity) of more than 2 diagnostic studies
2b Exploratory cohort study with good reference standards, clinical decision rule after derivation, or validated only on split-sample or databases
2c
3a Systematic review (with homogeneity) of 3b and better studies
3b Non-consecutive study; or without consistently applied reference standards
4 Case-control study, poor or non-independent reference standard
5 Expert opinion without explicit critical appraisal, or based on physiology, bench research or ‘first principles’
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Table 2.11: Levels of evidence according to the Oxford Centre for Evidence-based 
Medicine (Phillips et al. 2001): Economic and decision analyses
Level Criteria
1a Systematic review (with homogeneity) level 1 economic studies
1b Analyses based on clinically sensible costs or alternatives; systematic review(s) of the evidence; and including multi-way sensitivity analyses
1c Absolute better-value or worse-value analyses
2a Systematic review (with homogeneity) of level 2 or better studies
2b Analyses based on clinically sensible costs or alternatives; limited review(s) of the evidence, or single studies; and including multi-way sensitivity analyses
2c Audit or outcomes research
3a Systematic review (with homogeneity) of 3b and better studies
3b Analyses based on limited alternatives or costs, poor quality estimates of data, but including sensitivity analyses incorporating clinically sensible variations
4 Analyses with no sensitivity analysis
5 Expert opinion without explicit critical appraisal, or based on physiology, bench research or ‘first principles’
All these schemes have in common that they aim at grouping the evidence according to its 
scientific impact following from design and quality of the study in relation to the study type. 
That this is not a straightforward task becomes obvious from the Oxford-scheme (Phillips et al. 
2001), which defines its levels of evidence individually for different questions. Evidence about 
therapy and prevention is graded slightly differently from evidence about prognosis, diagnostic 
procedures, and evidence from differential diagnosis/symptom prevalence studies. Also 
evidence from economic and decision analysis is graded according to own criteria. This 
demonstrates that different questions can not be answered optimally by one single type of 
study. Evidence is therefore dependent on the question to be answered.
A clear disadvantage of the Oxford-scheme is that it can be applied only to straightforward 
quantitative questions. This limits its use when addressing complex, qualitative, or non-
empirical questions, such as on patient satisfaction, or attitudes towards certain care schemes. 
Unfortunately, such questions play a major role when assessing the entire properties of 
antenatal care. For such questions, a grading system would be needed in which the scientific 
impact of qualitative methods is mirrored. When assessing this in relation to antenatal care, it 
was found that the debate on evidence became more differentiated over the last years. 
Especially professionals from other disciplines than medicine, such as nursing, argue that 
there are many interventions which can not be assessed easily with the instruments 
traditionally used for generating evidence for evidence-based care (Forbes & Griffiths 2002).
Flowever, when addressing questions that can be answered by scientific studies, there is one 
crucial criterion for the inclusion of studies relating to any of the grading systems. This is the 
fact that there are trials of high and low scientific quality within each of the categories. There 
are randomised controlled trials, which are well designed and conducted. Unfortunately, there 
are also ones for which this is not the case. Nevertheless it has to be acknowledged that 
scientific research means that data have been gathered and critically appraised according to 
explicit and sound principles of scientific inquiry (Policy Hub 2005). However, these criteria are 
only useful for distinguishing evidence from within the same category, but not to define the 
level of evidence that should be added to a certain category of studies.
When the aim is to answer a clinical or research question, it is necessary to determine what 
study design is appropriate to answer the question best. On the basis of that decision, studies 
need to be identified, which fulfil the scientific standards for the respective category. 
Unfortunately, there are not only straightforward questions in health care. It can be extremely 
difficult to producing sound evidence for complex health care questions involving non-empirical 
questions (Forbes & Griffiths 2002). One suggestion to deal with these problems was to 
develop methods complementary to the principles of evidence-based health care have, which 
deal with complexity and different forms of empirical expression (Forbes & Griffiths 2002).
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Different kinds of evidence
In order to get an idea about the kinds of evidence available, some examples for evidence 
used in policy-making are discussed in the following. However, it has to be noted that these 
examples have been chosen specifically for their relevance to policy-making, having in mind 
that the study relates to guidelines on antenatal care on the national policy level. The kinds of 
evidence available to assess the effectiveness of individual tests used for the 
recommendations within a guideline is represented well in the grading system of the National 
Collaborating Centre for Women’s and Children’s Health (2003), which has been demonstrated 
above. However, the kinds of evidence available for policy-making and for making decisions 
about medical practice are not mutually exclusive. The following examples therefore be 
regarded as additions to those commonly represented in the above mentioned grading 
systems. If not indicated otherwise, the following categories of evidence are derived from the 
internet service of the Government Chief social Researcher’s Office (Policy Hub 2005).
Experimental and quasi-experimental evidence, such as randomised controlled trials, 
controlled before-and-after studies, or the various types of matched comparison studies. Such 
studies are useful when valid and reliable information about the effectiveness of an 
intervention is needed in comparison to other interventions or no intervention at all. This kind of 
evidence, together with the levels of the scientific impact of the respective methods, is 
commonly represented in grading systems, such as those presented previously (National 
Collaborating Centre for Women’s and Children’s Health 2003, Phillips et al. 2001). When 
searching for an overall classification of such approaches to generate knowledge, it can be 
said that it is the traditional approach to develop new or more detailed insights into a previously 
defined field. It has been described as more theoretically driven and linear, trying to discover 
independent and objective knowledge (Smith 2004:114). Understanding the findings from the 
viewpoint of those involved, or in relation to a specific situation plays a minor role.
Survey and administrative evidence comes from social surveys and administration, such as the 
General Household Survey in the UK, or crime statistics. This evidence can either be used as
a basis for experimental or quasi-experimental studies, or as additional information about the 
nature, size, frequency, and distribution of the subject under investigation.
Qualitative research evidence provides information about why something works in practice, 
how this happens, for whom and under what conditions. It is also about perceptions, attitudes 
and opinions of the key players involved and uses diverse methods, such as in-depth 
interviews, ethnographies, or observational studies. With regard to the process of policy 
making, this evidence becomes especially relevant during the implementation phase.
Economic evaluation evidence is needed when decisions have to be made of what can be 
done to achieve an outcome in the light of limited resources, and about how the available 
resources can be optimally used in order to achieve the highest benefit. Economic evaluation 
evidence comes from studies such as cost-effectiveness analyses and cost-benefit analyses.
Philosophical and ethical evidence plays an important role in policy making, although it is 
presumably not often applied in a formal manner. When using such evidence from needs 
analyses or studies using consultative techniques, the values, beliefs, ideologies and 
aspirations of those affected by a policy are considered. Also difficult decisions can be made 
safer, when competing values are involved.
Systematic review evidence finally balances the methodological flaws of single studies through 
the rigorous analysis of research evidence, using a previously defined scientific strategy for the 
identification, selection and analysis of studies. Systematic reviews aim at making a reasoned 
case about what the available evidence from other studies tells about a topic, or a policy area. 
The different methods applied for this range from narrative reviews to meta-analyses.
Innovative approaches for generating evidence
Despite the inclusion of several different kinds of evidence and the ways of generating them, 
the above list is not exhaustive. Evidence comes in different forms and from different 
disciplines. It has been shown that scientific evidence is not only findings from randomised
controlled trials on clinical effectiveness, but also findings e.g. from social scientific research. 
Moreover, over the last years, innovative ways to generate new knowledge keep coming up. 
One main feature of these new ways is the idea to mix multiple stakeholders in order to use 
their specific knowledge and resources, such as competing values, agendas and expectations 
(Smith 2004:114). Inter-disciplinary work, with regard to disciplines, as well as to institutions, 
is of key importance to such approaches. Projects following these new ways might e.g. include 
the ideas of users, commissioners and providers of research. Moreover, it seems to be 
observable that formerly uncommon research methods in health care are entering the scene, 
such as action research and participatory methods (Smith 2004:120).
This need for more flexible and innovative approaches might be caused by the increasing 
complexity of questions, framing health care much more comprehensive than as being the 
treatment of illnesses alone. One example for attempts to overcome the limitations of the 
strong reliance on randomised controlled trials, the method of cross design synthesis was 
introduced by an expert panel for the United States General Accounting Office (European 
Commission Directorate General for Employment, Industrial Relations and Social Affairs 1999: 
70). This complementary method aims at extending the results of controlled studies to the 
conditions of medical practice. It combines randomised controlled trial designs with database 
analyses and was claimed to be an ‘extension of the logic of meta-analysis’. Such innovative 
approaches towards the gathering of evidence for the production of new knowledge are very 
likely gaining importance in the years to come. However, at the moment they seem to be of 
minor relevance for the production of guidelines on screening tests for antenatal care. These 
new methods seem to be useful when innovative and flexible approaches are required, 
addressing particularly the needs of the recipients of care (Smith 2004:121).
In addition, such innovative seem to be a good instrument to adopt the delivery and 
organisation of health care to specific circumstances. Also the European Commission 
concluded that there are many types of information that may be valid and relevant under 
particular circumstances (European Commission Directorate General for Employment,
Industrial Relations and Social Affairs 1999: 34). It is explicitly stated that there is no reason to 
exclude any particular type of information as long as an appraisal is made of its validity and 
relevance and the information is given ‘due weight’. What this due weight might be will be 
explored in the section of how to weight evidence. However, the new approaches to generate 
knowledge are not at the focus of this study, although these new ways for the production of 
knowledge might start to complement obstetric knowledge in the future. Up to now, the 
involved health professionals seem to be still in the phase of struggling with the medical or 
obstetrical evidence about the individual measures. At this stage, the interested reader is 
therefore referred to the current and the upcoming literature on the subject (Smith et al. 2004).
Although the wealth of possible sources of evidence is stimulating the thought that for every 
question there is potentially the appropriate evidence, there are limitations and dangers to 
scientific evidence. Especially when dealing with complex questions, leading to a wealth of 
literature of different scientific quality, it is often difficult to find simple recipes for complex 
questions. One example is a multidisciplinary group of experts trying to set up evidence-based 
quality standards in an online educational project. In the excellent description of the research 
process, the authors state that they found repeatedly that the collective reflection of their 
practical experience enabled them to test the validity and transferability of published evidence 
better than following formal processes, such as the course of critical appraisal checklists 
(Greenhalgh et al. 2003). This demonstrates well that evidence and experience are neither 
necessarily exclusive, nor are they necessarily congruent. However, experience, expert 
opinion and authority are definitely concepts worth assessing in greater depth. This is even 
more so, as this kind of evidence is continuously ranked lowest in the grading schemes for 
evidence. In the grading system of the National Collaborating Centre for Women’s and 
Children’s Health, expert committee reports or opinions and/or clinical experience of respected 
authorities marks as Level 4 the lowest grade in the ranking (National Collaborating Centre for 
Women’s and Children’s Health 2003). In the classification system of the Oxford Centre for 
Evidence-based Medicine (Phillips et al. 2001), expert opinion without explicit critical appraisal, 
or based on physiology, etc. ranks on Level 5 which is again the lowest possible level. For the
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following exploration of the properties of expert opinion, not only scientific publications were 
reviewed. Also the case of a medical expert was analysed, which was fiercely discussed in the 
newspapers. This case was selected for its good documentation and its properties for 
providing an extreme example for the limitations and dangers of expert opinion.
3.4.3 Expert opinion
Within the legal system in the UK, “great store is laid by expert opinion which is regarded as 
synonymous with research-based evidence; both the prosecution and the defence try to find 
the best expert they can, that is, the best expert to support their case,... after an expert has 
given an opinion, its generalisability and relevance to the individual case under judgement 
appears to be treated with remarkable naivety” (Muir Gray 1997:192-93).
Although this statement relates to the legal system of the UK, it demonstrates well some of the 
major problems related to using expert opinion as evidence. First of all, the question of 
selection of the respective expert is relevant. As the above statement indicates, it is always 
possible to find an expert who supports one’s own opinion. Although this does not mean that 
expert opinion should be ignored in any case, it rather guides to assess carefully how this 
expert was selected, and what the possible reason for his or her selection were.
Secondly, the above statement is a reminder of the fact that expert opinion might come from 
personal experiences under certain conditions. Therefore, expert opinion should be assessed 
with regard to the circumstances under which it was gained. The generalisability of expert 
opinion should be scrutinised as rigorously as this is done in empirical research. It has to be 
kept in mind that expert recommendations might be biased due to outdated assumptions, 
personal bias from clinical experience, training and self interest (Woolf 1998 cited by European 
Commission Directorate General for Employment, Industrial Relations and Social Affairs 1999: 
45). However, it has to be noted that there are different kinds of expert opinion. It might be that 
expert opinion is only the opinion of a single expert, but it is also possible that it relates to
practical experience over many years. However, both are possible and the term ‘expert’ does 
not necessarily mean one or the other. It nevertheless makes a difference with regard to the 
validity of an expert’s testimony.
With regard to setting up guidelines, also ‘fatigue from the guidelines development process’ 
was discussed as a possible source for biasing expert opinion. All this indicates that in order to 
equate expert opinion and research-based evidence, the same care must be taken to assess 
its quality and independence. Otherwise, the following case might happen again.
Only recently, the cases of Sally Clark, Angela Cannings and Trupti Patel demonstrated that 
expert opinion has to be handled with care. All three women were sentenced to serve life 
sentences for murdering two or three of their children shortly after their births on the basis of 
expert medical evidence. The court followed what is known under ‘Meadow’s Law’. According 
to Professor Roy Meadow, the former president of the British Paediatric Association, it was 
extremely unlikely that more than one child dies from cot death in one family. In short terms the 
‘law’ states that “one sudden infant death is a tragedy, two is suspicious and three is murder, 
unless proven otherwise” (BBC 2003). As this unfortunately happened in all three cases, the 
above mentioned women were imprisoned on the basis of Professor Meadow’s expert opinion. 
Only in 2003, Sally Clark came free after the revision of the case by the Court of Appeal.
Before this, she was imprisoned for more than three years.
To restore his reputation, Professor Meadow explained that his expert testimony played a 
minor role in some cases. Nevertheless are convictions based on medical expert opinion only 
since his case now judged as unsafe practice (Doward 2005, Meadow 2002). Due to this, the 
Attorney General announced in January 2005 that nearly 300 cases in which parents were 
accused to have killed their children will be reviewed. An additional 30 000 cases in which 
children had been separated from their parents need to be reviewed as well (Doward 2005).
The tragedy in all these cases is that this expert and specialist for child protection and forensic 
paediatrics very likely had only the best intentions. He will have been convinced that he acted
in the best interest to protect children, and was even knighted for his efforts (BBC 2003, 
Doward 2005, Kite 2004). However, this case demonstrates well that special care has to be 
taken when one expert discovered a condition, was the first person to describe it, coined its 
name and was the only one who researched the subject. Even more care is needed if the 
theory helps to answer difficult questions, or closes uncomfortable gaps in knowledge. In such 
cases there is a chance that the whole phenomenon is an artefact and exists only in the logic 
system of this expert who describes it so convincingly that it appears real. A member of the 
House of Lords called this with regard to the case of Professor Meadow inventing a theory 
without science and fitting evidence into a diagnosis (Howe cited by BBC 2003), as never any 
real and peer-reviewed evidence was produced to prove the existence of the phenomenon.
In such a case, it could be useful not to accept a theory as true until the contrary is proven, but 
as provisional, until further evidence underpins it. In the case of Professor Meadow, it took 25 
years until his theory was discredited. Before this, it was used as a diagnosis throughout the 
world (Kite 2004). However, in order to finally clarify the question of the reliability of Professor 
Meadow’s theory, the UK Minister for Children named setting up an international panel to 
review it as an option (Kite 2004). Despite the fact that it would be interesting to know what 
happened to Professor Meadow, his theory and the families, whose cases have been reviewed 
after July 2005, this is not included in the thesis. It does not matter whether Professor Meadow 
was right or wrong with his theory, but his case itself can serve as a good example of what 
might happen, if expert opinion can or is not substantiated by scientific evidence, or is at least 
scrutinised according to similarly rigorous criteria as scientific research.
Similar to the consequences drawn from the Meadow-case, another source claims that “The 
opinions and judgements of experts that are based upon up-to-date scientific research clearly 
constitute high quality valid and reliable evidence. Those opinions that are not based upon 
such scientific evidence, but are unsubstantiated, subjective and opinionated viewpoints do not 
constitute high quality, valid and reliable evidence.” (Policy Hub 2005). This implies that expert 
opinion can be accepted as evidence, as long as it is not too subjective and can be clearly
justified. Otherwise it can not be accepted as evidence and should not be used for any 
purposes but the decision that more research is necessary on a subject. The crucial question 
regarding expert opinion is therefore, whether the opinion is primarily based on personal 
experience only (Polit & Hungler 1999: 8). However, a major problem arises when an opinion 
is coming from more than one expert. In such cases, questions must be posed, such as 
whether an expert panel is independent, or whether it is influenced by a certain case, member 
of the panel, etc. The validity of expert opinion increases with other evidence supporting it, not 
necessarily with the number of experts stating that it is true.
However, if expert opinion needs to be substantiated with other evidence, what is it then? Is it 
a variation or synthesis of the findings from research, adding a personal flavour to it? Is it a 
mixture of experience and evidence? Or is it an interpretation or addition to limited scientific 
evidence? If these questions have some kind of truth in them, another question arises:
At which point and under what circumstances do scientific evidence and expert knowledge 
become congruent? It might be that scientific and expert evidence become congruent for old 
disciplines, to which little knew knowledge was added over the past decades. In this case, all 
members of the profession are up-to-date as the facts did not change since their professional 
training. They can therefore act as experts. Another explanation could be that a very active 
research community exists, which has the determination to keep the entire profession up-to- 
date, and is successful with its strategies. As a third option, it is a very small profession, so that 
the same persons are regarded as experts, who acquire the scientific evidence. However, if 
expert opinion must be based on the latest scientific evidence in order to be acceptable, it can 
just be an interpretation of the findings, adapting them to the individual circumstances.
3.4.4 Health policy
From the literature on guidelines and on evidence it was concluded that the crucial point in 
developing guidelines and health policy of the highest quality is the decision-making about how
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to weigh up the available evidence. To explore this, some standard texts on policy-making in 
general (Parsons 1995), as well as on policy-making in health care were read to broaden the 
horizon, before setting off to a more focused search (Dolowitz & Marsh 2000, Klein 1990, Klein 
1998, Muir Gray 1997, Walt 1994). Also texts relating to the special traits of making health 
policy in the EU were explored (Graham 2004, Radaelli 2000). For all searches, policy was 
operationally defined as the decision to act on some particular problem and the subsequent 
decisions relating to its implementation and enforcement (Walt 1994: 41). This means that 
policy includes statements of intent, of action, and of what will not be done. According to this, 
guidelines are policy. Another important point implied is that policy needs decisions.
Health policy, as a specific kind of policy, is a difficult matter. This can be demonstrated well by 
using a simple definition. It can be defined in the widest sense as any managerial activities 
striving to produce strategies to improve outcomes and quality in health care (Klein 1998). 
What makes this definition, and the issue itself difficult is the fact that it contains the notion of 
quality. Quality is a complex concept. It includes several sub-concepts and dimensions. At the 
very least, effectiveness, efficiency, equity, access, acceptability and appropriateness are 
regarded as the essential components entailed in the idea of quality (Maxwell cited by Klein 
1998). On top of these, another author found respect, choice, availability of information, as well 
as technical competence to be a part of quality (Klein 1998). Although these ideas behind the 
concept of quality are not a problem in themselves, they shed light onto how complicated it is 
to make decisions for health care on the macro level.
First of all, already the amount of information is challenging, when complex situations are 
addressed. Evidence must be identified, gathered and examined with regard to its quality and 
applicability to the situation. An example for the possible extent, the reference list of the NICE- 
guideline on antenatal care can be used (National Collaborating Centre for Women’s and 
Children’s Health 2003). 631 studies were reviewed for the purpose of setting up a guideline 
on the basic care of healthy pregnant women. In addition to the mere extent of the literature, 
also strategies need to be developed on how to deal with the very likely situation of
contradictory evidence. However, these are issues relating to methodological quality in 
science, and are therefore manageable when adequate resources are available.
Another major problem when making health policy is that all of the above mentioned 
components can be assessed individually, but the assessment of each will lead to a result in 
its own right. Each component is likely to recommend a certain course of action, which can be 
the exact opposite as the course of action recommended by the findings on another 
component of quality on the same issue. In this case, decisions are required about what is the 
most desired outcome, what price can be paid for this, and at the cost of which other outcome 
variable. This type of problem can e.g. occur for monetary reasons, when there is only money 
for one intervention, but not for others. Another reason for such a problem could be that an 
intervention has positive effects for some people, but not for others, or at the cost of other 
desired outcomes. It can also happen that an intervention is found to be effective and 
affordable, but not acceptable for ethical, moral, or cultural reasons. Yet another problem can 
be the lack of either high-quality evidence or the lack of any evidence at all. In all these cases, 
managerial decisions are required about which weight should be given to the competing goals, 
and which course of action should be pursued accordingly. Furthermore, when making health 
policy, not only patient’s interests and medical necessities have to be considered. Also the 
ideas of government and interest groups, such as professional organisations, the 
pharmaceutical industry and the church play a role. In addition to that, foreign interests or 
responsibilities, e.g. the regulations from the EU have to be taken into account (Walt 1994: 3). 
Considering then that health itself and also the related research are highly sensitive issues 
with high public interest, decision-making is highly demanding in this area.
Despite the complexity of policy-making, the idea to use policy analysis as framework for the 
study was tempting. Initially, this framework appeared to provide tools to study the decision­
making for specific strategies, such as guidelines on antenatal care. When reviewing the 
literature in greater depth, it was found that there is a full body of literature relating to diverse 
fields in which policy is made (Parsons 1995, Walt 1994). This was explored to a certain
degree, before it was concluded that policy analysis does not provide the right framework. The 
main problem with using this approach was that this study is concerned with one individual 
aspect of antenatal care only. The focus is not on the complete national strategies regarding 
antenatal care, but on the national guidelines which specify the content and sequence of 
measures directed at pregnant women. Relating this back to the definitions as discussed 
above, national guidelines can be regarded as programmes, which are set up in order to 
implement a part of the overriding strategy, defining the specific actions to be taken (Dolowitz 
& Marsh 2000). Using policy analysis as a framework would have meant to consider the 
organisation of antenatal care as well, e.g. who is providing it and who is paying for it. 
However, the original aspect which led to the consideration of the above framework still needs 
to be explored: the problem of deciding about the recommendations for a guideline or policy in 
the light of limited or contradictory scientific evidence and limited resources.
In order to gain insights into the processes of policy making, the literature was explored. Care 
was taken to address the problem in direct relation to the EU, as well as to link it to guidelines 
and antenatal care. At the outset of the analysis, the entire question was approached on the 
basis of the perception that decision-making on that level can follow two different paradigms.
Within the first paradigm, policy is made on the basis of scientifically acquired evidence 
(Davies 1991 cited by Policy Hub 2005, European Commission Directorate General for 
Employment, Industrial Relations and Social Affairs 1999, Muir Gray 1997).
Within the second paradigm, lessons drawn from former policies, or experience with the same 
approach in another setting (Dolowitz & Marsh 2000, Radaelli 2000).
The analysis of policy-making under these two paradigms intended to set the scene for the 
development of a model for decision-making, which can be used to set up a common minimum 
guideline on antenatal care in the EU. However, during the reading process it became clear 
that the second paradigm plays only a minor role in the context of the thesis. Antenatal care is 
a complex intervention, involving regular check-ups of maternal and foetal wellbeing, but also
preventive measures and social support. As outcomes of care are also determined by social 
environment and lifestyle, genetics, health care and physical environment (Muir Gray 1997:12) 
it is extremely difficult to relate outcomes to care. For this, it is unlikely that the strategy of 
‘learning from the best’, which would mean the transfer e.g. of the Swedish model of antenatal 
care to a country with a higher perinatal mortality rate, plays a major role within the EU.
After this decision to concentrate on health care decisions under the first paradigm, the 
literature around evidence-based medicine [EBM] was explored. However, it did not take long 
to discover that medicine is not the only issue that claims to be evidence-based. Due to this, 
the search was broadened to evidence-based health care, evidence-based practice and 
evidence-based health policy. In addition to the internet links listed in the section on the review 
of guidelines, again the links available under the heading ‘evidence based medicine’ were 
used for this search (Appendix 1, Reference 9). In addition to those entrance links, the internet 
service of the British Cabinet Office’s Government Social Research Unit was used, which also 
regularly issues a bulletin to keep all interested parties informed (Appendix 1, Reference 2).
3.4.5 Factors with the potential to modify decisions
The fact that more than scientific evidence is needed for making decisions has been discussed 
already. The British Cabinet Office’s Government Social Research Unit identified five important 
factors to policy making, which are demonstrated in Figure 2.1.
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Figure 2.1: Important contributing factors to policy making (Policy Hub 2005)
Despite its straightforward appeal, this model of factors is not that simple. The problems 
related to the definition and to the utilisation of evidence have already been discussed. At this 
point, only some of the different kinds of evidence available for health care decisions should be 
briefly named. When making decisions on the population level, results from clinical research, 
epidemiology, health economics, health system research together with the systematic review 
of outcome-research, effectiveness research, appropriateness research, cross design 
synthesis, satisfaction research and quality development could and should be used (Canadian 
Health Services Research Foundation 2005, European Commission Directorate General for 
Employment, Industrial Relations and Social Affairs 1999). With this, also the key questions 
about equity, effectiveness, safety, patient satisfaction, cost-effectiveness, quality and 
appropriateness of measures have to be answered (Muir Gray 1997:103ff).
When planning to implement a policy, it is necessary to transfer these factors to the strategic 
level of financing, organising and delivering health care. In this process, again other factors 
contribute to decisions, such as contracting, budgeting, accreditation, skill mix, education, etc. 
(European Commission Directorate General for Employment, Industrial Relations and Social
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Affairs 1999). These factors could probably be summarised under the heading ‘resources’.
However, although they need not be necessarily defined as evidence, there are several other 
factors to be considered, such as habits, tradition, reluctance to change, or radically different 
opinions. Such factors might fall into the realm of experience, or what can be defined as non- 
scientific colloquial evidence (Canadian Health Services Research Foundation 2005). As such 
factors definitely have an influence on decisions, models with less than the above mentioned 
five factors bear the danger of not grasping the entire situation. One example for such a model 
would be that of Muir Gray, who claimed that decisions about groups of patients or populations 
are made by combining three factors: evidence, values and resources (Muir Gray 1997:1).
The fact that also the limited model mentions the factor ‘values’ indicates that it might have 
special importance for policy-making. Unfortunately, for this factor no universal definition can 
be given. Values are likely to vary from patient to patient and from practitioner to practitioner, 
but also from decision-maker to decision-maker. An example for this might be that Jehova’s 
witnesses rather die than to accept blood from other people. Another example might be the 
decision to save the life of the mother, rather than that of the unborn foetus, if only one can be 
saved. It is especially important to acknowledge the factor values when making decisions for 
entire populations. The decision to allocate resources to maximize health gain in return for any 
given level of expenditure represents a very basic, but important value decision in the health 
sector (Harrison & Moran 2000:498). Another example for such a general decision is the rule 
of rescue, which means to prioritise the treatment of live-threatening conditions, before serving 
other needs (Harrison & Moran 2000: 498). After that, other factors can be considered, such as 
effectiveness and uncertainties, cost-effectiveness, cost-utility, equity and equality, i.e. to 
enhance equity, which is to ameliorate the position of people who cannot afford the care form 
which they might benefit (Harrison & Moran 2000: 498). This indicates that usually an open or 
covered ranking of priorities exists, according to which resources are allocated.
Thinking the consequences of individual decisions through, it seems to be likely that the 
establishment of such a prioritising system is a sensitive and difficult task. This seems to be
even more difficult, when the values of diverse cultures, religions, ethnicities, classes, genders 
and age groups have to be considered, such as in the EU. Moreover, also the values and 
interests of governments and their policy makers, such as politicians and bureaucrats, of 
interest groups like the military, trade unions, church, professional groups, community 
structures, and foreign interests might play an important role (Walt 1994: 3). In addition to the 
above mentioned factors, there are other influences and decision-modulating factors in making 
context-sensitive health policy. Under the header ‘colloquial evidence’, not only values were 
named, but also political judgment, professional experience and expertise, habits and tradition, 
as well as pragmatics and contingencies were subsumed. Not the least, also lobbyists and 
pressure groups influence decision-making in health care (Canadian Health Services 
Research Foundation 2005). Despite the extensive review of the important contributing factors 
to policy making (Policy Hub 2005), a last one remains: judgement. This can be regarded in 
line with the crucial question of
3.4.6 How to weight the evidence to set up guidelines?
Integrating external evidence with experience, resources, values and judgement has been 
defined as the task of evidence-based health care and evidence-based policy. This means 
essentially balancing and weighting evidence from different sources, and the process of 
adapting the findings to the specific circumstances of a patient or a population. Although the 
methods of evidence-based health care help to make decisions transparent, they do not 
resolve the difficult value judgements, which are usually at the core of most strategic decisions 
(European Commission Directorate General for Employment, Industrial Relations and Social 
Affairs 1999: 36 citing Hicks 1997). When setting up guidelines, also strategies are needed to 
deal with the absence of evidence. This constellation needs to be considered as some authors 
claim that to date only for 20% of all processes in medicine there is sufficient evidence 
(Kreienberg & Berg 2002). As a consequence, most of the currently available guidelines are 
based on limited scientific evidence and the judgement of the person or persons who made the
decisions. Scientific evidence and the judgement of the decision-maker are therefore 
intertwined, and not mutually exclusive. All the doubts and questions relating to any activity 
that claims to be evidence-based, are summarised in the following statement (Klein 1998):
“One of the fashionable mantras of our time is the demand that policy making should be 
‘evidence-based’. It is a misconceived demand. For the real trick of policy making is how to 
make sensible decisions, given inadequate, incomplete, and ambiguous evidence.”
In this respect it is important to acknowledge the difficulties in making evidence-based 
decisions, but that inadequate, incomplete, and ambiguous evidence is not the only reason for 
this. One author tried to explain this, differentiating between decision making and decision 
taking (Muir Gray 1997:210):
“Although evidence is influential in decision making, in decision taking the fears, anxieties and 
values of the patient may predominate.”
Although this statement relates to an individual patient and a decision about a specific 
situation, it nevertheless makes clear that decisions are influenced by the person who is 
making it. Consequently, questions must be asked of who is in the position to make decisions, 
and how decisions should be reached. From the above statement it becomes clear that it is 
difficult to reach decisions for reasons of weak or ambiguous evidence, but also for reasons 
that lay within the decision-maker. This is likely to be the case not only if the decision-maker is 
personally affected by a decision, but also for political reasons, monetary constraints, as well 
as any kind of external and internal values and pressures. This applies at least for decisions, 
affecting more than one patient, e.g. when setting up guidelines. In such cases, an 
independent decision-maker is needed who is not directly affected by either course of action 
and is independent from the interests of third parties. When unpopular decisions have to be 
made, also a certain degree of courage is needed. Decision-making is therefore a demanding 
task, needing a well developed and independent personality. However, it might be questioned 
whether such a personality could be found in practice, irrespective of the issue under
consideration. It might be also questioned whether important decisions relating to entire 
populations should be made by one single person, or whether such decisions should be made 
by a group. Another issue to consider is whether the decision-makers should follow a certain 
strategy in order to make their decisions transparent.
With regard to decision-making, the European Commission makes a clear statement as to who 
should decide about the weight to be attached to the evidence for setting up guidelines 
(European Commission Directorate General for Employment, Industrial Relations and Social 
Affairs 1999:41). According to this, decisions should be based on scientific evidence and 
expert professional consensus on good medical care. It is made clear that decisions should 
finally lead to a ‘consensus’ and are to be made by ‘experts’. This means that not only an 
independent and well developed character is required to make decisions, but also expertise. 
Decisions should be based on scientific evidence, but should also be complemented by 
expertise. What becomes also clear is that it is obviously recommended to use a group, rather 
than a single person for the decision-making process. In the above statement, it is also 
highlighted that the group of experts should come to a ‘consensus’ decision. The definition of 
consensus is in this context a formal one (European Commission Directorate General for 
Employment, Industrial Relations and Social Affairs 1999: 59), saying that
“Consensus methods are based on (usually expert) scientific panel conventions designed to 
establish recommendations on health-care practice within a professional community. 
Consensus methods utilise the process of group interaction to arrive at a collective opinion.”
In order to shed light onto the rigour of the final stage of consensus finding in the guideline 
development process, the classification system of the German Cancer Society can be used as 
an example (Deutsche Krebsgesellschaft 2005). On top of certain requirements with regard to 
the underlying evidence and the way of gathering it, the German classification system 
prescribes how the final consensus must be reached, and therefore clarifies the role of 
experts. The grading system of the German Cancer Society is demonstrated in Table 2.12.
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Table 2.12: Levels of guidelines according to the method of consensus finding 
(Deutsche Krebsgesellschaft 2005)
Level Consensus finding procedure
1 informal consensus reached by a ‘representatively chosen’ group of experts
2 formal consensus procedure, e.g. Delphi method, or consensus conference
3 extended formal consensus procedure, including decision-analysis and outcome analysis
Although the above system of reaching consensus seems to be clear and logical, there are 
several concerns with regard to consensus ratings. The first question relates to the idea of a 
‘representatively chosen’ group of experts. From this statement it can be concluded that the 
composition of the panel influences the results, i.e. the decisions (European Commission 
Directorate General for Employment, Industrial Relations and Social Affairs 1999: 58). As a 
consequence, the first task in the consensus procedure is to define the expertise needed in the 
panel. In a second step, persons with the respective expertise need to be identified, 
considering that they need to be independent, but representative for the group they stand for. 
Otherwise it might well be that they introduce more bias than expertise.
With regard to national guidelines on antenatal care, a consensus panel might involve not only 
obstetricians and midwives, but also general practitioners, pregnant women, women who have 
given birth, paediatricians, a representative from an ethics committee, economists, politicians, 
or funding bodies. Introducing the necessary obstetrical and scientific expertise for a 
consensus panel is important for the scientific quality and the practical applicability of a 
guideline. Introducing patient representatives is essentially an act of democracy and ensures 
that the guideline is acceptable to those affected by it. The inclusion of persons focusing on 
ethical and religious questions helps to ensure that the general values of the population are 
respected. Although a person from government is an elected representative of a nation, it 
would go too far to regard such a person as a representative of patient’s will. Such a person
might be e.g. useful to advocate the economic aspects in a tax-financed health system. 
However, with regard to selecting the best expertise for a consensus panel to set up national 
guidelines, the drive to limit bias can produce a myriad of research, literature and management 
activities. For this the amount of effort to be invested should be thought through.
When finally selecting the representatives of the respective groups, it has to be kept in mind 
that the method of consensus finding is vulnerable to the subjective opinion of forceful 
members of a panel (Phelps 1993 cited by European Commission Directorate General for 
Employment, Industrial Relations and Social Affairs 1999: 61). As a consequence, either the 
representatives have to be chosen to balance the forces within the panel, or strategies have to 
be developed to balance the influence of individuals. To name only three examples for such 
strategies, it might be an option to use more than one representative for weaker groups, to use 
consensus procedures, which blind the person opting for or against a decision, or to use an 
independent and well-skilled moderator to assist in balancing the influences. As conclusion to 
these considerations, it should be kept in mind that even formal consensus procedures do not 
guarantee the independence of the resulting decisions and guidelines, but that a critical eye is 
needed on what interest groups are represented, who the representatives are, and which 
consensus procedures are used. Yet another excellent idea is that not all possible views and 
positions must be represented in the decision-making panel, but consultations with relevant 
interest groups can be used instead (Canadian Health Services Research Foundation 2005 + 
2006a). By this, the views of all relevant parties are included, but also weighed up against 
possible other interests. This process also enhances the independence of a decision-maker, or 
limits the potential of conflicting interests in a group of decision-makers.
Despite the above mentioned factors that can compromise the quality of guidelines, a distinct 
process of consensus finding has clear benefits compared to decision-making by a single 
person. This is especially the case, the more limited, ambiguous, or contradictory the 
underlying evidence is, or the more ethical or value judgements are to be made. If 
contradictory interests are involved, it is beneficial that a formal consensus procedure brings
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together the competing disciplines with their respective goals to solve a certain health problem. 
This helps to balance views and to make the most out of the given resources under the 
respective circumstances and improves the acceptance of the final guideline across 
disciplines. For national guidelines, such a process helps to balance the needs of individual 
patients and those of the entire population, optimising the allocation of scarce resources by 
investing into the most beneficial measures.
In order to produce good guidelines, the consensus panel has to develop the most effective 
combination of their respective expertise, which stimulates co-operation and the co-ordination 
of efforts. This bringing together of ambitions contributes a lot to avoid redundancies as well as 
gaps in a certain health field and ensures that evidence from various sources and disciplines is 
considered. Moreover, such an approach produces synergies and stimulates continuing co­
operation across disciplines. Drawing all the above arguments together, it becomes clear that 
the strategies and the ‘experts’ used to weigh up the evidence play a key role in setting up 
evidence-based guidelines. The need to select both the strategies for consensus finding as 
well as the experts with utmost care and critical thought can not be overestimated. However, it 
should be kept in mind that the first step in the process of developing a guideline is to decide 
on its aims, based on the existing evidence.
Evidence and expert opinion
The European Commission acknowledged in its document on developing a methodology for 
setting up guidelines for optimum medical practice that there are many types of information 
that may be valid and relevant in particular circumstances (European Commission Directorate 
General for Employment, Industrial Relations and Social Affairs 1999:34). It was also made 
clear that as long as the validity and relevance of any information are appraised, there is no 
particular type of information that should be excluded. However, also in this text it was again 
highlighted that the information should be given due weight. In the following, an attempt is 
made to grasp the notion of ‘due weight’ for developing guidelines on antenatal care in the EU.
In May 2005, the Canadian Health Services Research Foundation released “Conceptualizing 
and Combining Evidence for Health System Guidance”, a systematic review on the meaning of 
evidence in health care (Canadian Health Services Research Foundation 2005). As a major 
intellectual step forward, the authors of the report developed two categories for the different 
kinds of scientific evidence: context-free and context-sensitive. This goes in line with the 
conclusions from the chapter on the hierarchy of evidence in this thesis, which were that 
evidence should not only be ranked according to the scientific impact following from the 
perceived independence from any external factors of a study, but that the levels of evidence 
and the study types need to be defined individually for different questions. The main 
conclusion was that it is necessary to determine which approach is suitable to answer the 
question under consideration best, and to rank the appropriate study designs accordingly.
However, setting up hierarchies of evidence implies that questions in health care are such as 
to be answered by one single set of studies. Unfortunately, questions in health care, and 
especially those relating to decisions about complex care situations, are usually not to be 
answered by one single question. When setting up guidelines, different questions and 
therefore evidence on different aspects of a situation play a role. Hence, it is therefore 
necessary to define what types of information should count as evidence, and how they can be 
appropriately combined to create guidance. Guidance is defined as recommendations for 
action. In the thesis, guidance is used synonymous to guidelines, although it generally refers to 
health care situations on a larger scale.
When setting up guidelines on antenatal care, evidence is needed e.g. about the effectiveness 
of individual screening tests, but also about the acceptability and the cost-effectiveness of 
them. While the first aspect might be addressed best by randomised controlled trials, the 
second one is likely to be covered well by a qualitative approach. Assessing the cost- 
effectiveness of a screening test again needs a totally different study design. After gathering 
scientifically valid evidence on all aspects of one individual test, a ranking of the evidence is 
needed in order to decide about the inclusion or exclusion of the test in the guideline. As the
evidence addresses different aspects of the same measure, a clear ranking of the evidence 
according to the scientific properties of the underlying studies is not possible. As a measure to 
resolve this problem, the idea of categorising research evidence as suggested by a systematic 
review provides a useful framework (Canadian Health Services Research Foundation 2005):
- context-free, i.e. evidence about what works in general, and what might be achieved under 
ideal circumstances, and
- context-sensitive, which is evidence about the conditions of implementation.
The classification into context-free and context-sensitive allows to assess the relevance of 
evidence, and to make decisions accordingly. After the general effectiveness of a measure has 
been proven by context-free evidence, context-sensitive evidence is especially useful. This is 
due to the twofold advantage of relating to both, studies testing how contextual factors 
moderate an effect, but also about the factors which influence the possibility to implement an 
intervention. This strategy helps to overcome the current heavy reliance on randomised 
controlled trials and meta-analyses of them, which have despite their high status also 
disadvantages. One of these problematic issues is that the subjects, who are part of the later 
target group of an intervention, are excluded by the study protocol to control for possible co­
factors. Therefore, the findings of randomised controlled trials have a lower external validity 
compared to studies with non-randomised designs (European Commission Directorate 
General for Employment, Industrial Relations and Social Affairs 1999: 47). This represents well 
the difference between effectiveness and theoretical efficacy, demanding ways to link the 
results of controlled trials to patient outcomes in the real world. Another issue that needs 
consideration in this respect is the fact that trials do not always measure all the outcomes of 
interest to patients and physicians (European Commission Directorate General for 
Employment, Industrial Relations and Social Affairs 1999: 65). This leads directly to the fact 
that there are several other factors that have an influence on decision-making in health care. 
This third kind of evidence, which represents any non-scientific information that plays a role in 
producing health systems guidance, was defined as ‘colloquial evidence’ (Canadian Health
services Research Foundation 2005 + 2006a).
However, although useful to weigh up the relevance of scientific research for health care 
practice, the above mentioned classification of evidence to produce guidance in health care is 
only the first step towards the final integration of the gathered evidence. Acknowledging this, 
the Canadian Health Services Research Foundation hosted an international workshop in 
September 2005, in which leaders from organisations providing guidance in health care 
discussed the role of different kinds of evidence for decision-making and explored models to 
combine multiple forms of evidence (Canadian Health Services Research Foundation 2006a). 
As this workshop seems to be the first of this kind on an international basis, it is concluded that 
the question of how to use different kinds of evidence to guide practice is just starting to come 
onto the agenda. Moreover, it is obviously a topic of interest at the highest level. This might be 
due to the fact that over the past years, the production of new evidence has reached a degree 
such as to require strategies to control the flood of information. In addition, there might be the 
perception that research is not a stand-alone measure and needs translation into practice.
Deliberative processes to combine multiple forms of evidence
In their international workshop in September 2005, leaders from organisations providing 
guidance in health care explored models for best practice to use deliberative processes to 
combine multiple forms of evidence (Canadian Health Services Research Foundation 2006a). 
Although the final conclusion of this workshop was that the review of deliberative processes 
did not reveal anything conclusive, it nevertheless led to important recommendations for good 
practice and laid the groundwork for future experimentation.
One of the central problems identified when producing guidance for health care was the need 
to develop clear strategies to consider all the contributing factors, which can be subsumed 
under the header ‘colloquial evidence’. In addition to the factors discussed in the previous 
sections, professional experience and expertise, political judgement, resources, values, habits 
and tradition, lobbyists and pressure groups as well as pragmatics and contingencies were
identified (Canadian Health Services Research Foundation 2006a). The term ‘colloquial 
evidence’ is therefore used to subsume the many types of non-scientific forms of information, 
which are likely to play a role in the process of decision-making. Despite its role in decision­
making, evidence on such decision-modulating factors is usually criticised for not being 
gathered in a rigorous or systematic way (Canadian Health Services Research Foundation 
2006a). In the rare case of having been gathered with replicable methods, e.g. from the social 
sciences, evidence on values, habits, etc. can be treated as scientific evidence. Otherwise, 
care has to be taken to consider the quality and nature of the information, but also the source 
of the colloquial evidence and its potential to introduce bias (Canadian Health Services 
Research Foundation 2006a). Unfortunately, the participants of the workshop concluded that 
decision makers should consider the sources of colloquial evidence and give appropriate 
weights. As the overriding question in decision-making and producing guidelines is how to 
weigh up evidence, here the problem starts again. This clearly demonstrates that the workshop 
ends with the same question that was asked at the beginning of the chapter, only at a later 
stage in the decision-making process.
Despite this unsatisfactory final conclusion, the report of the workshop of the Canadian Health 
Services Research Foundation provides a valuable discussion around the problem of weighing 
up evidence. Most interestingly, it was discussed that research evidence could and should not 
be combined with ‘colloquial evidence’. Colloquial evidence should be used inform scientific 
evidence, guiding and interpreting science and filling gaps when they appear (The Canadian 
Health Services Research Foundation 2006a). This means that colloquial evidence comes into 
play when the step is made from summarising research findings to providing clear guidance for 
practice. It is important to note that the evidence should be assessed first, and then expert 
opinion, colloquial evidence and debate should be added. Colloquial evidence is not a 
substitute for scientific evidence, but should be used to make sense of research findings. 
However, it was also stated that colloquial evidence should inform the selection and 
interpretation of research findings. At least the first notion must be viewed critically, as the 
selection of evidence according to values might introduce selection bias. There is the danger
of considering only part of a problem or of selecting only part of the literature, rather than 
summarising the scientific evidence, and then assessing it in the light of additional factors.
Although technical methods for combining different kinds of evidence are possible and were 
identified by a systematic review, these approaches were criticised for their tendency to 
generalise, and the difficulty of including new knowledge and experience into the system 
(Canadian Health Services Research Foundation 2005). Moreover, it is likely that e.g. complex 
technical approaches using assigned relative weights improve the rigour of decision-making for 
straightforward questions, but it is not sure how such approaches work for complex questions 
in health care. As long as no rigorously developed and evaluated tool is available for complex 
questions in health care, a deliberative process, which is likely to ensure evidence-based 
guidance in the light of heterogeneous evidence is recommended (Canadian Health Services 
Research Foundation 2005 + 2006a). Although not neutral in their design, deliberative 
processes have the chance to enhance the acceptability of a guideline. However, it was found 
that there is still little evaluation of the best way to design such a process (Canadian Health 
Services Research Foundation 2005). After the workshop of the Canadian Health Services 
Research Foundation, the following core features of such a process were defined:
- the presence of a strong, skilful chairperson,
- consideration of different types of evidence,
- engagement between the scientific and decision-maker communities leading to a fair 
representation of scientists and stakeholders, and additional consultations with all parties 
affected by the outcome,
- an explicit process of exclusion and inclusion, together with a high-quality syntheses of the 
scientific evidence,
- face-to-face discussions,
- an appropriate timeline for questions, and finally
- a mechanism to elicit the values of the participants.
However, this process could and possibly should not be used only in the presence of 
heterogeneous evidence, but in all cases where evidence does not prescribe only one possible 
way of action. Whenever views, opinions, finances, prioritising, etc. come into play, this 
process appears to be suitable. The crucial sentence from the summary of the Canadian 
Health Services Research Foundation was that different forms of evidence do not combine of 
themselves into guidance (Canadian Health Services Research Foundation 2006a). A decision 
is always necessary in order to implement a certain course of action. However, although the 
deliberative process as recommended is convincing and principally plausible, it was also 
admitted that there is little evidence on its effectiveness to date.
The use of deliberative processes has several advantages, such as making decisions 
transparent. Although the documentation of such processes can help to demonstrate which 
influences led to decisions, and which weight was given to the individual components, it is 
extremely difficult to identify all the points at which non-scientific evidence has influenced a 
decision and in what ways. This is nevertheless the desirable level on which policy should be 
discussed. Moreover, the way of dealing with different forms of evidence determines how 
accurate, achievable and acceptable recommendations, e.g. guidelines are (Canadian Health 
Services Research Foundation 2005). The use of a deliberative process to deal with different 
kinds of evidence, as well as the idea to make the methods of policy-making explicit seems to 
be a possible way to achieve this. However, in the worst case, the entire process is only a new 
managerial variation of what has always been done in practice.
Although the above mentioned positive aspects of transparency in decision-making prevail, 
there are also possible problems related to it. One idea that has to be critically thought through 
is to whom and to what degree the decision-making is made transparent. Although there might 
be a wealth of pros and cons, only one example should be made in order to not be led too far 
from the core of the study here, but to demonstrate the need to address the issue. If a 
decision-making process is made transparent to all, individual parties might have insights that
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help them to increase their influence in future decision-making processes.
Another concern is that despite the valuable attempts to make decisions transparent, such 
processes might not be reliable. It is questionable, whether another decision-making panel with 
the same expertise would arrive at the same decisions. Unfortunately, there is not yet any 
evidence on this aspect. Moreover, it is also questionable, if the same panel of experts would 
again arrive at the same decisions at another point in time. This is most likely not the case, but 
can be justified with the rapid advancements of science and the permanent increase in 
individual knowledge and experience of the group members. However, it needs to be proven 
whether this effect could be also a weakness of the methodology.
3.5 Implications of the analysis of concepts and of the literature
When finally synthesising the findings of the review on the quality of recommendations and on 
instruments for the systematic appraisal of guidelines, it was found that the appraisal of the 
scientific quality of a guideline’s recommendations is an important step in its overall evaluation, 
though not the only one. Instruments exist from national, as well as from international 
agencies, with which the overall methodological quality of guidelines can be assessed. 
However, the most important conclusion to this analysis was that the link between the overall 
quality of a guideline and the quality of its recommendations, which is their actual content, is 
missing. As no tool was found to assess this relationship, the crucial question remains: do 
good guidelines make good recommendations?
To narrow this gap in knowledge, it is also necessary to critically appraise the implications that 
different methods for setting up guidelines have on guideline quality. This will be achieved by a 
critical in-depth assessment of two guidelines based on entirely different paradigms. For this, 
the evidence-based guideline from England and Wales (National Collaborating Centre for 
Women’s and Children’s Health 2003) and the expert-opinion based guideline from Germany 
will be appraised (Bundesausschuss der Arzte und Krankenkassen 2003), using the
instrument developed by a collaboration funded by the European Commission (The AGREE 
Collaboration 2001). The detailed method for this appraisal will be described later in this 
chapter.
Developing a model to set up a common minimum guideline for the EU
Despite the above suggestions for using and weighing up different kinds of evidence to 
produce guidance in health care, it is important to note that up to now there has been no 
evidence to support any model of decision-making in such a process. It is therefore not 
surprising that there is also no data available as to whether such a process is suitable to 
produce guidance at national or even international level. Most importantly, it was found that as 
yet there is no tool available to set up genuine international guidelines. Instead, by the critical 
analysis of the concepts of evidence and the problems involved in dealing with it, the idea was 
reinforced that it is of critical importance to respect national decisions and values.
From the above analysis it was concluded that the existing national guidelines on antenatal 
care from the member states should be used as the basis to develop a model to set up a 
common minimum guideline for the EU. These guidelines represent the national decisions 
about what is wanted and acceptable for the respective populations, and what was found 
suitable in the light of the need to distribute limited resources. It would not be appropriate to 
disregard such important decisions. As the consequence of these considerations, a model is 
needed, by which the national ideas about good antenatal care will be respected, but which 
also enables the utilisation of the potential benefits of a common minimum guideline.
Developing a model for setting up a common minimum guideline for the EU on the basis of 
existing national guidelines contributes fundamentally to reach the aims of the thesis: it will 
further develop the theoretical basis for health policy on antenatal care on EU-level, it 
contributes to the acceptance of widely recommended methods for antenatal care and helps to 
optimise the allocation of resources. By integrating the decisions and values of the member 
states, the shaping of a common European set of values with regard to antenatal care might
be encouraged, opening up the opportunity for a true European approach in the future.
However, before such a model can be developed, deeper insights are needed into what 
models of decision-making already exist at the level of the European Union, and what the 
current public health policy of the EU is. Unfortunately, it was found to be nearly impossible to 
determine the current state of the art of this aspect. Official documents of the diverse 
institutions of the EU keep coming up on a daily basis. It was therefore attempted to identify 
the fundamental traits of health policy in the EU, and to present them together with comments 
on the current discussion in the field. However, completeness, i.e. topicality on a daily basis 
can not be achieved by the thesis. Despite these obstacles, in the following the current state of 
the art with regard to health care in the policy of the EU is critically assessed. Special care is 
taken to answer the question of whether a common minimum guideline on antenatal care 
would be possible under the regulations of the EU.
Guidelines on antenatal care in the EU
From the previous review of the literature, an area was identified, for which the gap in 
knowledge is sufficiently large as to justify further inquiry. This is the lack of knowledge about 
guidelines on antenatal care in the member states of the EU. As the extensive review of the 
literature did not bring up sufficient data, a survey design was regarded as most appropriate to 
establish the existence and the content of national guidelines on antenatal care in the EU 
states. The survey details will be specified at a later stage within this chapter. Before that, the 
public health policy of the EU is critically analysed together with the decision-making in the EU.
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Part 2 - Health care and decision-making in the EU
3.6 Health care and decision-making at European level
The review on antenatal care, as well as the reviews on the making of health policy in general 
highlighted the need to undertake a review on decision-making within the institutions of the EU. 
This specific search was necessary to achieve the planned comprehensive overview of the 
concepts, their theoretical discussion and synthesis for the theoretical framework for the thesis. 
However, during the review on the current state of the art it became clear that EU health policy 
can not be separated from the underlying principles of the EU and the current debates. Hence, 
this part of the review needed to be more extensive than previously thought. However, it was 
most interesting to find how the institutions of the EU relate to each other, how attempts are 
made to solve the problems arising from ambiguity of mandates for health matters, and what 
the member states, as well as their individual inhabitants contribute to the constant change of 
the system. Special care was taken to assess the issues at the policy level, as well as at the 
organisational and output levels. With the review on the EU and its implications for health care 
it was aimed at identifying:
- all relevant institutions occupied with health care in the EU, together with the analysis of their 
interrelations and
- all key features of EU (health) policy that are important to the study.
To achieve this, the systematic and repeated search of diverse information systems was 
necessary. The sources searched were
- official websites of the EU, such as the homepage of the Department General for Health and 
Consumer Protection of the European Commission (Appendix 1, Reference 15),
- the official e-mailing service of the Department General for Health and Consumer Protection 
of the European Commission. These e-mails provide “timely, readable and reliable accounts of 
activities and developments in the field of consumer protection, public health, feed and food
safety, health and welfare of animals”, including official documents, speeches, minutes of 
meetings of working groups, etc. In addition to that, the internet links to documents are also 
provided (Appendix 1, Reference 7),
- ‘health and consumer voice’ and ‘consumer voice’, the monthly newsletters on public health, 
and also the yearly publication ‘EU public health information network newsletter’,
- the internet source of SCADPIus, i.e. Summaries of the Union’s legislation, which has a 
special section on public health (Appendix 1, Reference 18),
- CORDIS, the Community Research and Development Information System (Appendix 1, 
Reference 5), and
- other media, which provided comments on EU (health) policy.
However, it was a major challenge to find that health care issues are represented in nearly all 
policies of the EU. Some effort was taken to extract the public health issues from other EU 
activities, such as from the framework programmes on community action for research and 
development, in order to get an impression of how deep the strategies of the EU go to develop 
health care issues (CORDIS 2002). In contrast to the framework programmes and the 
programmes of community action in the field of public health, the yearly action plans within 
these programmes were not analysed, which break down the overriding programmes into 
manageable pieces. If publications of that level had been included it would have broadened 
the search to an unmanageable degree, without adding new information.
From the documents identified it was found that one of the major challenges of the European 
integration process is the right of free movement (Paton et al. 2002: 4), as was explained in the 
section on free movement of persons, services, capital and goods at the beginning of the 
thesis. On the basis of the latest ruling of the courts, the influence of patient and health care 
providers’ mobility on the health care systems of the member states was assessed. In 
particular the need to ensure the quality of care was examined.
The next issue assessed, which is presented in the following section, was public health as part 
of EU policy. Public health was for the purposes of this operationally defined as health care for 
populations, and the treatment of those who feel well. Another feature of public health is that 
decisions are made for entire populations, not for the individual (Muir Gray 1997:11). From the 
starting point of a dedicated public health strategy, the development of public health policy in 
the EU was followed up as far as the Union’s current public health programme (CORDIS 2002, 
European Parliament and the Council of Europe 2002, Treaty of Maastricht 1992). In this 
context, also the impact of health policy on the European integration process was assessed.
Other findings explored to considerable depth were the organisational conflicts, task overlaps 
and gaps, as well as an ambiguity of mandates between the institutions of the EU and their 
programmes. In relation to this, the current attempts to overcome these problems were also 
assessed. Attempts to bring divided actions on the same issue together could be 
demonstrated well for the framework programmes for research and development and the 
Community’s public health programmes (Commission of the European Communities 1998, 
2000 + 2005, CORDIS 2002, European Commission Research Directorate General 2001, 
European Parliament and the Council of Europe 2002, Watson 2001).
However, the most important question for this part of the review was, whether a common 
minimum guideline on antenatal care would be possible under the EU regulations. To assess 
this, the Treaties of Maastricht and Amsterdam (1992 + 1997) were analysed in depth, and the 
findings were complemented by the analysis of current initiatives at EU level.
As has been stated before, it was concluded from the literature on guidelines and on evidence, 
as well as from the literature on health policy that the making of health policy and the 
development of guidelines requires decisions about how to weight the available evidence. As a 
logical consequence, decisions have already been made in each member state of the EU 
about what should be contained in a national guideline on antenatal care. Evidence has been 
assessed and weighted according to the circumstances of the respective member state, e.g. 
the budget available for health care, prevalence rates of certain conditions, or the ethical
acceptability of diagnostic tests. On the basis of this fact, it was thought that a common 
minimum guideline should acknowledge and respect the national decisions about what was 
perceived as important for antenatal care. As a consequence, a model was needed to bring 
the national guidelines together, acknowledging that only the core measures should be 
included in a minimum guideline. For this, only measures should be considered which are 
acceptable to the majority of member states. It was acknowledged that special care needs to 
be taken not to exclude less wealthy states or states with many citizens to care for from the 
potential benefits of a common minimum guideline.
From the broad reading of official EU documents, it was evident that the European Union 
operates sophisticated models for decision-making in order to ensure the balance of interests 
of its member states. As it was thought that these models might be suitable for the selection of 
tests for the common minimum guideline, the decision-making structures within the EU needed 
to be critically analysed. It was hoped to find that with the help of a model for decision-making 
in the EU, a kind of consensus guideline could be established. Searching for information about 
decision-making in the EU, the Treaty of Nice and the proposed Constitution were found to be 
the most fruitful sources (The European Union Constitution 2004, Treaty of Nice 2001).
Due to the diverse aspects of antenatal care in the context of the EU, the framework for the 
study could not be based on a single concept from a pre-defined discipline, e.g. medicine, or 
the political sciences. Instead, a comprehensive critical descriptive review of the state of the art 
was necessary in order to disentangle the conceptual underpinnings of the research problem. 
This approach was recommended by experts as being appropriate for complex questions, 
especially when addressing conceptual literature. Such a search should demonstrate 
reasonable knowledge of the field, giving evidence of what was included and why, rather than 
being exhaustive with regard to having systematically accessed all publications on the topic of 
interest. Nevertheless, measures were taken to ensure the rigour of the searches. For this, 
pre-defined open questions, which were derived from the literature as well as from textbooks 
on research methods were used to ensure the rigour of the review method. This approach
allowed access to publications and intellectual ideas from various disciplines, on various 
aspects and of varying scientific quality, but ensured methodological rigour by providing a 
framework for inclusion/exclusion and analysis. By this, a comprehensive picture evolved, 
which clarified the underlying concepts of the study, their individual properties, and how they 
relate to each other. The critical descriptive review of the state of the art therefore provided a 
broader scope than a narrow systematic review, acknowledging the complexity of the situation.
Despite the obvious advantages of this approach, there are also possible points of critique. 
One of them could be that the search itself is not reproducible, and that a lack of rigour and 
depth in the retrieval of the relevant literature can easily lead to a haphazard collection of 
ideas. Attempts were made to overcome this by ensuring sufficient depth and breadth, using a 
pre-defined set of questions to guide the searches. Special care was taken to formulate the 
questions in order to
- ensure the methodological quality of the included material,
- determine, whether the evidence about a concept sufficed, and to
- conclude, whether there were additional concepts to be analysed.
In addition to the clear concept, a detailed track record of the review gives evidence of which 
sources of information were accessed, which criteria were used for scrutinising it, and how the 
concepts evolved. From this it becomes clear that substantial effort has been taken to include 
all relevant material, and all related concepts. Although the review of the state of the art is not 
reproducible with regard to identifying all the same publications, a search following the track 
record should end up with the same concepts. Until the searches are reproduced, only the face 
validity and plausibility can be judged, i.e. how convincing the review and the argument are.
3.7 European integration and public health in the EU
3.7.1 Health care in the Treaties of Maastricht and Amsterdam
Since July 1992, the European Union has had a dedicated common public health strategy. 
Public health in Europe has its legal basis within the Treaty on European Union, known as 
“The Maastricht Treaty” (Treaty of Maastricht 1992). Within Article 129, the member states of 
the EU decided to coordinate their health policies and programmes with the co-operation of the 
European Commission. By this, the member states wanted to ensure a high level of health 
protection and prevent widespread and severe illnesses.
In November 1997, Article 152 of the Treaty of Amsterdam enlarged the duties of the 
European Union in the field of health care compared to its predecessor (Treaty of Amsterdam 
1997). Especially in Article 152 §1 of the Treaty of Amsterdam it is clearly stated that 
community action shall complement national health policies in order to improve public health, 
prevent human illness and diseases and to obviate sources of danger to human health. The 
position of public health was strengthened by the Treaty of Amsterdam, as from then on all 
Community policies and activities needed to consider what was called a high level of human 
health protection. Co-operation between the member states was highlighted as very important 
for the health sector, although the organisation and delivery of health services remains 
according to §5 of the Treaty entirely the responsibility of the member states (Paton et al.
2002: 4, Treaty of Amsterdam 1997). The harmonisation of laws and regulations of the 
member states is explicitly excluded in §4c.
Although direct arguments could not be found within the treaties for the decision to exclude a 
harmonisation of the health system within the EU, there might be several good reasons for this 
approach. One argument of the current Commissioner for Health and Consumer Protection is 
that the EU started as a Coal and Steel Community, an Atomic Energy Community and an 
Economic Integration Community, so the history on the EU shows no relation either to culture, 
or health (Kyprianou 2005b). Although this historical argument is plausible, there must be 
several other reasons for this clear decision to leave the health systems a national obligation.
157
One of them might be that limiting patient mobility helps to control costs and enables effective 
planning, as has been discussed in the section on implications of crossing borders (European 
Commission Health & Consumer Protection Directorate-General (n.d.)).
Costs
It is not unavoidable that allowing patients to cross borders means losing control over health 
care costs and rising expenses. When continuing to use antenatal care as an example, there 
could be another effective way to control costs. Cost control could be achieved by defining a 
common guideline for routine antenatal care applying to all member states. By this strategy, 
crossing borders would not enable pregnant women to extend their care, forcing their health 
system to pay for measures not financed otherwise. Effective planning would be possible, as 
there would be no additional benefit for pregnant women to seek care in a country other than 
their home country, purely for the sake of travelling there to access it. Another positive side- 
effect of a common guideline would be that crossing borders to a country with a common 
guideline in operation helps to avoid the dangers of omissions or duplications of care.
Checking this idea against Article 152 §4c of the Treaty of Amsterdam, it is concluded that only 
the superimposition of guidelines by a body of the EU is forbidden, but not the creation of 
freely accepted consensus guidelines delivered by the member states themselves. §4c can be 
interpreted as to exclude the harmonisation laws and regulations through the institutions of the 
EU, but to allow a common approach to public health problems. In accordance with §1 of the 
same article, a common guideline on antenatal care would contribute to ensuring that 
community action complements national health policies to improve public health. It might be 
also suitable to contribute to the Union’s aim of providing added value in the sense of 
continuity of health protection provisions across the Union, by dissemination of “best practice 
information” (The European Commission (n.d.) c). A common guideline should therefore be 
facilitated by the institutions of the EU, though not prescribed or developed.
A negative side-effect of a common guideline would be that greater choice and access for
patients, which are the arguments in favour of increasing patient mobility (European 
Commission Health & Consumer Protection Directorate-General n.d.), are restricted in their 
positive effects. Choice would be limited to selecting where care is provided, but would exclude 
choice about the content of care. Better access to care would nevertheless be guaranteed by 
the fact that care can be provided wherever there is capacity, and not along national frontiers. 
International collaboration and interaction would therefore allow sharing of resources.
Another reason for leaving the organisation and delivery of health care to the member states 
could be that the health system is often regarded as a prestigious achievement of a state. The 
health care system in each member state is highly politicised and ideologically driven, like the 
National Health Service in the United Kingdom. National governments may perceive any 
directives from the EU as unnecessary interference with their national health policy. Opting too 
early for a harmonisation of sensitive areas during the process of growing together might 
cause unnecessarily increased resistance against the EU amongst its citizens. If 
harmonisation is achieved later on from within and on the basis of good arguments, the 
process of growing together is actually supported, rather than hampered. Hence, the exclusion 
of the harmonisation of health systems might be a strategic measure to promote harmonisation 
in the long run.
Conflict between national and European interests
The situation might be similar with the idea that health is always a sensitive issue and that 
member states and their citizens fear that their needs would not be adequately met when an 
impersonal body, such as the EU, is in charge of this sensitive matter. The perceived lack of 
control weighs especially heavily in vital areas of life. As a consequence, the harmonisation of 
health systems must be either avoided or postponed until the EU is no longer perceived as an 
impersonal body, but as a competent institution which brings additional benefit for its citizens.
The aforementioned conflict between independence and unification is not only evident in the 
health sector, but is also symptomatic of the entire European integration process (Wismar &
Busse 2002: 270). Despite these conflicting forces, the member states of the European Union 
are encouraged as well as obliged to co-ordinate their actions in the health sector (Treaty of 
Amsterdam 1997). Unfortunately, it was often concluded that the Treaties are more explicit 
with regard to what is not to be done, compared to more vague statements with regard to what 
should be done in the health sector (Graham 2004). Nevertheless, the European Union has a 
clearly defined strategy for public health. This is analysed below.
Health issues were acknowledged from the beginning of the European Union. As mentioned at 
the beginning of this section, the Maastricht Treaty required that the member states 
coordinated their health policies and programmes with the co-operation of the European 
Commission (Treaty of Maastricht 1992). With the Treaty of Amsterdam, the health care duties 
of the EU were extended (Treaty of Amsterdam 1997). This was partially ascribed to a new 
awareness of health policy at community level, originating from developments, such as the 
“mad cow” crisis (Commission of the European Communities 1998). From then on, it was 
required that specific action of the EU complements national health policies. By this strategy, 
public health should be improved, as well as human illnesses prevented. Moreover, also 
sources of danger to human health should be reduced. In addition to that, the position of public 
health was strengthened further, as according to the Treaty of Amsterdam all Community 
policies and activities needed to consider a high level of human health protection.
3.7.2 Framework programmes on community action for research and development
In order to achieve the overriding public health aims, the European Commission includes 
health issues in its framework programmes on community action for research and 
development to direct and coordinate activities in the member states (CORDIS 2002). It is the 
aim of these framework programmes to break overriding aims down into action plans, to 
coordinate and stimulate actions across the member states and to contribute to project 
funding. The framework programmes run for five years and specify what research and action is 
currently at the centre of interest to the EU.
The current 6th framework programme has a total budget of 17.5 billion Euros (10.94 billion 
GBP) for the years 2002 to 2006. The main objective of this programme is to contribute to the 
creation of the European Research Area by improving integration and co-ordination of 
research in Europe which is so far largely fragmented. At the same time research will be 
targeted at strengthening the competitiveness of the European economy, solving major 
questions of society and supporting the formulation and implementation of other EU policies. 
“Life sciences, genomics and biotechnology” is one of the seven thematic priority areas of the 
current framework programme. The “thematic priority areas cover those areas where the EU in 
the medium term intends to become the most competitive and dynamic, knowledge-based 
economy in the world capable of sustainable economic growth with more and better jobs and 
greater social cohesion” (CORDIS 2002). Public health is one of the sub-titles under the 
header of life sciences, with a budget of 353.8 million Euros (221 million GBP).
Despite the inclusion of public health matters in the framework programmes for research and 
development, the framework programmes have two main strategic objectives which are not 
directly related to health. These objectives are strengthening the scientific and technological 
bases of industry and encouraging its international competitiveness while promoting research 
activities in support of other EU policies. These two objectives are setting the general scene for 
choosing priorities and instruments (CORDIS 2002). Health is acknowledged insofar as a high 
level of health protection has to be ensured in all Community policies (Treaty of Amsterdam
1997), and that it is one of the sub-interests addressed by the programmes. Although health 
matters are explicitly addressed under the framework programmes, it must be kept in mind that 
its primary objectives are directed at international competitiveness and the interests of 
industry. Although research activities under the framework programmes should support other 
EU policies, health matters also have to be examined from the competitiveness perspective.
When analysing the framework programmes it becomes clear that the focus is on new 
technologies and competitiveness also in the health sector. Less interest is put on structural, 
political and low-profit issues, which are important issues in public health. This weighting of
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interest becomes even clearer when realising that projects are much more likely to be funded 
when small or medium sized enterprises [SMEs] are part of the consortium applying for 
funding. In addition to generally better funding opportunities when SMEs are included in the 
consortium, at least 15% of the budget of the 6th framework programme is reserved for SMEs 
only (CORDIS 2002). In addition to these financial aspects, the 6th framework programme has 
been heavily criticised for favouring of biomedical and basic sciences, often with the more or 
less hidden objective of industrial production development (Saracci et al. 2005) As a 
consequence, the framework programmes for research and development can not be judged as 
an optimum, or sufficient means to improve public health in the EU. Nevertheless they make 
an important contribution with regard to strengthening international co-operation amongst 
scientists, and channelling research interests in the direction of the overall health aims.
However, in order to strengthen the framework programmes’ capacity to improve the health of 
the European population, international experts have recommended an epidemiological 
approach for the 7th framework programme, targeting the whole population (Saracci et al. 
2005). The authors subsumed the suggested population based investigations on genetic, 
social, environmental, and economic determinants of health under the header of “health 
systems research”. For this health systems research, the authors claim at least 20% of the 
total financial means provided under the section of life sciences in the framework programmes. 
This might be judged as adequate when bearing in mind that under the 7th framework 
programme for research and development, health is the first and foremost theme (Saracci et 
al. 2005).
3.7.3 Organisational conflicts, task overlaps and ambiguities of mandates
Following the ratification of the Treaty of Maastricht in 1992, the European Union implemented 
a public health strategy with five specific action programmes in 1993: Cancer, Acquired 
Immune Deficiency Syndrome, drug dependence, health promotion and health monitoring 
(Commission of the European Communities 1998). After the completion of the 1993 action
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programme, the Commission has drawn two main conclusions. The use of action programmes 
was positively judged as making a difference in making public health priorities between the 
member states manageable. Unfortunately, the advantages were limited by the considerable 
administrative burden and a lack of flexibility (Commission of the European Communities
1998). Despite these disadvantages, the strategy of the EU with regard to the management of 
its public health objectives stayed unaltered.
The Union’s current public health programme (CORDIS 2002, European Parliament and the 
Council of Europe 2002) provides a strategy aiming on the one hand at ensuring a high level of 
health protection in all Community policies, which is still a direct quotation from the Treaty of 
Amsterdam (Treaty of Amsterdam 1997). On the other hand, the public health strategy of the 
EU strives to supplement and co-ordinate policies and actions carried out by the member 
states in the field of health surveillance and information systems (Commission of the European 
Communities 2005: 51). By introducing the corresponding measures, the EU tries to build up 
and strengthen the capacity to react to health threats in a coordinated manner (European 
Parliament and the Council of Europe 2002).
Most interesting is, however, the overlap in tasks between the framework programmes for 
research and development and the Union’s public health programmes (Commission of the 
European Communities 1998, CORDIS 2002, European Parliament and the Council of Europe 
2002). It must to be noted that both programmes are launched and answered for by the 
European Commission. However, the framework programmes are under the administrative 
control of the Directorate General for Research, situated in Brussels, and the public health 
programme is under the control of the Directorate General for Health and Consumer Protection 
in Luxembourg. What this means in practice will be demonstrated in the following discussion.
The current 6th framework programme for research and development has set three major 
public health themes on the agenda (Commission of the European Communities 2000,
CORDIS 2002, European Commission Research Directorate General 2001):
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• improving health information and knowledge
• responding rapidly to health threats
• addressing health determinants
The same aims and strands of action were set out in an extended version in the Union’s public 
health programme for the years 2003 to 2008 (Commission of the European Communities 
1998, European Parliament and the Council of Europe 2002, Watson 2001):
• improving information and knowledge with a view to promoting public health and health 
systems (this is to be achieved by developing a comprehensive system for collecting, 
analysing and evaluating data and knowledge)
• boosting the ability to respond rapidly and coherently to health threats (this relates 
mainly to infectious diseases and should be achieved by installing an inter-linked 
surveillance and early-warning system together with rapid-reaction mechanisms on EU- 
level)
• addressing health determinants (this involves health-promotion activities on a broad 
basis to reduce premature deaths. This should be achieved by addressing some of the 
underlying causes of major illnesses, such as lifestyle behaviours, socio-economic 
circumstances and the environment).
This overlap of aims leads to the situation that on top of the financial means available from the 
framework programmes for research and development, a budget of another 312 million Euros 
(195 million GBP) is available to achieve the same aims under the Union’s public health 
programme. As a consequence, the budget is split up between two sub-organisations of the 
European Commission. This might lead to a waste of resources, as a duplication of activities 
can occur under the different programmes, instead of one activity building upon the findings of 
another under the same programme. Moreover, there is less control over the financial means 
being used most effectively or not, and it is additionally problematic that there are two 
administrations to be financed and run to reach the same aims. There might be open or covert 
rivalry between the two organisations, which can prove to be most counter-productive.
Finances of the EU might then be wasted through internal conflicts, rather than used to make
164
the most effective contribution towards the pubic health aims of the Union.
In a critical remark, the European Commission once acknowledged the problem of ambiguity of 
task division, using health information systems as an example (European Commission Health 
& Consumer Protection Directorate General 2004). The statement says that the cause of 
malfunctioning of the health information system in the EC could be the rather haphazard and 
blurred assignment of tasks among units and organizations responsible for data collection, 
analysis and diffusion. There is a major ambiguity of task division, e.g. between Eurostat, DG 
SANCO, DG EMPL, the Community Agencies, PHP surveillance networks, etc. This ambiguity 
of task division was found to go with overlapping authority and responsibilities among different 
organisations. It is most likely that the same problems apply to the programmes.
A first step towards resolving the ambiguity of mandates
Acknowledging these problems, the latest development towards a true common European 
strategy for public health is the introduction of an executive agency for the Union’s public 
health programme in Luxembourg. Since 1 January 2005, the executive agency for the 
management of Community action in the field of public health is recruiting personnel in order to 
support the Commission in raising the profile of the European Community in the field of public 
health. This agency should start to work together with the European Commission in order to 
implement and reach the aims of the public health strategy from autumn 2005 onwards 
(European Parliament and the Council of Europe 2002). On the basis of a decision of the 
Council of Europe, the new agency is responsible for the implementation of the public health 
programme for the years 2003 to 2008 and the respective annual work programmes. It 
manages the calls for proposals and evaluates them. In addition to that, the agency has the 
executive power over the programmes’ finances. It awards contracts and grants on behalf of 
the Commission and manages all payments. In contrast to the current situation, the new 
executive agency provides additional logistical, scientific and technical support to the funded 
projects.
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The agency's main source of funding is a subsidy from the European Union’s general budget, 
and the operating budget for its six years of existence is 28 229 million Euros (about 17 600 
million GBP). This sum is intended to cover staff and infrastructure costs, administrative 
expenditure and management expenditure. As this budget is on top of that allocated to the 
public health programme, it has to be hoped that the new agency is not just another actor in 
the bureaucracy of the EU, but that it ends up as the one and only coordinating institution for 
all public health matters of the Community. Otherwise it would be an unnecessary waste of 
resources, undermining the trust of Europe’s citizens in the Union.
3.7.4 A new strategy to overcome the ambiguity of mandates
In order to overcome the problems arising from the aforementioned overlap of mandates 
between the Directorate General for Research and the Directorate General for Health and 
Consumer Protection, the European Commission has proposed to combine the programmes of 
both directorates under one framework (Commission of the European Communities 2005).
This idea finally acknowledges the fact that EU health and consumer protection policies have 
core joint objectives, which are to
• protect citizens from risks and threats which are beyond the control of individuals and 
that cannot be effectively be tackled by individual member states alone
• increase the ability of citizens to take better decisions about their health and consumer 
interests
• mainstream health and consumer policy objectives across all Community policies in 
order to put health and consumer issues at the centre of policy-making.
In the proposed Programme of Community action in the field of Health and Consumer 
Protection, the intention to improve health and consumer confidence has been specified as 
overall aim of both directorates for the years 2007 to 2013 (Commission of the European 
Communities 2005: 2). Common objectives are to enhance European citizens’ health, make 
them feel safer and more confident, but also to bring Europe closer to its citizens and to
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contribute to enhance the competitiveness of the EU. These ideas were recently reinforced by 
the Commissioner for Health and Consumer Protection (Kyprianou 2005b).
To reach the above mentioned aims and objectives, for the first time, it is proposed that public 
health and consumer protection policies and programmes be combined under one framework 
with one executive agency (Commission of the European Communities 2005). From the public 
health side, the aims of promoting health protection, information and education, safety and 
integration of health and consumer concerns into all EU policies are brought into the common 
framework. However, within the common framework, specific structural objectives were also 
defined, which were judged as important by the Health Ministers of the member states, 
representatives of Europe’s health care sector, the European Parliament and the Commission 
(Commission of the European Communities 2005, South East Partners 2003). The objectives 
are to
• contribute to the development of more effective and efficient health systems
• support the objectives above by providing health information and analysis.
• improve European co-operation to enable better use of resources
• meet the information requirements of patients, professionals and policy-makers
• enable access to and to improve the quality of care
• reconcile national health policy with European obligations.
In general, health and consumer policies have similar objectives, e.g. information to citizens. 
Therefore, it is not only recommended that a common framework is established, but also a 
common executive agency which streamlines administrative and budgetary procedures. This 
agency is planned to consist of an extended version of the existing public health programme’s 
executive agency, then including a consumer institute. The agency shall then be divided into a 
health department and a consumer department, and only common actions are to be managed 
jointly between the two departments. These strategies were introduced to increase policy 
coherence, bringing up synergies for the benefit of all member states. As a controlling
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institution to the envisaged agency, the Commission will stay in charge of all policy decisions 
related to defining and managing policy priorities and action, including the annual work plans. 
The proposed programme budget is 1203 million Euros, which as about 750 million GBP.
However, although the new common framework for health and consumer protection is a 
promising step into the direction towards a single strategy for health in the EU, there is still a 
long way to go. As has been demonstrated before, the same issues are not only tackled by the 
institutions in charge of health and consumer protection, but also by the Department General 
for Research. This problem will not be solved by a common agency and framework for health 
and consumer protection. The 7th Framework programme for research will again interact with 
some of the interests proposed by the draft Programme of Community action in the field of 
Health and Consumer Protection 2007-2013 (Commission of the European Communities 
2005). Some of the issues which arise from the perspective of health and consumer protection 
were recommended to be tackled with instruments and resources provided under the 7th 
framework programme for research. This recommendation demonstrates well that there is still 
an overlap in mandates and tasks, which enables the different parties to transfer unwanted 
tasks to the other party, or to produce an unnecessary and ineffective duplication of work.
3.7.5 General trends, reproductive health and patient mobility
Over the last years, a shift of paradigms has been recognisable in the EU health strategy. 
Initially, the European Commission and its subordinate committees were hesitant to exert 
influence on health systems and organisation, mainly due to §§4c and 5 of Article 152 of the 
Treaty of Amsterdam, and their clear statements that the organisation and delivery of health 
services has to be left with the member states (Treaty of Amsterdam 1997). However, the 
European Commission now takes a more active role and contributes to bringing public health 
from the member states alone to a true European level. This puts more weight onto §1 of 
Article 152 of the Treaty of Amsterdam, which highlights the co-ordinating and complementary 
role of the Community to improve public health. This has been particularly with regard to health
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information and infectious diseases as proposed by the combined programmes of health and 
consumer protection (Commission of the European Communities 2005: 42). In this nearly 
revolutionary proposal, two important issues with regard to harmonisation in health care are 
named as fields for common action. Actions within the new framework should
“... enhance scientific advice and expert risk assessment, e .g .... fostering harmonised 
approaches to risk assessment and promoting training for assessors.”
In contrast to previous documents, harmonisation is no longer excluded, but explicitly sought 
after. The same change in strategies can be observed in the area of product safety and the 
regulations for substances of human origin. Here, the document recommends the use of 
common guidelines and standards, fostering best practice exchange.
Despite these remarkable changes in strategy, these are only little steps towards a true 
European approach towards major health problems. For the rest of the health systems, there is 
still a long way to go. As the European Parliament and the Council of Europe stated, due to the 
principle of subsidiarity and the restrictions placed on the Union in health matters, the active 
co-operation and wholehearted commitment of all the member states is still essential to the 
smooth running of the public health programme and to achieving its objectives (European 
Parliament and the Council of Europe 2002). This situation opens up a window of opportunity 
for bottom-up approaches, which have their origin in the member states. A common guideline 
for antenatal care, which is not superimposed and reinforced by the institutions of the EU, 
would fit exactly into the current legislation and situation of the EU and its public health aims.
At present, there are major efforts to demonstrate to the member states and Europe’s citizens 
how promising it is to learn from other European countries. The current European 
Commissioner for health and consumer protection, Markos Kyprianou, gave some impressive 
examples for lessons, which could be learned from other member states (Kyprianou 2005b). 
One was that the five-year survival rates from breast cancer range from 81% in Sweden to 
58% in Poland and Slovakia. Similar differences exist for malignant melanoma. Kyprianou
used these examples to illustrate the potential for co-operation and learning from the strategies 
of the more successful states within the EU. Such examples might force some member states 
to act actively for their citizens and to start international co-operations. However, it might also 
lead to the situation that patients travel to another country with better treatment options for 
their disease. This would have major impact on the health system of their home country.
Shifting emphasis
Similar to this shift of paradigms in the role of the EU in public health, a shift of emphasis is 
also observable with regard to the content of health policy. From the former stance of treating 
illnesses as prime responsibility of health care, the trend goes now towards the promotion of 
good health, taking a pro-active stance. The idea is to prevent ill health before it develops 
(Byrne 2004). This is acknowledged in the 6th framework programme for research and 
development for the years 2002 to 2006 (CORDIS 2002) as well as in the Community’s public 
health programme for the years 2003 to 2008 (Commission of the European Communities 
1998, European Parliament and the Council of Europe 2002). Addressing health determinants 
is one of the three core objectives of both programmes. However, although the public health 
programme highlights that this involves health-promotion activities on a broad basis, the 
specifications relate mainly to major illnesses of older people, rather than taking a more 
general stance. Premature deaths due to major illnesses of adulthood should be reduced by 
addressing some of the underlying causes of major illnesses, such as lifestyle behaviours, 
socio-economic circumstances and the environment. However, in this respect, antenatal care 
has to make an important contribution. By considering a healthy lifestyle and a healthy diet 
throughout pregnancy, as well as by treating unfavourable conditions immediately, best 
starting conditions are ensured for the future citizens of the Union. As recent research 
suggests, conditions during the intra-uterine period can programme an organism for the rest of 
its life, mainly regarding a predisposition for coronary heart disease (Barker 1995, Barker et al. 
1993, Paneth et al. 1995, Eriksson 2005). As this is especially evident for cardio-vascular 
diseases -  one of the major health problems in Europe -  antenatal care fits perfectly into the
third major public health theme of the EU: Addressing health determinants (Commission of the 
European Communities 2005: 44). This is acknowledged under strand 3.2.3 of the proposed 
Programme of Community action in the field of Health and Consumer Protection for the years 
2007 to 2013 (Commission of the European Communities 2005). The aim of this strand is to 
promote health by tackling its determinants. In this section, reproductive health is also listed 
amongst life style factors and infectious diseases. Unfortunately, reproductive health is 
mentioned only as a keyword, with other issues being discussed in much greater detail. If there 
is any specification at all, sexual health and reproductive health are mentioned with regard to 
preventing sexually transmitted diseases, rather than putting the focus on improving intra­
uterine conditions to exert a positive influence on the health of future citizens.
When exploring the themes in the public health policy of the EU, it becomes evident that there 
is an imbalance with regard to the weighting of issues (Kyprianou 2005b). The focus of interest 
is on the prevention of
• the “big killer” cancer,
• communicable diseases, and of
• problems arising from demographic ageing.
The same neglect of children’s issues and factors related to reproductive health becomes 
obvious for the 6th framework programme on Community action for research and development 
(CORDIS 2002). This programme reflects a heavy reliance on genomics and major illnesses, 
such as cancer and communicable diseases. Children’s health is not mentioned at all, 
although it would be of utmost importance to include this into the EU’s public health policy. 
Children are citizens in their own right, but not yet able to act as self-advocates, particularly at 
the population level (Rigby et al. 2003). Here, the European Union could make a unique 
contribution towards the health of its citizens, as children’s health determines the health of the 
future population (Rigby et al. 2003).
In addition to the neglect of children’s health, other important public health themes just start to
be acknowledged in the proposed programme for a combined framework for health and 
consumer protection policies (Commission of the European Communities 2005: 5). Issues of 
inequality, which influence citizens’ health and life expectancy, such as poverty, housing and 
nutrition are now starting to be set on the agenda. However, although it is acknowledged that 
these are issues of equality, the focus is put on the idea that good health is needed for 
Europe’s competitiveness and economy by ensuring the health of the workforce.
The above described slow and still unsatisfactory shift of emphasis can be judged especially 
critically, as public health has been, e.g. in the UK, a specialist field of practice since the 
middle of the 19th Century (Department of Health, Chief Medical Officer 2003). Although it 
developed out of the field of hygiene, today the definition and the focus of modern public health 
is much more than that (Allin et al. 2004). The official definition used for England, which is also 
widely used throughout the EU is the one by Sir Donald Acheson (Allin et al. 2004, Department 
of Health, Chief Medical Officer 2003 citing Acheson), which grasps the essential focus of 
modern public health. It says that public health was the science and the art of preventing 
disease, prolonging life, and promoting health through the organised efforts of society.
According to the UK Department of Health (Department of Health, Chief Medical Officer 2003), 
the tasks are to monitor the health status of the community, identify health needs, develop 
programmes to reduce risk and screen for early disease, control communicable disease, foster 
policies which promote health, plan and evaluate the provision of health care, and manage and 
implement change. This demonstrates well that antenatal care fits perfectly into this, but 
demonstrates also that the public health strategy of the EU is very limited and far from 
developing its full potential. However, it is assumed that there is a decision behind the limited 
use of public health in the EU. One reason might be the focus on economic competitiveness, 
trying to produce additional benefit for e.g. small or medium sized enterprises from what is only 
labelled to be public health. However, if public health is to be used according to a deeper 
understanding of the subject, antenatal care has to make a real contribution. Offering the best 
starting conditions to Europe’s future citizens by improving intra-uterine conditions has the
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potential to prevent disease in later life and thus enhance the health of an entire population 
(Barker 1995, Barker et al. 1993, Paneth et al. 1995, Eriksson 2005).
3.8 Perceived legitimacy, health policy and harmonisation
At present, the European Union suffers from a major lack of confidence from its citizens and 
drifts towards an existential crisis. Problems with the ratification of the new Constitution 
perfectly illustrate this (The European Commission (n.d.) d). It is still not clear whether the new 
Constitution will ever be signed by all member states of the Union. The citizens of the founding 
members France and the Netherlands already voted against the new Constitution in 2005. 
Although it might be that the citizens of these member states simply did not like the idea of 
sharing a constitution with all other members of the Union, there might be other underlying 
reasons for their rejection, and there might be a more general rejection of the idea of a 
European Union as well (Falksohn et al. 2006). It becomes likely that financial considerations 
have played a role in rejecting the Constitution, when it is considered that two net payer states 
have voted against the new Constitution. From this perspective it is possible that the citizens of 
the rejecting member states have voted against the devalued Euro and the resulting problems, 
or too much regulation and publicised corruption scandals, rather than against the Constitution.
Effects of enlargement
A related motive could be the fear of cheap workers from less wealthy EU states who are now 
having more or less free access to the markets of the wealthier member states. Or the other 
way round, 84 percent of the Germans were found to be afraid of jobs being transferred to 
other member states, where labour is cheaper (Falksohn et al. 2006). For Italy and France, 
similarly high rates of this anxiety were reported. There is a realistic fear that this mechanism 
could leave many people of the states where labour is more expensive unemployed and the 
enterprises bankrupt. However, there could be also a xenophobic reason, with their negative 
attitudes arising from an underlying fear from the progressing enlargement of the Union, taking
‘unwanted’, or culturally different states on board.
The aforementioned reasons and probably many others seem to leave Europe’s citizens 
mistrustful about the new Constitution, which might be an indicator for the citizens’ general lack 
of trust into the EU. The most interesting feature in this respect is that the European 
Commission obviously has identified this phenomenon. In its proposed framework programme 
for public health for the years 2007 to 2013, the Commission states that the recommended 
measures and the common agency for public health and consumer protection will improve 
efficiency and effectiveness of EU actions and make them more visible (Commission of the 
European Communities 2005). In this document, it is especially highlighted that this will help to 
reconnect the EU with its citizens. It is evident that by revising their strategies, the European 
Commission seeks ways to bring the advantages of the European Union closer to its citizens 
by demonstrating an additional benefit in fields which lie at the heart of the citizens. One idea 
is to enhance activities for improving health, to improve policy coherence in the health sector, 
and to communicate these efforts effectively. The second idea is to make EU policies more 
visible and transparent by drawing efforts of different institutions together. One example of this 
is the attempt to bring public health and consumer protection under one framework 
(Commission of the European Communities 2005), as has been discussed in section 2.6.4.
The proposed measures are advantageous as they create the image of a de-bureaucratisation 
and the harmonisation of issues which share many objectives anyway. These are promoting 
health protection, information and education, safety and integration of health and consumer 
concerns into all policies of the EU (Commission of the European Communities 2005).
The new Constitution would have reinforced the European Union’s mandate for health and 
consumer protection by explicitly acknowledging its role in promoting the well-being of its 
peoples in article I-3 (The European Commission 2005, The European Union Constitution 
2004). In addition to that, the Treaty of Amsterdam (1997) is reinforced by Article II-95 of the 
new Constitution in its idea that all Union policies and activities should ensure high human 
health protection. In addition, the new Constitution states in its charter of fundamental rights
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that everyone has the right of access to preventive health care and the right to benefit from 
medical treatment (The European Commission 2005, Article II-95). It would also extend the 
European Union’s powers in health matters (Article MI-278). Unfortunately, the reinforcements 
and revisions with regard to the health policy of the EU have not yet brought the envisaged 
effects, as the new Constitution has already been rejected by the citizens of France and the 
Netherlands.
A factor which might have acted counterproductively could be the progression of the 
harmonisation in the EU. One example for this is the development of common health indicators 
(Bauer et al. 2003), which should be used also at member state level. Moreover, these 
indicators should subsequently also apply to the applicant countries, selling them with the 
entire package of issues to be fulfilled before entering the Union. Although such a 
harmonisation is appealing to the rational thinker, the pressure to harmonise increases for the 
established member states as well as for future members of the Union. This can be a 
psychological problem for citizens who feel already over-regulated by the EU.
3.9 Decision-making in the Council of Europe
Serious efforts for improving public acceptance of the European Union are made by changing 
the decision-making structures in the Council of Europe towards a faster, more flexible and 
more transparent system. Whether these efforts are effective has to be shown by the reactions 
of the citizens of the European Union with regard to the proposed Constitution for Europe (The 
European Union Constitution 2004).
As a basic principle, voting by qualified majorities is the way in which the European Council 
and the Council of Ministers are required to make their decisions. Despite its straightforward 
appeal, the notion of qualified majority needs exploration. What qualified majorities are at 
present is specified in the Treaty of Nice (2001), and what they might be from 1 November 
2009 on is specified in the Constitution for Europe (The European Union Constitution 2004).
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However, if the Constitution is finally not ratified, the Treaty of Nice will continue to regulate 
decision-making in the European Union (Berbalk et al. 2005). Unfortunately, the decision­
making system of the Treaty of Nice is even more complicated than that of the Constitution.
3.9.1 Decision-making according to the Treaty of Nice
In order to take a qualified majority vote under the current system specified Nice Treaty
• a threshold of weighted votes,
• a majority of member states, and
• 62% of the population of the Union
are necessary to take decisions (Treaty of Nice 2001). Reaching a decision therefore requires 
the effort to calculate the numbers of weighted votes which are assigned to the member states 
in accordance with Article 205(2) of the Maastricht Treaty (Treaty of Maastricht 1992). The 
member states with the highest number of weighted votes are Germany, the United Kingdom, 
France and Italy with 29 votes each, followed by Spain and Poland, which have 27 votes each. 
Malta is the country with the lowest number of weighted votes, with only 3 votes assigned 
(Treaty of Nice 2001). The number of weighted votes basically reflects the number of seats 
occupied by the individual member states in the European Parliament. Although the 
assignment of weighted votes according to the seats occupied seems simple, it was reported 
that often problematic and time consuming negotiation is required (SCADPIus (n.d.)).
The current threshold for decision-making in the European Council is at least 258 votes in 
favour of a decision. These votes must stem from a majority of the member states, when the 
proposal to be decided on comes from the European Commission. However, in all other cases 
the threshold is 258 votes, but at least two-thirds of the member states must be in favour.
In addition to passing the applying threshold for weighted votes and the minimum number of 
member states for a decision, calculations of the represented population sizes have to be 
made. For a motion to be passed, a 62% threshold is also required for every decision.
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When reflecting on this complicated procedure for decision-making, it appears likely to have an 
acceptance problem in the public of the European Union. On the one hand, the weight 
attached to the votes can be perceived as unjust, and on the other hand the decision-making 
process can not easily be followed by the public. In addition to problems with transparency and 
justice, this voting system has become much more complicated and involves even more effort 
since the enlargement of the European Union from fifteen to twenty-five states in May 2004.
3.9.2 Decision-making according to the Constitution for Europe
As a reaction to the weaknesses of the Nice Treaty regarding the decision-making in a Union 
of twenty-five members, the Constitution acknowledges this altered situation and seeks to 
improve the functioning of the enlarged Union (Treaty of Nice 2001). The voting system as 
specified in Article I-25 of the Constitutional Treaty still considers the population sizes of the 
member states and therefore constitutes another form of qualified majority voting (Berbalk et 
al. 2005, SCADPIus (n.d.), The European Union Constitution 2004). However, the Constitution 
proposes a new system of qualified majority voting. The suggested system within the 
Constitution is ‘double majorities’ and means that the majority of the member states must vote 
in favour of a decision and that they must represent the majority of the population of the EU.
However, instead of mathematically defining double majorities for a qualified majority vote as 
50% of the member states and 50% of the entire population of the European Union, the 
Constitution goes only half the way. The controversial weighting of votes is abandoned, but for 
a decision under the Constitution for Europe at least
• 55% of member states (including at least 15 of them) and
• at least 65% of the Union’s population
have to be in favour of a decision, before it is accepted.
The interesting feature is that as long as the EU consists of 25 member states, 15 states 
represent 60% of the total. However, when a 26th state joins the Union, 15 states automatically
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add up to 55%. Hence, the addendum of “including at least 15 of them” presently contradicts 
the 55% rule, and will become superfluous with the further enlargement of the Union 
(SCADPIus (n.d.)). However, as it might happen that a current member state leaves the Union, 
leaving this addendum in place assures stability in the decision-making system.
In order to further complicate procedures, the above mentioned criteria for qualified majorities 
under the Constitution again apply only for decisions about issues proposed by the European 
Commission, as this is the case for the Treaty of Nice. However, the same applies then for 
decisions about issues proposed by the under the Constitution existing Union Minister of 
Foreign Affairs (SCADPIus (n.d.)). In all other cases, the threshold for qualified majorities is 
higher and decisions must be supported by
• 72% of member states, representing
• at least 65% of the Union’s population.
In addition to the above mentioned criteria for decision-making by qualified majorities, the 
Constitution as well as the Treaty of Nice contain additional regulations for the case of 
decisions reached by narrow minorities only, and specify regulations for blocking minorities.
However, the problem starts with the content of the Constitution and its advantages being not 
properly explained to the public. The votes against the Constitution by the French and the 
Dutch in 2005 demonstrate the deep mistrust in the functioning, the administration and the 
current orientation of the European Union (Falksohn et al. 2006). Important advantages of the 
proposed Constitution have obviously not been translated to the public, which might have been 
simply caused by the sheer volume of the document. One example is the vital simplification of 
the decision-making procedure in the enlarged Union, and the resulting opportunity for far 
more combinations of member states to take decisions (SCADPIus (n.d.)). This lack of 
information to the public might finally lead to a rejection of the new Constitution for Europe, 
leaving the Treaty of Nice and all its flaws regarding the decision-making process in operation.
3.10 Implications of the reviews for the study
From the findings of the above reviews it was concluded that there might be a window of 
opportunity to introduce a common minimum guideline on antenatal care in the EU. However, it 
was perceived that it would be neither useful, nor appropriate to ignore the work and expertise 
that has already been invested to set up national guidelines in the member states. For this, a 
model was needed to synthesise the existing national guidelines, acknowledging the fact that 
special care needs to be taken not to exclude less wealthy states or states with many citizens 
to care for from the potential benefits of a common minimum guideline. In addition, only 
measures should be considered, which are acceptable to the majority of member states. This 
led to the idea that the models for decision-making within the EU might provide a good basis 
for this. Therefore, the treaties establishing the EU, as well as documents commenting on 
these structures, were analysed with regard to their properties which would inform the study.
The analysis of the current state of the art with regard to decision-making in the Council of 
Europe revealed that a voting system by qualified majorities is the basic principle for decision­
making. At present, the Treaty of Nice defined qualified majorities. However, the review gave 
also evidence of serious efforts to change the decision-making structures towards a faster, 
more flexible and more transparent system. What decision-making might be from 1 November 
2009 on is specified in the proposed Constitution for Europe. Both systems were assessed in 
depth for their properties regarding the subject of the thesis.
As a reaction to the weaknesses of the current system, the proposed Constitution seeks to 
improve the functionality of decision-making. The proposed voting system considers the 
population sizes of the member states and therefore constitutes a new system of qualified 
majority voting. The suggested system is called ‘double majorities’ and means that the majority 
of the member states must vote in favour of a decision and that they must represent the 
majority of the population of the Union. However, instead of mathematically defining a majority 
as a subset of a group, which is more than half of the entire group (Wikipedia 2006c), the 
Constitution goes only half way. For a decision under the Constitution for Europe, at least 55%
of member states, including at least 15 of them, and at least 65% of the Union’s population 
have to be in favour of a decision. In this context it is interesting to note that 15 members 
currently represent 60% of the States, which leads the 55%-rule ad absurdum. However, after 
the critical review, it was concluded that the qualified majority voting under the new 
Constitution for Europe according to ‘double majorities’ is worth exploration. It was decided 
that a more easily applicable model of ‘double majorities’ is needed for use on a broad basis.
In accordance with basic mathematics, a majority is defined as being more than 50%, and a 
double majority is defined as being a majority of votes according to two separate criteria 
(Wikipedia 2006c + d). For the study, ‘double majorities’ is therefore defined as more than 50% 
of the member states, and more than 50% of the inhabitants of the European Union.
To finally answer the question of whether a common EU minimum guideline on antenatal care 
is suitable, and what its content should be, the findings from the survey need to be considered. 
Also the question of whether such a guideline is financially possible for the less wealthy 
member states needs further exploration. The above analysis, complemented by texts on 
research methods, led to the detailed research plan. This will be described in the following 
section on the methods for the study presented in the thesis.
In the following section, the methods to reach the objectives of Phases 2 and 3 of the study are 
addressed. The first objective is to find out whether the basic principle for decision-making on 
the basis of ‘double majorities’ is suitable for making decisions on antenatal care, when 
national guidelines already exist. The second objective is to develop a framework according to 
which the existing national guidelines can be used to efficiently setting up a common minimum 
guideline, without compromising its quality.
For this, the hypothesis that a guideline based on ‘double majorities’ of all national guidelines 
on antenatal care in the EU contains the same recommendations as a guideline based on the 
principles of evidence-based medicine needs to be tested. To achieve this, the research plan 
was devised:
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• develop and conduct a survey on the content of national guidelines on antenatal care in 
all member states of the EU.
• extract all measures which are recommended by at least 50% of the member states 
and apply to at least 50% of the inhabitants of the EU.
• compare the measures recommended by double majorities to the measures 
recommended by the most comprehensive evidence-based guideline on antenatal care 
to date.
To find out whether such a guideline is achievable, exploration is needed as to whether a 
common minimum guideline based on the findings from the aforementioned investigations 
would mean insurmountable hardships for the less wealthy member states of the EU.
The following chapter therefore specifies the methods used to shed light onto these areas. 
Before this, the ethical implications of the collection of primary data, as well as of the findings 
of the study are discussed. After this, detailed reference is made to the development of the 
survey tool, its properties, and how the survey was finally conducted. How the findings will be 
analysed and used is also made clear. The second part of the chapter focuses on the 
methodology for the in-depth appraisal of the two national guidelines.
Part 3 - The research plan
3.11 Ethical considerations
As for all research projects, ethical aspects also have to be considered for this study. Although 
at first sight only the ethical implications of the survey might apply, it was considered 
necessary to address also the ethical implications of screening procedures and the potential 
ethical challenges when setting up a common minimum guideline for the EU. This section 
therefore ties into the discussion of the ethical implications of guidelines, which were critically 
analysed in sections 2.4.1 and 2.4.2 of the thesis.
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Before exploring the remaining ethical implications in greater detail, it has to be noted that it is 
the aim of this work to develop the theoretical background on antenatal care on the European 
level further. This will improve the EU-wide acceptance of widely recommended methods, 
optimising the use of limited resources. It is clearly aimed at improving services for pregnant 
women. Hence, the thesis itself intends to take a genuinely ethical approach. Moreover, the 
thesis is in line with the European Union’s general strategy to coordinate the health policies 
and programmes of the member states (Treaty of Maastricht 1992), and to complement 
national health policies in order to improve public health, prevent human illness and diseases 
and to obviate sources of danger to human health (Treaty of Amsterdam 1997). Especially in 
an extended version of the Union’s public health programme for the years 2003 to 2008, it was 
highlighted that information and knowledge should be improved with a view to promoting public 
health and health systems by developing a system for collecting, analysing and evaluating 
knowledge (Commission of the European Communities 1998, European Parliament and the 
Council of Europe 2002, Watson 2001). The planned overview and comparison of the national 
guidelines of the member states enhances transparency and therefore contributes to reaching 
these aims for antenatal care.
Ethical implications of the research process
Although the topic under investigation is antenatal care, i.e. the care for pregnant women, it 
does not directly involve any vulnerable persons, such as pregnant women or neonates. 
Moreover, no subjects are involved in the study at all, although contact is made with 
representatives of governments and professional organisations. Health and professional 
administrators are accessed, but asked to fulfil part of their normal tasks, one of which is the 
distribution of guidelines. These administrators are not used as research subjects, and they 
are not asked for any personal data, or their opinion. The persons addressed therefore fulfil 
none of the criteria, which are specified in the Declaration of Helsinki, e.g. those who are 
economically disadvantaged, those who cannot give or refuse consent for themselves, or who 
may be subject to giving consent under duress (World Medical Association 2000).
As this study does not research on human subjects or animals, the classical criteria for 
involving research ethics committees are not fulfilled (Neuberger 1992: 22, University of Surrey 
2001). Although the Declaration of Helsinki does not apply for the same reasons, it provides 
valuable input about what aspects need to be considered irrespective of the direct involvement 
of human subjects (World Medical Association 2000). When developing the questionnaire, 
care was taken to inform potential participants about the aims and methods of the survey, 
institutional affiliations of the investigator, the anticipated benefits of the study and the 
discomfort it may entail. Finally, the survey questionnaires are of a non-offensive and non­
distressing nature, two of the main ethical issues that need to be addressed when using 
questionnaires (University of Surrey 2001).
Another reason for not seeking major ethical clearance is that this work is based on already 
published material, but does not involve access to medical records (University of Surrey 2001). 
No confidential or personal data is accessed, processed or stored. Instead, guidelines are 
used, which were specifically developed for publication and distribution.
However, although no formal ethical clearance from an ethics committee was sought, care was 
taken to fulfil the requirements of fundamental research ethics. One of these basic principles is 
that research must, for example, conform to generally accepted scientific principles and be 
based on a thorough knowledge of the scientific literature and other relevant sources of 
information (World Medical Association 2000). The thorough knowledge of the field and the 
research problem has already been demonstrated in Chapter 2 of the thesis, as well as in 
Parts 1 and 2 of the current chapter. To ensure the scientific quality of the research, the project 
was designed to comply with the charters on good research practice of the University of 
Surrey/United Kingdom and of the University of Bielefeld/Germany. With this, the principles 
and precautions of two research institutions in member states of the EU were considered. In 
addition, the project was closely supervised by experienced researchers from the UK,
Germany and The Netherlands. Due to this close and also multi-national supervision, major 
and minor flaws of the study could be detected and eliminated at an early stage. Special care
was taken to ensure the validity of the methods, as this is a fundamental criterion that makes 
research ethical (Neuberger 1992: 22).
Ethical implications of screening procedures
According to the UK National Screening Committee (National Screening Committee (n.d.)), 
screening is defined as follows:
“Screening is a public health service in which members of a defined population, who do not 
necessarily perceive they are at risk of, or are already affected by a disease or its 
complications, are asked a question or offered a test, to identify those individuals who are 
more likely to be helped than harmed by further tests or treatment to reduce the risk of a 
disease or its complications.”
Following to this definition it is highlighted that screening has important ethical differences from 
clinical practice, as it is targeting apparently healthy people. This is especially important if there 
are risks involved. It was therefore highlighted that people should have realistic expectations of 
what a screening programme can deliver (National Screening Committee (n.d.)).
The United States Commission on Chronic Illness Conference (cited by Bouvier et al. 1995:
17) defines screening as:
“...the presumptive identification of unrecognised disease or defect by the application of tests, 
examinations, or other procedures which can be applied rapidly. Screening tests sort out 
apparently well persons who apparently have a disease from those who probably do not. A 
screening test is not intended to be diagnostic. Persons with positive or suspicious findings 
must be referred to their physicians for diagnosis and necessary treatment.”
According to the above definitions, screening intends to reduce complications that arise from 
certain illnesses or conditions, including the reduction of mortality from those illnesses (Bouvier 
et al. 1995:15). Another aim of screening is to decrease the overall incidence of an illness in a 
certain population. From these intentions of screening, questions arise.
When complications of conditions should be avoided by detecting a possible disease at an 
early stage, how should a test be judged, which screens for a condition for which no cure 
exists? As an example, genetic disorders, such as Down’s syndrome might be named. In such 
cases, neither a difference is made by an early detection during pregnancy, nor can the 
prevalence be reduced. There are only two possible reactions to the diagnosis of such 
conditions during pregnancy: either to induce abortion or to accept life with an affected child. 
Before screening for such conditions, the issue needs to be explored with the pregnant woman 
and her significant others. Even more so, if the screening itself carries risks.
This leads directly to another important problem of screening: what about invasive, dangerous 
and psychologically irritating procedures, especially when the prevalence of the condition to be 
screened for is low? Is it ethically justifiable to risk the life of an unaffected foetus, when the 
condition screened for is either lethal, extremely rare, or cannot be treated despite its early 
diagnosis? All these issues need consideration before a decision is made about introducing a 
screening test for routine practice, for a selected publication, or not offering it at all.
One of the most important ethical issues in screening is that the quality of the screening test 
should be high enough to minimise the number of false positive and false negative results, 
which can not be avoided completely. The UK National Screening Committee commented on 
this that although screening has the potential to save lives or improve quality of life through 
early diagnosis of serious conditions, it is not a foolproof process, and cannot offer a guarantee 
of protection (National Screening Committee (n.d.)). It was also highlighted that “In any 
screening programme, there is an irreducible minimum of false positive results (wrongly 
reported as having the condition) and false negative results (wrongly reported as not having 
the condition).” However, positive results from tests with a low predictive value and low 
specificity are usually followed by further, more invasive tests, if these are available. This was 
also highlighted by the definition of screening by the United States Commission on Chronic 
Illness Conference, which states that a screening test is not intended to be diagnostic, and that 
persons with positive or suspicious findings must be referred to their physicians for diagnosis
and treatment (United States Commission on Chronic Illness Conference cited by Bouvier et 
al. 1995:17). A good example for this is the triple-test, a test for three markers in maternal 
blood and a subsequent statistical calculation of risk for e.g. Down’s syndrome. If the result 
passes any subjective threshold of acceptable statistical risk, the procedure might be followed 
by an amniocentesis to assess the foetal chromosomes from a sample of amniotic fluid.
However, the following consequences of an initial positive test result can be manifold. By the 
positive test result from the triple-test, fears are caused, which can disrupt bonding between 
the pregnant woman and the foetus. This affects both the affected as well as the unaffected 
foetus. In addition to that, a positive result from the initial screening test will lead to an invasive 
procedure, which carries additional risks, such as miscarriage. This again applies to an 
affected as well as to an unaffected foetus. Safety in general, as well as the safety of 
measures applied on pregnant women is therefore a major issue in the ICM international code 
of ethics for midwives (International Confederation of Midwives 1999).
Another scenario might be that no further tests are performed, e.g. as no such test is available 
or wanted, and that it is therefore not possible to exclude any false positives. This might lead to 
the induction of abortion although the foetus is unaffected by the condition screened for. 
However, this goes beyond the screening as performed for routine antenatal care for healthy 
women. The ethical as well as legal implications of prenatal diagnosis are widely discussed in 
the literature and are far too complex and specific to be discussed in the context of the thesis 
(Deutsche Gesellschaft fur Gynakologie und Geburtshilfe 2002). However, the thesis will 
contribute to a more critical use of some of the tests for routine antenatal care.
An issue not to be ignored is the reactions of the pregnant woman’s social environment when 
she either opts against screening itself, or against treatment/abortion, after a certain condition 
has been diagnosed. Opting for a probably handicapped child might lead to stigmatisation and 
a lack of social as well as financial support. The mother/the parents run the risk of being 
blamed for their decision and are prone to social isolation and disadvantages. It has to be 
considered also that people in different societies and social circumstances tend to react
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differently to such decisions and procedures. What is culturally acceptable to some might not 
be acceptable to others. Religious aspects also play an important role. Therefore, screening in 
the antenatal period has to be sensitive to cultural and personal circumstances.
Another way of dealing with screening tests is to respect or support the autonomy of the 
pregnant woman, as is suggested by the ICM international code of ethics for midwives 
(International Confederation of Midwives 1999). This code of ethics clearly states that 
midwives should respect a woman's informed right of choice and promote the woman's 
acceptance of responsibility for the outcomes of her choices (International Confederation of 
Midwives 1999). This would mean introducing a screening test for a population, but leaving the 
final decision about what is acceptable with the pregnant woman herself. This is also 
acknowledged in the definition of screening of the UK National Screening Committee, with the 
statement that that the candidate for screening should be offered a test, but not tested without 
being asked (National Screening Committee (n.d.)).
However, the claim to enable informed decisions calls for professional preparation of the 
person to be screened. Before deciding about a screening procedure, pregnant women need 
to be aware of the implications of the procedure and of the possible following consequences 
from positive as well as negative test results. Also the issue of false negative and false positive 
results needs to be discussed. When opting for or against screening, the personal conviction of 
the person to be screened should be respected. The wish for a certain screening, possible 
fears of the screening itself or of the condition for which is screened need to be explored. It 
depends much on personal values, if feelings of relief and gratitude result from a positive as 
well as a negative test result, or whether resentment occurs after finding out about a condition, 
which the screened person did not want to know about. Enabling informed decisions therefore 
requires knowledge and skills, as well as the resources to discuss the relevant issues.
However, this becomes more important with the severity of the condition and possible 
consequences following a screening test. This applies more to tests from the realm of prenatal 
diagnosis, rather than to screening tests performed for the routine care of healthy pregnant
women. The extensive procedures described above would be inappropriate e.g. when 
screening the mother for iron deficiency, which has minor or no ethical implications at all.
Consequences for a common minimum guideline on the EU-level
Another important aspect to consider is the position that it is the task of health professionals to 
treat individuals according to the latest evidence, but not necessarily to have entire populations 
in sight (Hunter 1997: 76, citing Sheldon & Long). However, advances in health care have their 
costs, and only by the strategic, intelligent and effective allocation of resources is it possible to 
keep the current system of social justice and equal treatment. It is therefore absolutely 
necessary to avoid an arbitrary and inconsistent allocation of limited resources (Hunter 1997: 
62). Here, high-quality and broadly approved guidelines help to plan strategically and to 
allocate resources most effectively. How difficult it is to set up guidelines of high quality, which 
are also sensitive to values, culture, ethics, and other decision-modifying factors has been 
discussed at an earlier stage of the thesis. However, at the end of the extensive analysis it was 
concluded that the need for sensitivity for specific national situations do not stand against a 
common minimum guideline on antenatal care in the EU. In contrast to that, a common 
minimum guideline lays a sound basis for the care of all pregnant women, which can 
subsequently topped up according to national, regional or even individual preferences.
3.12 The survey
There were indications that guidelines on antenatal care exist in most of the member states of 
the EU, as has been discussed in the corresponding section in the literature review (Backe & 
Buhaug 1994, Blondel et al. 1985, Hemminki & Blondel 2001, World Health Organization 
1987). However, the respective national guidelines are not available outside the countries and 
could not be located by means of a literature review using the databases of the medical and 
related professions, such as midwifery. If it was possible to trace them, e.g. via a national 
society of midwives or the society of obstetricians, the documents were published in the
national languages only. As an alternative, part of the content of the guidelines could be 
extracted from studies on certain aspects of care (Backe & Buhaug 1994, Bundesausschuss 
der Arzte und Krankenkassen 2003, Den Almindelige Danske Jordemoderforening 1998, 
Goberna I Tricas et al. 1996 [Spanish], Kristensen et al. 1995, Ministry of Health and Social 
Affairs 1984 [Finnish], cited by Hemminki & Gissler 1993, The Ministry of Health 1997). The 
existing guidelines are therefore neither reasonably accessible for international researchers or 
decision-makers, nor is their content known to health professionals in the other EU states.
On account of these problems, it was decided to conduct a survey to get a clear picture of 
whether guidelines on antenatal care already exist in the member states of the EU, and what 
their content is. The answer to this question was planned to show whether guidelines are a 
common and accepted way to guide practice in the member states. Moreover, the content of 
the national guidelines was established in order to use it as the basis of a common minimum 
guideline at a later stage. It was assumed that using the national recommendations as the 
basis would enhance the acceptability of the common minimum guideline.
To gain a complete overview and enhance the comparability of data, a structured 
questionnaire was used. However, as no such survey had been conducted on this topic 
previously, a questionnaire needed to be developed from which guidelines could be extracted 
and commented on directly in the member states. As the survey was planned to include only 
guidelines for the routine care for normal pregnancies, antenatal care was defined as the 
baseline clinical care of all pregnancies of a healthy woman with an uncomplicated singleton 
pregnancy (National Collaborating Centre for Women’s and Children’s Health 2003). Baseline 
clinical care was limited to the individual recommendations of what test should be performed 
and at which stage of pregnancy. Moreover, only antenatal care up to the estimated date of 
delivery was considered. The research question was: What national guidelines exist and what 
tests are recommended in each member state for antenatal care?
3.12.1 Designing the questionnaire
To extract the individual recommendations from guidelines, tables with tick-boxes were used. 
All 37 routine tests identified from the critical review of the literature were listed in the tables, 
including physical tests, such as the measurement of blood pressure, technical tests, such as 
abdominal or vaginal ultrasound, and laboratory tests, such as taking blood samples for an HIV 
test. As all tests identified by the literature review were included, it was made explicit that this 
did not imply a value judgement as to whether these tests were effective and/or should be 
offered. To facilitate the extraction of data from the original guidelines, tests were organised 
under the aforementioned sub-headings: physical tests, technical tests and laboratory tests. In 
each category, space was provided to record tests additionally recommended in each country. 
The complete set of tests asked for is presented in Appendix 2, where the final questionnaire is 
provided together with the covering letter and consent form.
Another important feature in the tables introduced the time factor. Each test had to be located 
on a time line, which represents gestational weeks. By this it could be made clear if a test 
should be performed at a specific gestational week, or if there is a time span, within which a 
test should be performed. However, when the tables were used for gathering the data on 
national guidelines during the literature review, it was found that they needed to be refined and 
tailored for extracting the relevant data. Reporting tests to be performed at the first visit during 
pregnancy required the introduction of the section “1st visit” in addition to the time line 
representing weeks of pregnancy. Starting with the 6th gestational week was not appropriate, 
as this would have forced the respondent to determine a virtual first visit on the timeline.
In addition to the tables to extract the recommendations, questions were introduced to 
document which country is represented by the respondent and for which organisation he or 
she works. The next question clarifies whether there is a national guideline, or not. If there is 
one, the issuing body should be named and the respondents were asked to provide the full 
reference of it. No further questions were introduced, as the information extracted from this 
questionnaire was judged as adequate with regard to the aims of the survey. It was also
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concluded that any additional questions might have had a negative influence on the response 
rate by introducing more dimensions and requiring more time to complete the questionnaire.
Finally, the survey tool was completed with instructions on how to use it, an accompanying 
letter stating the purpose of the study, and a consent form. The latter were required and 
designed in order to fulfil the University of Surrey’s Ethical Guidelines for Teaching and 
Research (University of Surrey 2001). The format and content of the survey and the 
associated project procedures did not require a formal submission to the Advisory Committee 
on Ethics. The question of whether formal ethical clearance was required was discussed and 
decided upon in consultation with the secretary of the University’s Advisory Committee on 
Ethics and the PhD supervisors.
3.12.2 Pilot study and properties of the questionnaire
In order to optimise the questionnaire’s user-friendliness, validity and reliability, it was piloted 
and revised before its distribution. In accordance with the statistician of the European Institute 
of Health and Medical Sciences it was decided that it was neither necessary, nor appropriate 
to calculate inter- or intra-rater reliabilities by means of statistics according to the purposes of 
the study. A test-and re-test run with the questionnaire after four weeks, together with a 
comparison of the answers against the original guideline and the thorough and detailed 
description of findings was regarded as appropriate. Moreover, this procedure provided the 
opportunity to comment in depth on the questionnaire’s advantages and disadvantages. To 
achieve this, the questionnaire was tested and re-tested against the German guideline 
(Bundesausschuss der Arzte und Krankenkassen 2003). The German guideline was selected 
for the pilot, as it avoided any language difficulties for the German test raters. As the final 
questionnaire will be also used in English, but on guidelines published in the national language 
of the raters, it was regarded as appropriate to apply the same principle for the pilot run.
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The test raters were:
• one professor of gynaecology and obstetrics,
• one scientific assistant in nursing sciences,
• one midwife, and
• the person conducting the study.
These test raters were chosen according to their professional specialty together with their level 
of professional education, which represents the target groups for the survey. Sending the 
questionnaires to Ministries of Health, and the societies of midwives and the societies of 
obstetricians, it was assumed that the following persons could be involved in filling in the 
questionnaires: health professionals from varying specialties including physicians, but also
nurses or other health care personnel. In addition to them, also obstetricians and midwives as
experts in the field could be the respondents, but representing different professional grades. 
Therefore, the persons piloting the questionnaire were selected to represent the target groups. 
They were planned to include a health professional without any knowledge of obstetrics, i.e. 
the scientific assistant in nursing sciences, a staff midwife as the specialist for normal 
pregnancies, and a professor of obstetrics to represent the highest level of specialisation. In 
addition to their profession and level of expertise, the raters needed to be able to work in 
German and English, and had to be willing to give feedback on the questionnaire.
With regard to user-friendliness and time needed, the test raters found that the questionnaire 
was easily understandable and applicable. Although the test raters gave generally positive 
feedback, the example given on the instruction sheet was made more explicit and clear, and 
the sentence limiting the answers to normal uncomplicated pregnancies was re-worded and 
highlighted. On average, the time needed to complete the questionnaire was calculated as 15 
minutes. The professor of gynaecology and obstetrics needed the least time. The scientific 
assistant from the nursing sciences needed the longest, as he was not familiar with antenatal 
care and the corresponding terminology. However, although the scientific assistant from a 
discipline other than obstetrics needed longer and found it more difficult to fill the questionnaire 
in, this rater was also able to extract the German guideline correctly, when comparing it to the
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original guideline. This finding was important, as the questionnaire needed to be applicable by 
persons from diverse disciplines, and particularly such without expert knowledge of antenatal 
care. It was also necessary that the recommendations from the guidelines were not altered by 
the level of expertise of the respondent.
Finally, all test raters found no unclear or ambiguous items. Moreover, they could not identify 
any important information within the German guideline, which could not be reported in the 
questionnaire. To demonstrate that this was also the case for a guideline from another country, 
the questionnaire was also used on the guideline from England and Wales by the principal 
investigator of the study (National Collaborating Centre for Women’s and Children’s Health 
2003). For language reasons, the English guideline was selected. In addition to that, the 
guidelines from Germany and England and Wales are based on different models for setting up 
guidelines. The German one is based on expert opinion, making no referral as to what sources 
of evidence have been used and how they have been integrated. In contrast to this, the 
guideline from England and Wales has been developed according to a clearly specified 
scheme of identifying, selecting and integrating scientific evidence, therefore representing the 
evidence-based model. This step of testing the questionnaire on the guideline of another 
member state based on another paradigm was introduced, as the final questionnaire needed 
to be able to extract recommendations of guidelines from different countries based on different 
paradigms. However, as the information from the guideline from England and Wales also could 
be extracted, the questionnaire was found to have the property to model the recommendations 
adequately from guidelines of different member states and based on different methods of 
setting them up.
3.12.3 Intra-rater reliability
In addition to user-friendliness and validity, the intra-rater reliability of the questionnaire 
needed to be proven. Answers were judged to be identical when they reported the same tests 
and the same number of these tests. Their distribution was accepted to be identical when the
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frequency was the same, irrespective of the exact gestational week, as this depends on when 
care commences. Responses were counted as similar when they reported the same tests, but 
with a different number of repetitions for them. In order to ascertain whether the answers of the 
test raters were identical to the original, they were compared to the recommendations in the 
guideline. When comparing the tests and re-tests of the raters according to the aforementioned 
criteria, the following was found:
• In the two questionnaires filled in by the professor of gynaecology and obstetrics, all 
items were coded identically (100%). Obviously, this rater’s interpretation of the 
guideline as well as his reporting of it was stable over the four-week period. Also the 
recommendations of the guideline were extracted correctly.
• The scientific assistant from the nursing sciences also coded identically at both 
instances (100%). However, as he had no professional view on the subject, he 
extracted the recommendations from the guideline without clinical judgement. This led 
to a specific problem. He overlooked a page, on which the blood tests were listed that 
should be performed at the first visit. The most likely reason for this problem is probably 
the misleading order of subjects within the German guideline. In this, a section on how 
to detect and monitor high risk pregnancies is inserted between the general section on 
normal pregnancies and the section on laboratory tests for normal pregnancies. The 
raters with a background in obstetrics found this page, as they knew that information on 
laboratory tests was missing. The scientific assistant did not have this knowledge and 
therefore did not look especially for this page. As a consequence, the scientific 
assistant’s answers were reliable, but not complete.
• The midwife coded 32 of 37 tests identically (86.5%). Differences occurred when the 
midwife used her clinical judgement in the re-test, but relied entirely on what was 
written in the guideline in the first run. The problem occurred when a test was 
recommended by the guideline for each visit, but starts to make sense in clinical terms 
later on. Palpating the foetal position at each visit is an example for this from the
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German guideline. However, recommending a test to be performed at each visit while 
common clinical knowledge of midwives says that it starts to make sense only in the 
second half of pregnancy is a weakness of the guideline. The unreliable finding is 
therefore not a problem of the questionnaire, but due to an unclear or clinically 
questionable recommendation in the original guideline.
• 35 of 37 items (94.6%) were coded identically by the person conducting the study. As
this person is a midwife, too, the same error occurred as described for the midwife 
above. On one occasion, the rater reported strictly what was written in the guideline, 
but used professional judgement in the second run.
Drawing these findings together, it was found that problems related to the intra-rater reliability 
seem to be due to ambiguous formulations and the misleading order of subjects in the 
guideline, rather than to weaknesses of the questionnaire. Errors occurred systematically, 
when a test was recommended to be conducted at each visit, but does not make sense 
clinically in the early weeks of pregnancy. With regard to this issue, the raters seemed to be in 
doubt whether they should report what was written in the guideline, or whether they should 
apply their clinical knowledge to the text. This problem could not be solved by altering the 
questionnaire. However, it has to be noted that the error occurred in both instances at the re­
test, i.e. that clinical knowledge started to compromise the one-to-one extraction of 
recommendations when the questionnaire was familiar to the raters - and the instructions 
sheet was not read a second time. Considering this in greater depth, it might be that the 
questionnaire models a phenomenon of clinical practice. It would be worthwhile to explore 
whether more experienced clinicians are more likely to deviate from guidelines than their 
inexperienced counterparts. However, for the questionnaire this finding means that its reliability 
is good, when the questionnaire is filled in for the first time.
3.12.4 Inter-rater reliability
In order to comment on the inter-rater reliability, all test questionnaires completed on the first 
occasion by the four raters were compared to each other and to the original guideline, in order 
to establish potential differences. A decision was made in favour of the responses provided in 
the first run, as the respondents in the survey will use the guideline only once, hence when 
seeing it for the first time. As a consequence, the responses need to have sufficient inter-rater 
reliability at the first application of the questionnaire, which was to be tested.
In this comparison it was found that the midwife reported a vaginal examination at each visit, 
which is not within the guideline, but common practice in Germany. As discussed in the section 
on intra-rater reliability, the scientific assistant overlooked one page containing laboratory 
tests. However, the major inconsistency between the raters was the different onset of care. 
Based on the rater’s idea of when the first visit takes place, the recommended weeks for visits 
changed. When care was theoretically started at week 6 instead of week 8 or 10, more visits 
and tests were reported, although they were based on the same frequency and schedule of 
care. Therefore, the gestational weeks at which tests are recorded should not be regarded as 
absolute measures. This applies at least to all measures recommended for each visit. There is 
a variance of two weeks according to time at which antenatal care was thought to commence.
This finding has to be interpreted in the light of the knowledge, that the gestational week to 
start with antenatal care is not necessarily specified in each guideline. In practice, the starting 
point represents entirely the decision of the woman about when to seek care. It should not be 
taken therefore as an absolute measure. Despite this, the frequency of visits can be regarded 
as reliable, with the gestational week showing a variance of two weeks. However, as the 
experts setting up the guideline were obviously aware of this problem, for specific measures 
which are recommended only once or at certain stages of a pregnancy, time spans are always 
given within which the test should be performed. As an example, in the German guideline 
abdominal ultrasound scans are recommended to take place between 9 and 12 gestational 
weeks, between 19 and 22 weeks, and again between weeks 29 and 32 (Bundesausschuss
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der Arzte und Krankenkassen 2003). The ultrasound examinations can therefore be performed 
within the normal course of antenatal appointments. However, it has still to be noted that the 
authors of the guideline were specific in this point, but recommend other tests, such as the 
measurement of maternal blood pressure, to be performed “every four weeks”.
On the basis of the findings from the pilot study and the tests for intra-rater in inter-rater 
reliability, the user-friendliness, and validity as well as the reliability of the final questionnaire 
was judged as appropriate for the planned survey.
3.12.5 Distribution of the questionnaire
As the institutions issuing national guidelines, Ministries of Health, as well as the societies of 
obstetrics and the societies of midwives were selected as the target groups for the survey. 
These organisations were identified through lists provided by the German Society of 
Gynaecology and Obstetrics, the European Board and College of Obstetrics and Gynaecology, 
the German Association of Midwives, and the International Confederation of Midwives. The 
Ministries of Health were identified via the internet. In addition to addressing the organisations 
mentioned above, the president of the European Board and College of Obstetrics and 
Gynaecology (EBCOG), Professor Andre van Assche, contributed to the study. He was 
prepared to contribute after the investigator presented the study and the survey questionnaire 
briefly to him at a conference of EBCOG in Athens in May 2004. As he considered the survey 
worth supporting, he sent a letter of reference and the survey material by e-mail to the 
presidents and the delegates of the national societies of obstetrics and gynaecology. Using the 
president of EBCOG as a distributor and referee for the study was seen as of key importance, 
as it was regarded as unlikely to being able to include data from all member states of the EU 
without a trusted person as an advocate. At the same conference, at which professor van 
Assche was approached, it was also possible to distribute three questionnaires to obstetricians 
from Sweden, the Netherlands and Greece.
As initially planned, 132 questionnaires were sent to the Ministries of Health, and to the 
national societies of obstetricians and midwives of the EU-15 States. However, as the first 
answers were obtained and a preliminary analysis was conducted, it seemed inappropriate to 
exclude the new member states from 1st May 2004, when the study would be published in 
2005. Therefore, the survey was extended to the 10 accession countries. With these states 
being now fully integrated into the Union, it could not be justified that a recommendation for the 
entire EU could be based on the data of the pre-2004 states only. Including the accession 
states, the survey was finally conducted between May and August 2004 by surface and e-mail.
Considering all 25 member states of the EU together, a total of 155 questionnaires and 61 
reminders were distributed. If after a reminder no response was obtained, individual health 
professionals were approached, who were well known beyond the borders of their countries, 
identified through their publications, or through personal contacts. As a whole population 
approach was chosen for the study, this was continued until there was at least one response 
from each member state.
With regard to potential compromise of findings, approaching individual health professionals 
might introduce bias. Interpreting guidelines in the light of one’s own professional practice does 
have an influence on responses, which has been discussed for the midwife in the section on 
intra-rater reliability. However, the same error occurs when a specialist working for a society of 
obstetricians or a midwife from a society of midwives fills in the questionnaire. Hence, the error 
is similar across the institutions approached, but could not be alleviated. It can not be avoided 
that the thoughts and interpretations influence results when using a survey design. Using 
individual experts for the survey if no answer could be obtained from an institution was 
regarded as appropriate, as it does not compromise the reliability of results.
Another error that could be introduced by approaching individual health professionals could 
have been that they do not have the latest version of their national guideline, such as a 
respondent from an institution occupied with antenatal care might have. However, as all health 
professionals are accountable for their professional practice, this is unlikely.
3.12.6 Analysis of the survey data
The selection of questionnaires
For analysis, one questionnaire was selected per member state. If there was more than one 
answer from a country, the one from the most official source was used in case there were 
differences in the reported recommendations. As the most official source, the issuing body of 
the guideline was defined. In case of being issued by a multidisciplinary group, the Ministries 
were seen as the most official source, followed by the professional societies of obstetricians 
and midwives. Answers were judged to be identical when they reported the same tests and the 
same number of these tests. Their distribution was accepted to be identical when the 
frequency was the same, irrespective of the exact gestational week, as this depends on when 
care commences. Responses were counted as similar when they reported the same tests, but 
with a different number of repetitions of them. When the response from the most official source 
needed to be selected, the following ranking was used: a governmental body, a national 
professional society, an individual health professional.
In case of differences in the reported recommendations, an explanation should be found for 
them by the investigator. If differences can not be explained, clarification is to be sought from 
the respondents directly. Moreover, it should be assessed, what implications these differences 
might have. However, in case that no explanation was found, and the response could therefore 
not be included in the analysis, it was planned to consult the original guideline from which the 
recommendations were extracted. To enable this, the respondents were asked to provide the 
reference of their national guideline. If there were different recommendations for first and 
subsequent pregnancies, the care scheme for first pregnancies is considered.
After this selection procedure, the questionnaires were analysed with regard to how many 
countries recommended a test and as to how many people were affected by this. As reference 
numbers, the population sizes of the official statistics of the European Commission were used 
(Amt fur amtliche Veroffentlichungen der Europaischen Gemeinschaften 2004). Numbers from 
the year 2000 were used, as they are the most up-to-date numbers that are based on
population census, rather than on estimations.
The development of a common minimum guideline
Based on the findings from the procedures described above, a common minimum guideline for 
the member states of the EU will be developed. To find a model to integrate the guidelines 
from the member states, the models for decision-making in the Council of Europe were 
explored (The European Union Constitution 2004, Treaty of Nice 2001). After the critical 
analyses of these models, which was discussed in the chapter “decision-making in the Council 
of Europe”, it was concluded that at present there are serious efforts to change the decision­
making structures towards a faster, more flexible and more transparent system (The European 
Union Constitution 2004). It was therefore decided, not to use the currently operated model of 
qualified majority votes, which is difficult to calculate and suffers from a lack of acceptance 
(SCADPIus (n.d.), Treaty of Nice 2001).
In contrast to this, the model as suggested in the proposed Constitution seeks to improve the 
functioning of decision-making (The European Union Constitution 2004), but still considers the 
population sizes of the member states. It therefore constitutes a new system of qualified 
majority voting. The suggested system was called ‘double majorities’ and means that the 
majority of the member states must vote in favour of a decision and that they must represent 
the majority of the population of the EU. However, instead of mathematically defining a 
majority as more than 50%, the Constitution was found to go only half the way.
Triggered by these problems, but also by its broad basis in the Council of Europe, voting 
according to the principle of double majorities was explored further. Finally, a more easily 
applicable model was needed to ensure sufficient transparency. In accordance with basic 
mathematics, a majority is therefore defined as being more than 50% (Wikipedia 2006c), and 
‘double majorities’ refers to more than 50% of the member states, and more than 50% of the 
inhabitants of the European Union (Wikipedia 2006d). In order to be included in the common 
minimum guideline, a test needs to fulfil two criteria: being recommended by at least 50% of
the member states with a guideline, and applying to at least 50% of the inhabitants of these 
countries. This approach of ‘double majorities’ was chosen to take account of two principles of 
the EU, i.e. that each member state counts, and therefore should have a vote irrespective of its 
size, but also that the member states have responsibilities for different population sizes, which 
should be acknowledged when making decisions. Therefore the principle of 50% of member 
states and 50% of inhabitants appeared as a reasoned case to ensure that a common 
minimum guideline can be accepted and implemented by all member states.
With regard to defining double majorities in the mathematical sense it was found more than 
reassuring that Wolfgang Schussel, the President of the Council of Europe from January to 
June 2006, recommended exactly this model of decision-making for the Constitution of Europe 
(Falksohn et al. 2006, Heil 2006). In June 2006, Schussel pledged to hold a plebiscite 
throughout all member states to pass the common constitution for Europe. In this context 
Schussel specified that the constitution should be accepted, if the majority of the European 
population and the majority of member states voted in favour of the constitution (Heil 2006).
The link between the Gross National Product and the number of tests
The next step was aimed at finding out whether there is a correlation between the Gross 
National Product/GNP and the number of tests recommended. For this, the figures of the 
World Bank for the year 2003 were used (World Bank 2004). However, the GNP was provided 
in US dollars and subsequently calculated in Euros, as this is a purely European study. In 
order to make reference to the different price levels in the countries, the same calculations 
were conducted using the figures of the official statistics of the European Commission for the 
year 2003 (Amt fur amtliche Veroffentlichungen der Europaischen Gemeinschaften 2004). 
These were not used primarily, as for 2003 only prognoses were available and the purchasing 
power parities given instead of the GNP per capita in Euro.
For this part of the study, a null hypothesis was formulated as follows: That there would be no 
difference between the Gross National Product of each member state and the number of tests
recommended for antenatal care. This additional analysis was introduced, as it was assumed 
that a common minimum guideline could only be implemented, if it does not mean 
insurmountable financial hardship for the less wealthy member states of the European Union. 
For this it was regarded necessary to explore whether there is a relation between the financial 
status of a Member State and the number of tests recommended in the respective guideline.
National recommendations and published evidence
To explore the robustness of the common minimum guideline, its recommendations will be 
compared to the available evidence about the individual tests. A hypothesis is also used here: 
a guideline based on double majorities of all national guidelines contains the same 
recommendations as a guideline based on the current evidence-base. For comparison, the 
recommendations of the guideline from England and Wales are used (National Collaborating 
Centre for Women’s and Children’s Health 2003). These recommendations represent the most 
extensive critical literature review on the subject to date. All in all, 631 pieces of original 
publication and meta-analyses were cited and analysed by a multi-professional group of nine 
specialists and two consumers. The literature review was systematic, and the methods used 
for identifying, selecting, analysing and integrating the evidence were clearly specified. Where 
available and appropriate, economic data about cost-effectiveness was also introduced.
However, despite this extensive review, the guideline development group of the National 
Collaborating Centre could not find sufficient evidence to come to a clear recommendation for 
all measures without a final judgement of the group. Therefore, recommendations were 
classified from grades A to D, depending on the robustness of the underlying evidence. In 
addition to these grades, also the label “good practice point” was introduced for 
recommendations based on the view of the guideline development group. As this grading 
system for guidelines does not demonstrate the lack of skill of the development group, but 
mirrors the current state of knowledge, it was concluded that this report is appropriate as a 
comparison for the findings of the survey. Most useful is in this respect that the guideline for 
England and Wales provides excellent transparency so that a skilled critical reader is able to
follow the argument, access the underlying literature, and draw his or her own conclusions 
(National Collaborating Centre for Women’s and Children’s Health 2003). As evidence is rarely 
clear and unambiguous and guidelines represent decisions based on the best available 
evidence, it was decided to use the transparent decisions and underlying evidence of the UK's 
National Collaborating Centre for Women’s and Children’s Health for comparison.
Another reason for using the guidelines from England and Wales as a comparator follows the 
argument of the WHO, which claimed that many of the studies underlying the WHO basic 
model for antenatal care have been carried out in different settings and countries, and that 
generalising from these results may be very difficult (World Health Organization 2003). 
However, as the WHO recommends its basic model also for the European region, it was 
critically assessed in a previous chapter entitled “the WHO new model of antenatal care”. Only 
one of the reasons for considering the model of the WHO as inappropriate for the EU was that 
it had not been tested in any single European state, but in Cuba, Thailand, Saudi Arabia and 
Argentina (Villar et al. 2001). The guideline from England and Wales is a better comparator, as 
its recommendations were made on the background of a genuine member state of the EU.
The recommended frequency of tests
The last analysis of the survey data will complete the list of tests recommended for the routine 
care of healthy pregnant women in the EU and extract the frequencies with which individual 
tests are recommended during each pregnancy.
3.13 In-depth appraisal of two national guidelines
Another important issue that evolved from the review of the state of the art was the need to 
distinguish clearly between recommendations and guidelines. This is clarified and discussed in 
a concept analysis in the chapter on guidelines and their quality, and especially in the section 
“evaluation of recommendations”. In addition to this, other indicators of the quality of guidelines 
are explored. After clarifying the operational definitions as well as the underlying concepts, and
after the critical appraisal of the identified instruments, it was concluded that there is a useful 
instrument for the purposes of the study (The AGREE Collaboration 2001).
Objectives of the in-depth appraisal
The objective of Phase 1 of the study is to critically appraise the relation between evidence- 
based guidelines and guidelines based on expert opinion for the defined public health task 
‘antenatal care’. To achieve this, the paradigms underlying and the methods for setting up 
evidence-based guidelines and guidelines based on expert opinion have already been 
theoretically discerned and analysed in the previous chapter. Within this, the nature of 
evidence was critically discussed, and the differences and similarities between scientifically 
generated evidence and evidence referred to by experts were highlighted.
From the critical review on guidelines, their underlying evidence and the challenges of 
decjsion-making it was found that the appraisal of the scientific quality of a guideline’s 
recommendations is an important step in its evaluation, though not the only one. Other 
indicators, such as the methodological and structural quality of the guideline itself also play a 
role. However, it was also concluded that there is still the missing link between the overall 
quality of a guideline, and the quality of its recommendations. Although the AGREE- 
Collaboration claims that there is a relation between the overall quality of a guideline and the 
quality of its recommendations (The AGREE Collaboration 2001), clarity is missing as to 
whether there is a stable relationship between the two, and to what extent.
Selection of an instrument for appraising two national guidelines
Answering this question for guidelines on antenatal care is regarded as one of the 
cornerstones with regard to the completion of Phase 1 of this study, and therefore for its 
contribution to the body of knowledge. In order to achieve this, deeper insights are needed into 
the implications that different methods for setting up guidelines have on their overall quality. 
Two guidelines based on entirely different paradigms will be analysed in depth for their 
methodological and structural quality, using the instrument of the AGREE-Collaboration (The
AGREE Collaboration 2001). Why this instrument was selected has been already discussed 
extensively in the sections entitled “Instruments for the systematic appraisal of guidelines 
and “Appraisal of guidelines for research and evaluation in Europe” of the thesis. In these 
sections, the findings from a systematic review of the literature are presented together with the 
critical analysis of the identified instruments (The AGREE collaboration 2001, AZQ 
Zentralstelle der Deutschen Arzteschaft zur Qualitatssicherung in der Medizin 1999, 
Bundesarztekammer & Kassenarztliche Bundesvereinigung 1997, Cluzeau et al. 1999, 
Ollenschlager et al. 1998, Scottish Intercollegiate Guidelines Network 2002).
In brief, it was found that the instrument of the AGREE-Collaboration was specifically designed 
to assess the overall quality of guidelines set up by multidisciplinary teams, and is applicable to 
guidelines from any disease area, including also those on diagnosis, health promotion, 
treatment or interventions. Moreover, this is the first instrument with proven validity and 
reliability for the appraisal of guidelines from different countries. All these factors qualified the 
AGREE-instrument to be used for appraising guidelines on antenatal care for the purposes of 
this study. Finally, it was reassuring to find that the AGREE-instrument was also judged by the 
Council of Europe as the most promising instrument for the evaluation of guidelines in different 
countries that were set up by different groups of experts and recommends the use of the 
instrument (Europarat 2001:17ff, Europarat 2001: 30 + 44).
In addition to these advantages, the instrument has been reported to be in use by well 
respected national and international organisations occupied with quality assurance in 
medicine, such as the National Institute for Clinical Excellence in the UK, the National 
Federation of Cancer Centres in France, The Agency for Quality in Medicine in Germany, the 
Scottish Intercollegiate Guidelines Network and also the World Health Organization (Cluzeau 
2004). Using this instrument will therefore enhance the international comparability of guideline 
quality, as well as improve the consistency and quality of reporting them.
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The appraisers
Tests of the AGREE instrument’s reliability demonstrated that the number of raters appraising 
a guideline affects the reliability of the intra-class correlations. Intra-class correlations 
substantially improved with the number of raters. To achieve acceptable Cronbach a values for 
the individual quality domains as specified by the instrument, four raters are recommended 
(Cluzeau 2004, The AGREE Collaboration 2001 + 2003). In order to ensure the reliability of the 
appraisal, the recommended number of four raters will be used.
However, although the AGREE-instrument is used for the appraisal of the guidelines, the 
method for this part of the study goes beyond the simple appraisal of two national guidelines 
using this tool. As was discussed in section 3.3.4 of the thesis, the AGREE-collaboration 
reported the questionable internal consistency for the domain ‘clarity and presentation’. 
Unfortunately, this was not explained. To shed light on this, the method for the in-depth 
appraisal of the two national guidelines was amended. The appraisers using the AGREE- 
instrument were treated as a panel of experts, which was selected purposefully in order to elicit 
informed judgements about the quality of the two national guidelines. Special care was taken 
to relate the interpretations of the experts back to the original guidelines in order to shed light 
onto their individual professional views.
Although the estimated time needed for appraising a guideline is 1.5 hours (Cluzeau 2004), the 
professionals who had already piloted the survey questionnaire were willing to support the 
study again. This was regarded as a good mixture of skills and knowledge of the topic. All 
appraisers had demonstrated that they are able to work in German and English. Moreover, 
they had proven that they can interpret guidelines, can now be more easily instructed about 
the difference between a guideline’s recommendations and the other criteria to be assessed. 
However, most important for their selection was that the appraisers cover different disciplines, 
but are all involved either with using, or the process of developing or appraising guidelines. 
Again, one person has no special knowledge of antenatal care.
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The selected appraisers therefore are:
• one professor of gynaecology and obstetrics,
• one scientific assistant in nursing sciences,
• one midwife, and
• the person conducting the study.
Guidelines selected for the in-depth appraisal
As guidelines for the in-depth appraisal, the evidence-based guideline from England and 
Wales (National Collaborating Centre for Women’s and Children’s Health 2003) and the 
expert-opinion based guideline from Germany (Bundesausschuss der Arzte und 
Krankenkassen 2003) will be used. These two guidelines have been selected, as the guideline 
for England and Wales is a document of a unique and extensive multidisciplinary process 
according to the principles of evidence-based care and excellence in guideline development. 
Just published in October 2003, it represents the most recent approach towards excellence in 
antenatal care for the normal pregnant woman.
In contrast to that, the German guideline represents a legally binding guideline which has been 
used for several years now, based on less formal criteria, agreed on and developed by the 
Federal Joint Committee of the self-governing body of physicians and health insurance funds 
(Bundesausschuss der Arzte und Krankenkassen 2003). Therefore, the guidelines from the 
England and Wales and Germany are based on completely different approaches to the same 
problem, hence offering best opportunities to comment on strengths and weaknesses. 
Moreover, both guidelines were either set up, or amended in 2003, which makes them also 
comparable with regard to the state of the evidence at the time of issuing the guidelines.
The overall quality of the guidelines and the quality of their recommendations
At the outset of this paragraph, the objective of this part of the study has been specified as to 
add knowledge about the link between the overall quality of a guideline, and the quality of its
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recommendations. After the in-depth appraisal of the overall quality of the guidelines from 
England and Wales and Germany, it is finally necessary to link these findings to the quality of 
the recommendations of both guidelines. However, the developers of the AGREE-instrument 
state clearly that their instrument is neither intended to assess the clinical content of a 
guideline, nor the evidence that underpins the recommendations (The AGREE Collaboration 
2003). This means that there is still no tool to assess this relation, and the crucial question 
remains of whether good guidelines make good recommendations.
Due to this lack of a suitable tool, it was decided to additionally compare the recommendations 
from the two national guidelines against each other. However, it has to be noted that due to its 
outstanding qualities the guideline for England and Wales is used as a comparator for the 
findings from the survey. Despite this, the guideline from England and Wales is not used as an 
untouchable gold standard. As has been demonstrated in Table 2.8, the recommendations of 
the guideline for England and Wales are graded from A to D depending on the robustness of 
the underlying evidence. Therefore, the critical discussion of the recommendations from this 
guideline will be used to compare the German guideline. In case of the underlying evidence 
being weak or ambiguous, it is acknowledged that different recommendations have to be 
accepted without necessarily judging one as more appropriate.
With the approach demonstrated above, it is hoped to
• answer the question of whether different approaches to set up guidelines on antenatal 
care lead to similar recommendations, or not.
• demonstrate the difficulties involved with the assessment of the overall quality of 
currently available national guidelines on antenatal care.
• provide insights into the relation between the recommendations of a guideline and its 
overall quality according to internationally accepted criteria.
• shed light onto the question of whether scientific evidence and expert knowledge on 
antenatal care are similar or congruent on the highest national level, i.e. whether the 
guideline based on expert opinion contains the same recommendations as the one set 
up on the basis of scientific evidence.
Chapter 4 -  Results
4.1 Results from the survey
4.1.1 Response rates
Although the aim of obtaining at least one answer from each member state of the EU was 
achieved, not all questionnaires sent out led to a response. A total of 36 responses to the 
survey were obtained from all 25 member states of the European Union. This represents an 
overall response rate of 23.22% of all 155 addressed institutions and individuals. As the 
questionnaires were distributed separately to the EU-15 States and the States joining the EU 
on 1 May 2004, separate response rates were calculated for these groups. Twenty-three 
answers from 132 institutions and individuals were received from the EU-15 countries, which is 
equivalent to a response rate of 18.18% in the EU-15 group. Twelve responses were obtained 
from the 10 new member states after sending 23 letters. This means a response rate of 
52.17% in this group. In Table 4.1, all completed questionnaires are listed per member state 
and with the respective respondent. Thirteen questionnaires (36.11%) were filled in by 
obstetricians, with one Czech obstetrician working for the Institute for the Care of Mother and 
Child. Nine questionnaires (25%) were completed by personnel from Ministries of Health and 
midwives respectively, and another five (13.89%) by representatives of other institutions.
Seven member states provided more than one response and are described in more detail 
below.
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Table 4.1: Completed questionnaires
Respondent Member state
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Ministry of Health X X X X X X X X X
Ministry of Social Affaires X
Society of obstetricians X X X X X X X X X X X
Obstetrician X
Society of midwives X X X
(Independent) midwife X X X X X X
Research Council /  Centre for 
Research & Development X X
Institute for the care of mother 
& child X
Institute of Public Health X
University professor X
Using professional contacts to distribute the questionnaires to persons willing and able to 
contribute to the study as described in Chapter 3.12.5 was necessary for Austria and Greece, 
where there would otherwise have been no response. As the official institutions of Portugal 
overran the deadline significantly, two more questionnaires were sent through professional 
contacts, which led to two additional responses. Although the Italian Ministry of Health also 
overran the deadline, the completed questionnaire was finally returned after an official of the 
Ministry had asked the investigator by telephone, if the response was required.
4.1.2 Multiple responses
From the Republic of Ireland, both respondents reported the non-availability of national 
guidelines. From the UK, one letter referred to the new guideline for England and Wales
(National Collaborating Centre for Women and Children’s Health 2003), the other respondent 
transferred the content of the same guideline into the survey table. This extract of the guideline 
was subsequently included in the analysis.
Denmark provided answers from the society of obstetricians, the Ministry of Interior and Health 
and the society of midwives. The responses reflected the situation of shared antenatal care 
between general practitioners, midwifery centres and hospital departments. Each professional 
group may have reported mainly on the measures for which they are responsible. The 
response from the Ministry was a summary of the answers from both professional societies. As 
the recommendations cited by the professional societies were included in the response from 
the Ministry, and as it was assumed that this is the least biased source with regard to 
professional judgements about individual tests, the response from the Ministry of Interior and 
Health was included in the analysis, and those of the professional societies excluded.
Portugal provided answers from the Ministry of Health, a University Professor and a midwife. In 
this case, the answers from the Ministry were included in the analysis as representing the data 
from the most official source as discussed above. In addition to that, the Portuguese guideline 
has been issued by the Ministry of Health. Therefore, the answer from the institution most 
closely related to the guideline was selected as the one accessing the latest version of the 
document, and being less prone to misinterpreting the recommendations.
The answers from a University-based midwife in Sweden and an obstetrician from a University 
Hospital were almost identical. The Swedish Research Council correctly responded that it does 
not issue a guideline, as the guideline is issued by the National Board of Health and Welfare.
Institutions from the Czech Republic and Lithuania provided two answers each. Their answers 
were again similar in content, with one Czech institution reporting to start care at ten 
gestational weeks, and one at twelve. However, as the onset of care depends on both the 
realisation of the woman of being pregnant, and her decision of when to contact health 
professionals, care will inevitably start at different times. Even if a guideline recommended
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starting care as early as possible, not every woman will discover that she is pregnant at the 
same stage. Therefore it would be unrealistic if a guideline recommended to always 
commencing care at the same defined gestational week. Apart from the different starting date, 
the recommendations were the same from each source.
4.1.3 Sources of national guidelines
When analysing the selected questionnaires according to the framework described in Chapter 
3, it was found that 20 member states (80%) have a national guideline on antenatal care. For 
these 20 member states with a national guideline it was found that 13 States have a guideline 
issued by the government, mainly the Ministry of Health. Four states have a guideline issued 
by the national society of obstetricians, and 3 states have a guideline published by a 
governmental institution in co-operation with the society of obstetricians. However, although 
most guidelines are issued by a governmental body, they are set up by multidisciplinary teams, 
always including obstetricians, but also experts from health insurances and other related 
disciplines. The guidelines from the United Kingdom and Germany serve as examples of this. 
The German guideline has been developed and issued by the Federal Joint Committee of the 
self-governing body of physicians and health insurance funds, but now has legal status. The 
guideline for England and Wales has been set up by a multidisciplinary team of experts from 
obstetrics, but also consumers, a radiographer and other specialties. However, the final 
guideline has been issued by the National Collaborating Centre for Women’s and Children’s 
Health, commissioned by the National Institute for Clinical Excellence, which is part of the 
National Health Service. From these findings it became clear that each guideline has an 
issuing body, but from the issuing body a conclusion can not necessarily be drawn about who 
set the guideline up. It is therefore concluded that the issuing body has an impact on the status 
of the guideline and on how (legally) binding it is, rather than reporting on the quality of the 
guideline.
4.1.4 Tests recommended for antenatal care
Five member states, i.e. Belgium, Cyprus, Greece, Ireland and Malta, do not have a guideline 
on antenatal care. However, only 5.75% of the total inhabitants of the 25 member states live in 
these countries. The data from the other 80% of member states is presented in Tables 4.2 to 
4.7. In Table 4.2 the data shows in descending order, which and how many member states 
recommend each test for antenatal care. Similarly, Table 4.3 shows the size of the population 
to which the individual recommendations apply.
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Drawing the findings of these two tables together, it was found that 23 tests are recommended 
by more than 50% of the member states and additionally apply to more than 50% of 
inhabitants. This approach has already been explained in the paragraph on data analysis in 
the methodology section. The thus identified tests are shown in Table 4.4 together with the 
frequency with which they are recommended. The other 14 tests asked for in the survey failed 
to fulfil either one or both of the criteria for double majorities and are shown in Table 4.5. In 
both tables the tests are ranked with the test recommended by most member states on top and 
the test recommended by the lowest number of member states at the bottom.
2 1 6
Table 4.4: Recommended number of individual tests per pregnancy 
(by more than 50 % of countries applying to more than 50% of inhabitants)
Test Number
________________________________1 2 3 4 5 6 7 8 9 10 11 12 13 14
Blood group H I
Blood pressure I----------------------1-------------------------------------- 1
Rhesus factor determination H------------------- 1
Maternal weight I I I
Urinalysis / Bacteria I I I
Haemoglobin I-------------- 1-----------------------------------------------------1
Lues I I I
Urinalysis/Protein---------------------------------------- I-------------------------1-------------------------------------------------1
Auscultation of foetal heart I I I
Foetal position I I I
Fundal height I----------------- 1-----------------------------1
Hepatitis B virus H I
Ultrasound, abdominal I I I
Urinalysis/Glucose-------------------------------------- I------------------------- 1------------------------------------------------ 1
Vaginal examination I---------------------1--------------------------------------------------------------------1
Alpha-Feto-Proteine or Triple I I I 
Atypical red cell antibodies I I I
Formal risk scoring I I I
Body Mass Index I---------------1---------------------------------1
HIV I------ 1--------------1
Rubella titer I
Gestational diabetes - OGTT H I
Ultrasound, transvaginal I— I--------------- 1
min mean max
25% below 
mean
25% above 
mean
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Table 4.5: Recommended number of individual tests per pregnancy 
(by less than 50% of countries or applying to less than 50% of inhabitants)
Test Number
6 7 * 9 10 11 12 13 14
Full physical examination 
Breast examination 
Papanicolaou smear 
Toxoplasmosis 
Cardio-tocography 
Doppler ultrasound 
Foetal movement count 
Chlamydia trachomatis 
Gonorrhoea
Hepatitis C virus 
Streptococcus group B
Haemoglobinopathies
Placental hormones 
Foetal fibronectin
min mean max
25% below 25% above
mean mean
Although it was found that all 37 tests asked for in the survey are recommended by at least 
one member state, only 3 tests (8.1%) are recommended by all 25 member states of the 
European Union. These universally recommended tests are measuring the maternal blood 
pressure and determining her blood group and Rhesus factor. However, respondents from four 
member states made additional use of the opportunity to report tests from their guidelines 
which were not asked for in the survey. The respondents from these countries added 10 more 
tests so that the entire number of tests used for routine antenatal care in the EU rose to 47. 
There were no overlaps in the additional recommendations. This means that all added tests 
are recommended by the respective member state only. These are listed below:
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• Austria additionally recommends measurement of maternal height as well as abdominal 
circumference. Regular checks for oedema and varicose veins are also recommended. 
Up to the 16th gestational week, a gynaecological examination should take place, 
during which also a vaginal smear is taken and checked for pathogens. An erythrocyte 
count or the determination of the haematocrit also takes place once up to the 16th 
gestational week, and for a second time between weeks 25 and 28.
• Hungary recommends a non-stress test between 36 and 38 weeks, and another one 
between the 38th and the 40th gestational week. In addition to that, the Hungarian 
guideline recommends an oxytocin challenge test between 38 and 40 weeks, which is 
again not recommended for normal pregnancies in the other member states.
• Luxembourg recommends between weeks 21 and 25 a test for glycaemia, which 
means the measurement of blood sugar without any controlled intake of glucose.
• Poland recommends the testing of the vaginal pH at weeks 10, 20, 32 and 37.
4.1.5 National recommendations and published evidence
When the tests recommended by at least 50% of member states and applying to at least 50% 
of inhabitants (double majorities) were finally compared to the published evidence, the idea of 
using these recommendations for a common minimum guideline gained support. It was found 
that 19 tests were recommended by the member states with double majorities, and can 
additionally be recommended according to the published scientific evidence as documented in 
the evidence tables of the National Collaborating Centre for Women’s and Children’s Health 
(National Collaborating Centre for Women’s and Children’s Health 2003). Fourteen tests were 
neither recommended with double majorities, nor are they supported by the literature (Table 
4.5). Most interesting is the finding that only four tests were recommended by double 
majorities, but are currently not sufficiently supported or discouraged by the literature as 
specified in the guideline from England and Wales (National Collaborating Centre for Women’s
and Children’s Health 2003). For vaginal examinations, there is strong evidence that it is 
ineffective to predict a premature ripening of the cervix. The auscultation of the foetal heart 
rate is not recommended as it has no further clinical or predictive value than to confirm that the 
foetus is alive at the time of auscultation. Performing urine glucose tests is discouraged on the 
basis of its low sensitivity and high number of false positives. The routine use of oral glucose 
tolerance tests for gestational diabetes is also discouraged, as currently there is neither any 
consent about the definition, nor about the management of gestational diabetes mellitus. The 
National Collaborating Centre for Women’s and Children’s Health came to the conclusion that 
the evidence does not support routine screening for gestational diabetes mellitus.
4.1.6 The link between the gross national product and the number of tests
The answer to the question of whether there is a correlation between the Gross National 
Product and the number of recommended tests is provided in Tables 4.6 and 4.7. From these 
tables it becomes evident that member states with a GNP above average (GNP50+) do in fact 
recommend fewer types of tests and a smaller total number of tests per pregnancy than the 
member states with a GNP below average (GNP50-).
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Table 4.6: Correlation between Gross National Product (GNP) per capita in Euro and intensity of 
care
Country GNP in €
Recomm 
Types of tests
endation
Total No. of tests
Luxembourg 34 598 15 40
Denmark 26 575 15 49
Sweden 22 709 25 65
United Kingdom 22 323 18 52
Finland 21 276 26 118
Austria 21 039 30 68
The Netherlands 20 716 19 38
Germany 19 882 20 114
France 19 504 25 62
Italy 18819 20 35
Spain 13 378 32 120
Portugal 9 551 24 111
Slovenia 9315 22 140
Czech Republic 5 307 32 106
Hungary 4 984 25 136
Poland 4 150 22 96
Estonia 3 906 25 127
Slovak Republic 3 874 37 171
Lithuania 3 535 22 61
Latvia 3 205 27 70
The GNP50- countries recommend on average 1.3-times more types of tests compared to the 
GNP50+ countries. For the average total number of tests for one pregnancy, the results are 
even more impressive. The GNP50- countries recommend 1.8-times as many tests as the 
GNP50+ group. The same associations were found when the GNP was adapted to the national 
purchasing power parities (data not shown). Of the member states without a guideline,
Belgium and Ireland have a GNP above the average of € 14 432.30. Cyprus, Greece and 
Malta have a GNP below.
Table 4.7: Correlation between average Gross National Product (GNP) and 
intensity of care
Group of countries
Recomm 
Types of tests
endation
Total No. of tests
GNP above average 21.3 64.1
GNP below average 26.8 113.8
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4.1.7 Frequency of tests
Tables 4.4 and 4.5 show how often tests are recommended during pregnancy and that most of 
the tests are recommended to be performed more than once during pregnancy. Using a box- 
and-whiskers type of diagram, the means are clear, as well as the respective 25% ranges 
below and above the mean. In addition to this, the highest and lowest number of repetitions 
can also be seen. However, although these tables provide a useful overview, it has to be 
considered that the reported repetitions of a test depend on the point at which the care began. 
This differs widely and is a product of the national recommendations of when to start care, but 
also of when pregnant women decide to first contact health professionals.
4.2 Results from the in-depth appraisal of two national guidelines
In accordance with what was described in Chapter 3 on methodology, the in-depth appraisal of 
the national guidelines from England and Wales and Germany was conducted in two stages. In 
a first step, the methodological quality of the two guidelines was assessed with the AGREE- 
instrument by four raters with purposefully selected different professional backgrounds. In a 
second step, the recommendations of the guidelines were compared to each other. The 
findings of both stages are presented in the following section.
4.2.1 Appraisal of the methodological quality of the two national guidelines
The following critical appraisal of the methodological quality of the guidelines from England 
and Wales and Germany is intended to contribute to reach the objective of Phase 1 of the 
study, which is to critically appraise the relation between evidence-based guidelines and 
guidelines based on expert opinion for the defined public health task ‘antenatal care’. As 
planned, the appraisals of both guidelines were conducted between May and August 2004, 
using the instrument of the AGREE-Collaboration. They could not be conducted 
simultaneously, as it was not possible to fix a date with all appraisers at the same time.
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However, the appraisers neither knew each other, nor had any contact. Moreover, the 
appraisers’ names were kept confidential. Any influence from discussions or other contact was 
therefore excluded. In line with the recommendations of the developers of the AGREE- 
instrument, four appraisers were chosen to critically assess the guidelines. However, as an 
amendment to using four unspecific appraisers, the method was expanded by purposefully 
selecting four raters with different professional backgrounds, involved with different stages of 
using or setting up guidelines. By this, a deeper and more critical view on the assessed 
guidelines should be obtained.
Although appraising the guidelines demanded time and effort from the appraisers, the 
guidelines were finally assessed by the designated four appraisers. Each appraiser answered 
all 23 questions for both guidelines and made a final comment on whether the guideline should 
be recommended. To ease analysis and to ensure anonymity, the following numbers were 
assigned to the appraisers:
• A1: Professor of gynaecology and obstetrics
• A2: Scientific assistant in nursing sciences
• A3: Midwife
• A4: The person conducting the study.
After all appraisers returned their material, the analysis was conducted according to the 
instructions of the AGREE-Collaboration, which are explained in the following. The guidelines 
are therefore assessed in the domains ‘scope and purpose’, ‘stakeholder involvement’, ‘rigour 
of development’, ‘clarity and presentation’, ‘applicability’ and ‘editorial independence’.
According to the instructions for analysis, the scores for each domain were calculated 
separately by summing up all scores on the individual questions in a domain and subsequently 
calculating the total as a percentage of the maximum possible score for that domain. Using the 
following formula it is possible to calculate every domain score for each individual appraiser, 
but also to calculate the standardised domain score out of the ratings of all appraisers 
together:
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obtained score -  minimum possible score
--------------------------------------------------------------------- = (standardised) domain score in %
maximum possible score -  minimum possible score
This formula explains also, why for example in Table 4.8 a score of 12 means a domain score 
of 100%, but a score of 6 is equal to 33%, rather than to 50%, which would be normally 
expected. However, if the minimum score of a domain with three questions is 3 and the 
maximum score is 12, a score of 6 means a domain score of 33%. This would be only different 
if the lowest score were 0. As this might be a source of misunderstandings, this logical problem 
has to be kept in mind while reading all following tables and the results section on the 
appraisal of the methodological quality of the two national guidelines. Another important point 
to be noted is that it is not possible to aggregate the domain scores into a single quality score, 
but to use the scores separately to comment on the particular strengths and weaknesses of a 
guideline. Unfortunately, the developers of the AGREE-instrument could not set thresholds for 
marking good or bad guidelines. As this does not lend itself directly to an explanation, and due 
to the fact that the AGREE-collaboration has not provided an explanation either, the reason for 
this might be discovered when using the instrument to assess the two national guidelines. Due 
to the lack of thresholds for good or bad guidelines, the ratings of the appraisers have to be 
considered together with the additional comments and the final overall assessment they made, 
which might be regarded as a subjective factor in the appraisal system. However, also the 
different rating patterns of the different professionals are used to gain additional insights.
In order to ease the assimilation and understanding of the findings, first of all the ratings of all 
four appraisers will be analysed for the individual domains of the England and Wales guideline, 
and in the next step the corresponding domain of the guideline from Germany. At the same 
time, the ratings of the individual appraisers will be assessed with regard to specific traits of 
their ratings. It will be critically analysed whether the raters with a background in obstetrics 
show a different rating pattern than the scientific assistant from another discipline. In addition
to the individual scores, the written comments of the appraisers will also be considered.
After that, the findings for the individual domains will be brought together to ease a clear view 
on the overall quality of each guideline. In a last step, the findings from this will then be 
compared to the overall assessment of each guideline as provided by the appraisers.
Scope and purpose
As becomes clear from Table 4.8, all four appraisers were convinced by the descriptions of the 
scope and the purpose of the guideline from England and Wales. All three items were rated 
with the maximum score. All appraisers found that the objectives, as well as the target group 
and the clinical condition covered by the guideline are clearly described. The description is 
clear and understandable to readers without prior knowledge of the field, but according to the 
high ratings of raters A1, A3 and A4 also acceptable to specialists.
Table 4.8: Scope and purpose of the guideline from England and Wales
Question Indivic
A1
lual scores 
A2
by apprais 
A3
;er No. 
A4
1. The overall objective(s) of the guideline 
is(are) specifically described 4 4 4 4
2. The clinical question(s) covered by the 
guideline is(are) specifically described 4 4 4 4
3. The patients to whom the guideline is 
meant to apply are specifically described 4 4 4 4
Score type Score
Domain score per appraiser (%) 100 100 100 100
Standardised domain score 100%
In contrast to that, the purpose of the German guideline was probably easier to understand for 
the appraisers with a background in obstetrics, which was explicitly stated by appraiser A2.
The scientific assistant from the nursing sciences commented that the patients to whom the 
guideline is meant to apply are not explicitly described, and that it is rather difficult to 
understand without deeper knowledge of obstetrics. As can be seen from Table 4.9, the 
appraiser without prior knowledge rated the domain scope and purpose with only 33%, which 
is by far the lowest rating. In particular, the description of the clinical questions covered by the 
guideline did not convince this appraiser. However, the practising midwife was also not entirely 
satisfied with this. She stated that the overall objective of the guideline was not specifically 
described, as only two sentences referred to the benefits of medical treatment during 
pregnancy in general. Appraiser A2 commented that the overall objectives are mentioned, but 
rather unspecific. However, appraiser A3 stated that the guideline gives detailed information 
about when a medical check up during pregnancy has to take place. In addition, she found that 
the guideline provides information about normal results and how to act on irregular findings.
Table 4.9: Scope and purpose of the German guideline
Question Indivic
A1
lual scores 
A2
by appraU 
A3
;er No. 
A4
1. The overall objective(s) of the guideline 
is(are) specifically described 4 3 1 4
2. The clinical question(s) covered by the 
guideline is(are) specifically described 4 1 3 4
3. The patients to whom the guideline is 
meant to apply are specifically described 4 2 4 3
Score type Score
Domain score per appraiser (%) 100 33 56 89
Standardised domain score 69%
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Although the ratings from the appraisers with a professional background were generally higher, 
only the professor of gynaecology and obstetrics rated all items within this domain with the 
maximum score. This might be due to additional information provided by the professional 
organisation, which is not known to the other appraisers. Another possible explanation is that 
the high rating is associated with having practical experience of working with the guideline.
Although appraiser A4 attached a high score to all items, an additional critical remark was 
made with regard to the specification of patients to whom the guideline is meant to apply. 
Appraiser A4 commented that the guideline seemed to apply to all pregnant women, but that it 
is not specified whether the guideline applies irrespective of the number of the pregnancy or 
maternal age etc. Moreover, it was also stated that the guideline applies to all pregnant women 
who are covered by general health insurances and not to pregnant women per se. Appraiser 
A3 commented also that there was no doubt about who the patient group were, i.e. pregnant 
women, while reading the guideline, while appraiser A2 mentioned that the patients were not 
described in greater detail and that the guideline was very physician-oriented. However, 
despite some criticism, a standardised domain score of 69% was calculated for the German 
guideline when finally drawing the individual ratings of the appraisers together.
Stakeholder involvement
Table 4.10 shows that all appraisers were convinced that the guideline development group of 
the guideline for England and Wales was adequately chosen, including individuals from all 
relevant professional groups. The same level of satisfaction was demonstrated with regard to 
the clear definition of the target users of the guideline. Moreover, all but appraiser A4 were 
completely satisfied with the degree to which patients’ views and preferences have been 
sought. Appraiser A4 reported that two consumers were in the guideline development group.
However, only appraiser A3 was entirely satisfied with the piloting of the guideline. This finding 
is important, as appraiser A3 has experience as a user of guidelines, but virtually no 
knowledge about the principles of scientific work. The three raters with knowledge and
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experience in dealing with scientific questions and with guideline development were not 
convinced that the guideline from England and Wales was sufficiently piloted. However, 
appraiser A4 acknowledged that the guideline reported on pages 3 to 7 had undergone an 
“external review process”. Appraiser A2 also stated that he did not find any report of piloting, 
but that the guideline was externally reviewed. Despite the doubts about the appropriate 
piloting of the guideline, the final standardised domain score of 88% demonstrates a high 
overall level of satisfaction with regard to stakeholder involvement in the guideline 
development process.
Table 4.10: Stakeholder involvement of the guideline from England and Wales
Question Indivic
A1
lual scores 
A2
by apprais 
A3
;er No. 
A4
4. The guideline development group 
included individuals from all the relevant 
professional groups
4 4 4 4
5. The patients' views and preferences 
have been sought
4 4 4 3
6. The target users of the guideline are 
clearly defined 4 4 4 4
7. The guideline has been piloted among 
target users 3
2 4 2
Score type Score
Domain score per appraiser (%) 92 83 100 75
Standardised domain score 88%
With a standardised domain score of 25%, the German guideline is rated extremely low with
regard to stakeholder involvement in the guideline development process (Table 4.11). 
Especially appraiser A2, i.e. the scientific assistant from the nursing sciences, was critical and 
found no single criterion of the domain fulfilled. He found that for the development of the 
German guideline neither the relevant professional groups were chosen, nor were patients’ 
views sought. He even found that the target users of the guideline were not clearly defined. 
However, the ratings of the other appraisers indicate the same extremely critical view only on 
the issues that patients’ views were obviously not sought and that the guideline does not 
contain any hint as to whether it was piloted at all.
Table 4.11: Stakeholder involvement of the German guideline
Question Indivic
A1
lual scores 
A2
by apprais 
A3
»er No. 
A4
4. The guideline development group 
included individuals from all the relevant 
professional groups
3 1 4 1
5. The patients' views and preferences 
have been sought 1 1 1 1
6. The target users of the guideline are 
clearly defined 4 1 2 4
7. The guideline has been piloted among 
target users 1 1 1 1
Score type Score
Domain score per appraiser (%) 42 0 33 25
Standardised domain score 25%
An interesting finding was made with regard to the judgment about the appropriate selection of
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the guideline development group. According to the original document, the German guideline 
was decided upon by the Federal Joint Committee of the self-governing body of physicians 
and health insurance funds. No further reference can be found in the document as to who the 
actual individuals were, and what were their professions, or positions in the guideline 
development group. The practising midwife, i.e. appraiser A3, did not challenge the fact that 
the contribution of neither a midwife, nor of a patient representative is reported in the guideline. 
The professor of gynaecology and obstetrics (appraiser A1) was also satisfied with the 
selection of the development group, which might be explained with a possibly biased view onto 
the subject, as only physicians and health insurances were represented in the group. However, 
appraisers A2 and A4 were more critical about this issue and were not convinced that all 
relevant professional groups were involved. Even the scientific assistant from another 
discipline, i.e. appraiser A2, noted that the recommendations were defined by physicians only.
In contrast to appraisers A2 and A3, who found that the target users of the guideline were not 
clearly defined, appraisers A1 and A4 awarded the guideline the highest possible score in this 
area. As this rating could not be explained by possible prior knowledge or experience, the 
original guideline was consulted in order to clarify the issue. According to the explanation from 
within the AGREE-instrument, the question was whether the target users of the guideline are 
clearly defined, so that they can immediately determine if the guideline is relevant to them. In 
the first section of the original guideline it is stated that the guideline was introduced to ensure 
sufficient, appropriate and cost-effective antenatal and postnatal care for women insured under 
general health insurance, and refers to care which is provided by physicians. In a later section 
on the same page, it is further specified that the guideline applies to those physicians, who are 
qualified to do so according to their knowledge, experience and equipment, and who are 
allowed to do so according to professional regulations. Only under paragraph seven on page 6 
is reference made to the fact that some of the recommended measures can also be performed 
by a midwife, as long as the physician has either given the order to do so, or if a physician has 
diagnosed a normal pregnancy and has no objections to the continuation of antenatal care by 
a midwife. However, it has to be noted that the guideline refers to antenatal care as funded by
general health insurances only. Despite this, the guideline is used as a gold standard by all 
professions involved in antenatal care in Germany. Why appraiser A2 did not count the above 
information as a clear definition of the target users of the guideline is not clear. It might be that 
the information was not provided in a manner which can be easily picked up, and the appraiser 
put the focus on target users needing to be “clearly” defined. It might have helped, if the 
guideline provided the information in a structured and more straightforward manner. The 
practising midwife commented that she was not satisfied with definitions. She was critical that 
it was not written in the guideline, “what kind of doctor is responsible for the medical check ups 
during pregnancy”. The practising midwife realised from her experience that it is normally the 
obstetricians practising independently in the community, who provide antenatal care. This is a 
special trait of the German system, and appraiser A3 holds obviously the opinion that those 
physicians who are normally providing the care should be called by their name.
Rigour of development
Also in the domain ‘rigour of development’, the guideline from England and Wales was rated 
high with a standardised domain score of 88%. The detailed numbers as compiled in Table 
4.12 demonstrate that all four appraisers found that systematic methods were used to search 
for evidence and that the criteria for selecting it did become clear. All appraisers were also 
satisfied with the level to which the envisaged positive, but also the possible negative effects of 
the recommendations have been considered. They were also convinced that there is an 
explicit link between the recommendations and the supporting evidence. When addressing 
question number 13 of whether the guideline has been externally reviewed, the rating of the 
appraisers was again uniform and attained the highest possible score. This reinforces what 
was stated in the previous section on stakeholder involvement, where the appraisers 
commented that there was no evidence of piloting, but that the guideline was externally 
reviewed. Appraisers A2 and A4 in particular acknowledged that the guideline reported 
undergoing an external review process. For the question of whether the methods used for 
formulating the recommendations are clearly described, the ratings were generally high,
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although two raters did not give the highest possible score.
Table 4.12: Rigour of development of the guideline from England and Wales
Question Indivic
A1
iual scores 
A2
by apprais 
A3
»er No. 
A4
8. Systematic methods were used to 
search for evidence 4 4 4 4
9. The criteria for selecting the evidence 
are clearly described 4 4 4 4
10. The methods used for formulating the 
recommendations are clearly described 3 4 3 4
11. The health benefits, side effects and 
risks have been considered in formulating 
the recommendations
4 4 4 4
12. There is an explicit link between the 
recommendations and the supporting 
evidence
4 4 4 4
13. The guideline has been externally 
reviewed by experts prior to its 
publication
4 4 4 4
14. A procedure for updating the 
guideline is provided 1 1 4 2
Score type Score
Domain score per appraiser (%) 81 86 95 90
Standardised domain score 88%
In contrast to the homogenous rating for the other items, there was major disagreement on 
whether a procedure for updating the guideline is provided. The practising midwife thought that 
it was provided, whereas the other three appraisers were not convinced that this was the case. 
Appraiser A4 might have brought up the reason for this by stating that no date and no specific
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process for updating were specified, but that on pages 19 and 20 of the guideline 
recommendations are made for future research. While the midwife without deeper knowledge 
about the theoretical ideas behind guidelines has accepted this as an appropriate procedure, 
the more experienced appraisers might have regarded this as appropriate for a piece of 
academic work, but would have expected a specific date for updating a guideline.
Table 4.13: Rigour of development of the German guideline
Question Indivic
A1
iual scores 
A2
by apprak 
A3
;er No. 
A4
8. Systematic methods were used to 
search for evidence 1 1 3 1
9. The criteria for selecting the evidence 
are clearly described 1 1 1 1
10. The methods used for formulating the 
recommendations are clearly described 1 1 1 1
11. The health benefits, side effects and 
risks have been considered in formulating 
the recommendations
2 1 2 1
12. There is an explicit link between the 
recommendations and the supporting 
evidence
1 1 1 1
13. The guideline has been externally 
reviewed by experts prior to its 
publication
1 1 1 1
14. A procedure for updating the 
guideline is provided 1 2 4 1
Score type Score
Domain score per appraiser (%) 5 5 29 0
Standardised domain score 10%
With a standardised domain score of 10% for the category rigour of development, the rating of 
the German guideline stands in sharp contrast to the high rating of the guideline from England 
and Wales (Table 4.13). For the German guideline, appraiser A4 attached to each item the 
lowest possible score. Appraisers A1 and A2 each rated only one item higher than the most 
basic score, and only the ratings of appraiser A3 show a more heterogeneous picture.
For the question of whether systematic methods were used to search for evidence, appraiser 
A3 noted that there is a number on the front page where the guideline is archived, and she 
speculated about whether it might be possible to get more information. As this is only an 
archive number, where the guideline can be found, this is definitely not the case. The same 
appraiser commented also that there are “useful comments on the bottom of some pages”, e.g. 
pages 9,10 and 17. Flowever, these footnotes refer to requirements for laboratory or 
ultrasound examinations, but do not provide any information about how the search for 
evidence was conducted. As there is no information about how the search for evidence took 
place, all other appraisers judged this item as not fulfilled by the guideline.
In contrast to the search for evidence, all appraisers agreed that the German guideline does 
not provide any data about the inclusion or exclusion of evidence. They also agreed that the 
guideline did not provide any information about the methods used for formulating the 
recommendations, which implies also that the link between the recommendations and the 
evidence is not clear. All appraisers judged item 12 accordingly with the lowest possible score. 
Due to the entire lack of procedural information, the question of whether the guideline had 
been externally reviewed could not be answered, i.e. was scored as low as possible.
With regard to the question of whether the guideline describes health benefits, side effects and 
risks in relation to its recommendations, appraisers A2 and A4 decided that no information was 
provided. However, appraiser A4 made the additional comment that the guideline intends to 
avert potential dangers for the life and the health of mother and infant. This appraiser stated 
also that potential side effects and risks are not mentioned, and therefore did not give a higher 
score. Appraiser A3 comments that neither risks, nor health benefits nor side effects are
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mentioned except for two sentences on page 2 of the guideline. Despite this, she ranked the 
issue one score higher than appraisers A2 and A4.
The ratings of appraisers A1 and A4 refer to the fact that the German guideline gives no 
specific date for updating it. Appraiser A4 mentioned additionally that the guideline specifies 
the day from which it is effective, but does not give a date for updating. The above ratings 
demonstrate a straightforward answer to the question of whether a procedure for updating the 
guideline is provided. However, appraisers A2 and A3 realised and commented that on the first 
page of the guideline there is evidence of updates, but that it does not become clear why, how 
and by whom the updates were made.
Clarity and presentation
The standardised domain score of 90% demonstrates well that the four appraisers were 
satisfied with the clarity and the presentation of the guideline from England and Wales (Table 
4.14). They all concluded that the recommendations of the guideline are specific and 
unambiguous, and that the key recommendations are easily identifiable. Appraiser A4 added 
the comment that a separate page and a poster with the clinical algorithm are provided, which 
makes the guideline easily applicable. Information for consumers and for professionals is given 
separately in the appendix, which might be also useful. As all these materials are provided by 
the guideline, it is not clear why appraiser A2 decided that the guideline is not supported with 
tools for application. In addition to this potential criticism, the practising midwife found that the 
different options for management of the condition are not clearly presented. Unfortunately, she 
did not elaborate further on this issue.
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Table 4.14: Clarity and presentation of the guideline from England and Wales
Question Indivic
A1
iual scores 
A2
by apprais 
A3
>er No. 
A4
15. The recommendations are specific 
and unambiguous 4 4 4 4
16. The different options for management 
of the condition are clearly presented 4 4 3 4
17. Key recommendations are easily 
identifiable 4 4 4 4
18. The guideline is supported with tools 
for application 3 1 4 4
Score type Score
Domain score per appraiser (%) 92 75 92 100
Standardised domain score 90%
Although the difference was not as large as for the other domains, the German guideline 
scored 30% lower than the guideline from England and Wales with regard to its clarity and 
presentation (Table 4.15). While the professor of gynaecology and obstetrics was more or less 
satisfied and scored this domain with 15 out of 16 possible points, the scientific assistant from 
the nursing sciences was not convinced by the guideline and scored clarity and presentation 
with 5 out of 16. Most interesting is, however, that all appraisers with a background in 
obstetrics scored this domain significantly higher than the scientific assistant from another 
discipline. Background knowledge might have helped to judge for example whether the 
recommendations are specific and unambiguous enough. However, although appraiser A2 
found that there were at least partially concrete statements it did not become clear, which of
them are evidence-based. As he obviously wanted this particular information, he rated item 15 
lower than the other appraisers. In this case, the appraisers with knowledge of obstetrics might 
interpret the guideline and judge for themselves whether the recommendations are plausible, 
or not. In this respect these appraisers might be biased and interpret something into the 
guideline, which is not written there.
Table 4.15: Clarity and presentation of the German guideline
Question Indivic
A1
lual scores 
A2
by apprak 
A3
;er No. 
A4
15. The recommendations are specific 
and unambiguous 4 2 4 4
16. The different options for management 
of the condition are clearly presented 4 1 2 3
17. Key recommendations are easily 
identifiable 3 1 3 3
18. The guideline is supported with tools 
for application 4 1 3 3
Score type Score
Domain score per appraiser (%) 92 8 67 75
Standardised domain score 60%
As can be also seen from Table 4.15, the professor of gynaecology and obstetrics was 
convinced that the different options for management of the condition are clearly presented. 
The other three raters were not entirely convinced, and e.g. appraiser A3 commented “Are 
there different options in treatment? It’s not written. There is just an option between the one 
who treats the pregnant women ...” However, appraiser A4 found that different options for 
management are presented, such as by giving time windows for ultrasound screening, and by
specifying that haemoglobin levels should be re-assessed according to the initial test result. 
However, there are no real alternative options discussed, which relate to preferences of the 
pregnant woman, or to any uncertainties with regard to the benefits of a test.
With regard to the clarity of presenting the key recommendations such as to make them easily 
identifiable, appraiser A3 commented that users would be able to find the most important 
recommendations. However, she suggested also that the key recommendations would be 
easier to find if there were more emboldened words. The other two appraisers with knowledge 
in obstetrics were also not entirely satisfied, and the one without prior knowledge was 
completely dissatisfied with the presentation.
Most evident was the difference between those with background knowledge in obstetrics and 
the one without, when the question was asked as to whether the guideline is supported with 
tools for application. It might be that the three appraisers with prior knowledge thought of the 
so-called “Mutterpass”, which is a concise booklet in which the results of all examinations are 
recorded, when they answered this question. At least appraiser A4 made reference to this 
booklet, which is carried by the pregnant woman herself, and in which all test results should be 
documented. Its format is such as to provide defined spaces for each examination, thus 
helping to prevent any omissions in care. As it mirrors the recommendations of the guideline, it 
definitely helps to apply it to all pregnant women. This might have not been known to appraiser 
A2, as he is not professionally involved in antenatal care.
Applicability
Table 4.16 shows that the guideline from England and Wales scores with a standardised 
domain score of 69% for its applicability, which was the lowest score. No appraiser was 
entirely convinced by the properties of the guideline in this domain, although appraiser A3 
awarded 11 out of 12 possible points, which was by far the highest rating. This might again be 
due to her lack of experience with scientific work, and the assessment of guideline quality.
Most interesting was the finding that appraisers A2 and A3 both found that the potential
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organisational barriers in applying the recommendations had been discussed in the guideline. 
Appraiser A1, the professor of gynaecology and obstetrics, disagreed without further 
comments. However, appraiser A4 disagreed even more strongly and added that the potential 
organisational barriers have not been discussed, and that there is no comment as to how the 
guideline should be implemented, or what changes are necessary. The same appraiser added 
also that this might be self-explanatory for health professionals working in the system, but that 
this is not that obvious for interested parties who are not familiar with the health system.
Table 4.16: Applicability of the guideline from England and Wales
Question Indivic
A1
iual scores 
A2
by apprak 
A3
ser No. 
A4
19. The potential organisational barriers 
in applying the recommendations have 
been discussed
2 4 4 1
20. The potential cost implications of 
applying the recommendations have been 
considered
3 3 3 4
21. The guideline presents key review 
criteria for monitoring and/or audit 
purposes
4 2 4 3
Score type Score
Domain score per appraiser (%) 67 67 89 56
Standardised domain score 69%
The ratings on the question whether potential cost implications of applying the 
recommendations have been considered were generally high, and appraiser A2 added that 
they were partially discussed in the guideline. Also high ratings were made as the appraisers 
found that the guideline presents key criteria for monitoring or audits. However, appraiser A2, 
who has experience in this field, judged the provided criteria as not necessarily plausible.
Also in the domain ‘applicability’ the German guideline was rated lower than the one from 
England and Wales. Table 4.17 provides the detailed ratings of the appraisers and thus 
demonstrates from where the standardised domain score of 36% was derived. First of all, none 
of the appraisers found sufficient evidence about a discussion of the potential organisational 
barriers in applying the recommendations. The appraisers’ interpretation of whether the 
potential cost implications of applying the recommendations were considered was interesting. 
Whereas appraisers A2 and A3 found that these implications were not at all considered, 
appraisers A1 and A4 were convinced that they were considered. The latter two appraisers 
were possibly satisfied with the introductory statement about the aims of the guideline. These 
were to recommend care, which is sufficient, suitable and economical, as noted by appraiser 
A4. Appraiser A4 also mentioned that this is claimed by the guideline, but that there is no 
comment about how this has been assessed, or to what degree it is achieved. However, it 
should be borne in mind that health insurance played a major role in the guideline 
development process. It is therefore unlikely that the cost implications were not considered.
Table 4.17: Applicability of the German guideline
Question Indivic
A1
lual scores 
A2
by apprais 
A3
ser No. 
A4
19. The potential organisational barriers 
in applying the recommendations have 
been discussed
1 1 1 2
20. The potential cost implications of 
applying the recommendations have been 
considered
4 1 1 4
21. The guideline presents key review 
criteria for monitoring and/or audit 
purposes
2 1 4 3
Score type Score
Domain score per appraiser (%) 44 0 33 67
Standardised domain score 36%
For the last question in this domain, i.e. whether the guideline presents key review criteria, 
there was again disagreement. Appraiser A2 with experience in the field was again not at all 
satisfied with the criteria provided. From the added statement of appraiser A3, it became clear 
that she did not understand what was meant by “review criteria for monitoring and/or audit 
purposes”. This might be explained by her experience as a practising midwife, but lack of 
experience with academic work and management processes, such as monitoring and auditing. 
The other two appraisers were indifferent about whether adequate, or the most suitable criteria 
had been provided.
Editorial independence
All four raters found that the guideline from England and Wales was editorially independent 
from the funding body. This is demonstrated well by the high ratings, which can be seen in 
Table 4.18. However, in an additional comment, appraiser A4 added that the reason for the 
high score was that too many organisations and individuals were involved in the guideline 
development process, as to be dependent. However, this appraiser noted also that there was 
no explicit comment with regard to independence from the funding body of the guideline 
development process. Appraiser A3’s comment again mirrors her lack of experience with 
academic conventions, as she stated that she could not find any reasons to believe that this 
guideline was funded by any companies. It is definitely worth considering that dependence 
from a funding body means more than funding by for example pharmaceutical companies.
As appraiser A3 made a statement that she could not find information about conflicts of 
interest, questions arise about why she rated this item 23 with a score of 2. This might have 
been a mistake, as it is not logical. In contrast, the score of 3 for this item as attached by 
appraiser A2 is plausible, as he expected that possible conflicts of interest were recorded, 
although he found that this was not explicitly done. However, appraiser A4 found that 
declarations of interest are reported on page 3, but that they are not in the book.
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Table 4.18: Editorial independence of the guideline from England and Wales
Question Indivic
A1
lual scores 
A2
by apprais 
A3
;er No. 
A4
22. The guideline is editorially 
independent from the funding body 3 4 4 4
23. Conflicts of interest of guideline 
development members have been 
recorded
3 3 2 4
Score type Score
Domain score per appraiser (%) 67 83 67 100
Standardised domain score 79%
Table 4.19: Editorial independence of the German guideline
Question Indivic
A1
lual scores 
A2
by apprais 
A3
serNo.
A4
22. The guideline is editorially 
independent from the funding body 1 4 4 1
23. Conflicts of interest of guideline 
development members have been 
recorded
1 1 1 1
Score type Score
Domain score per appraiser (%) 0 50 50 0
Standardised domain score 25%
Again in this category, the German guideline ended with a low standardised domain score of 
25% (Table 4.19). In this case, all four raters held the same opinion that potential conflicts of
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interest of guideline development members have not been recorded. Despite this, appraisers 
A2 and A3 were convinced that the guideline is editorially independent from the funding body. 
Appraisers A1 and A4 were entirely convinced of the dependence from the funding body. How 
the first two appraisers came to their opinion is not clear, as they unfortunately did not 
comment on this item. In contrast to that, appraiser A4 commented that editorial independence 
was not even intended, as the guideline has been developed and issued by the self-governing 
body of physicians and health insurance funds. This means that this guideline has been issued 
by an obviously non-independent committee.
Overall assessment
In Tables 4.20 and 4.21 the appraisals of all four raters have been compiled to give an 
overview of the ratings in each domain for both guidelines. This has been done for three 
reasons. Firstly, this helps to get an overview about the particular strengths and weaknesses 
of each guideline. Secondly, the guidelines can be compared to each other. Finally, this 
strategy helps to compare the actual rating of the individual appraiser to the overall 
assessment, i.e. the final judgement about the quality of the guidelines they made.
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Table 4.20: In-depth appraisal of the guideline from England and Wales by all four raters
Domain QuestionNo.
Indivi
A1
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by apprais 
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sr No. 
A4
Sum Standardised domain score (%)
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Table 4.21: In-depth appraisal of the German guideline by all four raters
Domain QuestionNo.
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A1
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From the comparison of the in-depth appraisals it becomes clear that both guidelines have the 
highest score in the domain ‘scope and purpose’. From the previous detailed analysis, it is 
known that both the appraiser without prior knowledge about antenatal care and the specialists 
were entirely satisfied with the description provided by the guideline from England and Wales. 
Although all appraisers had an idea about the scope and the purpose of the German guideline, 
it was difficult for them to extract the information. Moreover, the appraisers did not all draw the 
same conclusions from what they found in different sections of the guideline. These problems 
are reflected in the lower standardised domain score of 69% for the German guideline.
The domain ‘clarity and presentation’ was ranked with the second highest standardised 
domain score for both guidelines. Also in this domain, the guideline from England and Wales 
was superior to the German guideline. The appraisers found that the recommendations of the 
guideline from England and Wales are specific and unambiguous, and that the key 
recommendations are easily identifiable. Especially the separate page and the poster with the 
clinical algorithm were found helpful. When addressing the German guideline, the most 
interesting finding was that all appraisers with a background in obstetrics scored this domain 
significantly higher than the scientific assistant from another discipline. Background knowledge 
obviously helped to find the way through the guideline with a lack of structured presentation.
When addressing the two domains that relate to the selection of the guideline development 
group, the involvement of patients as well as to the scientific quality of the guideline, great 
differences are observable between the in-depth appraisals of the two guidelines. In the 
domains ‘stakeholder involvement’ and ‘rigour of development’, the guideline from England 
and Wales has particular strengths. Despite some criticism about the lack of piloting and an 
appropriate procedure for updating the guideline, the standardised domain scores are high for 
both domains with a rating of 88% each.
In contrast to that, the German guideline received its lowest scores in the domains ‘stakeholder 
involvement’ and ‘rigour of development’. The perceived lack of rigour in guideline 
development was especially criticised. All appraisers with knowledge and experience about
academic work and about guideline development could not find the relevant information about 
the procedures used for identifying, selecting and using scientific evidence for setting up the 
recommendations. For all other questions which referred to the rigour of the guideline 
development process, the ratings were similarly low.
In addition, the appraisers were also not satisfied with the involvement of stakeholders in the 
guideline development process, which led to a standardised domain score of 25%. The ratings 
of the appraisers indicate an extremely critical view on the fact that patients’ views were 
obviously not sought and that the guideline does not contain any hint as to whether it was 
piloted. A heterogeneous picture was evident for the question of whether all relevant 
professions were represented in the guideline development group. Whereas the obstetrician 
and the practising midwife were satisfied with the selection of the panel, the other two 
appraisers were not. This might indicate that the two professional groups involved with 
providing antenatal care see obstetricians as the outstanding experts for antenatal care. 
However, it became clear that representatives of other disciplines hold another view.
As can be seen in Table 4.20, the guideline from England and Wales has a standardised 
domain score of 69%, its weakest point, in the domain ‘applicability’. It was found that no 
appraiser was entirely convinced by the properties of the guideline in this domain, although it 
became clear that the appraiser with a specialisation in monitoring and audit was more critical 
than the other appraisers. However, although the guideline from England and Wales could be 
improved in this domain, the standardised domain score is high enough to still regard it as 
satisfactory. Compared to the rating of the guideline from England and Wales, the 
standardised domain score of 36% of the German guideline is again disappointing. However, it 
has to be noted that this is not the weakest part of the German guideline itself.
The standardised domain score of 79% indicates that the appraisers were quite positive about 
the editorial independence from funding bodies of the guideline from England and Wales. 
Nevertheless there was some critique that declarations of possible conflicts of interest are 
reported, but that they are not directly available in the guideline. It is therefore impossible to
make a judgement about the factors which might have had an influence. The standardised 
domain score of 25% for the editorial independence of the German guideline was a finding that 
could be explained. As the German guideline has been developed and issued by the Federal 
Joint Committee of the self-governing body of physicians and health insurance funds, editorial 
independence from the funding body was obviously not even intended.
Does the overall assessment support the ratings of the individual appraisers?
To make a final statement about whether the appraisers would recommend the guideline they 
assessed, the AGREE-instrument offers four categories: strongly recommend, recommend 
(with provisos or alterations), would not recommend and unsure.
For the guideline from England and Wales, the overall assessment was ‘strongly recommend’ 
by all four appraisers. Appraiser A3 made the final comment that the guideline means a lot to 
read, but that it is very clear and specific, and should be strongly recommended. Appraiser A2 
also commented that he strongly recommends the guideline. The only criticism from this 
appraiser was that it did not become clear from his point of view, how the implementation of 
the guideline was planned, and how it should be evaluated. In addition, appraiser A2 describes 
the guideline from England and Wales as being extensive and that the transfer into practice 
appeared to be difficult at first sight. However, when he assessed the guideline in depth, he 
found that the recommendations are easily comprehensible and finally not that difficult to 
transfer into practice. Appraiser A2 also commented that it was not that simple to appraise 
both guidelines as the terminology is difficult to understand for a nurse without any background 
in obstetrics.
In accordance with the standardised domain scores of 79% and above, it can be concluded on 
the basis of this small modelling exercise that the overall assessment of the appraisers to 
strongly recommend the guideline from England and Wales is justified.
In contrast to the straightforward recommendation of the guideline from England and Wales, 
appraisers A1, A3 and A4 came to the overall assessment that they would recommend the
German guideline with provisos or alterations. Appraiser A2 would not recommend the 
German guideline at all. This might be due to the fact that appraiser A2 has never used the 
guideline in practice, and has also no knowledge about its achievements. This is supported by 
the fact that appraiser A2 scored the domain applicability significantly lower than the other 
appraisers, which can be seen from Table 4.21. However, it might also be true that the other 
three raters are used to working with this guideline and have no idea about how antenatal care 
might be performed otherwise. However, appraiser A2 named the reasons for not 
recommending the guideline. These were that the development of the guideline was not clear, 
that there was no comment on the scientific basis of the recommendations, that the guideline 
is not patient-oriented and that it is mono-professional as well. He also found that the German 
guideline is not clearly arranged and therefore difficult to appraise. Although appraiser A2 has 
most likely not calculated the domain scores of his rating, his concluding remarks go in line 
with the results of his in-depth appraisal using the AGREE-instrument. As can be seen from 
Table 4.22, especially the domains stakeholder involvement, rigour of development and 
applicability were scored extremely low by this appraiser. With a score of only 8%, the domain 
clarity and presentation followed suit.
Table 4.22: Individual appraisers' and standardised domain scores of the German guideline
Domain
Apprais
A1
er's indi 
(%
A2
vidual s 
)
A3
cores
A4
Standardised domain score (%)
Scope and purpose 100 33 56 89 69
Stakeholder involvement 42 0 33 25 25
Rigour of development 5 5 29 0 10
Clarity and presentation 92 8 67 75 60
Applicability 44 0 33 67 36
Editorial independence 0 50 50 0 25
Appraiser A3 with practical experience as midwife, but without prior knowledge about dealing 
with the theoretical background of guidelines finally stated she liked the guideline because it is
easy to read, very clear and not too long. As can be seen from Table 4.22, this is partially 
reflected by her ratings. Appraiser A3 rated the questions around the domain clarity and 
presentation higher than the standardised domain score. The other domains relating to her 
final comment, i.e. scope and purpose and applicability were scored lower than the 
standardised domain score, but obviously high enough to still recommend the guideline with 
provisos or alterations. In addition, she commented that she did not even notice the hints about 
additional texts when she was reading the guideline without AGREE-instrument, but would be 
interested in reading them. She also mentioned that she would be interested in the discussions 
that took place during the guideline development process and also in the opinions and 
experiences of patients. Moreover, appraiser A3 would like to know about the costs of what 
she called “special examinations”. However, despite the wish for such procedural information, 
appraiser A3 attached the highest rating of all appraisers to the domain rigour of development, 
which therefore lies also by far higher than the standardised domain score.
The overall assessment of appraiser A4 was that the German guideline recommends a 
traditional model of care, which has been used for ‘ages’ and is well known to practitioners as 
well as to pregnant women and their relatives. This has its own benefits. However, there is an 
obvious need for more documentation about the individuals involved in setting up the 
guideline, the development process and the underlying evidence. This becomes especially 
evident from the scores of 0% in the domains rigour of development and editorial 
independence, as well as from the score of 25% for stakeholder involvement. In addition to the 
previously mentioned comments, appraiser A4 stated that a framework for regularly updating 
the guideline is also needed. Moreover, this appraiser stated also that if there was not only a 
lack of documentation about who contributed to the guideline, the involvement of other relevant 
parties should be considered, at least that of consumers and midwives.
From the above findings it can be concluded that the questions from the in-depth appraisal 
with the AGREE-instrument guided the appraisers’ thoughts towards the crucial issues of 
guideline quality. This was reflected in the rating of the appraisers when using the AGREE-
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instrument, but also in the final comments without having calculated the domain scores, and 
also without having the rating of other appraisers at hand to compare their views against.
4.2.2 Comparison of the recommendations of the two national guidelines
It is the aim of this part of the study to add knowledge about the link between the overall quality 
of a guideline, and the quality of its recommendations. As the AGREE-Collaboration claims 
that there is a relation between the overall quality of a guideline and the quality of its 
recommendations, two hypotheses were generated on the basis of the findings from the 
previous in-depth appraisal of the two guidelines. From this appraisal it was found that the 
overall quality of the guideline from England and Wales is higher than that of the German 
guideline. The difference was large enough to lead the appraisers to strongly recommend the 
guideline from England and Wales as it is, but to recommend the German guideline only with 
provisos or alterations. One of the appraisers even did not recommend the German guideline 
at all. On the basis of these findings, the hypotheses were formulated as follows:
Hypothesis 1: There are major differences between the recommendations of the
guideline from England and Wales and the recommendations of the 
guideline from Germany.
Hypothesis 2: In case of different recommendations, the evidence-base suggests
following the recommendation of the guideline from England and Wales.
For the comparison of the individual recommendations, the original guidelines were consulted.
It is a clear advantage that both guidelines date from 2003, which implies that the available 
evidence was the same for both guidelines. As a consequence it is assumed that only the 
conclusions drawn from the evidence are different. Whenever only one of the guidelines 
recommended a test, the evidence-base is consulted to clarify what course of action the 
currently available knowledge suggests, or what kind of evidence is missing to make a 
conclusive decision. For this, the level of the underlying evidence for the test is extracted from 
the guideline from England and Wales, and especially the grade of the recommendation is
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examined. The grading system of the guideline from England and Wales has been discussed 
extensively in the chapter on the evaluation of recommendations, and for a clear picture of it, 
the reader is referred to Tables 2.7 and 2.8 of the thesis.
Another important issue to consider was to compare not only the tests recommended by both 
guidelines for routine antenatal care, but also what both do not recommend. Also these tests 
are counted as identical ‘recommendations’ of both guidelines. The tables of the survey 
questionnaire, which made reference to all tests, which are recommended throughout the EU, 
were used as the basis for the comparison. As in the original tables, the tests are divided up 
into the categories ‘physical tests’, ‘technical tests’ and ‘laboratory tests’. All the tests are 
finally listed in Table 4.23, irrespective of when and how often they are recommended to be 
performed during pregnancy. The findings from this comparison are described in the following.
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Table 4.23: Similarities and differences in the recommendations for routine antenatal care of 
the guidelines from England/Wales (E/W) and Germany (GER)
Category Test Recommended by
of tests E/W + GER E/W GER None*
Blood pressure X
Body Mass Index X
Breast examination X
Foetal movement count X
O
<75 Foetal position X>£ Formal risk scoring X
CL Full physical examination X
Fundal height X
Maternal weight X
Vaginal examination X
Auscultation of foetal heart X
(0
o Cardio-tocography X
c£ Doppler Ultrasound X
V1- Ultrasound, abdominal X
Ultrasound, transvaginal X
Alpha-Feto-Proteine or Triple X
Atypical red cell antibodies X
Blood group X
Chlamydia trachomatis X
Foetal fibronectin X
Gestational diabetes OGTT X
Gonorrhoea X
Haemoglobin X
Haemoglobinopathies X
> Hepatitis B virus X
+-■
(0 Hepatitis C virus X
o£ HIV X
CO_J Lues X
Papanicolaou smear X
Placental hormones X
Rhesus factor determination X
Rubella titer X
Streptococcus group B X
Toxoplasmosis X
Urinalysis / Bacteria X
Urinalysis / Glucose X
Urinalysis / Protein X
* The category none refers to all routine tests identified from the critical review of the literature, which 
were also used in the survey questionnaire.
Physical tests
In the category ‘physical tests’, in 6 out of 10 cases both guidelines are identical. The 
guidelines from England and Wales and Germany recommend the measurement of maternal 
blood pressure. When assessing the recommendations in greater depth, it was found that both 
guidelines recommend this examination for each visit. Also recommended by both guidelines 
are determining the foetal position, measuring fundal height and weighing the mother. Not 
recommended are breast examinations and foetal movement count.
In contrast to the above measures, calculating the body mass index and formal risk scoring are 
recommended by the guideline from England and Wales only. However, instead of calculating 
the body mass index, the German guideline recommends measuring maternal height and 
weight. With regard to formal risk scoring, both guidelines contain catalogues of what risk 
pregnancies are, and in which cases more than routine care should be provided. However, in 
the German guideline this is not called formal risk scoring. In contrast to the guideline from 
England and Wales, the German guideline recommends a full physical examination in addition 
to taking the woman’s history, and also provides catalogues of which conditions might cause 
risks. Taking these factors together, it is obvious that both guidelines lead the practitioners to 
determine the health status of a woman at the beginning of pregnancy.
The discussion about vaginal examinations during pregnancy is interesting. The guideline from 
England and Wales does not recommend this measure to predict preterm birth. This guideline 
makes a Grade A recommendation, which implies that the underlying scientific evidence is 
strong. In contrast to that, the German guideline recommends a ‘gynaecological’ examination 
at the first visit, which normally refers to a vaginal examination. However, this initial 
examination is not intended to assess the risk for preterm birth. Also in this case, the 
recommendations are nearly identical with regard to their practical implications. Drawing the 
above arguments together, it can be concluded that the recommendations of both guidelines 
are nearly identical with regard to the physical examinations.
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Technical tests
In the category ‘technical tests’, the two guidelines give the same recommendations for four 
out of five tests considered. From the second part of Table 4.23 it is evident that both 
guidelines only recommend abdominal ultrasound for routine care. While the German guideline 
recommends three abdominal ultrasound examinations for normal pregnancies, the guideline 
from England and Wales recommends only two. In contrast to the German guideline, which 
recommends that the third examination should take place between the beginning of the 29th 
and the end of the 32nd gestational week, its English counterpart makes the Grade A 
recommendation that no routine use should be made of ultrasound scanning after 24 weeks. 
However, both guidelines agree again that cardio-tocography should only be performed if there 
is an indication to do so. Moreover, both guidelines do not recommend the use of Doppler 
ultrasound on a routine basis. The same applies to transvaginal ultrasound examinations.
Although it was found that the German guideline recommends the regular auscultation of the 
foetal heart rate, the England and Wales guideline reports good reasons for not doing so. This 
guideline explains that the auscultation may confirm that the foetus is alive, but that it is 
unlikely to have any predictive value. As this is a Grade D recommendation, there might still be 
some positive aspects to be discovered in the future. However, with the constant improvement 
of technological equipment, such as ultrasound scanners, this is unlikely. As the low predictive 
value of auscultation is likely to be also known to developers of the German guideline, they 
might have put more weight onto the second aspect of this examination, which is the 
reassurance of the mother. This was named as a valid reason to perform an auscultation by 
the England and Wales guideline.
Laboratory tests
For 19 out of 22 tests, the two guidelines make the same recommendations. As the overlap is 
that large, only those tests which need further comments are discussed in greater detail. The 
results for all other tests are provided in Table 4.23.
The first test, i.e. screening for Alpha-Fetoproteine, or a triple test mainly relates to screening 
for structural anomalies of the foetus. According to the guideline from England and Wales, 
screening for Down's syndrome should be offered to every pregnant woman. However, the 
triple test should be only offered in combination with other tests to provide the highest possible 
detection rate and in order to limit the number of false positive results. No reference is made to 
other structural anomalies, such as spina bifida. Also in the German guideline, reference is 
made to additional tests to screen for foetal genetic aberrations. However, in contrast to the 
policy to offer such testing to every pregnant woman, the German guideline only recommends 
testing if a risk for genetic aberrations was identified otherwise.
On routine screening for Chlamydia trachomatis, the guideline from England and Wales states 
that there is insufficient evidence on its effectiveness and cost effectiveness. However, the 
guideline states also that this policy is likely to change in the future with the introduction of the 
national opportunistic screening programme for all men and women under the age of 25 years. 
This can be interpreted as a sign of the guidelines becoming identical on this point. In contrast 
to that, both guidelines already recommend offering HIV-testing to pregnant women early in 
pregnancy. However, both guidelines state that the pregnant woman should make an informed 
choice about whether she wants to be tested or not.
A real difference between the two guidelines is the recommendation of the German guideline 
to perform urine dipstick tests to screen for glucose at each visit. According to the guideline 
from England and Wales, urine testing for glucose has a low sensitivity ranging from 7% to 
46%, and a high rate of false positives. Therefore the conclusion was that it is not useful as a 
screening test. However, according to the discussion of the evidence in the guideline from 
England and Wales, urine testing for glucose has a high specificity ranging from 84 to 99%. 
The specificity is also reported to be higher than that of the 50g glucose challenge test. The 
policy suggested in the German guideline is to use dipsticks at every visit, but to reduce the 
number of false positives by performing a 75g oral glucose challenge test in case of positive 
results. Although this does not solve the problem of the low sensitivity of the test, it is an
acceptable decision to apply this cheap and non-invasive urine dipstick test for universal 
screening. This can be at least justified in health systems, where this investment does not 
prevent the introduction of more useful tests into the guideline. The decision of the German 
guideline developers might have been that it is better to pick up only a small proportion of the 
women with gestational diabetes, rather than providing no screening at all. Unfortunately, 
neither the guideline, nor any additional documents comment on this, and this leaves the users 
of the guideline to speculate about the reasons for this decision.
However, the decision of the guideline developers for the guideline from England and Wales to 
currently not recommend any screening for gestational diabetes at all can also be justified. The 
guideline reports that to date there is no consensus on the definition, management or the 
treatment of gestational diabetes mellitus. As an example, the definition of impaired glucose 
tolerance during pregnancy of the World Health Organization was criticised for its use of cut-off 
levels of non-pregnant women. In addition to the problem of clearly identifying women at risk, 
there is a lack of evidence that any of the currently available treatment options of the condition 
are effective in reducing the number of adverse outcomes. The guideline from England and 
Wales therefore draws the conclusion that the results of currently ongoing studies have to be 
awaited before any sort of screening should be introduced. It represents another, though also 
acceptable, strategy that the developers of the German guideline have decided in favour of 
cheap screening and an attempt to treat the condition, as long as more conclusive evidence 
suggests another course of action.
Summary
Drawing the findings from the comparison of the recommendations of both guidelines together 
it was found that 29 out of 37 (78%) of the tests are viewed identically by the guidelines from 
England and Wales and Germany. 15 tests are recommended by both guidelines, and 14 tests 
are not recommended by both guidelines. In addition to those identical recommendations, the 
guideline from England and Wales recommends 3 tests, which are not recommended by its 
German counterpart. The German guideline recommends another 5 tests, which are not
included in the guideline from England and Wales.
However, when examining the differences in greater depth it became clear that only very few 
real differences exist. Both guidelines recommend assessing maternal height and weight at the 
first visit. The guideline from England and Wales adds with calculating the body mass index 
only a mathematical model of interpretation. Similarly, both guidelines provide catalogues to 
identify pregnancies which carry additional risks. Only the German guideline does not call this 
formal risk scoring, and backs it up with a full physical and gynaecological examination. With 
regard to the auscultation of the foetal health rate, both guidelines use the same evidence, but 
draw different conclusions. While the German guideline focuses on the aspect of reassurance 
to the mother, the England and Wales guideline leaves the decision of whether she wants this 
examination up to the mother. However, it is most likely that the limited predictive value of the 
examination was known to both guideline development groups.
For the two other examinations recommended by the German guideline only, explanations 
could also be found, which relate to the currently limited evidence on these tests and different 
strategies of dealing with this. However, it is expected that these differences will vanish in the 
near future. As long as the underlying evidence is weak or ambiguous, different 
recommendations have to be accepted without necessarily judging one as more appropriate 
than the other. Drawing these findings together, it is concluded that as true differences, the 
following remain: the German guideline recommends a full physical examination and a 
gynaecological examination at the first visit, and urine dipstick tests for glucose. The guideline 
from England and Wales recommends the screening for Down’s syndrome on a routine basis. 
As a consequence, the number of similar or identical recommendations is 33 out of 37 (89%).
Conclusion to the comparison of recommendations
Relating the findings back to the hypotheses, the results of the comparison of the guidelines’ 
recommendations suggest rejecting both of them.
Hypothesis 1 is rejected because it was found that there are only minor differences between
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the recommendations of the guideline from England and Wales and Germany. 89% of the 
recommendations were found to be similar or identical.
Also hypothesis 2 is rejected, as
in case of vaginal examination, the guideline from England and Wales refers to evidence about 
the predictive value of vaginal examinations to assess the risk for preterm birth. However, this 
is not the reason, for which the examination is recommended in the German guideline. This 
guideline recommends it as a surrogate to a routine preventive gynaecological check-up, as it 
is recommended for all women in Germany once a year.
the guideline from England and Wales does not provide any evidence about the benefits of a 
full physical examination at the beginning of pregnancy.
the guideline from England and Wales states that universal screening for chlamydia 
trachomatis is very likely to be offered in the near future for all women on a population basis. It 
will then interpret the evidence as the German guideline already does.
the evidence on screening for gestational diabetes can be regarded as inconsistent. Therefore 
it is acceptable to recommend either one of the possible policies, until more conclusive 
evidence is available.
How the above described findings might be interpreted will be discussed in the following 
chapter.
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Chapter 5 - Discussion and conclusion to the study
5.1 Introduction
As the findings from the review of the state of the art and the related aspects have been 
critically discussed alongside the review process, and especially in sections 3.5 and 3.10 of the 
thesis, the final discussion is focused on the findings from the survey and the critical in-depth 
analysis and comparison of the two national guidelines. Despite this, it should become 
transparent, how the focal theory developed and how the different parts of the study contribute 
to reach the overall aim of the study. Therefore, in this concluding chapter the discussion is 
focused on how to integrate the findings of the study into theory and into what was previously 
known. It is aimed at demonstrating what can be learned from the study, and what the thesis 
adds to current knowledge, although a critical stance is taken regarding its potential 
weaknesses and limitations. Special care is taken to highlight implications for practice, as well 
as to make suggestions, what might better be backed up by further investigations.
5.2 The link between the methodological quality of guidelines and the 
quality of their recommendations
When critically analysing the current state of the art in assessing guideline quality, as was 
described in Part 1 of Chapter 3, the most important conclusion was that there is still the link 
missing between the overall quality of a guideline and the quality of its recommendations. To 
narrow this gap in knowledge, the methodological quality of the guidelines from England and 
Wales and Germany were appraised in-depth and their recommendations were compared, 
using a refined application of the AGREE-instrument (The AGREE Collaboration 2001).
From the literature review and the practical application of the AGREE-instrument it was found 
that this tool has introduced for the first time a measure for assessing the level, to which 
criteria indicating the methodological quality of a guideline are fulfilled. By this, specific weight
is added to the individual strengths and weaknesses of a guideline. This goes far beyond the 
simple recognition of the presence or absence of a criterion, which was common in earlier 
instruments to assess guideline quality. However, the dominating point of critique on the 
AGREE-instrument is that its calculations lead to a presentation of results, which seem to 
contradict basic arithmetic principles. The AGREE-instrument offers 1 as the lowest possible 
score for each question. As a consequence, for a domain consisting of three questions, the 
minimum score is 3. This is unfortunate, as it can also be argued that when adding a score of 1 
out of 4 to an item, 25% of the points towards the rating for ‘strongly agree’ are already given, 
which can in the best case be called misleading. It would be more appropriate to provide a 
score of 0 for such cases, in which an appraiser wants to ‘strongly disagree’. This would be 
especially appropriate, as the category ‘strongly disagree’ also should be used if the relevant 
information is not provided by a guideline. Reducing this to the essence, it could be said: no 
information -  no credits. Everything else is misleading, as a score of 1 could be interpreted 
that even in case of complete disagreement a rudimentary level of acceptance is still present.
It is therefore suggested that this slightly illogical trait of the instrument should be remedied.
When using the provided formula for calculating a domain score with three items (The AGREE 
Collaboration 2001), a score of 12 equals 100%. The problem starts with the baseline value 
being 3, which equals to 0%. When using the formula for a score of 6, this equals to 33%. 
However, 6 out of 12 are normally 50%. However, the result is only arithmetically correct when 
using the formula together with the knowledge that 3 is the ‘background noise’. This is, 
however, out of the realm of investigation. It is especially regarded critical that it hampers the 
presentation of results such as to establish credibility. This is even more so, as the level of this 
‘background noise’ is always different, depending on the number of questions asked in a 
domain. Due to this, variations of the problem occur, which are even more difficult to explain to 
a reader without deeper knowledge of the procedures behind the AGREE-instrument. It is 
therefore impossible to demonstrate results without explanations, as at first sight the domain 
scores seem to contradict basic arithmetic principles. By simply introducing 0 as the lowest 
score, the principles would not be violated, while the results of the appraisal are not distorted.
Yet another question arising from the use of the instrument for appraising the two guidelines is, 
whether the order, in which the guidelines were appraised, might have had an influence on 
results. This question arose as one of the appraisers wrote that he recommends the guideline 
from England and Wales even more, as it represents the exact opposite of the 
methodologically weak German guideline. It might therefore be problematic, when an appraiser 
appraises more than one guideline on the same topic. Effects, such as getting more or less 
rigorous in scoring might be observable. It might happen that an appraiser assessed a good 
guideline first, and appraises a weaker one more harshly than without having appraised the 
better first. Also the opposite is possible, if after appraising a weak guideline, the positive 
properties of a better one are overestimated. Another issue that needs clarification is whether 
differences in reporting and presentation have an influence on ratings. A neat presentation 
might be able to impress the appraisers, leading to a more generous scoring. As the AGREE- 
Collaboration provides no information about such effects, these are questions to investigate 
further.
The internal consistency of the domain ‘clarity and presentation’ of the AGREE-instrument
In contrast to that, a question that has arisen from the literature review, and which was not 
answered by the AGREE-Collaboration, can now be answered to some degree. In Chapter 
3.3.4, the question was asked of whether the rating of the appraisers is sufficiently reliable, or 
whether it might be subjective. It was discussed there that the developers of the instrument 
calculated the Cronbach a coefficient for each quality domain to demonstrate the internal 
consistency (The AGREE Collaboration 2003). Intra-class correlations were calculated to 
assess the reliability within each domain, and it was found that the internal consistency ranged 
between 0.64 and 0.88 and was therefore acceptable for most domains. Nevertheless, the 
domain ‘clarity and presentation’ scored low with a Cronbach a of 0.69 and an intra-class 
correlation of 0.57. The effect was not explained by the AGREE-Collaboration. However, the 
findings from the in-depth appraisal of the two guidelines on antenatal care shed light on this. 
For the domain ‘clarity and presentation’ it was found that the appraisers with background
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knowledge on the topic scored significantly higher than the appraiser from another discipline. 
Background knowledge might therefore help to decide whether the recommendations are 
specific and unambiguous. However, it might also be the case that appraisers with background 
knowledge interpret something into the appraised guideline, which is not written there. The use 
of the domain ‘clarity and presentation’ is therefore questionable, due to a lack of reliability. 
This is definitely an issue that has to be worked on by the AGREE-Collaboration, as it implies 
that the appraisal of guidelines is subjective on this issue, although an instrument is used.
Despite the above harsh criticism, the AGREE-instrument has its strengths in appraising the 
methodological quality of a guideline. It is especially useful to indicate to the appraiser the 
strengths and the weaknesses of a guideline, dissecting the individual domains in a structured 
manner. However, this is only the case, when a guideline and its development process are well 
documented, as has been stated by the developers of the instrument themselves (The AGREE 
Collaboration 2003). This would mean that the instrument of the AGREE-Collaboration has a 
lack of discriminating properties between guidelines of minor quality, which do not fulfil the set 
criteria, and guidelines with a lack of documentation. It can not be excluded that a guideline 
makes good recommendations, but that a lack of documentation leads to categorisation of a 
guideline as of minor quality. This is exactly what happened with the German guideline. Only 
the practical experience of the benefits of this guideline prevented three of the four appraisers 
from judging it as not at all recommendable. The appraiser without background knowledge 
would have withdrawn this guideline from practice.
Good guidelines = good recommendations?
As a consequence of the review of the literature and on the basis of the above critique on the 
AGREE-instrument, the question arose of whether good guidelines make good 
recommendations. To critically address the potential lack of discriminating properties between 
guidelines of poor quality and guidelines with a lack of documentation, the content of the 
guidelines from England and Wales and Germany were compared. After the in-depth appraisal 
of the two guidelines, this question of whether good guidelines make good recommendations
can be answered to some degree. From the in-depth appraisal it was found that both assessed 
guidelines make equally good recommendations. The guideline from England and Wales, 
which scored high in all domains and was therefore judged to be a good guideline -  makes 
good recommendations. However, the German guideline, with doubtful quality according to the 
appraisal with the AGREE-instrument -  makes equally good recommendations. These findings 
can be interpreted as demonstrating that the methodological quality of guidelines and the 
quality of their recommendations are not related in a manner, stable enough to permit 
conclusions to be drawn about the quality of one in relation to the other.
However, the above findings have to be treated with caution, as they are derived from a 
comparison of two guidelines at a national level. It can therefore be only claimed that at a 
national level at least, the recommendations emanating from guidelines can be expected to be 
of the highest quality, though their presentation and documentation might not necessarily 
suggest this. Withdrawing the German guideline from practice would have been completely 
inappropriate, as the comparison of the recommendations within the two national guidelines 
clearly demonstrated that the recommendations of the German guideline are as good as those 
of the guideline from England and Wales. It is therefore concluded that the methodological 
quality of a guideline as assessed by the AGREE-instrument is not linked to the quality of its 
recommendations. On the basis of this finding it is suggested that the speculations of the 
AGREE-Collaboration about the potential link between them should be changed so as to warn 
the users of the instrument not to draw preliminary and unjustified conclusions.
The warning not to draw conclusions about the content of guidelines by appraising their 
methodological quality cannot be overestimated, as the AGREE-Collaboration recommends its 
instrument as a tool for policy makers to help them decide which guidelines could be 
recommended for use in practice (The AGREE Collaboration 2001). After the detection of the 
weaknesses of the instrument, the additional comment of the AGREE-Collaboration is 
regarded as a vital amendment. It states that the instrument should be p art of a formal 
assessment process in such an instance (The AGREE Collaboration 2001). However, this
264
amendment should be placed in a more prominent position. Moreover, it should be highlighted 
that the appraisal of the quality of a guideline’s recommendations should form the core of such 
an appraisal, rather than being just surplus to the findings from the appraisal with the AGREE- 
instrument. Relating this back to the practical example as provided in this thesis, the German 
guideline would have been rejected if the recommendations were not assessed additionally, or 
if the guideline was appraised by individuals without experience in using the guideline only. As 
the guideline is universally implemented in Germany and makes recommendations which are 
as good as the evidence-based guideline from England and Wales, this would mean a wrong 
decision.
However, if the AGREE-instrument was used by the guideline developers, it could have helped 
to improve the guideline’s structure, and would have therefore enhanced its credibility. The 
AGREE-instrument might therefore be more useful to stimulate good documentation of the 
guideline development process, rather than for the appraisal of a guideline’s true quality, or for 
comparing two or more guidelines. This means that not only the instrument should be criticised 
for its methodological problems, but also the German guideline for not providing important 
background information. It is no longer appropriate to keep the underlying evidence used to set 
up a guideline in a cloud of mystery, claiming that experts have “done the thing right”. The 
movement for evidence-based care and quality in medicine might lead to a trend that 
guidelines with a lack of documentation and transparency will be replaced by more 
sophisticated ones in the future. However, it is also expected that this does not necessarily 
mean an improvement of the quality of the future guidelines’ recommendations.
5.3 Limitations of the study and suggestions for future research
5.3.1 The categories ‘evidence-based guidelines’ and ‘expert-opinion-based guidelines’ 
are not appropriate at a national level
One of the questions to be answered from the in-depth appraisal of the guidelines from
England and Wales and Germany was how an evidence-based guideline on antenatal care 
and a guideline based on expert opinion on the same topic relate to each other. In contrast to 
the initial idea of the comparison, it was found from the critical in-depth appraisal that the two 
guidelines under scrutiny could not be put into these categories. It was found that the German 
guideline mainly suffers from a lack of documentation about how the developers of the 
guidelines reached their recommendations, e.g. how they searched for, selected and used the 
evidence. After the comparison of the recommendations of the two guidelines, it seems that 
the German guideline is not only based on the opinion of experts, but on scientific evidence. 
Instead, the issuing body covers the real developers of the guideline, as well as the 
procedures used. Hence, it contributes to speculation about the lack of standards behind the 
guideline development process. The lack of documentation does not mean that such activities 
have not taken place, and it can therefore not be concluded that the German guideline is 
based on expert opinion, rather than on scientific evidence.
Similarly to the problems in categorising the German guideline the label ‘purely evidence- 
based’, it is also not correct for the guideline from England and Wales. Although this guideline 
follows the principles of evidence-based health care, and provides a detailed track record of 
the underlying evidence, not all recommendations are based on conclusive evidence. This can 
be seen from the grades attached to the recommendations to demonstrate how strong the 
evidence-base is for each of them. In case of a recommendation for or against the screening 
for gestational diabetes, it was found that the current evidence allows both decisions, 
depending on what is expected from future research.
The study did therefore not contribute as much to the initial idea to critically appraise the 
relation between evidence-based guidelines and guidelines based on expert opinion, as was 
initially expected. However, this was outweighed by the critical theoretical discussion of 
guidelines and their quality, as well as by the discussion of decisions and their underlying 
evidence. In particular the discourse on how to weight the evidence to set up guidelines 
brought up important aspects. As a deviation from the initial idea it is now hypothesised that
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guidelines at a national level are of good standard, irrespective of what is reported of the 
guideline development process. However, the critical in-depth comparison of two national 
guidelines is too small an investigation to draw valid conclusions about whether this applies to 
national guidelines generally, or whether this applies to the appraised two guidelines on 
antenatal care. Further research is therefore needed to test this hypothesis.
5.3.2 The link between the methodological quality of guidelines and their 
recommendations
From the previous discussion of the properties of the AGREE-instrument on the basis of the 
critical in-depth appraisal of the national guidelines from England and Wales and Germany, it 
was concluded that the methodological quality of a guideline as assessed by the AGREE- 
instrument is not linked to the quality of its recommendations. However, this conclusion might 
not be entirely justified. From the appraisal it was found that both national guidelines made 
equally good recommendations, irrespective of what was suggested by the appraisal with the 
AGREE-instrument. This means that in fact the methodological quality of the guideline from 
England and Wales and the quality of its recommendations are congruent. Only for the 
German guideline it was found that its poor methodological quality as assessed by the 
AGREE-instrument did not indicate the minor quality of the guidelines content.
As a consequence of these findings it can only be said that a guideline of poor methodological 
quality does not necessarily make inappropriate recommendations. The findings from the in- 
depth appraisal of the two guidelines therefore highlight the need for further research into the 
relationship between the methodological quality of guidelines and the quality of their 
recommendations. As the relationship was tested for two national guidelines only, comparisons 
of the recommendations of more guidelines and on other topics are needed to establish
- whether methodologically good guidelines always make good recommendations, or
- whether the quality of a guideline’s recommendations is independent from the methodological
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quality of the guideline itself.
Despite the need for further research, the innovative approach of extending the properties of 
the AGREE-instrument by using a purposefully selected sample of appraisers together with the 
critical comparison of the appraised guidelines’ recommendations enabled insights into the 
relation between the methodological quality of guidelines and the quality of their 
recommendations, which have not been commented on in previously published work.
5.3.3 Guidelines are only an instrument for improving antenatal care
Within this study, a narrow operational definition of antenatal care was used. Only the baseline 
clinical care of healthy women with uncomplicated singleton pregnancies was considered. This 
routine antenatal care was further limited to care up to the estimated date of delivery. Within 
this narrow definition, the focus was additionally put onto screening tests. Preventive 
measures, such as the administration of anti-D to Rhesus negative women to prevent maternal 
iso-immunisation against foetal blood cells, or the prescription of folic acid before and in early 
pregnancy to prevent neural tube defects, were also not considered.
Despite this narrow focus on the diagnostic part of antenatal care, it is acknowledged that 
antenatal care is a complex intervention, also including the preparation for childbirth and 
parenthood, preventive measures and should also address maternal expectations from care as 
well as psycho-social needs. It is also perceived necessary to acknowledge that the living 
conditions of pregnant women as well as young families, such as housing, nutrition, physical 
exercise, their income and their general health status play a major role in ensuring the health 
of the future citizens of the European Union. However, addressing all the factors with a 
potential influence on the outcome of pregnancies would have led too far from what the study 
wanted to achieve, which was to make cross-border antenatal care safer and to contribute to a 
true European approach to antenatal care in the future. It is nevertheless recommended to 
further investigate into the other components of antenatal care.
Another potential critique could be that the focus was put on healthy women experiencing 
uncomplicated pregnancies, who are most likely to experience a good outcome of pregnancy 
without any intervention. This means that the study did not address conditions with the likely 
effect of lowering maternal and infant morbidity and mortality, such as gestational diabetes or 
premature birth. However, the focus of the study can on the one hand be seen as a first step to 
establishing co-operation at the European level with all the Member States, by not discussing 
controversial issues in the first instance. On the other hand, the focus of the study was to 
improve awareness of cross-border antenatal care, to highlight the importance of basic safety 
for the majority of pregnant women, before addressing specific aspects of care.
The same deviation from the aim of the study applies to the potential criticism that the focus 
has been put on guidelines, neglecting that on the one hand, the existence of guidelines does 
not necessarily mean that they are used, and on the other hand does not necessarily 
guarantee that the quality of the provided care is adequate. Guidelines are not an end in 
themselves, but a means to improve care. To develop their potential, guidelines need to be 
implemented. Although it is acknowledged that guidelines are not a stand-alone instrument for 
guaranteeing the quality of care, the investigator took the stance that it must be ensured that 
guidelines are of the highest possible quality, before they are implemented. The study was 
therefore directed at the gaps in knowledge about guideline quality, before setting off to 
address the implementation stage. However, the implementation of the developed minimum 
guideline is addressed in the conclusion to the thesis, and first steps have already been taken.
5.4 Contributions made by this study
A recent investigation into the definition of quality in social policy research found that for 
experts in the field, it is of central importance that research makes a contribution to policy and 
practice (Becker et al. 2006). However, for approximately half of the studied population it was 
found to be equally important that research contributes to the advancement of knowledge. An
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effective synthesis of theory and knowledge was also seen as to be of critical importance, 
although a contribution to the advancement of theory was regarded as much less important 
compared to contributions to policy and practice and the advancement of knowledge. Despite 
this ranking in importance, it is aimed in the following sections to address the contributions, the 
thesis makes in all three areas.
5.4.1 Contributions to knowledge and understanding
Suggestions to improve the guidelines from England and Wales and Germany
With regard to the methodological quality of the guidelines from England and Wales and 
Germany it was found that according to the latest state of the art, the German guideline is no 
longer appropriate. It should be revised in order to enhance the identification of key messages 
and should be supported by a work-up set out in a graph of what has to be done at what time 
during pregnancy. However, the most impressive problem related to clarity and presentation of 
the German guideline was the complete absence of a clearly defined and stated aim. This 
means that there was no way of assessing whether the guideline had achieved its planned 
outcomes. Clarity and presentation have to be improved to ensure that all interested parties 
can get the message of the guideline. This is of special importance to newly qualified health 
professionals from this discipline, but also to ‘outsiders’ from agencies dealing with guideline 
quality, patients, and those who have to decide about policies and funding. Understanding the 
guideline as it is has proven to be difficult for those who are not experienced in using it. 
Especially against the background of increasing patient mobility and mobility of health 
professionals in the European Union, transparency of national guidelines becomes a key 
aspect for ensuring patient safety. In addition to improving clarity and presentation of the 
guideline’s content, background information is needed to shed light onto what the underlying 
evidence of the guideline is, and how it is used. To ensure transparency, this information 
should at least be provided in an additional document. Also here, the German guideline can be 
improved substantially.
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Despite its outstanding methodological quality compared to its German counterpart, the 
guideline from England and Wales can also be improved. As an example, the guideline 
urgently needs to fix a date for review. Otherwise, there might be the danger of adhering to a 
guideline, which is based on outdated evidence for too long. As the guideline from England 
and Wales acknowledged, substantially new knowledge is awaited for e.g. the diagnosis and 
the treatment of gestational diabetes. This is the main critique on the guideline from England 
and Wales. It is published as a book, containing all the background information as well as a 
clinical algorithm. However, the book is extensive, expensive and appears as if it were 
designed for eternity. It is unlikely that it will be thrown away by practitioners every time a new 
one is published. However, amending it by loose sheets of paper is also not a foolproof 
measure to ensure that all practitioners are kept up to date. The guideline from England and 
Wales therefore holds the danger of being used for much longer than it should be with regard 
to the rapidly growing evidence-base. Also for this guideline it might be useful to publish the 
clinical guideline separately from the procedural information and the underlying evidence.
A complete overview of guidelines on antenatal care in all EU member states
The aim of guidelines is to assure and maintain a high level of health care, in order to 
continually improve it to avoid outdated and possibly harmful interventions, which may also 
lead to unnecessary costs. Another major aim of guidelines is to keep up to date about the 
latest state of the art of their respective subject (The European Commission (n.d.) a). This 
need for information attains even more importance since patients as well as health care 
professionals make use of the right of free movement throughout the EU. Health care workers 
practising in a country other than that in which they were trained need guidelines to familiarise 
and integrate themselves into the respective national practice. Moreover, health care 
professionals need information when a non-resident of their country seeks care. Also patients, 
politicians and institutions financing health care need information about what care is provided 
in the other member states of the EU. This study provides such an overview for guidelines on 
antenatal care in the member states of the European Union for the first time. As it was seen as
important to make this contribution widely available, for the above reasons, the findings were 
published immediately in well respected scientific journals (Bernloehr et al. 2005, Bernloehr et 
al. 2007).
Before the commencement of the survey, a review of the literature revealed that there is a 
significant lack of knowledge about antenatal care in the member states of the EU. Moreover, 
only five publications were found, which compare antenatal care in Europe (Blondel et al.
1985, Hemminki & Blondel 2001, Heringa & Huisjes 1988, Langer et al. 1999, World Health 
Organization 1987). However, all of them were focused on the organisation of care, but not on 
the content of care, or the guidelines according to which care should be provided. None of 
these studies included all current member states of the Union.
The most comprehensive study found was that of the World Health Organization’s (WHO) 
study group on perinatal care in the WHO European region (World Health Organization 1987). 
Between 1981 and 1982, the group conducted a postal survey on routine antenatal care in 31 
of the 33 countries of the European region. Unfortunately, the names of the countries are not 
given in relation to the findings, and the countries of the European region are not exactly the 
same as the current member states of the EU. Therefore, only general and limited information 
could be extracted. For example, one finding of the WHO study was that 18 out of the 23 
countries have official guidelines on routine examinations that are recommended during 
pregnancy. The findings from the survey for this study were similar, in that 20 of the 25 
member states had official guidelines. The WHO survey found that 12 of the 18 countries have 
guidelines issued by the state. The survey brought up that 13 member states of the EU have 
such a guideline. Six countries were reported by the WHO to have recommendations issued by 
major universities. In the survey, no such guideline was mentioned. In contrast to that, the 
survey found that four countries have guidelines published by the national society of 
obstetricians, and three countries having a guideline published by a governmental institution in 
co-operation with the society of obstetricians. However, most relevant to our study was the 
WHO's conclusion that even after their major survey very little information was available about
the actual content of antenatal care. This gap is now narrowed by this study as it provides the 
most comprehensive data set about the content of guidelines on antenatal care in the EU 
published to date. The publications are provided as Appendix 3 to the thesis (Bernloehr et al. 
2005, Bernloehr et al. 2007). Making the current state of the art within the EU transparent is 
seen as a means to make decision-makers, health professionals as well as the recipients of 
antenatal care, aware of how their own care scheme relates to the current state of the art in 
the European Union. Moreover, potential gaps in care for pregnant women seeking antenatal 
care in different member states can be identified and eliminated effectively, which 
fundamentally contributes to the aim of the study, which is to help to make cross-border 
antenatal care safer.
However, the study also contributes towards the aims of the European Union. Making national 
guidelines on a specific health issue transparent and additionally developing a common 
minimum guideline on the basis of them stimulates co-operation and co-ordination amongst 
the member states of the EU. This is important, as co-operation and co-ordination were named 
as two major aims of the European Union in the health sector, which was discussed 
extensively in Chapters 3.7 and 3.8 of the thesis.
Identification of outdated and of widely recommended measures
Although guidelines are being widely used and accepted, not all recommendations for 
antenatal care are based on sound scientific evidence. This is well demonstrated in the 
guideline for England and Wales, in which recommendations are graded according to the 
strength of the evidence on which they are based (National Collaborating Centre for Women’s 
and Children’s Health 2003). In this publication, several recommendations are made with a 
clear statement that more information is needed and that the recommendation is either likely to 
be changed soon, or is provisional. Screening for Chlamydia trachomatis and the routine 
screening for group B streptococcus can be named as examples. Both are currently not 
recommended, but evidence is classified as insufficient. This might lead to a change in 
recommendations as more conclusive evidence is coming up. Another example is the
recommendation to take a urine sample on every occasion at which the blood pressure is 
measured. This is supported by limited evidence only, but it is included in the guideline. The 
publication of the findings from the survey, and especially the clear presentation of the 
measures recommended by more than half of the member states and for more than half of the 
EU population help national decision-makers to identify widely recommended, but also the 
outdated measures for antenatal care. It was also attempted to present the results in such a 
manner as to enable the reader to easily identify what each member state is recommending, 
and how this compares to the recommendations of the other member states.
As has been discussed extensively in Chapter 3.4 of the thesis, expert advice is vital to 
complement limited or contradictory evidence for making decisions in health care. This 
becomes even clearer when finding that one author claims that to date only 20% of all 
processes in medicine are evidence-based (Kreienberg & Berg 2002). The process of setting 
up a common minimum guideline on the basis of double majorities of what the national 
guidelines recommend played another important role to reach the aim of improving the starting 
conditions for the Union’s future citizens. With this, not only the widely recommended methods 
were established, but also outdated and possibly harmful interventions were identified. The 
issuing bodies of the current national guidelines are therefore encouraged to scrutinise their 
guidelines for measures which are not recommended by double majorities, and especially for 
those recommended by very few member states only.
5.4.2 Implications for practice
Recommendation of a common minimum guideline on antenatal care for the EU
In the Treaties of Maastricht and Amsterdam it is clearly stated that Community action shall 
complement national health policies in order to improve public health, prevent human illness 
and diseases and to obviate sources of danger to human health (AuBen- und Finanzminister 
der Europaischen Gemeinschaft 1992, Generaldirektion Gesundheit und Verbraucherschutz
2000, The European Commission n.d. b). Co-operation between the member states was 
highlighted as very important, although organisation and delivery of health services remains 
entirely the responsibility of the member states (Paton et al. 2002). Although this prevents the 
superimposition of a single health care system to the member states, it nevertheless allows a 
common approach or guideline for a clearly defined public health problem.
Therefore, countries without a guideline might consider setting up a guideline similar to that of 
their European neighbours in addition to just comparing their approach to antenatal care to 
those of the other countries. Although it is acknowledged that the absence of a national 
guideline does not necessarily imply less quality of care, some advantages of having a national 
guideline can be important. Local protocols for antenatal care can be highly efficient for the 
local population, but they do not necessarily cover the needs of a rapidly changing population 
within the framework of the EU. In addition, transparency for care seekers as well as care 
providers is limited. Moreover, setting up and revising an unlimited number of similar 
guidelines continuously consumes more resources than revising one European guideline.
From the findings of this study it became clear that money is not a factor militating against the 
establishment of a common European guideline on antenatal care, as currently the less 
wealthy member states recommend more tests per pregnancy than the wealthier ones. This 
was even evident when the GNP per capita was adapted to the respective national price level 
according to the purchasing power parity. Potential reasons for this might be the fact that 
labour is cheaper in those member states, but also bureaucratic reasons, such as routines 
which are based on outdated protocols. However, the results of the study also provided 
evidence about the use of more expensive tests, rather than simply multiplying the cheaper 
ones. Despite this extensive antenatal care, which might be similar to the extent of care for 
other health problems, the overall level of resources invested in the health sector is in the new 
member states still much lower than in the ones of before May 2004. In recent years, the new 
member states invested on average around 4.5% of their GNP into health care, compared to 
8.5% of the GNP in the EU-15 States (Commission of the European Communities 2004).
Another reason for the more extensive care might be that the movement for evidenced-based 
medicine is more advanced in the ‘older’ member states, which led to a reduction of 
examinations and tests with doubtful effectiveness. This mechanism might work hand in hand 
with a well established bureaucracy in the new member states. It might be that low efforts into 
evidence-based medicine, together with a highly developed bureaucracy and routine in 
meeting bureaucratic targets lead to an unjustified extension of antenatal care. In this respect, 
a common European guideline for antenatal care might help the less wealthy member states to 
save money without compromising the outcome of pregnancies in their countries.
Acknowledging all these facts, an EU-wide guideline on the minimum requirements for 
antenatal care in uncomplicated singleton pregnancies is recommended. This neither goes in 
the direction of the unwanted harmonisation of health systems, nor does it pose 
insurmountable financial hardships to the less wealthy member states of the Union. Introducing 
a common minimum guideline based on the current recommendations of the national 
guidelines would potentially mean lower costs for the less wealthy member states. The 
suggested common minimum guideline consists of the 23 tests, which are recommended by 
the national guidelines of at least 50% of the member states and which additionally apply to at 
least 50% of inhabitants of the Union. The thus identified tests are shown in Tables 5.1 to 5.3, 
again grouped into physical, technical and laboratory tests.
Table 5.1: Physical tests recommended for the EU-guideline
Blood pressure 
Body Mass Index 
Foetal position 
Formal risk scoring 
Fundal height 
Maternal weight 
Vaginal examination
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Table 5.2: Technical tests recommended for the EU-guideline
Auscultation (foetal heart)_____________________________________
Ultrasound, abdominal________________________________________
Ultrasound, transvaginal______________________________________
Table 5.3: Laboratory tests recommended for the EU-guideline
Alpha-Feto-Proteine/T riple______________________________________
Atypical red cell antibodies______________________________________
Blood group___________________________________________________
Gestational diabetes OGTT_____________________________________
Haemoglobin__________________________________________________
Hepatitis B virus________________________________________________
HIV___________________________________________________________
Lues__________________________________________________________
Rhesus factor__________________________________________________
Rubella titer____________________________ _______________________
Urinalysis /  Bacteria____________________________________________
Urinalysis /  Glucose____________________________________________
Urinalysis / Protein_______________________________________
As all but four of these tests are additionally supported by the most up to date scientific 
evidence, the above recommended minimum guideline for the EU has a sound basis grounded 
on the opinion of experts from all member states of the EU as well as on evidence (National 
Collaborating Centre for Women’s and Children’s Health 2003). For the four tests for which the 
evidence is not clear or does not support the routine use of a test to date, but which are 
recommended by double majorities, further investigation and expert discussion is required. 
These tests are vaginal examinations to predict a premature ripening of the cervix, the 
auscultation of the foetal heart rate, an oral glucose tolerance test to screen for gestational 
diabetes, and performing urinalyses for glucose.
Another important factor to consider is the timing and frequency, with which the individual tests 
should be performed during pregnancy. In addition to their presentation in Tables 5.1 to 5.3, all 
tests representing the mathematical consensus of double majorities were shown in Table 4.4 
of the thesis. In this table, the wide variations with regard to the national recommendations are
shown. As an example, the maternal blood pressure is recommended to be measured about 
eight times during each pregnancy as a mean of all national guidelines. However, the 
individual recommendations for measuring the blood pressure vary between five and fourteen 
times during pregnancy. This indicates that although convincing, the suggested minimum 
guideline marks the beginning of a process, which might culminate in a consensus conference 
at which national representatives of the relevant institutions as well as individual health 
professionals can find a consensus, which can be finally accepted by all member states.
Another important fact to consider is that despite the potential benefits of the suggested 
minimum guideline, it is clearly a minimum guideline for healthy women with uneventful 
pregnancies. Specific health problems of individual member states of even regions must be 
additionally addressed by e.g. the national governments. States or regions with a high 
prevalence of haemoglobinopathies might set up screening programmes, which pick up such 
conditions. The same applies to states or regions with a high prevalence of sexually 
transmitted diseases, which are not covered by the minimum guideline. The issuing bodies of 
the current national guidelines are therefore advised to supplement the suggested common 
minimum guideline with the tests important for their respective populations.
5.4.3 Contributions made to further developing methodology
Suggestion of a new model for setting up guidelines on EU-level
From the reviews of the literature and of the state of the art it was concluded that evidence 
does not translate into guidelines by itself, although guidelines should be evidence-based. 
Moreover, it was reinforced that producing guidelines requires sound evidence, but also 
decisions. To gain insights into this act of policy, the literature was explored to greater depth. 
From the critical analysis of the literature on decision-making in health policy, it was found that 
the cornerstone in making sensible decisions is the way of dealing with inadequate, 
incomplete, and ambiguous evidence, as well as with the factors which were subsumed under
the header of ‘colloquial’ evidence as explained in the section on how to weight the evidence to 
set up guidelines. It was found that although scientific evidence should always be prioritised 
over other decision-modulating factors, the development of guidelines never takes place 
independent from values, habits and tradition, judgement, political factors, resources, 
pragmatics and contingencies, lobbyists and pressure groups, as well as experience and 
expertise of the decision-makers. Despite suggestions for using and weighing up different 
kinds of evidence to produce guidance in health care, such as the deliberative process as 
recommended by the Canadian Health Services Research Foundation (Canadian Health 
Services Research Foundation 2005 + 2006a), it was found that up to the present time there is 
no evidence to back up any model of decision-making, and that as yet there is no tool available 
for the production of guidelines at an international level.
Based on the findings from the reviews, it was perceived necessary to use the existing national 
guidelines on antenatal care from the member states as the basis to develop a model to set up 
a common minimum guideline for the EU. These guidelines represent the national decisions 
about what is wanted and acceptable for the respective populations, and what was decided to 
be appropriate in the light of the need to distribute limited resources. It would not be 
appropriate to disregard such important decisions that have been made at a member state 
level of the European Union. This applies at least as long as decisions cannot be kept value- 
free by using research-based strategies for weighing up the different kinds of evidence. Hence, 
a model is needed, by which national ideas about good antenatal care will be respected, but 
which also enables the utilisation of the potential benefits of a common minimum guideline.
To find out whether there are any models for decision-making at an EU-level, which are used 
to reach common decisions for the Union, the literature review was extended to decision­
making in the Council of Europe. From this it was hoped to be able to develop a framework 
according to which the existing national guidelines on antenatal care could be used to 
efficiently set up a common minimum guideline, without compromising its quality. The findings 
of this review were demonstrated and discussed in detail in Chapter 3 of the thesis, but led to
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the following result: A voting system by qualified majorities is the basic principle for decision­
making in the Council of Europe. However, the current system is complicated and often judged 
as suffering from a lack of transparency and justice (SCADPIus (n.d.), Treaty of Nice 2001). It 
was therefore not suitable for the purposes of the study.
However, the proposed Constitution for Europe already seeks to improve the functioning of 
decision-making by reforming the system of qualified majority voting, while still considering the 
population sizes of the member states (Berbalk et al. 2005, SCADPIus (n.d.), The European 
Union Constitution 2004). The suggested system was called ‘double majorities’ and means 
that the majority of the member states must vote in favour of a decision and that they must 
represent the majority of the population of the EU. However, instead of mathematically defining 
a majority as more than 50%, the Constitution goes only half way and sets slightly different 
percentages as thresholds. This was judged to be a step in the right direction, but not 
sufficiently clear and easy to apply.
On the basis of the above findings, finally an alternative model was set up as a variation of 
official EU policy. However, it was decided that for the model of decision-making in the thesis, 
basic mathematic principles should not to be violated. Otherwise, it might neither be easily 
applicable, nor acceptable on a broad basis. In general terms, the model arose from the EU 
policy of double majority voting, attempts were made to eliminate the disadvantages of the EU 
model, making it more transparent and easier to apply. The suggested model for decision­
making to set up European guidelines can therefore be regarded as a variation of official EU 
policy, developed from critically appraising the current state of the art in decision-making in the 
EU together with what was found from the comparison of the survey and the critical in-depth 
appraisal of the two national guidelines. In accordance with basic mathematics, the model of 
‘double majorities’ for setting up European guidelines was defined as follows:
more than 50% of the member states need to vote in favour of a decision, and the decision 
must apply to more than 50% of the inhabitants of the EU.
The proposed new model of ‘double majorities’ is not only just, with an equal vote being given 
to every member state. It also acknowledges the specific problems of the countries, which 
have to serve a large population. That this model of decision-making might be acceptable on a 
broad basis was reinforced by a recent finding. During his presidency of the Council of Europe, 
Wolfgang Schussel pledged in June 2006 to hold a plebiscite throughout all member states of 
the EU on the same day to pass the common constitution for Europe. In this context, Schussel 
specified that the constitution should be accepted, if the majority of the European population 
and the majority of member states voted in favour of it (Falksohn et al. 2006, Heil 2006). The 
Austrian Chancellor’s proposal is covered fully by the findings of this study, which were already 
formulated at the time of his proposal.
The proposed model of true double majorities works for bringing national guidelines on 
antenatal care together into a common European approach, without compromising quality. 
Especially the finding that all but four measures, which are suggested by the national 
guidelines with double majorities are identical to a guideline based on the highest currently 
available level of scientific evidence supported the decision-making model. This is even more 
so as the evidence for the four remaining measures is not (yet) sufficiently conclusive to decide 
finally for or against the introduction of them into a common guideline. It is therefore 
acceptable to recommend them until more evidence is available, which is done in the 
suggested common minimum guideline on antenatal care as proposed by this thesis.
Drawing the theoretical considerations and the findings from all parts of the study together the 
above model of ‘double majorities’ is suggested for setting up common guidelines at EU-level. 
However, it has to be kept in mind that the model was developed on the basis of national 
guidelines, which were found to be of sufficient quality for such a process. One is therefore 
warned not to use the model uncritically on guidelines from sub-national level, without critically 
assessing the quality of the guidelines’ recommendations before. In addition, it is 
recommended to test the model on guidelines from other disciplines. However, although these 
limitations of the study need to be considered, it has to be acknowledged that for the
suggested model for setting up common minimum guidelines in the EU a range of evidence 
was triangulated with an extensive critical review of the state of the art. The suggested model 
is therefore well grounded in the current theoretical knowledge of how to develop guidelines of 
the highest quality, backed up with what was found from the investigation.
This approach of triangulation and mixing methods was taken on purpose in order to 
specifically tailor the methods to answer the research questions, rather than on the basis of the 
perception that a mixed methods approach is superior in itself. Using one of the methods alone 
would not have led to a complete picture of the problem. In this study, each source of data, i.e. 
the survey, the critical review of the state of the art and the in-depth appraisal of the two 
national guidelines contributes its part to develop the theoretical background for policy-making 
on antenatal care in the European Union. However, to use the potential of such a triangulation 
of methods, care was taken to achieve a real integration of findings. The findings are therefore 
initially presented separately, but were then used to make sense of the quantitative findings of 
the survey. This approach of one part of the study informing the other, enabled to gain more 
from the findings than would have been possible when using them separately.
Using this approach ensured the originality, i.e. the development of new theoretical and 
practical insights and concepts, as it not only brought together what the national guidelines 
recommend for antenatal care, but also how this compares to the published evidence. 
Moreover, the reasoning behind the guidelines was explored, especially acknowledging the 
decision-making necessary for setting up guidelines at a national level.
Suggestions to substantially modify the AGREE-instrument
AGREE, which stands for Appraisal of Guidelines for Research and Evaluation in Europe, is an 
international collaboration of experts from 13 European countries that was funded under the 
BIOMED-2 Programme of the European Commission (The AGREE Collaboration 2003). This 
collaboration developed a framework and an instrument for assessing the quality of clinical 
practice guidelines, by which a global assessment of an entire guideline can be achieved.
The AGREE-instrument has, for the first time, introduced a measure for assessing the level, to 
which criteria to assess the methodological quality of a guideline are fulfilled, and therefore 
adds a specific weight to the individual strengths and weaknesses of a guideline. This goes far 
beyond the simple recognition of the presence or absence of a criterion, which was common in 
the earlier instruments to assess guideline quality.
However, the AGREE-instrument has flaws, which were discussed extensively in Chapter 5.2 
of the thesis. The most prominent point of critique is that the calculations of the domain scores 
lead to a presentation of results, which seem to contradict basic arithmetic principles. The 
AGREE-instrument offers 1 as the lowest possible score for each question. As a consequence, 
for a domain consisting of three questions, the minimum score is 3. This is unfortunate, as it 
can also be argued that when adding a score of 1 out of 4 to an item, 25% of the points 
towards the rating for ‘strongly agree’ are already given, which can be called misleading in the 
best case. It would be more appropriate to provide a score of 0 for such cases, in which an 
appraiser wants to ‘strongly disagree’. This would be correct, as the category ‘strongly 
disagree’ also should be used if the relevant information is not provided by a guideline. It is 
therefore suggested that this illogical trait of the instrument should be remedied by simply 
introducing 0 as the lowest possible score. This would ensure that the principles would not be 
violated, while the results of the appraisal are not distorted.
Another weakness of the AGREE-instrument is the lack of information about potential effects 
when an appraiser is appraising more than one guideline on the same topic. Effects, such as 
getting more or less rigorous in scoring might be observable. Another issue needing 
clarification is whether differences in reporting and presentation of guidelines have an 
influence on ratings. It might be that a neat presentation is able to impress the appraisers, 
leading to a more generous scoring. It is desirable that the AGREE-Collaboration provides 
such information in the future. The same applies to the observed differences in the ratings of 
appraisers with and without background knowledge of the appraised guidelines’ subject. It 
might be useful in this context to recommend a purposive selection of appraisers, rather than
simply recommending the number of appraisers to enhance the reliability of the appraisal. As 
could be demonstrated in section 4.2.1 of the thesis, the different rating patterns and 
comments of the appraisers with purposefully chosen backgrounds provide important 
additional insights into the properties of an appraised guideline.
Despite the above harsh criticism, the AGREE-instrument has its strengths in appraising the 
methodological quality of a guideline. It is especially useful to hint the appraiser towards the 
strengths and the weaknesses of a guideline, dissecting the individual domains in a structured 
manner. However, this is only the case, when a guideline and its development process are well 
documented, as has been stated by the developers of the instrument themselves (The AGREE 
Collaboration 2003). This is obviously the most serious point of critique.
By additionally comparing the recommendations of the two national guidelines for the thesis it 
could be demonstrated that the instrument of the AGREE-Collaboration has a lack of 
discriminating properties between guidelines of minor quality, which do not fulfil the set criteria, 
and guidelines with a lack of documentation. It was found that the German national guideline 
makes recommendations which are as good as those of the guideline from England and 
Wales, but that a lack of documentation leads to categorisation as a guideline of minor quality.
It is therefore concluded that the methodological quality of a guideline as assessed by the 
AGREE-instrument is not linked to the quality of the recommendations made by the appraised 
guideline. On the basis of this finding it is suggested that the speculations of the AGREE- 
Collaboration about the potential link between them are changed into a profound warning so 
that the users of the instrument will not draw preliminary and unjustified conclusions.
The warning about drawing conclusions about the content of guidelines by appraising their 
methodological quality can not be overestimated, as the AGREE-Collaboration recommends 
its instrument as a tool for policy makers to help them decide which guidelines could be 
recommended for use in practice (The AGREE Collaboration 2001). After the detection of the 
weaknesses of the instrument, the additional comment of the AGREE-Collaboration is seen as 
a vital amendment. It states that the instrument should be part of a formal assessment process
in such an instance (The AGREE Collaboration 2001). However, this amendment should be 
placed in a more prominent position. Moreover, it should be highlighted that the appraisal of 
the quality of a guideline’s recommendations should form the core of such an appraisal, rather 
than being just a surplus to the findings from the appraisal with the AGREE-instrument. Also 
the idea of using a purposefully selected panel of appraisers could be considered.
However, if the AGREE-instrument had been used by guideline developers, it could have 
helped to improve the future guideline’s structure, and to therefore enhance its credibility. The 
AGREE-instrument might therefore be more useful to stimulate a good documentation of the 
guideline development process, rather than for the appraisal of a guideline’s true quality, or for 
comparing two or more guidelines. It is therefore expected that guidelines with a lack of 
documentation and transparency will be replaced by more sophisticated ones in the near 
future. However, it is also expected that this does not necessarily mean an improvement of the 
quality of the guidelines’ recommendations.
5.4.4 Contributions made to theory and theoretical understanding
A central ambition of this study was to further develop the theoretical understanding of 
antenatal care at the European level. The theoretical background was intended to be 
developed for making health policy on antenatal care in the European Union. This aim was 
mainly tackled in Part 1 of Chapter 3 of the thesis. There, the underlying principles of guideline 
development were explored and two major gaps in current theory were identified.
The first identified lack in knowledge was that the link between the overall quality of a guideline 
and the quality of its recommendations, which is their actual content, is missing. The previous 
section on the contributions made to further developing methodology already made reference 
to this. Although there the focus was put on improving the AGREE-instrument, it nevertheless 
became clear that there is no stable and reliable relationship between the overall, i.e. the 
methodological quality of a guideline and the quality of the guideline’s content. The in-depth
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appraisal using purposefully selected experts and the subsequent comparison of the 
recommendations of the guidelines from England and Wales and Germany could clearly 
demonstrate this.
The second identified lack in knowledge was the question of how to deal best with the different 
kinds of evidence for making evidence-based health policy. This was exhaustively explored in 
the review of the state of the art of the concepts within the theoretical framework. Within the 
framework of evidence-based policy making, the concepts of evidence-based health care and 
evidence-based policy were explored. Special care was taken to critically analyse the nature 
and the hierarchy of evidence, highlighting the role of expert opinion. However, from the 
analysis of the factors with the potential to modify decisions, it became clear that the crucial 
question in setting up guidelines as well as in making other health policy decisions is how to 
weight the different kinds of evidence. As in the theoretical discourse, the concepts are 
presented as they relate to each other, the reader is referred back to Part 1 of Chapter 3.
As a conclusion, from analysing the concepts within the theoretical framework, it became clear 
that the question of how to deal best with the different kinds of evidence is currently high on 
the agenda of institutions in health care, such as the Canadian Health Services Research 
Foundation. However, it became also clear that currently no model or strategy for weighing up 
the different kinds of evidence to produce guidance in health care has scientifically proven 
properties. For this it was suggested that it is most appropriate to develop a model for setting 
up guidelines on the European level using the national guidelines as the basis. This model has 
been presented under 5.4.3 as a suggestion of a new model for setting up guidelines on the 
European level.
5.5 Conclusion
In this study, the best available sources with regard to antenatal care within all member states 
of the European Union were critically analysed. By this, it was possible to establish for the first
time, what guidelines on antenatal care existed in the different member states. For this survey, 
a tool was developed and tested, with which it is possible to reliably extract the 
recommendations of guidelines on antenatal care. This tool might be used by other 
investigators in the future.
As another major step forward, it is now known what the member states of the European Union 
recommend for antenatal care. Before the survey, such data was not transparent. The 
detrimental effects of this lack of information could be demonstrated in the section on 
randomised controlled trials comparing different schedules of care. In this chapter trials were 
presented testing ‘new’ models, which were identical to the established care in another 
country. From the analysis of the current health policy of the EU it was found that antenatal 
care fits perfectly into the health aims of the EU. It addresses fundamental health determinants 
and has the potential to prevent ill health in the first place by improving the intrauterine starting 
conditions of the future citizens of the European Union. Making efforts in antenatal care 
transparent can also contribute to the alleviation of the current acceptance problem of the EU 
by addressing a health problem, which lies at the heart of Europe’s citizens. Transparency of 
what care is recommended in the member states of the European Union is therefore seen as 
crucial for reaching the public health aims of the European Union as well as for making cross- 
border health care safe for pregnant women.
From the review of the literature and of the state of the art it was found that to date there was 
no tool available for setting up international guidelines, but the idea was reinforced that it is of 
critical importance to respect national decisions and values. These guidelines represent 
national decisions about what is wanted and acceptable for the respective populations, and 
what was found suitable in the light of the need to distribute limited resources. It was therefore 
concluded that the existing national guidelines on antenatal care from the member states 
should be used as the basis to develop a model to set up a common minimum guideline for the 
EU. From this process, two achievements emanated: a common minimum guideline on 
antenatal care for the member states and a model for setting up guidelines at European level.
From the findings of the survey it became clear that money is not a factor militating against the 
establishment of a common European guideline on antenatal care. It could be demonstrated 
that the member states with a Gross National Product below the EU-average recommend 
more tests per pregnancy than the more wealthy members. This was even evident when the 
Gross National Product per capita was adapted to the respective national price level according 
to the purchasing power parity. Although it is acknowledged that there are complex reasons for 
more intensive antenatal care recommended by the guidelines in the less wealthy member 
states, the findings of this study suggest that a common European guideline for antenatal care 
might help the less wealthy member states to potentially save money without compromising 
the outcome of pregnancies in their countries.
Acknowledging the findings from all parts of the thesis, an EU-wide guideline on the minimum 
requirements for antenatal care in uncomplicated singleton pregnancies is recommended. This 
neither goes in the direction of the unwanted harmonisation of health systems, nor does it pose 
insurmountable financial hardships to the less wealthy member states of the Union. For 
initiating discussion amongst the national experts of antenatal care, a common minimum 
guideline is suggested. It consists of the tests recommended by at least 50% of the member 
states and which additionally apply to at least 50% of inhabitants of the Union. As all but four 
tests within this guideline are additionally supported by the currently available scientific 
evidence, it has a sound basis grounded on the opinion of experts from all member states of 
the EU as well as on evidence. By these double majorities it was acknowledged that special 
care needs to be taken not to exclude the less wealthy member states or states with many 
citizens to care for from the potential benefits of a common minimum guideline. The four tests 
for which evidence is not clear to date, but which are recommended by double majorities of the 
national guidelines, require further investigation. Moreover, the timing and frequency of the 
individual tests need to be considered.
However, before addressing controversial issues, such as screening for gestational diabetes, a 
trusting relationship and co-operation needs to be established at the European level. A
common minimum guideline, based on double majorities of the national recommendations for 
antenatal care is an excellent starting point for the development of such processes. By 
integrating the decisions and values of the member states, the shaping of a common European 
set of values with regard to antenatal care is encouraged, opening up the discussion for a true 
European approach in the future. At present, there is a window of opportunity to introduce a 
common minimum guideline on antenatal care in the EU, which should be used to ensure the 
best starting conditions for the future citizens of the Community.
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Appendix 1
Databases used for the review of the literature 
and of the state of the art
Table A1: Databases used for the review of the literature and of the state of the art
Ref.
No. Name of database or search term
Abbrevi­
ation Source
1 Arztliches Zentrum fur Qualitat in der Medizin AZQ http://www.aezq.dehttp://www.leitlinien.de
2 British Cabinet Office’s Government Social Research Unit PolicyHub
http://www.policyhub.gov.uk
http://www.policyhub.gov.Uk/bulletins/i
ndex.asp
3 Centre for evidence-based medicine, Oxford http://www.cebm.net
4 Cochrane Collaboration University of Surrey’s gateways http://www.cochrane.org
5 Community Research and Development Information System CORDIS http://www.cordis.lu
6 Cumulative Index to Nursing and Allied Health Literature CINAHL
University of Surrey’s online 
databases
7 Department General for Health and Consumer Protection e-mailing service sanco-news@cec.eu.int
8 Deutsches Institut fur Medizinische Dokumentation und Information, Koln DIMDI http://www.dimdi.de
9 Evidence Based Medicine EBM http://www.evidence.de
10 International Confederation of Midwives ICM http://www.internationalmidwives.org
11 Medical Literature On-Line MEDLINE University of Surrey’s online databases
12 Midwives Information & Resource Service MIDIRS http://www.midirs.org
13 National electronic Library for Health http://www.nelh.nhs.uk
14 National Institute for Health and Clinical Excellence NICE
http://www.nice.org.uk
http://www.nice.org.uk/page.aspx?o=c
9
15 Official websites of the EU http://www.europa.eu.int
16 Royal College of Obstetricians and Gynaecologists RCOG http://www.rcog.org.uk
17 Scottish Intercollegiate Guidelines Network SIGN http://www.nhshealthquality.org
18 Summaries of the Union’s legislation SCADPIus http://europa.eu.int/scadplus/scad_en.htm
19 US National Library of Medicine MeSH http://www.nlm.nih.gov/mesh/MBrowser.html
20 World Health Organization WHO http://www.who.org http://www.who.int http://www.euro.who
Appendix 2
Survey questionnaire, covering letter and 
consent form
UniS
University 
of Surrey
European 
Institute of
Guildford
Surrey G U 2 7XH, UK  
Telephone
+44 (0 )1483 3 0 0 8 0 0  
Facsimile
+44 (0)1483 3 0 0803
Health &
Medical
Sciences
Annette Bernlohr -  Husener Str. 81 -  33098 Paderborn -  Germany U n iv e rs ity  C am pus
Duke of Kent Building 
Stag Hill 
Guildford 
Surrey G U 2 7TE
Telephone
+44  (0 )1483 6 8 6700  
Facsimile
+4 4  (0 )1483 686701
Prof. Dr. P.A. Smith 
A. Bernlohr, MSc
P.A.Smith@surrey.ac.uk
annette.bernloehr@t-online.de
11 May 2004
European Study
ANTENATAL CARE IN THE EUROPEAN UNION:
EQUAL CHANCES FOR ALL NEW CITIZENS OF THE COMMUNITY
Dear Sir or Madam,
As a person professionally involved in the health sector of your country, you are well 
aware of the importance of international studies to address major health issues. Within 
the framework of a project on antenatal care in the Member States of the European 
Union, we would therefore like to ask you for your co-operation.
The project aims at making cross-border health care safer for pregnant women. It is 
based on the premise that despite growing awareness for trans-national health issues 
there is still a major lack of transparency and knowledge about care in the neighbour­
ing countries. In order to narrow this gap in knowledge, we decided to conduct a sur­
vey on guidelines on antenatal care in the Member States of the European Union.
The study has been developed as a PhD project at the University of Surrey in co­
operation with the University of Bielefeld. It is closely supervised and is anonymous 
and confidential. If you have any further questions, please do not hesitate to contact us 
under the e-mail addresses provided in the header of this letter.
In order to take only a minimum of your limited time, the questionnaire has been de­
signed to need only about 15 minutes to be filled in. Please have a look at the brief 
instructions and the survey sheet, and contribute to the ambitious aims of our project. 
Please find also a consent form to be signed. In order to stay within the limited time 
frame of the project, we would be grateful to receive your answer until 30 May 2004. 
Many thanks for your co-operation.
Yours sincerely
Annette Bernlohr, MSc
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Consent form
Antenatal care in the European Union:
Equal chances for all new citizens of the Community
I the undersigned voluntarily agree for this organisation to take part in this study.
I have read and understood the information provided. I have been given a full written 
explanation by the investigators of the nature and purpose of the study, as well as of 
what I will be expected to do. In addition to that, I have been given contact details under 
which I have the opportunity to ask questions on all aspects of the study.
I understand that the data are strictly anonymous and the information is provided in 
confidence. I therefore agree that I will not seek to restrict the use of the results of the 
study on the understanding that my anonymity is preserved.
I confirm that I have read and understood the above and freely consent to participating in 
the study.
Name:
Position:
Workplace address:
Signed:
Date:
MATERIAL REDACTED AT REQUEST OF UNIVERSITY
